Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Melanoma in situ,A1BG,Alpha-1B-glycoprotein,14443,100,1.15 [0.37-3.55],0.8125264876399857
Chapter II Neoplasms,Melanoma in situ,AAMDC,Mth938 domain-containing protein,14058,96,0.94 [0.65-1.38],0.7672728176607592
Chapter II Neoplasms,Melanoma in situ,AARSD1,Alanyl-tRNA editing protein Aarsd1,16439,110,1.11 [0.82-1.50],0.5077858560159443
Chapter II Neoplasms,Melanoma in situ,ABCA2,ATP-binding cassette sub-family A member 2,13959,100,0.45 [0.25-0.81],0.0073090193427566
Chapter II Neoplasms,Melanoma in situ,ABHD14B,Protein ABHD14B,16320,109,1.04 [0.77-1.40],0.7902611627596601
Chapter II Neoplasms,Melanoma in situ,ABL1,Tyrosine-protein kinase ABL1,16439,110,1.08 [0.84-1.39],0.5561531960101831
Chapter II Neoplasms,Melanoma in situ,ABO,Histo-blood group ABO system transferase,14434,100,0.97 [0.85-1.11],0.6516944195899668
Chapter II Neoplasms,Melanoma in situ,ABRAXAS2,BRISC complex subunit Abraxas 2,13959,100,0.92 [0.68-1.25],0.602724064880763
Chapter II Neoplasms,Melanoma in situ,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16170,109,0.98 [0.79-1.22],0.8775888036298817
Chapter II Neoplasms,Melanoma in situ,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14160,99,1.01 [0.77-1.32],0.9511853299872362
Chapter II Neoplasms,Melanoma in situ,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14415,100,0.95 [0.76-1.18],0.6412430740216383
Chapter II Neoplasms,Melanoma in situ,ACAN,Aggrecan core protein,16328,107,1.02 [0.55-1.92],0.9411634119442872
Chapter II Neoplasms,Melanoma in situ,ACE,Angiotensin-converting enzyme,14434,100,0.87 [0.43-1.74],0.6905453202830669
Chapter II Neoplasms,Melanoma in situ,ACE2,Angiotensin-converting enzyme 2,16217,107,0.77 [0.54-1.12],0.1697835458017061
Chapter II Neoplasms,Melanoma in situ,ACHE,Acetylcholinesterase,14132,98,1.18 [0.67-2.08],0.5746062634648739
Chapter II Neoplasms,Melanoma in situ,ACOT13,Acyl-coenzyme A thioesterase 13,14355,100,1.00 [0.85-1.19],0.9707344239690832
Chapter II Neoplasms,Melanoma in situ,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16502,110,1.14 [0.82-1.57],0.4352458019642425
Chapter II Neoplasms,Melanoma in situ,ACP1,Low molecular weight phosphotyrosine protein phosphatase,13991,93,1.13 [0.74-1.73],0.5561969293702052
Chapter II Neoplasms,Melanoma in situ,ACP5,Tartrate-resistant acid phosphatase type 5,16617,110,0.61 [0.36-1.04],0.0698706005327459
Chapter II Neoplasms,Melanoma in situ,ACP6,Lysophosphatidic acid phosphatase type 6,16639,112,1.24 [0.95-1.62],0.1203949264286806
Chapter II Neoplasms,Melanoma in situ,ACRBP,Acrosin-binding protein,14369,100,0.88 [0.53-1.47],0.6290079934367343
Chapter II Neoplasms,Melanoma in situ,ACRV1,Acrosomal protein SP-10,13991,93,1.20 [0.95-1.52],0.1342214952053206
Chapter II Neoplasms,Melanoma in situ,ACSL1,Long-chain-fatty-acid--CoA ligase 1,13959,100,0.77 [0.43-1.39],0.3878655317311184
Chapter II Neoplasms,Melanoma in situ,ACTA2,"Actin, aortic smooth muscle",16217,107,0.80 [0.51-1.24],0.3187230938594276
Chapter II Neoplasms,Melanoma in situ,ACTN2,Alpha-actinin-2,13959,100,1.18 [0.86-1.62],0.2955428738067963
Chapter II Neoplasms,Melanoma in situ,ACTN4,Alpha-actinin-4,16225,109,1.15 [0.72-1.85],0.5623031872974635
Chapter II Neoplasms,Melanoma in situ,ACVRL1,Serine/threonine-protein kinase receptor R3,16341,108,0.80 [0.39-1.64],0.5505736808214922
Chapter II Neoplasms,Melanoma in situ,ACY1,Aminoacylase-1,16502,110,1.08 [0.81-1.44],0.5841946724550056
Chapter II Neoplasms,Melanoma in situ,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,13959,100,1.01 [0.71-1.44],0.9595145363291604
Chapter II Neoplasms,Melanoma in situ,ACYP1,Acylphosphatase-1,14080,98,0.97 [0.72-1.31],0.8511595895071057
Chapter II Neoplasms,Melanoma in situ,ADA,Adenosine deaminase,16683,112,0.94 [0.58-1.52],0.8081188797045112
Chapter II Neoplasms,Melanoma in situ,ADA2,Adenosine deaminase 2,16453,110,1.01 [0.68-1.50],0.9689794580920988
Chapter II Neoplasms,Melanoma in situ,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,13991,93,1.15 [0.63-2.11],0.644997591980046
Chapter II Neoplasms,Melanoma in situ,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16217,107,0.64 [0.36-1.12],0.1186191517656623
Chapter II Neoplasms,Melanoma in situ,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16369,109,0.82 [0.50-1.33],0.420673639962358
Chapter II Neoplasms,Melanoma in situ,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16683,112,0.86 [0.54-1.37],0.5336404201679895
Chapter II Neoplasms,Melanoma in situ,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16610,112,0.92 [0.51-1.65],0.7677613617341528
Chapter II Neoplasms,Melanoma in situ,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14355,100,0.88 [0.46-1.69],0.6978065715310032
Chapter II Neoplasms,Melanoma in situ,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,13991,93,0.83 [0.42-1.62],0.5808474710428826
Chapter II Neoplasms,Melanoma in situ,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16720,111,1.03 [0.50-2.13],0.929782580474246
Chapter II Neoplasms,Melanoma in situ,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16439,110,0.80 [0.55-1.16],0.2348702673555656
Chapter II Neoplasms,Melanoma in situ,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16217,107,0.54 [0.28-1.05],0.0712027662185388
Chapter II Neoplasms,Melanoma in situ,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,13991,93,0.79 [0.44-1.43],0.4400890313008074
Chapter II Neoplasms,Melanoma in situ,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16578,111,0.92 [0.63-1.35],0.6811394269491315
Chapter II Neoplasms,Melanoma in situ,ADAMTSL2,ADAMTS-like protein 2,14428,100,0.83 [0.45-1.54],0.5555581308789139
Chapter II Neoplasms,Melanoma in situ,ADAMTSL4,ADAMTS-like protein 4,14058,96,1.44 [0.61-3.40],0.4008970745269932
Chapter II Neoplasms,Melanoma in situ,ADAMTSL5,ADAMTS-like protein 5,14415,100,0.60 [0.37-0.98],0.039608118628926
Chapter II Neoplasms,Melanoma in situ,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16170,109,0.86 [0.49-1.52],0.6136300014877341
Chapter II Neoplasms,Melanoma in situ,ADD1,Alpha-adducin,14132,98,1.02 [0.77-1.34],0.9143874306518032
Chapter II Neoplasms,Melanoma in situ,ADGRB3,Adhesion G protein-coupled receptor B3,16341,108,0.93 [0.56-1.56],0.7860015677575795
Chapter II Neoplasms,Melanoma in situ,ADGRD1,Adhesion G-protein coupled receptor D1,14132,98,1.18 [0.71-1.97],0.5302878331345999
Chapter II Neoplasms,Melanoma in situ,ADGRE1,Adhesion G protein-coupled receptor E1,14355,100,1.16 [0.82-1.65],0.3929456908424241
Chapter II Neoplasms,Melanoma in situ,ADGRE2,Adhesion G protein-coupled receptor E2,16583,112,0.57 [0.31-1.05],0.0712410211971738
Chapter II Neoplasms,Melanoma in situ,ADGRE5,Adhesion G protein-coupled receptor E5,16660,111,0.64 [0.36-1.14],0.126052004505096
Chapter II Neoplasms,Melanoma in situ,ADGRF5,Adhesion G protein-coupled receptor F5,14415,100,0.67 [0.34-1.33],0.2561320895439509
Chapter II Neoplasms,Melanoma in situ,ADGRG1,Adhesion G-protein coupled receptor G1,16439,110,1.09 [0.89-1.34],0.4025747458989585
Chapter II Neoplasms,Melanoma in situ,ADGRG2,Adhesion G-protein coupled receptor G2,16502,110,1.15 [0.61-2.16],0.6733153595447371
Chapter II Neoplasms,Melanoma in situ,ADGRV1,Adhesion G-protein coupled receptor V1,13980,98,0.99 [0.75-1.31],0.9397013382181956
Chapter II Neoplasms,Melanoma in situ,ADH1B,All-trans-retinol dehydrogenase,14132,98,0.89 [0.67-1.17],0.4045360190472741
Chapter II Neoplasms,Melanoma in situ,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16217,107,0.87 [0.70-1.08],0.2070767617700276
Chapter II Neoplasms,Melanoma in situ,ADIPOQ,Adiponectin,14443,100,1.03 [0.78-1.36],0.8428127231674507
Chapter II Neoplasms,Melanoma in situ,ADM,Pro-adrenomedullin,16669,112,1.22 [0.63-2.36],0.5606205814562149
Chapter II Neoplasms,Melanoma in situ,ADRA2A,Alpha-2A adrenergic receptor,13959,100,1.13 [0.89-1.45],0.3170218732594817
Chapter II Neoplasms,Melanoma in situ,AFAP1,Actin filament-associated protein 1,14132,98,0.82 [0.64-1.05],0.1215364588617389
Chapter II Neoplasms,Melanoma in situ,AFM,Afamin,14443,100,0.45 [0.17-1.16],0.098551874085007
Chapter II Neoplasms,Melanoma in situ,AFP,Alpha-fetoprotein,16316,107,1.02 [0.79-1.32],0.90252533643097
Chapter II Neoplasms,Melanoma in situ,AGBL2,Cytosolic carboxypeptidase 2,13980,98,0.87 [0.72-1.06],0.162477935831365
Chapter II Neoplasms,Melanoma in situ,AGER,Advanced glycosylation end product-specific receptor,16477,112,1.20 [0.79-1.80],0.3897979167736816
Chapter II Neoplasms,Melanoma in situ,AGR2,Anterior gradient protein 2 homolog,16006,108,0.89 [0.74-1.05],0.1685156986714767
Chapter II Neoplasms,Melanoma in situ,AGR3,Anterior gradient protein 3,16135,109,0.96 [0.72-1.28],0.7647668318890961
Chapter II Neoplasms,Melanoma in situ,AGRN,Agrin,16583,112,1.15 [0.70-1.88],0.5741441198976918
Chapter II Neoplasms,Melanoma in situ,AGRP,Agouti-related protein,16683,112,0.95 [0.68-1.31],0.7383452772234615
Chapter II Neoplasms,Melanoma in situ,AGT,Angiotensinogen,14434,100,0.82 [0.38-1.77],0.6135090934834365
Chapter II Neoplasms,Melanoma in situ,AGXT,Serine--pyruvate aminotransferase,16502,110,0.88 [0.69-1.12],0.2907934097389961
Chapter II Neoplasms,Melanoma in situ,AHCY,Adenosylhomocysteinase,16502,110,1.13 [0.88-1.45],0.322258255577001
Chapter II Neoplasms,Melanoma in situ,AHNAK,Neuroblast differentiation-associated protein AHNAK,14058,96,0.82 [0.42-1.59],0.5560905262298412
Chapter II Neoplasms,Melanoma in situ,AHNAK2,Protein AHNAK2,14058,96,0.74 [0.36-1.50],0.4011303416968353
Chapter II Neoplasms,Melanoma in situ,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14369,100,1.03 [0.78-1.36],0.8573594437360992
Chapter II Neoplasms,Melanoma in situ,AHSG,Alpha-2-HS-glycoprotein,14434,100,1.24 [0.61-2.51],0.5576488501452275
Chapter II Neoplasms,Melanoma in situ,AHSP,Alpha-hemoglobin-stabilizing protein,16496,111,1.13 [0.93-1.38],0.2228254593141901
Chapter II Neoplasms,Melanoma in situ,AIDA,"Axin interactor, dorsalization-associated protein",14048,97,0.93 [0.73-1.18],0.5435608934154894
Chapter II Neoplasms,Melanoma in situ,AIF1,Allograft inflammatory factor 1,16170,109,0.77 [0.55-1.07],0.1217947722616724
Chapter II Neoplasms,Melanoma in situ,AIF1L,Allograft inflammatory factor 1-like,14058,96,0.98 [0.68-1.40],0.8970140209649635
Chapter II Neoplasms,Melanoma in situ,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16415,109,0.98 [0.84-1.16],0.8449086189357763
Chapter II Neoplasms,Melanoma in situ,AK1,Adenylate kinase isoenzyme 1,16502,110,1.14 [0.88-1.48],0.3084380008907501
Chapter II Neoplasms,Melanoma in situ,AK2,"Adenylate kinase 2, mitochondrial",14404,100,1.01 [0.85-1.21],0.8863901235250923
Chapter II Neoplasms,Melanoma in situ,AKAP12,A-kinase anchor protein 12,14132,98,0.45 [0.17-1.25],0.1256888599994398
Chapter II Neoplasms,Melanoma in situ,AKR1B1,Aldo-keto reductase family 1 member B1,16170,109,1.16 [0.93-1.45],0.1851370818078924
Chapter II Neoplasms,Melanoma in situ,AKR1B10,Aldo-keto reductase family 1 member B10,14048,97,1.19 [0.89-1.59],0.2296381170584699
Chapter II Neoplasms,Melanoma in situ,AKR1C4,Aldo-keto reductase family 1 member C4,16217,107,1.03 [0.75-1.41],0.8694672689799028
Chapter II Neoplasms,Melanoma in situ,AKR7L,Aflatoxin B1 aldehyde reductase member 4,13991,93,1.18 [0.90-1.55],0.2349383980609927
Chapter II Neoplasms,Melanoma in situ,AKT1S1,Proline-rich AKT1 substrate 1,16136,109,1.02 [0.78-1.31],0.9066369455264494
Chapter II Neoplasms,Melanoma in situ,AKT2,RAC-beta serine/threonine-protein kinase,14396,100,1.01 [0.87-1.18],0.8680764955079943
Chapter II Neoplasms,Melanoma in situ,AKT3,RAC-gamma serine/threonine-protein kinase,16103,109,1.09 [0.80-1.47],0.5877713867123315
Chapter II Neoplasms,Melanoma in situ,ALCAM,CD166 antigen,16720,111,0.79 [0.32-1.92],0.6019892238196662
Chapter II Neoplasms,Melanoma in situ,ALDH1A1,Retinal dehydrogenase 1,16531,111,1.09 [0.80-1.48],0.588346219542346
Chapter II Neoplasms,Melanoma in situ,ALDH2,"Aldehyde dehydrogenase, mitochondrial",14369,100,1.00 [0.70-1.45],0.9802224106071732
Chapter II Neoplasms,Melanoma in situ,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16444,111,1.12 [0.89-1.40],0.3304301871769378
Chapter II Neoplasms,Melanoma in situ,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14396,100,0.76 [0.49-1.19],0.2316363781356828
Chapter II Neoplasms,Melanoma in situ,ALMS1,Alstrom syndrome protein 1,14160,99,0.54 [0.32-0.93],0.0255692460662803
Chapter II Neoplasms,Melanoma in situ,ALPI,Intestinal-type alkaline phosphatase,13991,93,1.09 [0.93-1.27],0.3102552472343226
Chapter II Neoplasms,Melanoma in situ,ALPP,"Alkaline phosphatase, placental type",16439,110,1.03 [0.87-1.22],0.7373492980457559
Chapter II Neoplasms,Melanoma in situ,AMBN,Ameloblastin,16225,109,1.04 [0.55-1.95],0.9103825568615816
Chapter II Neoplasms,Melanoma in situ,AMBP,Protein AMBP,16641,112,1.42 [0.63-3.24],0.399686801496351
Chapter II Neoplasms,Melanoma in situ,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14428,100,0.38 [0.19-0.75],0.005021735901732
Chapter II Neoplasms,Melanoma in situ,AMFR,E3 ubiquitin-protein ligase AMFR,16136,109,0.69 [0.51-0.93],0.0158239946648815
Chapter II Neoplasms,Melanoma in situ,AMIGO1,Amphoterin-induced protein 1,14048,97,0.65 [0.40-1.07],0.0907689249520275
Chapter II Neoplasms,Melanoma in situ,AMIGO2,Amphoterin-induced protein 2,16439,110,1.12 [0.54-2.33],0.756259146345477
Chapter II Neoplasms,Melanoma in situ,AMN,Protein amnionless,16225,109,1.25 [0.88-1.77],0.212182125565275
Chapter II Neoplasms,Melanoma in situ,AMOT,Angiomotin,14132,98,0.80 [0.47-1.36],0.3999913313221435
Chapter II Neoplasms,Melanoma in situ,AMOTL2,Angiomotin-like protein 2,14311,99,1.09 [0.76-1.58],0.6384221948137387
Chapter II Neoplasms,Melanoma in situ,AMPD3,AMP deaminase 3,14404,100,1.18 [0.91-1.53],0.2150610988509002
Chapter II Neoplasms,Melanoma in situ,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13478,92,0.92 [0.61-1.40],0.7123000234503273
Chapter II Neoplasms,Melanoma in situ,AMY2A,Pancreatic alpha-amylase,15861,105,1.01 [0.71-1.45],0.943810959140325
Chapter II Neoplasms,Melanoma in situ,AMY2B,Alpha-amylase 2B,15392,101,1.03 [0.72-1.49],0.857159449774937
Chapter II Neoplasms,Melanoma in situ,ANG,Angiogenin,16509,110,0.90 [0.54-1.51],0.6849112752420273
Chapter II Neoplasms,Melanoma in situ,ANGPT1,Angiopoietin-1,16441,111,1.01 [0.83-1.23],0.9227846152192886
Chapter II Neoplasms,Melanoma in situ,ANGPT2,Angiopoietin-2,16669,112,1.05 [0.67-1.65],0.842573668591928
Chapter II Neoplasms,Melanoma in situ,ANGPTL1,Angiopoietin-related protein 1,16280,109,1.24 [0.69-2.24],0.4790838925788305
Chapter II Neoplasms,Melanoma in situ,ANGPTL2,Angiopoietin-related protein 2,16529,112,0.98 [0.65-1.50],0.9437572870425356
Chapter II Neoplasms,Melanoma in situ,ANGPTL3,Angiopoietin-related protein 3,16547,110,0.98 [0.61-1.59],0.9381990683653252
Chapter II Neoplasms,Melanoma in situ,ANGPTL4,Angiopoietin-related protein 4,16558,112,0.93 [0.64-1.37],0.7240670915154871
Chapter II Neoplasms,Melanoma in situ,ANGPTL7,Angiopoietin-related protein 7,16669,112,0.71 [0.45-1.13],0.1529158411843769
Chapter II Neoplasms,Melanoma in situ,ANK2,Ankyrin-2,13959,100,0.94 [0.71-1.24],0.6640947797030519
Chapter II Neoplasms,Melanoma in situ,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,13991,93,1.11 [0.87-1.43],0.3942159288617181
Chapter II Neoplasms,Melanoma in situ,ANKRA2,Ankyrin repeat family A protein 2,13923,96,1.06 [0.76-1.48],0.7447539596567123
Chapter II Neoplasms,Melanoma in situ,ANKRD54,Ankyrin repeat domain-containing protein 54,16170,109,0.90 [0.66-1.23],0.5153170400323039
Chapter II Neoplasms,Melanoma in situ,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14058,96,0.83 [0.47-1.44],0.5017443460738347
Chapter II Neoplasms,Melanoma in situ,ANPEP,Aminopeptidase N,16586,110,0.96 [0.51-1.79],0.8985395875443212
Chapter II Neoplasms,Melanoma in situ,ANXA1,Annexin A1,14057,97,0.66 [0.39-1.10],0.1136699916573631
Chapter II Neoplasms,Melanoma in situ,ANXA10,Annexin A10,16136,109,0.99 [0.81-1.21],0.9086930436548925
Chapter II Neoplasms,Melanoma in situ,ANXA11,Annexin A11,16455,111,1.00 [0.78-1.28],0.9965924265831128
Chapter II Neoplasms,Melanoma in situ,ANXA2,Annexin A2,13840,96,0.93 [0.70-1.24],0.6295603354286743
Chapter II Neoplasms,Melanoma in situ,ANXA3,Annexin A3,16610,112,1.00 [0.79-1.27],0.9838304659831456
Chapter II Neoplasms,Melanoma in situ,ANXA4,Annexin A4,16430,108,1.00 [0.79-1.27],0.9782101989601198
Chapter II Neoplasms,Melanoma in situ,ANXA5,Annexin A5,16086,109,0.98 [0.55-1.74],0.946106179947807
Chapter II Neoplasms,Melanoma in situ,AOC1,Amiloride-sensitive amine oxidase [copper-containing],16225,109,1.05 [0.79-1.40],0.7127707793802273
Chapter II Neoplasms,Melanoma in situ,AOC3,Membrane primary amine oxidase,16607,110,0.85 [0.48-1.51],0.5826519371429237
Chapter II Neoplasms,Melanoma in situ,AP1G2,AP-1 complex subunit gamma-like 2,14369,100,1.07 [0.84-1.37],0.5670570553096863
Chapter II Neoplasms,Melanoma in situ,AP2B1,AP-2 complex subunit beta,14048,97,0.74 [0.47-1.15],0.1802542637214614
Chapter II Neoplasms,Melanoma in situ,AP3B1,AP-3 complex subunit beta-1,14355,100,0.91 [0.70-1.17],0.4554225847478211
Chapter II Neoplasms,Melanoma in situ,AP3S2,AP-3 complex subunit sigma-2,14404,100,0.81 [0.53-1.24],0.3356544492415153
Chapter II Neoplasms,Melanoma in situ,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16439,110,1.20 [0.85-1.70],0.2970057990939193
Chapter II Neoplasms,Melanoma in situ,APCS,Serum amyloid P-component,14295,100,0.86 [0.49-1.50],0.5886517285249582
Chapter II Neoplasms,Melanoma in situ,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16610,111,0.99 [0.74-1.31],0.9376628645636452
Chapter II Neoplasms,Melanoma in situ,APLP1,Amyloid-like protein 1,16502,110,0.97 [0.70-1.35],0.8459524232807175
Chapter II Neoplasms,Melanoma in situ,APOA1,Apolipoprotein A-I,14443,100,0.62 [0.28-1.34],0.2242759170014895
Chapter II Neoplasms,Melanoma in situ,APOA2,Apolipoprotein A-II,14434,100,0.92 [0.62-1.37],0.6953260438567226
Chapter II Neoplasms,Melanoma in situ,APOA4,Apolipoprotein A-IV,14443,100,0.71 [0.39-1.29],0.2591472015791825
Chapter II Neoplasms,Melanoma in situ,APOB,Apolipoprotein B-100,14434,100,0.45 [0.21-0.96],0.0397783161209333
Chapter II Neoplasms,Melanoma in situ,APOBR,Apolipoprotein B receptor,14058,96,0.87 [0.55-1.37],0.551367640782259
Chapter II Neoplasms,Melanoma in situ,APOC1,Apolipoprotein C-I,14416,100,0.99 [0.58-1.68],0.970243130514246
Chapter II Neoplasms,Melanoma in situ,APOD,Apolipoprotein D,13816,94,0.90 [0.54-1.50],0.6865968166839522
Chapter II Neoplasms,Melanoma in situ,APOE,Apolipoprotein E,14443,100,1.07 [0.84-1.37],0.5667145450313886
Chapter II Neoplasms,Melanoma in situ,APOF,Apolipoprotein F,14434,100,1.19 [0.47-3.01],0.7113674259443434
Chapter II Neoplasms,Melanoma in situ,APOH,Beta-2-glycoprotein 1,16531,111,1.00 [0.63-1.60],0.9844230981424548
Chapter II Neoplasms,Melanoma in situ,APOL1,Apolipoprotein L1,14434,100,0.70 [0.47-1.03],0.0689040638491345
Chapter II Neoplasms,Melanoma in situ,APOM,Apolipoprotein M,16577,110,0.77 [0.42-1.42],0.4052231335226532
Chapter II Neoplasms,Melanoma in situ,APP,Amyloid-beta precursor protein,16515,111,1.03 [0.80-1.33],0.7951239069930365
Chapter II Neoplasms,Melanoma in situ,APPL2,DCC-interacting protein 13-beta,14132,98,1.05 [0.88-1.26],0.5592933587869795
Chapter II Neoplasms,Melanoma in situ,APRT,Adenine phosphoribosyltransferase,16335,108,1.12 [0.77-1.61],0.5518089773485559
Chapter II Neoplasms,Melanoma in situ,ARAF,Serine/threonine-protein kinase A-Raf,14160,99,1.17 [0.92-1.50],0.1995653888161577
Chapter II Neoplasms,Melanoma in situ,AREG,Amphiregulin,16439,110,1.01 [0.66-1.53],0.974566220469228
Chapter II Neoplasms,Melanoma in situ,ARF6,ADP-ribosylation factor 6,14355,100,1.06 [0.88-1.27],0.5220230348400541
Chapter II Neoplasms,Melanoma in situ,ARFIP1,Arfaptin-1,14396,100,0.92 [0.69-1.22],0.5591808559280163
Chapter II Neoplasms,Melanoma in situ,ARG1,Arginase-1,16434,110,0.97 [0.71-1.35],0.8764485631982472
Chapter II Neoplasms,Melanoma in situ,ARG2,"Arginase-2, mitochondrial",14369,100,1.05 [0.68-1.63],0.8159869529590039
Chapter II Neoplasms,Melanoma in situ,ARHGAP1,Rho GTPase-activating protein 1,16170,109,0.95 [0.65-1.38],0.7906926276371589
Chapter II Neoplasms,Melanoma in situ,ARHGAP25,Rho GTPase-activating protein 25,16170,109,1.10 [0.83-1.45],0.5230591539930574
Chapter II Neoplasms,Melanoma in situ,ARHGAP30,Rho GTPase-activating protein 30,14160,99,0.76 [0.43-1.35],0.3438507127330104
Chapter II Neoplasms,Melanoma in situ,ARHGAP45,Rho GTPase-activating protein 45,14132,98,1.07 [0.84-1.36],0.6004753472538062
Chapter II Neoplasms,Melanoma in situ,ARHGAP5,Rho GTPase-activating protein 5,13923,96,0.91 [0.70-1.19],0.5071576832482612
Chapter II Neoplasms,Melanoma in situ,ARHGEF1,Rho guanine nucleotide exchange factor 1,14404,100,1.13 [0.91-1.40],0.265651852224836
Chapter II Neoplasms,Melanoma in situ,ARHGEF10,Rho guanine nucleotide exchange factor 10,14396,100,1.13 [0.93-1.39],0.2224235153884739
Chapter II Neoplasms,Melanoma in situ,ARHGEF12,Rho guanine nucleotide exchange factor 12,16479,111,1.12 [0.95-1.32],0.1857512438653035
Chapter II Neoplasms,Melanoma in situ,ARHGEF5,Rho guanine nucleotide exchange factor 5,13980,98,1.21 [0.96-1.53],0.1057176361774998
Chapter II Neoplasms,Melanoma in situ,ARID3A,AT-rich interactive domain-containing protein 3A,13980,98,0.97 [0.59-1.58],0.8998876656862005
Chapter II Neoplasms,Melanoma in situ,ARID4B,AT-rich interactive domain-containing protein 4B,16136,109,0.72 [0.44-1.18],0.191279823852948
Chapter II Neoplasms,Melanoma in situ,ARL13B,ADP-ribosylation factor-like protein 13B,13959,100,1.02 [0.77-1.35],0.8741851390026892
Chapter II Neoplasms,Melanoma in situ,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,13959,100,0.76 [0.46-1.25],0.2739574064371405
Chapter II Neoplasms,Melanoma in situ,ARMCX2,Armadillo repeat-containing X-linked protein 2,13980,98,1.06 [0.79-1.41],0.7082223462892017
Chapter II Neoplasms,Melanoma in situ,ARNT,Aryl hydrocarbon receptor nuclear translocator,16225,109,0.80 [0.48-1.33],0.3934797356568071
Chapter II Neoplasms,Melanoma in situ,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,13959,100,0.99 [0.68-1.42],0.947352206799092
Chapter II Neoplasms,Melanoma in situ,ARSA,Arylsulfatase A,16531,111,0.76 [0.51-1.15],0.1931374088353346
Chapter II Neoplasms,Melanoma in situ,ARSB,Arylsulfatase B,16439,110,0.95 [0.70-1.30],0.7551999232199108
Chapter II Neoplasms,Melanoma in situ,ART3,Ecto-ADP-ribosyltransferase 3,16607,110,0.78 [0.48-1.28],0.3317276895108291
Chapter II Neoplasms,Melanoma in situ,ART5,Ecto-ADP-ribosyltransferase 5,13980,98,1.11 [0.86-1.44],0.4165227722811661
Chapter II Neoplasms,Melanoma in situ,ARTN,Artemin,16225,109,0.66 [0.41-1.08],0.099071856328592
Chapter II Neoplasms,Melanoma in situ,ASAH1,Acid ceramidase,14281,100,0.91 [0.59-1.40],0.6541354596500648
Chapter II Neoplasms,Melanoma in situ,ASAH2,Neutral ceramidase,16369,109,0.83 [0.62-1.10],0.1981756611889888
Chapter II Neoplasms,Melanoma in situ,ASGR1,Asialoglycoprotein receptor 1,16369,109,1.44 [0.82-2.54],0.2022067872450934
Chapter II Neoplasms,Melanoma in situ,ASGR2,Asialoglycoprotein receptor 2,14434,100,1.19 [0.58-2.44],0.6317395739520457
Chapter II Neoplasms,Melanoma in situ,ASPN,Asporin,14415,100,0.56 [0.27-1.18],0.1258242440215529
Chapter II Neoplasms,Melanoma in situ,ASPSCR1,Tether containing UBX domain for GLUT4,14396,100,0.92 [0.69-1.23],0.5760303892596896
Chapter II Neoplasms,Melanoma in situ,ASRGL1,Isoaspartyl peptidase/L-asparaginase,14058,96,1.04 [0.86-1.26],0.6979691208193238
Chapter II Neoplasms,Melanoma in situ,ASS1,Argininosuccinate synthase,13959,100,0.85 [0.66-1.11],0.2283133262563517
Chapter II Neoplasms,Melanoma in situ,ATF2,Cyclic AMP-dependent transcription factor ATF-2,16136,109,0.88 [0.66-1.19],0.419144010009345
Chapter II Neoplasms,Melanoma in situ,ATF4,Cyclic AMP-dependent transcription factor ATF-4,13923,96,0.47 [0.25-0.90],0.022646051734447
Chapter II Neoplasms,Melanoma in situ,ATG16L1,Autophagy-related protein 16-1,14355,100,1.07 [0.86-1.35],0.5399290263447526
Chapter II Neoplasms,Melanoma in situ,ATG4A,Cysteine protease ATG4A,16170,109,1.03 [0.77-1.37],0.8322846677345881
Chapter II Neoplasms,Melanoma in situ,ATOX1,Copper transport protein ATOX1,16578,111,1.05 [0.83-1.34],0.6690683087691998
Chapter II Neoplasms,Melanoma in situ,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,13959,100,0.54 [0.31-0.94],0.0291415849721922
Chapter II Neoplasms,Melanoma in situ,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,13959,100,0.53 [0.27-1.04],0.0631959149055992
Chapter II Neoplasms,Melanoma in situ,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,13959,100,0.42 [0.22-0.80],0.0079027391502846
Chapter II Neoplasms,Melanoma in situ,ATP1B4,Protein ATP1B4,13923,96,0.89 [0.55-1.45],0.6434599743657536
Chapter II Neoplasms,Melanoma in situ,ATP2B4,Plasma membrane calcium-transporting ATPase 4,13959,100,0.89 [0.63-1.25],0.4980990831352461
Chapter II Neoplasms,Melanoma in situ,ATP5F1D,"ATP synthase subunit delta, mitochondrial",13959,100,0.64 [0.40-1.03],0.0677024193824655
Chapter II Neoplasms,Melanoma in situ,ATP5IF1,"ATPase inhibitor, mitochondrial",16583,112,1.00 [0.86-1.17],0.987491329305204
Chapter II Neoplasms,Melanoma in situ,ATP5PO,"ATP synthase subunit O, mitochondrial",16136,109,1.07 [0.71-1.60],0.7491080557966632
Chapter II Neoplasms,Melanoma in situ,ATP6AP2,Renin receptor,16170,109,1.12 [0.76-1.66],0.5579520942746721
Chapter II Neoplasms,Melanoma in situ,ATP6V1D,V-type proton ATPase subunit D,16439,110,0.64 [0.32-1.30],0.2158431852012399
Chapter II Neoplasms,Melanoma in situ,ATP6V1F,V-type proton ATPase subunit F,16107,109,0.98 [0.75-1.27],0.8648192298462148
Chapter II Neoplasms,Melanoma in situ,ATP6V1G1,V-type proton ATPase subunit G 1,14058,96,1.07 [0.82-1.40],0.6231101832100285
Chapter II Neoplasms,Melanoma in situ,ATP6V1G2,V-type proton ATPase subunit G 2,13959,100,0.99 [0.81-1.21],0.9488931343923424
Chapter II Neoplasms,Melanoma in situ,ATRAID,All-trans retinoic acid-induced differentiation factor,14355,100,0.70 [0.34-1.43],0.3213800134591494
Chapter II Neoplasms,Melanoma in situ,ATRN,"Attractin, Isoform 2",14443,100,0.39 [0.13-1.20],0.1008825424183931
Chapter II Neoplasms,Melanoma in situ,ATXN10,Ataxin-10,16136,109,1.07 [0.85-1.36],0.5567170625103
Chapter II Neoplasms,Melanoma in situ,ATXN2,Ataxin-2,13980,98,0.99 [0.83-1.19],0.9441927957446636
Chapter II Neoplasms,Melanoma in situ,ATXN2L,Ataxin-2-like protein,14396,100,1.00 [0.66-1.50],0.9894820607185012
Chapter II Neoplasms,Melanoma in situ,ATXN3,Ataxin-3,14404,100,1.07 [0.79-1.45],0.6555484899646968
Chapter II Neoplasms,Melanoma in situ,AXIN1,Axin-1,16479,111,1.12 [0.93-1.34],0.2222419992791861
Chapter II Neoplasms,Melanoma in situ,AXL,Tyrosine-protein kinase receptor UFO,16607,110,1.60 [0.87-2.94],0.129176408601422
Chapter II Neoplasms,Melanoma in situ,AZI2,5-azacytidine-induced protein 2,14396,100,1.25 [0.89-1.74],0.1924763659331136
Chapter II Neoplasms,Melanoma in situ,AZU1,Azurocidin,16006,107,0.94 [0.74-1.18],0.5837347077538365
Chapter II Neoplasms,Melanoma in situ,B2M,Beta-2-microglobulin,14443,100,0.85 [0.44-1.64],0.6225824113964581
Chapter II Neoplasms,Melanoma in situ,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,13959,100,0.38 [0.14-1.05],0.0626154584996642
Chapter II Neoplasms,Melanoma in situ,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14058,96,0.88 [0.51-1.51],0.6466925148120579
Chapter II Neoplasms,Melanoma in situ,B4GALT1,"Beta-1,4-galactosyltransferase 1",16583,112,0.73 [0.39-1.36],0.3223826942651938
Chapter II Neoplasms,Melanoma in situ,B4GAT1,"Beta-1,4-glucuronyltransferase 1",16531,111,0.95 [0.47-1.91],0.8833127567306085
Chapter II Neoplasms,Melanoma in situ,BABAM1,BRISC and BRCA1-A complex member 1,13991,93,0.97 [0.49-1.93],0.9347120773586388
Chapter II Neoplasms,Melanoma in situ,BACH1,Transcription regulator protein BACH1,16479,111,1.19 [0.95-1.49],0.1311819727403433
Chapter II Neoplasms,Melanoma in situ,BAG3,BAG family molecular chaperone regulator 3,16341,108,0.95 [0.62-1.44],0.794469649572038
Chapter II Neoplasms,Melanoma in situ,BAG4,BAG family molecular chaperone regulator 4,13991,93,1.12 [0.75-1.67],0.5694027381067274
Chapter II Neoplasms,Melanoma in situ,BAG6,Large proline-rich protein BAG6,16217,107,1.13 [0.69-1.82],0.6310794009517792
Chapter II Neoplasms,Melanoma in situ,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16170,109,0.92 [0.69-1.21],0.5330805354113815
Chapter II Neoplasms,Melanoma in situ,BAMBI,BMP and activin membrane-bound inhibitor homolog,16170,109,0.59 [0.32-1.10],0.097784582076202
Chapter II Neoplasms,Melanoma in situ,BANK1,B-cell scaffold protein with ankyrin repeats,16479,111,1.11 [0.94-1.31],0.2076396130386183
Chapter II Neoplasms,Melanoma in situ,BAP18,Chromatin complexes subunit BAP18,14404,100,1.10 [0.85-1.42],0.480982088518908
Chapter II Neoplasms,Melanoma in situ,BATF,Basic leucine zipper transcriptional factor ATF-like,14048,97,1.07 [0.88-1.32],0.4885761755745368
Chapter II Neoplasms,Melanoma in situ,BAX,Apoptosis regulator BAX,16113,109,1.00 [0.82-1.21],0.9753885914687522
Chapter II Neoplasms,Melanoma in situ,BCAM,Basal cell adhesion molecule,16531,111,0.57 [0.28-1.18],0.1303832767987534
Chapter II Neoplasms,Melanoma in situ,BCAN,Brevican core protein,16369,109,0.96 [0.59-1.58],0.8806700210368994
Chapter II Neoplasms,Melanoma in situ,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14415,100,0.76 [0.39-1.48],0.416978568954146
Chapter II Neoplasms,Melanoma in situ,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",13980,98,0.85 [0.57-1.27],0.4200818628898668
Chapter II Neoplasms,Melanoma in situ,BCHE,Cholinesterase,14163,97,1.60 [0.76-3.35],0.212030058065753
Chapter II Neoplasms,Melanoma in situ,BCL2,Apoptosis regulator Bcl-2,14355,100,0.91 [0.62-1.33],0.6336481626150358
Chapter II Neoplasms,Melanoma in situ,BCL2L1,Bcl-2-like protein 1,14404,100,1.04 [0.85-1.26],0.7140762744775699
Chapter II Neoplasms,Melanoma in situ,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16479,111,1.27 [0.83-1.93],0.2720802019143241
Chapter II Neoplasms,Melanoma in situ,BCL2L15,Bcl-2-like protein 15,13991,93,1.22 [0.90-1.64],0.1942981182852103
Chapter II Neoplasms,Melanoma in situ,BCL7A,B-cell CLL/lymphoma 7 protein family member A,13923,96,0.96 [0.70-1.32],0.7963815503517111
Chapter II Neoplasms,Melanoma in situ,BCL7B,B-cell CLL/lymphoma 7 protein family member B,14369,100,0.88 [0.57-1.37],0.577008494245626
Chapter II Neoplasms,Melanoma in situ,BCR,Breakpoint cluster region protein,16479,111,1.09 [0.91-1.31],0.3520924955321698
Chapter II Neoplasms,Melanoma in situ,BDNF,Brain-derived neurotrophic factor,14428,100,0.94 [0.75-1.17],0.5749077908001109
Chapter II Neoplasms,Melanoma in situ,BECN1,Beclin-1,14058,96,0.98 [0.70-1.37],0.8992483800053386
Chapter II Neoplasms,Melanoma in situ,BEX3,Protein BEX3,13923,96,0.51 [0.30-0.88],0.0155479192348797
Chapter II Neoplasms,Melanoma in situ,BGLAP,Osteocalcin,14428,100,0.99 [0.79-1.23],0.9269339747354496
Chapter II Neoplasms,Melanoma in situ,BGN,Biglycan,16138,109,0.95 [0.82-1.10],0.4942680417409169
Chapter II Neoplasms,Melanoma in situ,BHLHE40,Class E basic helix-loop-helix protein 40,13980,98,0.85 [0.63-1.15],0.3001113549251972
Chapter II Neoplasms,Melanoma in situ,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,13959,100,0.37 [0.18-0.77],0.0076717010750581
Chapter II Neoplasms,Melanoma in situ,BID,BH3-interacting domain death agonist,16479,111,1.03 [0.81-1.32],0.803123439660997
Chapter II Neoplasms,Melanoma in situ,BIN2,Bridging integrator 2,16531,111,1.07 [0.89-1.29],0.485042796111193
Chapter II Neoplasms,Melanoma in situ,BIRC2,Baculoviral IAP repeat-containing protein 2,16170,109,1.18 [0.90-1.53],0.2313012936631684
Chapter II Neoplasms,Melanoma in situ,BLMH,Bleomycin hydrolase,16720,111,1.01 [0.59-1.73],0.9823077514947116
Chapter II Neoplasms,Melanoma in situ,BLNK,B-cell linker protein,13991,93,0.83 [0.47-1.48],0.5359132736620394
Chapter II Neoplasms,Melanoma in situ,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,13980,98,1.11 [0.88-1.41],0.3660008995571985
Chapter II Neoplasms,Melanoma in situ,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14404,100,0.97 [0.60-1.59],0.9136148952086172
Chapter II Neoplasms,Melanoma in situ,BLVRB,Flavin reductase,16531,111,1.06 [0.83-1.35],0.6609222672444108
Chapter II Neoplasms,Melanoma in situ,BMP10,Bone morphogenetic protein 10,14132,98,0.60 [0.31-1.16],0.1268444120731211
Chapter II Neoplasms,Melanoma in situ,BMP4,Bone morphogenetic protein 4,16341,108,0.90 [0.61-1.32],0.5838406576688929
Chapter II Neoplasms,Melanoma in situ,BMP6,Bone morphogenetic protein 6,16198,107,0.91 [0.60-1.40],0.672115989682508
Chapter II Neoplasms,Melanoma in situ,BMPER,BMP-binding endothelial regulator protein,14132,98,0.57 [0.23-1.39],0.215627669849039
Chapter II Neoplasms,Melanoma in situ,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14415,100,0.69 [0.38-1.26],0.2317387053355732
Chapter II Neoplasms,Melanoma in situ,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,13991,93,1.37 [0.90-2.09],0.1433869403967675
Chapter II Neoplasms,Melanoma in situ,BOC,Brother of CDO,16217,107,0.56 [0.27-1.19],0.1339446575370395
Chapter II Neoplasms,Melanoma in situ,BOLA1,BolA-like protein 1,13980,98,0.98 [0.68-1.42],0.929090934152778
Chapter II Neoplasms,Melanoma in situ,BOLA2_BOLA2B,BolA-like protein 2,14058,96,1.05 [0.73-1.52],0.775930598226933
Chapter II Neoplasms,Melanoma in situ,BPIFA2,BPI fold-containing family A member 2,13569,91,0.86 [0.71-1.05],0.1324046995873997
Chapter II Neoplasms,Melanoma in situ,BPIFB1,BPI fold-containing family B member 1,16478,111,1.08 [0.82-1.41],0.5985538670542625
Chapter II Neoplasms,Melanoma in situ,BPIFB2,BPI fold-containing family B member 2,14386,99,1.18 [0.90-1.55],0.2361330835539555
Chapter II Neoplasms,Melanoma in situ,BRAP,BRCA1-associated protein,14220,99,1.09 [0.91-1.31],0.3478076744442281
Chapter II Neoplasms,Melanoma in situ,BRD1,Bromodomain-containing protein 1,14160,99,0.80 [0.41-1.58],0.5201555008559711
Chapter II Neoplasms,Melanoma in situ,BRD2,Bromodomain-containing protein 2,13980,98,1.23 [0.77-1.96],0.3903445600394781
Chapter II Neoplasms,Melanoma in situ,BRD3,Bromodomain-containing protein 3,13959,100,1.12 [0.80-1.57],0.5156609331355559
Chapter II Neoplasms,Melanoma in situ,BRDT,Bromodomain testis-specific protein,13959,100,0.68 [0.40-1.17],0.1680946120038098
Chapter II Neoplasms,Melanoma in situ,BRK1,Protein BRICK1,16136,109,1.13 [0.77-1.66],0.5169592079721317
Chapter II Neoplasms,Melanoma in situ,BRME1,Break repair meiotic recombinase recruitment factor 1,13980,98,0.93 [0.57-1.54],0.7906569373242571
Chapter II Neoplasms,Melanoma in situ,BRSK2,Serine/threonine-protein kinase BRSK2,14396,100,0.80 [0.47-1.37],0.4222345971651975
Chapter II Neoplasms,Melanoma in situ,BSG,Basigin,16658,112,0.85 [0.39-1.88],0.6928490153036566
Chapter II Neoplasms,Melanoma in situ,BSND,Barttin,13923,96,1.11 [0.64-1.92],0.7036818232145898
Chapter II Neoplasms,Melanoma in situ,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16642,112,1.26 [0.83-1.92],0.27180817727617
Chapter II Neoplasms,Melanoma in situ,BST2,Bone marrow stromal antigen 2,16642,112,1.07 [0.77-1.49],0.691868446383546
Chapter II Neoplasms,Melanoma in situ,BTC,Probetacellulin,16170,109,1.06 [0.86-1.32],0.569521024911664
Chapter II Neoplasms,Melanoma in situ,BTD,Biotinidase,14443,100,0.93 [0.37-2.35],0.8790306599483879
Chapter II Neoplasms,Melanoma in situ,BTLA,B- and T-lymphocyte attenuator,13923,96,0.98 [0.77-1.23],0.8378820554751691
Chapter II Neoplasms,Melanoma in situ,BTN1A1,Butyrophilin subfamily 1 member A1,14338,98,0.70 [0.39-1.27],0.2421797530874759
Chapter II Neoplasms,Melanoma in situ,BTN2A1,Butyrophilin subfamily 2 member A1,16583,112,1.14 [0.60-2.15],0.6957128033514473
Chapter II Neoplasms,Melanoma in situ,BTN3A2,Butyrophilin subfamily 3 member A2,16479,111,0.96 [0.61-1.50],0.8458198550442588
Chapter II Neoplasms,Melanoma in situ,BTNL10,Butyrophilin-like protein 10,13923,96,0.70 [0.39-1.27],0.2410101395754014
Chapter II Neoplasms,Melanoma in situ,C19orf12,Protein C19orf12,16136,109,0.75 [0.55-1.04],0.0855349549393963
Chapter II Neoplasms,Melanoma in situ,C1GALT1C1,C1GALT1-specific chaperone 1,13959,100,0.65 [0.34-1.25],0.1928239486906923
Chapter II Neoplasms,Melanoma in situ,C1QA,Complement C1q subcomponent subunit A,16604,110,0.87 [0.40-1.88],0.7241627042835329
Chapter II Neoplasms,Melanoma in situ,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14396,100,1.01 [0.78-1.29],0.9548653345421004
Chapter II Neoplasms,Melanoma in situ,C1QL2,Complement C1q-like protein 2,13991,93,1.08 [0.69-1.69],0.7327888991390545
Chapter II Neoplasms,Melanoma in situ,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16607,110,0.85 [0.57-1.28],0.43797905754842
Chapter II Neoplasms,Melanoma in situ,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14132,98,0.81 [0.49-1.36],0.4331565468652651
Chapter II Neoplasms,Melanoma in situ,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14396,100,0.38 [0.18-0.76],0.0068932078356884
Chapter II Neoplasms,Melanoma in situ,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14105,98,1.01 [0.67-1.51],0.9773395063660054
Chapter II Neoplasms,Melanoma in situ,C1R,Complement C1r subcomponent,14443,100,1.01 [0.36-2.85],0.989772816357299
Chapter II Neoplasms,Melanoma in situ,C1RL,Complement C1r subcomponent-like protein,14412,100,2.13 [0.77-5.91],0.1454394329187645
Chapter II Neoplasms,Melanoma in situ,C1S,Complement C1s subcomponent,14443,100,0.64 [0.26-1.57],0.3248539119185989
Chapter II Neoplasms,Melanoma in situ,C2,Complement C2,16577,110,0.68 [0.34-1.34],0.260683577528506
Chapter II Neoplasms,Melanoma in situ,C2CD2L,Phospholipid transfer protein C2CD2L,16107,109,0.84 [0.55-1.28],0.4141491124921611
Chapter II Neoplasms,Melanoma in situ,C2orf69,UPF0565 protein C2orf69,14048,97,1.21 [0.95-1.56],0.1282393682901065
Chapter II Neoplasms,Melanoma in situ,C3,Complement C3,13684,93,1.05 [0.68-1.62],0.8168655690844535
Chapter II Neoplasms,Melanoma in situ,C4BPB,C4b-binding protein beta chain,16578,111,1.11 [0.73-1.70],0.6302994033626139
Chapter II Neoplasms,Melanoma in situ,C5,Complement C5,14443,100,0.64 [0.17-2.41],0.5127550394842257
Chapter II Neoplasms,Melanoma in situ,C7,Complement component C7,14073,97,0.91 [0.49-1.69],0.7568568995581715
Chapter II Neoplasms,Melanoma in situ,C7orf50,Uncharacterized protein C7orf50,14404,100,0.97 [0.41-2.31],0.953571143697734
Chapter II Neoplasms,Melanoma in situ,C8B,Complement component C8 beta chain,14443,100,0.53 [0.29-0.98],0.0426441944345613
Chapter II Neoplasms,Melanoma in situ,C9,Complement component C9,14434,100,1.17 [0.81-1.70],0.4016455106508155
Chapter II Neoplasms,Melanoma in situ,C9orf40,Uncharacterized protein C9orf40,14355,100,1.02 [0.81-1.28],0.8930568981492865
Chapter II Neoplasms,Melanoma in situ,CA1,Carbonic anhydrase 1,16194,109,0.96 [0.73-1.27],0.7893291056959675
Chapter II Neoplasms,Melanoma in situ,CA11,Carbonic anhydrase-related protein 11,16170,109,0.64 [0.32-1.27],0.2024410293027903
Chapter II Neoplasms,Melanoma in situ,CA12,Carbonic anhydrase 12,16439,110,0.97 [0.57-1.67],0.9244537310041484
Chapter II Neoplasms,Melanoma in situ,CA13,Carbonic anhydrase 13,16334,108,1.05 [0.88-1.24],0.6031733923226973
Chapter II Neoplasms,Melanoma in situ,CA14,Carbonic anhydrase 14,16669,112,1.04 [0.64-1.68],0.8805493230350979
Chapter II Neoplasms,Melanoma in situ,CA2,Carbonic anhydrase 2,16468,111,1.10 [0.87-1.39],0.4112619425137492
Chapter II Neoplasms,Melanoma in situ,CA3,Carbonic anhydrase 3,16698,111,1.01 [0.77-1.34],0.9187581951565876
Chapter II Neoplasms,Melanoma in situ,CA4,Carbonic anhydrase 4,16720,111,0.63 [0.31-1.27],0.1978586975618822
Chapter II Neoplasms,Melanoma in situ,CA5A,"Carbonic anhydrase 5A, mitochondrial",16217,107,0.96 [0.79-1.17],0.6813097187734578
Chapter II Neoplasms,Melanoma in situ,CA6,Carbonic anhydrase 6,16478,111,0.82 [0.63-1.07],0.1450204239364265
Chapter II Neoplasms,Melanoma in situ,CA7,Carbonic anhydrase 7,14160,99,0.65 [0.35-1.21],0.1759398651539437
Chapter II Neoplasms,Melanoma in situ,CA8,Carbonic anhydrase-related protein,13991,93,0.44 [0.16-1.23],0.1162493050350096
Chapter II Neoplasms,Melanoma in situ,CA9,Carbonic anhydrase 9,16669,112,0.85 [0.60-1.22],0.3887280631484019
Chapter II Neoplasms,Melanoma in situ,CABP2,Calcium-binding protein 2,14048,97,1.02 [0.76-1.37],0.8898652351511459
Chapter II Neoplasms,Melanoma in situ,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,13980,98,0.67 [0.34-1.31],0.2385183648725373
Chapter II Neoplasms,Melanoma in situ,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,13959,100,0.40 [0.23-0.70],0.0012809798090568
Chapter II Neoplasms,Melanoma in situ,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,13980,98,1.39 [1.07-1.81],0.0123839256605706
Chapter II Neoplasms,Melanoma in situ,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14396,100,1.02 [0.81-1.28],0.8740591569022285
Chapter II Neoplasms,Melanoma in situ,CACYBP,Calcyclin-binding protein,14108,98,1.07 [0.88-1.30],0.4863700325127814
Chapter II Neoplasms,Melanoma in situ,CADPS,Calcium-dependent secretion activator 1,14048,97,1.04 [0.65-1.64],0.8812391614977719
Chapter II Neoplasms,Melanoma in situ,CALB1,Calbindin,16439,110,1.22 [0.82-1.81],0.3218032308046213
Chapter II Neoplasms,Melanoma in situ,CALB2,Calretinin,16136,109,0.58 [0.31-1.07],0.0811525453583268
Chapter II Neoplasms,Melanoma in situ,CALCA,Calcitonin,16340,109,0.81 [0.60-1.10],0.1820339704146992
Chapter II Neoplasms,Melanoma in situ,CALCB,Calcitonin gene-related peptide 2,14404,100,0.82 [0.49-1.40],0.476734287288137
Chapter II Neoplasms,Melanoma in situ,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16612,111,1.18 [1.00-1.38],0.0520242584775195
Chapter II Neoplasms,Melanoma in situ,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14058,96,1.02 [0.79-1.32],0.8854562513313712
Chapter II Neoplasms,Melanoma in situ,CALY,Neuron-specific vesicular protein calcyon,13959,100,0.73 [0.40-1.32],0.2941346368708279
Chapter II Neoplasms,Melanoma in situ,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16170,109,0.92 [0.62-1.39],0.7030802196974523
Chapter II Neoplasms,Melanoma in situ,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14048,97,1.44 [1.09-1.90],0.0092606996150387
Chapter II Neoplasms,Melanoma in situ,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14396,100,1.06 [0.89-1.27],0.4920066678507346
Chapter II Neoplasms,Melanoma in situ,CANT1,Soluble calcium-activated nucleotidase 1,16442,108,2.20 [0.95-5.09],0.0661993749285507
Chapter II Neoplasms,Melanoma in situ,CAPG,Macrophage-capping protein,16400,109,1.00 [0.74-1.34],0.9815095238313656
Chapter II Neoplasms,Melanoma in situ,CAPN3,Calpain-3,14369,100,0.71 [0.40-1.28],0.2582968704477701
Chapter II Neoplasms,Melanoma in situ,CAPS,Calcyphosin,14404,100,1.14 [0.98-1.32],0.0793399095675626
Chapter II Neoplasms,Melanoma in situ,CARHSP1,Calcium-regulated heat-stable protein 1,16136,109,1.03 [0.75-1.43],0.8388234086697727
Chapter II Neoplasms,Melanoma in situ,CASC3,Protein CASC3,14048,97,0.74 [0.45-1.22],0.2408325976842524
Chapter II Neoplasms,Melanoma in situ,CASP1,Caspase-1,16136,109,0.99 [0.77-1.27],0.9436354147363823
Chapter II Neoplasms,Melanoma in situ,CASP10,Caspase-10,16136,109,0.94 [0.74-1.19],0.6001705139774325
Chapter II Neoplasms,Melanoma in situ,CASP2,Caspase-2,16479,111,1.13 [0.88-1.44],0.3374567686869645
Chapter II Neoplasms,Melanoma in situ,CASP3,Caspase-3,16720,111,1.07 [0.88-1.30],0.5004865154323018
Chapter II Neoplasms,Melanoma in situ,CASP4,Caspase-4,14160,99,1.11 [1.01-1.23],0.0371814694270846
Chapter II Neoplasms,Melanoma in situ,CASP7,Caspase-7,14404,100,1.12 [0.89-1.41],0.3415223807717704
Chapter II Neoplasms,Melanoma in situ,CASP8,Caspase-8,16611,112,1.20 [0.93-1.55],0.1664646821402841
Chapter II Neoplasms,Melanoma in situ,CASP9,Caspase-9,13991,93,1.12 [0.82-1.54],0.473764912315246
Chapter II Neoplasms,Melanoma in situ,CASQ2,Calsequestrin-2,13959,100,0.55 [0.31-0.96],0.0354751851776418
Chapter II Neoplasms,Melanoma in situ,CAT,Catalase,14224,99,1.08 [0.76-1.52],0.6673129653370122
Chapter II Neoplasms,Melanoma in situ,CBLIF,Cobalamin binding intrinsic factor,16476,110,0.95 [0.77-1.17],0.6198705405568752
Chapter II Neoplasms,Melanoma in situ,CBLN1,Cerebellin-1,13980,98,0.96 [0.78-1.20],0.7332887062668234
Chapter II Neoplasms,Melanoma in situ,CBLN4,Cerebellin-4,16669,112,0.62 [0.36-1.04],0.0698255642580311
Chapter II Neoplasms,Melanoma in situ,CBS,Cystathionine beta-synthase,14058,96,0.71 [0.46-1.12],0.1404296248089178
Chapter II Neoplasms,Melanoma in situ,CBX2,Chromobox protein homolog 2,13959,100,0.60 [0.31-1.14],0.1189762353559837
Chapter II Neoplasms,Melanoma in situ,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16369,109,1.11 [0.88-1.40],0.3618742512229543
Chapter II Neoplasms,Melanoma in situ,CCAR2,Cell cycle and apoptosis regulator protein 2,14404,100,1.06 [0.77-1.47],0.7072937543232953
Chapter II Neoplasms,Melanoma in situ,CCDC134,Coiled-coil domain-containing protein 134,14369,100,1.12 [0.76-1.64],0.5680804309909138
Chapter II Neoplasms,Melanoma in situ,CCDC28A,Coiled-coil domain-containing protein 28A,14048,97,0.56 [0.29-1.08],0.083731722179569
Chapter II Neoplasms,Melanoma in situ,CCDC50,Coiled-coil domain-containing protein 50,14396,100,0.92 [0.70-1.20],0.5345961477044907
Chapter II Neoplasms,Melanoma in situ,CCDC80,Coiled-coil domain-containing protein 80,16502,110,0.89 [0.56-1.43],0.6425517177633373
Chapter II Neoplasms,Melanoma in situ,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14058,96,1.10 [0.80-1.49],0.5627075513759225
Chapter II Neoplasms,Melanoma in situ,CCL11,Eotaxin,16683,112,1.00 [0.64-1.57],0.9922823796563272
Chapter II Neoplasms,Melanoma in situ,CCL13,C-C motif chemokine 13,16655,111,1.03 [0.81-1.31],0.8129599135638925
Chapter II Neoplasms,Melanoma in situ,CCL14,C-C motif chemokine 14,16509,110,1.19 [0.79-1.80],0.3969391959404755
Chapter II Neoplasms,Melanoma in situ,CCL15,C-C motif chemokine 15,16720,111,1.00 [0.68-1.49],0.9808025320160024
Chapter II Neoplasms,Melanoma in situ,CCL16,C-C motif chemokine 16,16720,111,0.76 [0.57-1.02],0.0675883478914061
Chapter II Neoplasms,Melanoma in situ,CCL17,C-C motif chemokine 17,16494,112,0.92 [0.77-1.11],0.3741585085763182
Chapter II Neoplasms,Melanoma in situ,CCL18,C-C motif chemokine 18,16309,110,0.94 [0.73-1.21],0.6363423035144644
Chapter II Neoplasms,Melanoma in situ,CCL19,C-C motif chemokine 19,16642,112,1.00 [0.88-1.14],0.977640000034105
Chapter II Neoplasms,Melanoma in situ,CCL2,C-C motif chemokine 2,16341,108,1.16 [0.85-1.58],0.3615794240578657
Chapter II Neoplasms,Melanoma in situ,CCL20,C-C motif chemokine 20,16683,112,0.95 [0.78-1.15],0.6080000441304951
Chapter II Neoplasms,Melanoma in situ,CCL21,C-C motif chemokine 21,16583,112,0.91 [0.59-1.39],0.6622189064610859
Chapter II Neoplasms,Melanoma in situ,CCL22,C-C motif chemokine 22,16369,112,0.91 [0.66-1.27],0.5952771982728999
Chapter II Neoplasms,Melanoma in situ,CCL23,C-C motif chemokine 23,16583,112,1.16 [0.77-1.74],0.4798112562827973
Chapter II Neoplasms,Melanoma in situ,CCL24,C-C motif chemokine 24,16558,112,0.99 [0.81-1.21],0.892145028340545
Chapter II Neoplasms,Melanoma in situ,CCL25,C-C motif chemokine 25,16683,112,1.35 [0.96-1.91],0.0884302372686928
Chapter II Neoplasms,Melanoma in situ,CCL26,C-C motif chemokine 26,16479,111,0.95 [0.78-1.15],0.5877384391377019
Chapter II Neoplasms,Melanoma in situ,CCL27,C-C motif chemokine 27,16502,110,1.03 [0.77-1.38],0.8300582888237967
Chapter II Neoplasms,Melanoma in situ,CCL28,C-C motif chemokine 28,16414,111,1.06 [0.80-1.41],0.6974610641820456
Chapter II Neoplasms,Melanoma in situ,CCL3,C-C motif chemokine 3,16479,111,1.13 [0.86-1.49],0.386735034864206
Chapter II Neoplasms,Melanoma in situ,CCL4,C-C motif chemokine 4,16545,112,1.10 [0.89-1.36],0.3862321460655443
Chapter II Neoplasms,Melanoma in situ,CCL5,C-C motif chemokine 5,16607,110,0.98 [0.83-1.16],0.8059657145641248
Chapter II Neoplasms,Melanoma in situ,CCL7,C-C motif chemokine 7,16479,111,1.00 [0.75-1.34],0.9871095133616498
Chapter II Neoplasms,Melanoma in situ,CCL8,C-C motif chemokine 8,16641,112,1.16 [0.88-1.53],0.3046740531685155
Chapter II Neoplasms,Melanoma in situ,CCN1,CCN family member 1,16407,110,0.83 [0.67-1.04],0.109941228460141
Chapter II Neoplasms,Melanoma in situ,CCN2,CCN family member 2,16499,112,1.12 [0.83-1.51],0.462111447510441
Chapter II Neoplasms,Melanoma in situ,CCN3,CCN family member 3,16691,111,0.92 [0.55-1.54],0.7630010423607947
Chapter II Neoplasms,Melanoma in situ,CCN4,CCN family member 4,16669,112,1.09 [0.72-1.65],0.6942764712743191
Chapter II Neoplasms,Melanoma in situ,CCN5,CCN family member 5,16531,111,0.82 [0.52-1.28],0.3829190464696345
Chapter II Neoplasms,Melanoma in situ,CCND2,G1/S-specific cyclin-D2,14160,99,0.58 [0.39-0.86],0.0072120564701187
Chapter II Neoplasms,Melanoma in situ,CCNE1,G1/S-specific cyclin-E1,13991,93,1.04 [0.85-1.28],0.6969396256842189
Chapter II Neoplasms,Melanoma in situ,CCS,Copper chaperone for superoxide dismutase,16369,109,1.13 [0.80-1.61],0.4885604472402171
Chapter II Neoplasms,Melanoma in situ,CCT5,T-complex protein 1 subunit epsilon,16170,109,1.04 [0.71-1.52],0.8487286373774373
Chapter II Neoplasms,Melanoma in situ,CD101,Immunoglobulin superfamily member 2,14355,100,1.01 [0.65-1.56],0.9647834241291358
Chapter II Neoplasms,Melanoma in situ,CD109,CD109 antigen,16531,111,0.83 [0.50-1.38],0.4653497811901915
Chapter II Neoplasms,Melanoma in situ,CD14,Monocyte differentiation antigen CD14,16229,109,1.10 [0.73-1.68],0.6417764481642487
Chapter II Neoplasms,Melanoma in situ,CD160,CD160 antigen,16683,112,1.16 [0.82-1.65],0.397727641810374
Chapter II Neoplasms,Melanoma in situ,CD163,Scavenger receptor cysteine-rich type 1 protein M130,16607,110,0.90 [0.60-1.35],0.6220283428374421
Chapter II Neoplasms,Melanoma in situ,CD164,Sialomucin core protein 24,16531,111,0.90 [0.45-1.78],0.7558799650593303
Chapter II Neoplasms,Melanoma in situ,CD164L2,CD164 sialomucin-like 2 protein,14048,97,1.46 [0.91-2.32],0.1139142094128094
Chapter II Neoplasms,Melanoma in situ,CD177,CD177 antigen,16505,111,1.08 [0.94-1.23],0.2611397768847849
Chapter II Neoplasms,Melanoma in situ,CD1C,T-cell surface glycoprotein CD1c,16578,111,0.79 [0.39-1.57],0.4978849231473706
Chapter II Neoplasms,Melanoma in situ,CD2,T-cell surface antigen CD2,13959,100,1.11 [0.72-1.73],0.6292618938278884
Chapter II Neoplasms,Melanoma in situ,CD200,OX-2 membrane glycoprotein,16479,111,1.41 [0.74-2.67],0.2936306976308912
Chapter II Neoplasms,Melanoma in situ,CD200R1,Cell surface glycoprotein CD200 receptor 1,16425,110,1.56 [0.98-2.48],0.059672212952453
Chapter II Neoplasms,Melanoma in situ,CD207,C-type lectin domain family 4 member K,16123,109,0.80 [0.52-1.25],0.3353415895002546
Chapter II Neoplasms,Melanoma in situ,CD209,CD209 antigen,16572,110,1.00 [0.65-1.55],0.9917670511954711
Chapter II Neoplasms,Melanoma in situ,CD22,B-cell receptor CD22,16683,112,0.95 [0.63-1.43],0.80915439521473
Chapter II Neoplasms,Melanoma in situ,CD226,CD226 antigen,13991,93,1.25 [0.78-2.01],0.3462544015577481
Chapter II Neoplasms,Melanoma in situ,CD244,Natural killer cell receptor 2B4,16683,112,1.12 [0.61-2.08],0.7086021338804869
Chapter II Neoplasms,Melanoma in situ,CD248,Endosialin,14428,100,0.84 [0.52-1.36],0.4845449689633205
Chapter II Neoplasms,Melanoma in situ,CD27,CD27 antigen,16578,111,0.95 [0.63-1.44],0.8093612258848262
Chapter II Neoplasms,Melanoma in situ,CD274,Programmed cell death 1 ligand 1,16369,109,0.97 [0.58-1.62],0.8973135769594439
Chapter II Neoplasms,Melanoma in situ,CD276,CD276 antigen,16504,112,1.09 [0.68-1.76],0.7087493760348529
Chapter II Neoplasms,Melanoma in situ,CD28,T-cell-specific surface glycoprotein CD28,16170,109,0.90 [0.56-1.45],0.6668745715661555
Chapter II Neoplasms,Melanoma in situ,CD2AP,CD2-associated protein,16502,110,1.21 [0.93-1.56],0.1568089325016605
Chapter II Neoplasms,Melanoma in situ,CD300A,CMRF35-like molecule 8,14132,98,0.99 [0.52-1.90],0.9830101463225362
Chapter II Neoplasms,Melanoma in situ,CD300C,CMRF35-like molecule 6,16642,112,1.11 [0.69-1.80],0.6632085647890342
Chapter II Neoplasms,Melanoma in situ,CD300E,CMRF35-like molecule 2,16611,112,0.96 [0.64-1.46],0.8620587320966657
Chapter II Neoplasms,Melanoma in situ,CD300LF,CMRF35-like molecule 1,16669,112,0.97 [0.73-1.27],0.8028155793860865
Chapter II Neoplasms,Melanoma in situ,CD300LG,CMRF35-like molecule 9,16531,111,0.73 [0.47-1.14],0.1676663699554101
Chapter II Neoplasms,Melanoma in situ,CD302,CD302 antigen,16439,110,1.29 [0.75-2.23],0.3599760745404077
Chapter II Neoplasms,Melanoma in situ,CD33,Myeloid cell surface antigen CD33,16578,111,0.86 [0.70-1.05],0.1280386068123553
Chapter II Neoplasms,Melanoma in situ,CD34,Hematopoietic progenitor cell antigen CD34,16595,112,0.72 [0.36-1.45],0.3572293924228403
Chapter II Neoplasms,Melanoma in situ,CD36,Platelet glycoprotein 4,13991,93,0.95 [0.60-1.51],0.8391909114163242
Chapter II Neoplasms,Melanoma in situ,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16439,110,0.78 [0.46-1.33],0.3620811931430296
Chapter II Neoplasms,Melanoma in situ,CD3D,T-cell surface glycoprotein CD3 delta chain,13980,98,0.61 [0.31-1.22],0.1644555656381697
Chapter II Neoplasms,Melanoma in situ,CD3E,T-cell surface glycoprotein CD3 epsilon chain,14160,99,1.04 [0.63-1.71],0.8693031391474528
Chapter II Neoplasms,Melanoma in situ,CD3G,T-cell surface glycoprotein CD3 gamma chain,13991,93,1.03 [0.83-1.28],0.766583309935396
Chapter II Neoplasms,Melanoma in situ,CD4,T-cell surface glycoprotein CD4,16449,111,1.21 [0.74-1.99],0.4438246492106085
Chapter II Neoplasms,Melanoma in situ,CD40,Tumor necrosis factor receptor superfamily member 5,16520,112,1.07 [0.76-1.51],0.6903860119634244
Chapter II Neoplasms,Melanoma in situ,CD40LG,CD40 ligand,16683,112,1.03 [0.84-1.28],0.7527493538681393
Chapter II Neoplasms,Melanoma in situ,CD46,Membrane cofactor protein,16459,110,1.02 [0.56-1.88],0.938447700559364
Chapter II Neoplasms,Melanoma in situ,CD48,CD48 antigen,16558,112,1.05 [0.59-1.85],0.8745136009828165
Chapter II Neoplasms,Melanoma in situ,CD5,T-cell surface glycoprotein CD5,16641,112,1.06 [0.64-1.75],0.830145253121521
Chapter II Neoplasms,Melanoma in situ,CD55,Complement decay-accelerating factor,15960,106,0.70 [0.35-1.40],0.3157177125756989
Chapter II Neoplasms,Melanoma in situ,CD58,Lymphocyte function-associated antigen 3,16487,112,0.46 [0.18-1.14],0.0925110113965147
Chapter II Neoplasms,Melanoma in situ,CD59,CD59 glycoprotein,15959,106,0.66 [0.29-1.49],0.3201914976458672
Chapter II Neoplasms,Melanoma in situ,CD5L,CD5 antigen-like,14368,100,1.30 [0.86-1.95],0.208136135227311
Chapter II Neoplasms,Melanoma in situ,CD6,T-cell differentiation antigen CD6,16658,112,1.05 [0.76-1.45],0.7618303565233735
Chapter II Neoplasms,Melanoma in situ,CD63,CD63 antigen,16341,108,1.20 [0.86-1.69],0.2820981552750723
Chapter II Neoplasms,Melanoma in situ,CD69,Early activation antigen CD69,16446,110,1.07 [0.88-1.30],0.4890988420834523
Chapter II Neoplasms,Melanoma in situ,CD7,T-cell antigen CD7,13959,93,1.63 [1.12-2.38],0.011443648564356
Chapter II Neoplasms,Melanoma in situ,CD70,CD70 antigen,16479,111,0.99 [0.66-1.47],0.9574921204525992
Chapter II Neoplasms,Melanoma in situ,CD72,B-cell differentiation antigen CD72,14132,98,1.13 [0.71-1.81],0.5975342920041853
Chapter II Neoplasms,Melanoma in situ,CD74,HLA class II histocompatibility antigen gamma chain,16642,112,1.42 [0.88-2.28],0.1498098244314993
Chapter II Neoplasms,Melanoma in situ,CD79B,B-cell antigen receptor complex-associated protein beta chain,16683,112,0.83 [0.56-1.22],0.3403180194040374
Chapter II Neoplasms,Melanoma in situ,CD80,T-lymphocyte activation antigen CD80,14415,100,1.02 [0.57-1.84],0.9378045671363548
Chapter II Neoplasms,Melanoma in situ,CD82,CD82 antigen,14160,99,0.54 [0.29-0.99],0.0457225234959765
Chapter II Neoplasms,Melanoma in situ,CD83,CD83 antigen,16479,111,0.96 [0.57-1.59],0.8612894313993128
Chapter II Neoplasms,Melanoma in situ,CD84,SLAM family member 5,16479,111,1.30 [0.76-2.23],0.3394037361041762
Chapter II Neoplasms,Melanoma in situ,CD86,T-lymphocyte activation antigen CD86,14355,100,1.06 [0.54-2.05],0.8713357620379413
Chapter II Neoplasms,Melanoma in situ,CD8A,T-cell surface glycoprotein CD8 alpha chain,16642,112,1.28 [0.93-1.76],0.127900066873843
Chapter II Neoplasms,Melanoma in situ,CD93,Complement component C1q receptor,15932,107,0.71 [0.40-1.26],0.2387299417866293
Chapter II Neoplasms,Melanoma in situ,CD99,CD99 antigen,16531,111,0.93 [0.39-2.23],0.8763766075389702
Chapter II Neoplasms,Melanoma in situ,CD99L2,CD99 antigen-like protein 2,16531,111,1.41 [0.70-2.83],0.3386891908175799
Chapter II Neoplasms,Melanoma in situ,CDA,Cytidine deaminase,14387,100,1.35 [0.94-1.95],0.1069917572252148
Chapter II Neoplasms,Melanoma in situ,CDAN1,Codanin-1,14404,100,0.50 [0.19-1.28],0.1469235562589698
Chapter II Neoplasms,Melanoma in situ,CDC123,Cell division cycle protein 123 homolog,13923,96,0.88 [0.62-1.24],0.4636673043390545
Chapter II Neoplasms,Melanoma in situ,CDC25A,M-phase inducer phosphatase 1,13923,96,0.85 [0.50-1.45],0.555376543297327
Chapter II Neoplasms,Melanoma in situ,CDC26,Anaphase-promoting complex subunit CDC26,14324,99,1.17 [0.89-1.54],0.2527453388083894
Chapter II Neoplasms,Melanoma in situ,CDC27,Cell division cycle protein 27 homolog,16170,109,1.05 [0.80-1.40],0.7105533124227135
Chapter II Neoplasms,Melanoma in situ,CDC37,Hsp90 co-chaperone Cdc37,16578,111,1.06 [0.86-1.29],0.5976429388206879
Chapter II Neoplasms,Melanoma in situ,CDC42BPB,Serine/threonine-protein kinase MRCK beta,14355,100,1.04 [0.86-1.26],0.6704028635406037
Chapter II Neoplasms,Melanoma in situ,CDCP1,CUB domain-containing protein 1,16369,109,0.84 [0.60-1.17],0.2984088523909897
Chapter II Neoplasms,Melanoma in situ,CDH1,Cadherin-1,15990,104,1.03 [0.65-1.62],0.8976026363948998
Chapter II Neoplasms,Melanoma in situ,CDH15,Cadherin-15,16613,112,0.87 [0.65-1.16],0.3368307467845693
Chapter II Neoplasms,Melanoma in situ,CDH17,Cadherin-17,16502,110,1.19 [0.94-1.51],0.1445559545653417
Chapter II Neoplasms,Melanoma in situ,CDH2,Cadherin-2,16502,110,1.16 [0.72-1.90],0.5385714572425975
Chapter II Neoplasms,Melanoma in situ,CDH22,Cadherin-22,14160,99,0.67 [0.32-1.39],0.2800794915744143
Chapter II Neoplasms,Melanoma in situ,CDH23,Cadherin-23,14404,100,0.51 [0.24-1.09],0.0811893475699353
Chapter II Neoplasms,Melanoma in situ,CDH3,Cadherin-3,16642,112,1.02 [0.64-1.64],0.9179217755209508
Chapter II Neoplasms,Melanoma in situ,CDH4,Cadherin-4,13980,98,0.98 [0.65-1.49],0.9367593107942996
Chapter II Neoplasms,Melanoma in situ,CDH5,Cadherin-5,16720,111,0.59 [0.33-1.05],0.0716793221351102
Chapter II Neoplasms,Melanoma in situ,CDH6,Cadherin-6,16502,110,1.09 [0.69-1.71],0.7114718082665381
Chapter II Neoplasms,Melanoma in situ,CDHR1,Cadherin-related family member 1,16136,109,0.80 [0.52-1.24],0.3193510718062392
Chapter II Neoplasms,Melanoma in situ,CDHR2,Cadherin-related family member 2,16439,110,0.87 [0.69-1.12],0.2825840404990052
Chapter II Neoplasms,Melanoma in situ,CDHR5,Cadherin-related family member 5,16502,110,1.39 [0.88-2.20],0.1556940095694041
Chapter II Neoplasms,Melanoma in situ,CDK1,Cyclin-dependent kinase 1,13923,96,0.78 [0.46-1.34],0.3740170246573983
Chapter II Neoplasms,Melanoma in situ,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14396,100,0.85 [0.60-1.21],0.3736930379687689
Chapter II Neoplasms,Melanoma in situ,CDKL5,Cyclin-dependent kinase-like 5,13980,98,0.92 [0.63-1.36],0.6904209003848206
Chapter II Neoplasms,Melanoma in situ,CDKN1A,Cyclin-dependent kinase inhibitor 1,16439,110,1.08 [0.92-1.27],0.3184530330616634
Chapter II Neoplasms,Melanoma in situ,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16439,110,1.07 [0.89-1.28],0.4905433905655965
Chapter II Neoplasms,Melanoma in situ,CDNF,Cerebral dopamine neurotrophic factor,16439,110,0.89 [0.52-1.52],0.6718245079187157
Chapter II Neoplasms,Melanoma in situ,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16532,112,0.96 [0.49-1.84],0.8913494155045504
Chapter II Neoplasms,Melanoma in situ,CDSN,Corneodesmosin,16633,112,1.13 [0.77-1.66],0.5278684731477403
Chapter II Neoplasms,Melanoma in situ,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16551,111,1.06 [0.45-2.51],0.8975487252932193
Chapter II Neoplasms,Melanoma in situ,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14355,100,1.12 [0.87-1.44],0.3670051217961951
Chapter II Neoplasms,Melanoma in situ,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14160,99,1.05 [0.81-1.36],0.7136420815259374
Chapter II Neoplasms,Melanoma in situ,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14355,100,1.10 [0.69-1.77],0.6895772451130828
Chapter II Neoplasms,Melanoma in situ,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14160,99,0.79 [0.49-1.28],0.3395276880039155
Chapter II Neoplasms,Melanoma in situ,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16479,111,0.98 [0.81-1.20],0.8587930657051713
Chapter II Neoplasms,Melanoma in situ,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16170,109,0.92 [0.63-1.33],0.6518371057112098
Chapter II Neoplasms,Melanoma in situ,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,15982,109,1.32 [1.03-1.69],0.0294064933609285
Chapter II Neoplasms,Melanoma in situ,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14428,100,1.19 [0.73-1.92],0.4858699603635671
Chapter II Neoplasms,Melanoma in situ,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16217,107,1.01 [0.71-1.44],0.9624617665855734
Chapter II Neoplasms,Melanoma in situ,CEBPA,CCAAT/enhancer-binding protein alpha,13991,93,0.86 [0.46-1.58],0.6201227075512421
Chapter II Neoplasms,Melanoma in situ,CEBPB,CCAAT/enhancer-binding protein beta,16217,107,1.23 [0.80-1.89],0.3474972419727486
Chapter II Neoplasms,Melanoma in situ,CELA2A,Chymotrypsin-like elastase family member 2A,14428,100,0.93 [0.69-1.27],0.6652611888262041
Chapter II Neoplasms,Melanoma in situ,CELA3A,Chymotrypsin-like elastase family member 3A,16696,111,1.07 [0.81-1.43],0.625339986662163
Chapter II Neoplasms,Melanoma in situ,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14132,98,0.68 [0.34-1.36],0.2759568894171695
Chapter II Neoplasms,Melanoma in situ,CEMIP2,Cell surface hyaluronidase,13991,93,1.00 [0.54-1.85],0.992581109463445
Chapter II Neoplasms,Melanoma in situ,CEND1,Cell cycle exit and neuronal differentiation protein 1,13980,98,0.97 [0.69-1.38],0.8818290944287855
Chapter II Neoplasms,Melanoma in situ,CENPF,Centromere protein F,14160,99,1.13 [0.81-1.59],0.4694488865655331
Chapter II Neoplasms,Melanoma in situ,CENPJ,Centromere protein J,14160,99,0.89 [0.66-1.19],0.4242509746665425
Chapter II Neoplasms,Melanoma in situ,CEP112,Centrosomal protein of 112 kDa,13959,100,1.19 [0.82-1.71],0.3565441376720641
Chapter II Neoplasms,Melanoma in situ,CEP152,Centrosomal protein of 152 kDa,13923,96,1.08 [0.69-1.68],0.7508336264720241
Chapter II Neoplasms,Melanoma in situ,CEP164,Centrosomal protein of 164 kDa,16225,109,1.12 [0.89-1.40],0.3425166271325383
Chapter II Neoplasms,Melanoma in situ,CEP170,Centrosomal protein of 170 kDa,14058,96,1.06 [0.82-1.37],0.6527847544021671
Chapter II Neoplasms,Melanoma in situ,CEP20,Centrosomal protein 20,16170,109,1.02 [0.81-1.29],0.8390963411646575
Chapter II Neoplasms,Melanoma in situ,CEP290,Centrosomal protein of 290 kDa,14160,99,0.93 [0.64-1.36],0.7135995584481649
Chapter II Neoplasms,Melanoma in situ,CEP350,Centrosome-associated protein 350,13923,96,1.12 [0.68-1.85],0.6471350276126211
Chapter II Neoplasms,Melanoma in situ,CEP43,Centrosomal protein 43,16093,106,0.87 [0.67-1.13],0.288639823269064
Chapter II Neoplasms,Melanoma in situ,CEP85,Centrosomal protein of 85 kDa,16170,109,1.11 [0.85-1.45],0.4263278456263666
Chapter II Neoplasms,Melanoma in situ,CERT,Ceramide transfer protein,16136,109,1.02 [0.77-1.35],0.8753479263192887
Chapter II Neoplasms,Melanoma in situ,CES1,Liver carboxylesterase 1,16570,111,0.94 [0.76-1.16],0.5681827975634055
Chapter II Neoplasms,Melanoma in situ,CES2,Cocaine esterase,16439,110,0.93 [0.68-1.27],0.6317229380054585
Chapter II Neoplasms,Melanoma in situ,CES3,Carboxylesterase 3,16439,110,1.08 [0.86-1.36],0.5088475869283404
Chapter II Neoplasms,Melanoma in situ,CETN2,Centrin-2,16136,109,1.04 [0.80-1.34],0.7840678842770471
Chapter II Neoplasms,Melanoma in situ,CETN3,Centrin-3,14355,100,1.10 [0.85-1.41],0.4601152571292429
Chapter II Neoplasms,Melanoma in situ,CFB,Complement factor B,14186,96,1.27 [0.68-2.35],0.4513920699425385
Chapter II Neoplasms,Melanoma in situ,CFC1,Cryptic protein,16170,109,0.74 [0.49-1.12],0.1512088798596305
Chapter II Neoplasms,Melanoma in situ,CFD,Complement factor D,14443,100,0.40 [0.15-1.07],0.0687650026924787
Chapter II Neoplasms,Melanoma in situ,CFH,Complement factor H,13592,89,0.74 [0.30-1.81],0.5063523626120748
Chapter II Neoplasms,Melanoma in situ,CFHR2,Complement factor H-related protein 2,14338,99,1.10 [0.78-1.56],0.5782096721148542
Chapter II Neoplasms,Melanoma in situ,CFHR4,Complement factor H-related protein 4,14417,100,0.94 [0.73-1.22],0.6647664231288323
Chapter II Neoplasms,Melanoma in situ,CFHR5,Complement factor H-related protein 5,14236,98,1.28 [0.78-2.08],0.3249835631752334
Chapter II Neoplasms,Melanoma in situ,CFI,Complement factor I,14443,100,1.10 [0.41-2.93],0.8567485154372034
Chapter II Neoplasms,Melanoma in situ,CFP,Properdin,14443,100,0.68 [0.26-1.78],0.4345167261091297
Chapter II Neoplasms,Melanoma in situ,CGA,Glycoprotein hormones alpha chain,16531,111,0.88 [0.67-1.16],0.3646843140268201
Chapter II Neoplasms,Melanoma in situ,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14434,100,0.79 [0.48-1.31],0.3654160341969341
Chapter II Neoplasms,Melanoma in situ,CGN,Cingulin,14048,97,1.08 [0.68-1.71],0.74370355447885
Chapter II Neoplasms,Melanoma in situ,CGREF1,Cell growth regulator with EF hand domain protein 1,16502,110,1.21 [0.82-1.80],0.3418550022314082
Chapter II Neoplasms,Melanoma in situ,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16170,109,1.00 [0.75-1.33],0.9925934459614972
Chapter II Neoplasms,Melanoma in situ,CHAD,Chondroadherin,14132,98,0.88 [0.60-1.29],0.5023009819740973
Chapter II Neoplasms,Melanoma in situ,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14404,100,1.10 [0.68-1.77],0.7026523106804647
Chapter II Neoplasms,Melanoma in situ,CHCHD6,MICOS complex subunit MIC25,14369,100,0.51 [0.23-1.16],0.10845291393219
Chapter II Neoplasms,Melanoma in situ,CHEK2,Serine/threonine-protein kinase Chk2,16217,107,0.93 [0.54-1.57],0.774047603379545
Chapter II Neoplasms,Melanoma in situ,CHGA,Chromogranin-A,14428,100,1.01 [0.83-1.24],0.9114619888029084
Chapter II Neoplasms,Melanoma in situ,CHGB,Secretogranin-1,16589,112,0.92 [0.61-1.38],0.6760660172453241
Chapter II Neoplasms,Melanoma in situ,CHI3L1,Chitinase-3-like protein 1,16209,107,0.92 [0.74-1.15],0.4610784071470865
Chapter II Neoplasms,Melanoma in situ,CHIT1,Chitotriosidase-1,16606,111,1.05 [0.93-1.19],0.3925753598086555
Chapter II Neoplasms,Melanoma in situ,CHL1,Neural cell adhesion molecule L1-like protein,16586,110,0.82 [0.46-1.45],0.4908042109273971
Chapter II Neoplasms,Melanoma in situ,CHM,Rab proteins geranylgeranyltransferase component A 1,14048,97,0.95 [0.69-1.32],0.7659033774276636
Chapter II Neoplasms,Melanoma in situ,CHMP1A,Charged multivesicular body protein 1a,16369,109,1.06 [0.86-1.32],0.5708210335682496
Chapter II Neoplasms,Melanoma in situ,CHMP6,Charged multivesicular body protein 6,14415,100,1.00 [0.71-1.41],0.9985950541732088
Chapter II Neoplasms,Melanoma in situ,CHP1,Calcineurin B homologous protein 1,13980,98,1.02 [0.79-1.32],0.8752320224706472
Chapter II Neoplasms,Melanoma in situ,CHRDL1,Chordin-like protein 1,16558,112,0.88 [0.51-1.52],0.6434530650543636
Chapter II Neoplasms,Melanoma in situ,CHRDL2,Chordin-like protein 2,16502,110,0.75 [0.52-1.08],0.1199021589932161
Chapter II Neoplasms,Melanoma in situ,CHRM1,Muscarinic acetylcholine receptor M1,14048,97,0.73 [0.40-1.35],0.318993900414386
Chapter II Neoplasms,Melanoma in situ,CIAPIN1,Anamorsin,16578,111,1.15 [0.88-1.51],0.3042972759763482
Chapter II Neoplasms,Melanoma in situ,CILP,Cartilage intermediate layer protein 1,14428,100,0.79 [0.57-1.10],0.1685716151505466
Chapter II Neoplasms,Melanoma in situ,CINP,Cyclin-dependent kinase 2-interacting protein,14160,99,1.06 [0.69-1.62],0.7876128988444858
Chapter II Neoplasms,Melanoma in situ,CIRBP,Cold-inducible RNA-binding protein,14355,100,1.05 [0.86-1.29],0.6317413418488173
Chapter II Neoplasms,Melanoma in situ,CIT,Citron Rho-interacting kinase,14048,97,1.28 [0.87-1.87],0.2058162281992525
Chapter II Neoplasms,Melanoma in situ,CKAP4,Cytoskeleton-associated protein 4,16620,112,0.87 [0.46-1.64],0.6709126154068723
Chapter II Neoplasms,Melanoma in situ,CKB,Creatine kinase B-type,14428,100,1.05 [0.75-1.46],0.7680566040113738
Chapter II Neoplasms,Melanoma in situ,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16475,112,0.96 [0.76-1.22],0.7377765064512778
Chapter II Neoplasms,Melanoma in situ,CLASP1,CLIP-associating protein 1,13923,96,0.80 [0.59-1.09],0.1625186548043495
Chapter II Neoplasms,Melanoma in situ,CLC,Galectin-10,16473,110,1.21 [0.95-1.53],0.1210118568927433
Chapter II Neoplasms,Melanoma in situ,CLEC10A,C-type lectin domain family 10 member A,16369,109,0.66 [0.41-1.07],0.089234425289044
Chapter II Neoplasms,Melanoma in situ,CLEC11A,C-type lectin domain family 11 member A,16502,111,1.25 [0.88-1.77],0.2067843545085383
Chapter II Neoplasms,Melanoma in situ,CLEC12A,C-type lectin domain family 12 member A,13991,93,1.37 [0.54-3.44],0.5073129065656754
Chapter II Neoplasms,Melanoma in situ,CLEC14A,C-type lectin domain family 14 member A,16531,111,0.84 [0.49-1.43],0.5159771457147962
Chapter II Neoplasms,Melanoma in situ,CLEC1A,C-type lectin domain family 1 member A,16217,107,0.80 [0.47-1.35],0.3979506723030831
Chapter II Neoplasms,Melanoma in situ,CLEC1B,C-type lectin domain family 1 member B,16642,112,1.09 [0.91-1.29],0.3563817959713355
Chapter II Neoplasms,Melanoma in situ,CLEC2L,C-type lectin domain family 2 member L,14048,97,0.94 [0.63-1.40],0.7624321642914155
Chapter II Neoplasms,Melanoma in situ,CLEC3B,Tetranectin,14094,96,0.61 [0.23-1.58],0.3062116433283483
Chapter II Neoplasms,Melanoma in situ,CLEC4A,C-type lectin domain family 4 member A,16479,111,1.11 [0.68-1.83],0.6666654030286573
Chapter II Neoplasms,Melanoma in situ,CLEC4C,C-type lectin domain family 4 member C,16479,111,1.51 [1.08-2.13],0.0167724814182598
Chapter II Neoplasms,Melanoma in situ,CLEC4D,C-type lectin domain family 4 member D,16479,111,1.16 [0.89-1.53],0.2781283472378256
Chapter II Neoplasms,Melanoma in situ,CLEC4G,C-type lectin domain family 4 member G,16479,111,1.47 [0.89-2.43],0.1334510785785887
Chapter II Neoplasms,Melanoma in situ,CLEC4M,C-type lectin domain family 4 member M,14402,100,0.90 [0.61-1.34],0.6022644435929327
Chapter II Neoplasms,Melanoma in situ,CLEC5A,C-type lectin domain family 5 member A,16465,110,0.93 [0.52-1.66],0.8059079325659068
Chapter II Neoplasms,Melanoma in situ,CLEC6A,C-type lectin domain family 6 member A,16170,109,1.30 [0.92-1.85],0.1418318795871068
Chapter II Neoplasms,Melanoma in situ,CLEC7A,C-type lectin domain family 7 member A,16683,112,0.86 [0.69-1.09],0.2135103146168336
Chapter II Neoplasms,Melanoma in situ,CLGN,Calmegin,14048,97,0.98 [0.63-1.53],0.9338174403635552
Chapter II Neoplasms,Melanoma in situ,CLIC5,Chloride intracellular channel protein 5,14048,97,0.80 [0.41-1.56],0.5094143369198143
Chapter II Neoplasms,Melanoma in situ,CLINT1,Clathrin interactor 1,13923,96,0.86 [0.54-1.37],0.5186095682084333
Chapter II Neoplasms,Melanoma in situ,CLIP2,CAP-Gly domain-containing linker protein 2,16479,111,1.09 [0.94-1.27],0.2507438667334645
Chapter II Neoplasms,Melanoma in situ,CLMP,CXADR-like membrane protein,16669,112,0.68 [0.30-1.53],0.3483784621922134
Chapter II Neoplasms,Melanoma in situ,CLNS1A,Methylosome subunit pICln,14048,97,0.93 [0.52-1.68],0.8198075345463195
Chapter II Neoplasms,Melanoma in situ,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16340,109,1.06 [0.89-1.27],0.5138526875617067
Chapter II Neoplasms,Melanoma in situ,CLPS,Colipase,16496,111,0.99 [0.78-1.26],0.9337390119281422
Chapter II Neoplasms,Melanoma in situ,CLSPN,Claspin,16107,109,1.04 [0.65-1.67],0.8608610101678884
Chapter II Neoplasms,Melanoma in situ,CLSTN1,Calsyntenin-1,16136,109,0.88 [0.62-1.24],0.4691127968063315
Chapter II Neoplasms,Melanoma in situ,CLSTN2,Calsyntenin-2,16683,112,0.93 [0.60-1.45],0.7481478897819058
Chapter II Neoplasms,Melanoma in situ,CLSTN3,Calsyntenin-3,14404,100,0.76 [0.40-1.46],0.4153417916563455
Chapter II Neoplasms,Melanoma in situ,CLTA,Clathrin light chain A,16217,107,0.85 [0.58-1.25],0.4113038858435447
Chapter II Neoplasms,Melanoma in situ,CLU,Clusterin,14443,100,0.98 [0.51-1.89],0.9548554591878824
Chapter II Neoplasms,Melanoma in situ,CLUL1,Clusterin-like protein 1,16476,110,1.02 [0.70-1.50],0.908193861267487
Chapter II Neoplasms,Melanoma in situ,CMC1,COX assembly mitochondrial protein homolog,14415,100,0.96 [0.78-1.19],0.7322303205416236
Chapter II Neoplasms,Melanoma in situ,CMIP,C-Maf-inducing protein,14369,100,0.99 [0.78-1.24],0.908222957307057
Chapter II Neoplasms,Melanoma in situ,CNDP1,Beta-Ala-His dipeptidase,16607,110,0.83 [0.58-1.19],0.3183746363609501
Chapter II Neoplasms,Melanoma in situ,CNGB3,Cyclic nucleotide-gated cation channel beta-3,13980,98,0.79 [0.51-1.23],0.3034838998344056
Chapter II Neoplasms,Melanoma in situ,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14031,96,1.07 [0.83-1.37],0.6026032442809004
Chapter II Neoplasms,Melanoma in situ,CNPY2,Protein canopy homolog 2,16217,107,1.00 [0.76-1.32],0.994715856486933
Chapter II Neoplasms,Melanoma in situ,CNPY4,Protein canopy homolog 4,16439,110,1.02 [0.81-1.28],0.8700575325374326
Chapter II Neoplasms,Melanoma in situ,CNST,Consortin,16502,110,1.09 [0.93-1.27],0.287101611074156
Chapter II Neoplasms,Melanoma in situ,CNTF,Ciliary neurotrophic factor,13980,98,0.67 [0.38-1.18],0.1628542271698243
Chapter II Neoplasms,Melanoma in situ,CNTN1,Contactin-1,16720,111,1.20 [0.65-2.21],0.5684933743153014
Chapter II Neoplasms,Melanoma in situ,CNTN2,Contactin-2,16669,112,0.93 [0.64-1.36],0.7184669172231128
Chapter II Neoplasms,Melanoma in situ,CNTN3,Contactin-3,16531,111,1.49 [0.86-2.59],0.1555499461693933
Chapter II Neoplasms,Melanoma in situ,CNTN4,Contactin-4,16531,111,0.82 [0.41-1.67],0.5913974549195797
Chapter II Neoplasms,Melanoma in situ,CNTN5,Contactin-5,16545,112,0.87 [0.55-1.36],0.533294463025116
Chapter II Neoplasms,Melanoma in situ,CNTNAP2,Contactin-associated protein-like 2,16479,111,1.07 [0.71-1.61],0.7624688466248123
Chapter II Neoplasms,Melanoma in situ,CNTNAP4,Contactin-associated protein-like 4,14048,97,0.92 [0.74-1.13],0.4182693368060823
Chapter II Neoplasms,Melanoma in situ,COCH,Cochlin,14415,100,0.83 [0.54-1.27],0.3882927507406385
Chapter II Neoplasms,Melanoma in situ,COL15A1,Collagen alpha-1(XV) chain,14428,100,0.82 [0.39-1.70],0.5896484328609459
Chapter II Neoplasms,Melanoma in situ,COL18A1,Collagen alpha-1(XVIII) chain,16609,110,0.97 [0.47-2.00],0.9288559674293811
Chapter II Neoplasms,Melanoma in situ,COL1A1,Collagen alpha-1(I) chain,16720,111,0.97 [0.50-1.88],0.9186402751683984
Chapter II Neoplasms,Melanoma in situ,COL24A1,Collagen alpha-1(XXIV) chain,14355,100,1.03 [0.73-1.46],0.8692377980755158
Chapter II Neoplasms,Melanoma in situ,COL28A1,Collagen alpha-1(XXVIII) chain,14048,97,0.75 [0.57-0.99],0.0444808795277537
Chapter II Neoplasms,Melanoma in situ,COL2A1,Collagen alpha-1(II) chain,14058,96,0.98 [0.77-1.26],0.8938311041811927
Chapter II Neoplasms,Melanoma in situ,COL3A1,Collagen alpha-1(III) chain,14428,100,0.37 [0.16-0.84],0.0176256864806904
Chapter II Neoplasms,Melanoma in situ,COL4A1,Collagen alpha-1(IV) chain,16502,110,1.06 [0.68-1.64],0.7995614809788953
Chapter II Neoplasms,Melanoma in situ,COL4A4,Collagen alpha-4(IV) chain,14135,99,1.49 [1.00-2.22],0.0477492709689554
Chapter II Neoplasms,Melanoma in situ,COL5A1,Collagen alpha-1(V) chain,14132,98,0.93 [0.56-1.53],0.7716654608209355
Chapter II Neoplasms,Melanoma in situ,COL6A3,Collagen alpha-3(VI) chain,16720,111,0.90 [0.55-1.48],0.6864409887298328
Chapter II Neoplasms,Melanoma in situ,COL9A1,Collagen alpha-1(IX) chain,16479,111,1.34 [0.97-1.85],0.0773335340744793
Chapter II Neoplasms,Melanoma in situ,COL9A2,Collagen alpha-2(IX) chain,14160,99,1.04 [0.70-1.56],0.8470639545402784
Chapter II Neoplasms,Melanoma in situ,COLEC12,Collectin-12,16504,112,1.05 [0.55-1.99],0.8880954303532786
Chapter II Neoplasms,Melanoma in situ,COMMD1,COMM domain-containing protein 1,14058,96,1.04 [0.75-1.45],0.7997945813665807
Chapter II Neoplasms,Melanoma in situ,COMMD9,COMM domain-containing protein 9,14369,100,0.71 [0.41-1.22],0.2182326619109574
Chapter II Neoplasms,Melanoma in situ,COMP,Cartilage oligomeric matrix protein,16358,109,1.00 [0.60-1.68],0.9985666816605218
Chapter II Neoplasms,Melanoma in situ,COMT,Catechol O-methyltransferase,16059,107,1.01 [0.82-1.24],0.943805576641535
Chapter II Neoplasms,Melanoma in situ,COPB2,Coatomer subunit beta',13959,100,0.90 [0.57-1.42],0.6507657099871946
Chapter II Neoplasms,Melanoma in situ,COPE,Coatomer subunit epsilon,16136,109,0.69 [0.44-1.08],0.1086052287182655
Chapter II Neoplasms,Melanoma in situ,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14058,96,0.61 [0.36-1.06],0.0800461131059782
Chapter II Neoplasms,Melanoma in situ,CORO1A,Coronin-1A,16176,110,1.00 [0.83-1.21],0.9941546107805812
Chapter II Neoplasms,Melanoma in situ,CORO6,Coronin-6,13980,98,0.72 [0.40-1.29],0.2676873777983559
Chapter II Neoplasms,Melanoma in situ,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16439,110,0.92 [0.72-1.18],0.5026762127922559
Chapter II Neoplasms,Melanoma in situ,COX6B1,Cytochrome c oxidase subunit 6B1,14415,100,0.57 [0.30-1.06],0.0769368864408651
Chapter II Neoplasms,Melanoma in situ,CPA1,Carboxypeptidase A1,16720,111,1.00 [0.76-1.32],0.9766461212651504
Chapter II Neoplasms,Melanoma in situ,CPA2,Carboxypeptidase A2,16591,111,0.97 [0.75-1.25],0.8234043021524183
Chapter II Neoplasms,Melanoma in situ,CPA4,Carboxypeptidase A4,13855,98,1.02 [0.64-1.61],0.9463534387418304
Chapter II Neoplasms,Melanoma in situ,CPB1,Carboxypeptidase B,16720,111,1.11 [0.84-1.47],0.4613019308623424
Chapter II Neoplasms,Melanoma in situ,CPB2,Carboxypeptidase B2,14416,100,0.66 [0.28-1.58],0.3538865165016401
Chapter II Neoplasms,Melanoma in situ,CPE,Carboxypeptidase E,16525,112,0.86 [0.57-1.29],0.4688355507053042
Chapter II Neoplasms,Melanoma in situ,CPLX2,Complexin-2,13923,96,1.15 [0.65-2.02],0.6276838691004156
Chapter II Neoplasms,Melanoma in situ,CPM,Carboxypeptidase M,16552,111,0.66 [0.39-1.10],0.1109958381922203
Chapter II Neoplasms,Melanoma in situ,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",13991,93,1.16 [0.57-2.35],0.6893730043976716
Chapter II Neoplasms,Melanoma in situ,CPPED1,Serine/threonine-protein phosphatase CPPED1,16642,112,1.13 [0.88-1.45],0.3291763068645121
Chapter II Neoplasms,Melanoma in situ,CPQ,Carboxypeptidase Q,14395,100,0.55 [0.32-0.92],0.0220722336353664
Chapter II Neoplasms,Melanoma in situ,CPTP,Ceramide-1-phosphate transfer protein,13959,100,0.56 [0.31-1.02],0.0560244666564382
Chapter II Neoplasms,Melanoma in situ,CPVL,Probable serine carboxypeptidase CPVL,16648,112,0.65 [0.45-0.93],0.0192767151671767
Chapter II Neoplasms,Melanoma in situ,CPXM1,Probable carboxypeptidase X1,16578,111,1.20 [0.95-1.52],0.1214984550374626
Chapter II Neoplasms,Melanoma in situ,CPXM2,Inactive carboxypeptidase-like protein X2,14415,100,0.47 [0.22-1.02],0.0573238900203501
Chapter II Neoplasms,Melanoma in situ,CR1,Complement receptor type 1,14382,100,0.76 [0.44-1.30],0.3122969604180197
Chapter II Neoplasms,Melanoma in situ,CR2,Complement receptor type 2,16607,110,1.02 [0.71-1.46],0.9190024732151324
Chapter II Neoplasms,Melanoma in situ,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16170,109,1.08 [0.89-1.31],0.4518932541233672
Chapter II Neoplasms,Melanoma in situ,CRADD,Death domain-containing protein CRADD,16340,109,1.06 [0.84-1.33],0.6176198147383425
Chapter II Neoplasms,Melanoma in situ,CREB3,Cyclic AMP-responsive element-binding protein 3,13923,96,0.95 [0.66-1.37],0.8017473993476542
Chapter II Neoplasms,Melanoma in situ,CREBZF,CREB/ATF bZIP transcription factor,13923,96,0.48 [0.21-1.06],0.0707886326378467
Chapter II Neoplasms,Melanoma in situ,CREG1,Protein CREG1,16326,109,0.69 [0.43-1.10],0.1204740487622879
Chapter II Neoplasms,Melanoma in situ,CRELD1,Protein disulfide isomerase CRELD1,14132,98,1.00 [0.59-1.71],0.9869607527657648
Chapter II Neoplasms,Melanoma in situ,CRELD2,Protein disulfide isomerase CRELD2,16558,112,1.07 [0.77-1.47],0.7034066203520104
Chapter II Neoplasms,Melanoma in situ,CRH,Corticoliberin,16144,109,1.03 [0.85-1.26],0.7475681814376589
Chapter II Neoplasms,Melanoma in situ,CRHBP,Corticotropin-releasing factor-binding protein,16504,112,0.87 [0.47-1.61],0.6495796505752232
Chapter II Neoplasms,Melanoma in situ,CRHR1,Corticotropin-releasing factor receptor 1,16217,107,0.93 [0.69-1.25],0.6229227505841712
Chapter II Neoplasms,Melanoma in situ,CRIM1,Cysteine-rich motor neuron 1 protein,16583,112,0.63 [0.27-1.47],0.2847915426185319
Chapter II Neoplasms,Melanoma in situ,CRIP2,Cysteine-rich protein 2,16369,109,0.76 [0.46-1.23],0.2626403326221527
Chapter II Neoplasms,Melanoma in situ,CRISP2,Cysteine-rich secretory protein 2,16669,112,1.31 [0.98-1.77],0.0702726091130758
Chapter II Neoplasms,Melanoma in situ,CRISP3,Cysteine-rich secretory protein 3,14305,99,1.31 [0.64-2.69],0.4587287332620314
Chapter II Neoplasms,Melanoma in situ,CRKL,Crk-like protein,16541,112,1.08 [0.92-1.26],0.3678118069610363
Chapter II Neoplasms,Melanoma in situ,CRLF1,Cytokine receptor-like factor 1,16583,112,1.88 [0.95-3.73],0.0706943259136611
Chapter II Neoplasms,Melanoma in situ,CRNN,Cornulin,16090,108,0.96 [0.74-1.23],0.7190949131886315
Chapter II Neoplasms,Melanoma in situ,CRTAC1,Cartilage acidic protein 1,16720,111,1.08 [0.61-1.89],0.7944664513606174
Chapter II Neoplasms,Melanoma in situ,CRTAM,Cytotoxic and regulatory T-cell molecule,16369,109,1.11 [0.79-1.55],0.546669650811995
Chapter II Neoplasms,Melanoma in situ,CRTAP,Cartilage-associated protein,14048,97,0.75 [0.46-1.20],0.2257038679066984
Chapter II Neoplasms,Melanoma in situ,CRX,Cone-rod homeobox protein,16217,107,0.85 [0.69-1.04],0.1053934011890672
Chapter II Neoplasms,Melanoma in situ,CRYBB1,Beta-crystallin B1,14415,100,1.02 [0.76-1.39],0.8729330402897825
Chapter II Neoplasms,Melanoma in situ,CRYBB2,Beta-crystallin B2,14404,100,1.11 [0.91-1.36],0.3173917306247922
Chapter II Neoplasms,Melanoma in situ,CRYGD,Gamma-crystallin D,14404,100,1.09 [0.90-1.34],0.3755444502597546
Chapter II Neoplasms,Melanoma in situ,CRYM,Ketimine reductase mu-crystallin,13980,98,1.01 [0.77-1.31],0.9677368306920224
Chapter II Neoplasms,Melanoma in situ,CRYZL1,Quinone oxidoreductase-like protein 1,14058,96,1.04 [0.83-1.29],0.7501010455076363
Chapter II Neoplasms,Melanoma in situ,CSDE1,Cold shock domain-containing protein E1,13959,100,1.04 [0.89-1.21],0.6602723348745019
Chapter II Neoplasms,Melanoma in situ,CSF1,Macrophage colony-stimulating factor 1,16583,112,1.34 [0.72-2.48],0.3594262808017174
Chapter II Neoplasms,Melanoma in situ,CSF1R,Macrophage colony-stimulating factor 1 receptor,14434,100,0.83 [0.51-1.36],0.4634646717510954
Chapter II Neoplasms,Melanoma in situ,CSF2,Granulocyte-macrophage colony-stimulating factor,13959,100,0.70 [0.40-1.23],0.2133858070447096
Chapter II Neoplasms,Melanoma in situ,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16369,109,1.17 [0.90-1.51],0.2433530430083038
Chapter II Neoplasms,Melanoma in situ,CSF2RB,Cytokine receptor common subunit beta,13991,93,0.62 [0.40-0.98],0.0391631165589073
Chapter II Neoplasms,Melanoma in situ,CSF3,Granulocyte colony-stimulating factor,16225,109,0.88 [0.62-1.26],0.4933787938182544
Chapter II Neoplasms,Melanoma in situ,CSF3R,Granulocyte colony-stimulating factor receptor,13991,93,1.36 [0.72-2.57],0.3442575153480793
Chapter II Neoplasms,Melanoma in situ,CSH1,Chorionic somatomammotropin hormone 1,14434,100,0.95 [0.49-1.86],0.8783302740776371
Chapter II Neoplasms,Melanoma in situ,CSNK1D,Casein kinase I isoform delta,13991,93,0.94 [0.68-1.30],0.6954646082474321
Chapter II Neoplasms,Melanoma in situ,CSNK2A1,Casein kinase II subunit alpha,14396,100,0.83 [0.53-1.28],0.3879909443369169
Chapter II Neoplasms,Melanoma in situ,CSPG4,Chondroitin sulfate proteoglycan 4,14428,100,0.70 [0.39-1.27],0.2415984636839873
Chapter II Neoplasms,Melanoma in situ,CSPG5,Chondroitin sulfate proteoglycan 5,13980,98,1.02 [0.70-1.49],0.9185707141191672
Chapter II Neoplasms,Melanoma in situ,CSRP3,Cysteine and glycine-rich protein 3,13959,100,0.98 [0.80-1.20],0.8760684346704838
Chapter II Neoplasms,Melanoma in situ,CST1,Cystatin-SN,12553,88,0.93 [0.76-1.14],0.4819759076303817
Chapter II Neoplasms,Melanoma in situ,CST3,Cystatin-C,16580,110,0.89 [0.49-1.63],0.7181046353150946
Chapter II Neoplasms,Melanoma in situ,CST5,Cystatin-D,16194,107,0.64 [0.47-0.89],0.0069537206407766
Chapter II Neoplasms,Melanoma in situ,CST6,Cystatin-M,16082,104,0.96 [0.67-1.37],0.8015838431583413
Chapter II Neoplasms,Melanoma in situ,CST7,Cystatin-F,16545,112,1.03 [0.86-1.22],0.7664908559846668
Chapter II Neoplasms,Melanoma in situ,CSTB,Cystatin-B,16298,108,1.22 [0.82-1.82],0.3326443760072199
Chapter II Neoplasms,Melanoma in situ,CTAG1A_CTAG1B,Cancer/testis antigen 1,14135,98,0.81 [0.54-1.22],0.3237660017301351
Chapter II Neoplasms,Melanoma in situ,CTBS,Di-N-acetylchitobiase,14213,100,0.74 [0.37-1.49],0.4008925213715809
Chapter II Neoplasms,Melanoma in situ,CTF1,Cardiotrophin-1,16217,107,0.91 [0.73-1.12],0.3507391513391903
Chapter II Neoplasms,Melanoma in situ,CTHRC1,Collagen triple helix repeat-containing protein 1,14428,100,1.20 [0.62-2.33],0.5941786919361179
Chapter II Neoplasms,Melanoma in situ,CTLA4,Cytotoxic T-lymphocyte protein 4,14428,100,0.43 [0.23-0.82],0.0099093483574585
Chapter II Neoplasms,Melanoma in situ,CTNNA1,Catenin alpha-1,13980,98,1.06 [0.62-1.81],0.8233661990659956
Chapter II Neoplasms,Melanoma in situ,CTRB1,Chymotrypsinogen B,16531,111,0.84 [0.62-1.14],0.264616925232355
Chapter II Neoplasms,Melanoma in situ,CTRC,Chymotrypsin-C,16512,112,0.94 [0.73-1.22],0.6602198080069251
Chapter II Neoplasms,Melanoma in situ,CTRL,Chymotrypsin-like protease CTRL-1,14404,100,0.98 [0.74-1.29],0.8799191831163432
Chapter II Neoplasms,Melanoma in situ,CTSB,Cathepsin B,16554,110,0.82 [0.59-1.13],0.2232836809872591
Chapter II Neoplasms,Melanoma in situ,CTSC,Dipeptidyl peptidase 1,16486,112,0.90 [0.61-1.32],0.5886987533847612
Chapter II Neoplasms,Melanoma in situ,CTSD,Cathepsin D,15475,101,0.54 [0.33-0.91],0.0191752043741216
Chapter II Neoplasms,Melanoma in situ,CTSE,Cathepsin E,14132,98,0.98 [0.67-1.44],0.9269562098268496
Chapter II Neoplasms,Melanoma in situ,CTSF,Cathepsin F,16578,111,0.59 [0.38-0.90],0.0159083010383034
Chapter II Neoplasms,Melanoma in situ,CTSH,Pro-cathepsin H,16159,106,0.73 [0.58-0.92],0.0080985686812772
Chapter II Neoplasms,Melanoma in situ,CTSL,Cathepsin L1,16502,110,1.78 [0.92-3.46],0.0890180336547157
Chapter II Neoplasms,Melanoma in situ,CTSO,Cathepsin O,16683,112,1.11 [0.64-1.93],0.7137428933460807
Chapter II Neoplasms,Melanoma in situ,CTSS,Cathepsin S,12924,91,0.89 [0.37-2.10],0.7847455041800533
Chapter II Neoplasms,Melanoma in situ,CTSV,Cathepsin L2,16615,112,0.78 [0.51-1.19],0.241949199542596
Chapter II Neoplasms,Melanoma in situ,CTSZ,Cathepsin Z,16562,110,0.59 [0.35-1.00],0.0488527017623971
Chapter II Neoplasms,Melanoma in situ,CUZD1,CUB and zona pellucida-like domain-containing protein 1,14048,97,0.92 [0.53-1.60],0.7581590181021599
Chapter II Neoplasms,Melanoma in situ,CWC15,Spliceosome-associated protein CWC15 homolog,14263,100,0.98 [0.72-1.35],0.9228580051177662
Chapter II Neoplasms,Melanoma in situ,CX3CL1,Fractalkine,16369,109,0.59 [0.35-1.00],0.0482737309122158
Chapter II Neoplasms,Melanoma in situ,CXADR,Coxsackievirus and adenovirus receptor,16479,111,1.28 [0.94-1.74],0.1181643587257625
Chapter II Neoplasms,Melanoma in situ,CXCL1,Growth-regulated alpha protein,16500,112,1.06 [0.89-1.25],0.5108097361269215
Chapter II Neoplasms,Melanoma in situ,CXCL10,C-X-C motif chemokine 10,16583,112,1.01 [0.79-1.30],0.9238574942352924
Chapter II Neoplasms,Melanoma in situ,CXCL11,C-X-C motif chemokine 11,16642,112,1.22 [1.02-1.46],0.0320919660533845
Chapter II Neoplasms,Melanoma in situ,CXCL12,Stromal cell-derived factor 1,16225,109,0.80 [0.52-1.24],0.3234777860771013
Chapter II Neoplasms,Melanoma in situ,CXCL13,C-X-C motif chemokine 13,16642,112,0.94 [0.70-1.26],0.673286248294843
Chapter II Neoplasms,Melanoma in situ,CXCL14,C-X-C motif chemokine 14,16225,109,1.12 [0.86-1.47],0.3882397507814601
Chapter II Neoplasms,Melanoma in situ,CXCL16,C-X-C motif chemokine 16,16700,111,0.73 [0.35-1.50],0.3883561214428436
Chapter II Neoplasms,Melanoma in situ,CXCL17,C-X-C motif chemokine 17,16683,112,1.07 [0.71-1.63],0.7355484959664107
Chapter II Neoplasms,Melanoma in situ,CXCL3,C-X-C motif chemokine 3,16520,112,0.99 [0.83-1.18],0.8714073639432248
Chapter II Neoplasms,Melanoma in situ,CXCL5,C-X-C motif chemokine 5,16452,110,0.95 [0.82-1.10],0.4594319933742099
Chapter II Neoplasms,Melanoma in situ,CXCL6,C-X-C motif chemokine 6,16683,112,1.12 [0.90-1.39],0.2980223406949676
Chapter II Neoplasms,Melanoma in situ,CXCL8,Interleukin-8,16422,107,1.00 [0.79-1.28],0.9705270488592548
Chapter II Neoplasms,Melanoma in situ,CXCL9,C-X-C motif chemokine 9,16583,112,1.01 [0.78-1.30],0.9672096313679144
Chapter II Neoplasms,Melanoma in situ,CYB5A,Cytochrome b5,13923,96,1.17 [0.93-1.46],0.1722518478841135
Chapter II Neoplasms,Melanoma in situ,CYB5R2,NADH-cytochrome b5 reductase 2,14201,97,1.22 [0.86-1.72],0.2592711213587688
Chapter II Neoplasms,Melanoma in situ,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",13959,100,0.91 [0.72-1.17],0.4746286569475533
Chapter II Neoplasms,Melanoma in situ,CYTH3,Cytohesin-3,13923,96,0.91 [0.68-1.22],0.5348642482266432
Chapter II Neoplasms,Melanoma in situ,CYTL1,Cytokine-like protein 1,14428,100,0.67 [0.31-1.47],0.3199192155250804
Chapter II Neoplasms,Melanoma in situ,DAAM1,Disheveled-associated activator of morphogenesis 1,14132,98,1.07 [0.85-1.36],0.5540838339281958
Chapter II Neoplasms,Melanoma in situ,DAB2,Disabled homolog 2,16669,112,1.04 [0.89-1.20],0.650831008420055
Chapter II Neoplasms,Melanoma in situ,DAG1,Dystroglycan,16583,112,1.08 [0.75-1.55],0.6753390979417142
Chapter II Neoplasms,Melanoma in situ,DAND5,DAN domain family member 5,13991,93,0.86 [0.60-1.25],0.4331392926440821
Chapter II Neoplasms,Melanoma in situ,DAPK2,Death-associated protein kinase 2,13991,93,1.05 [0.74-1.49],0.7753585719919918
Chapter II Neoplasms,Melanoma in situ,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16479,111,1.03 [0.90-1.19],0.6514225802646405
Chapter II Neoplasms,Melanoma in situ,DARS1,"Aspartate--tRNA ligase, cytoplasmic",16340,109,1.12 [0.88-1.41],0.3543188095740081
Chapter II Neoplasms,Melanoma in situ,DBH,Dopamine beta-hydroxylase,14406,100,1.11 [0.91-1.35],0.2928668879899714
Chapter II Neoplasms,Melanoma in situ,DBI,Acyl-CoA-binding protein,16461,111,1.06 [0.85-1.32],0.6239891453321151
Chapter II Neoplasms,Melanoma in situ,DBN1,Drebrin,13991,93,1.08 [0.73-1.61],0.7013861013094159
Chapter II Neoplasms,Melanoma in situ,DBNL,Drebrin-like protein,16583,112,1.07 [0.89-1.29],0.4667155355325139
Chapter II Neoplasms,Melanoma in situ,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16578,111,1.11 [0.68-1.80],0.6716465191048422
Chapter II Neoplasms,Melanoma in situ,DCC,Netrin receptor DCC,14048,97,0.78 [0.31-1.99],0.6020690512203116
Chapter II Neoplasms,Melanoma in situ,DCDC2C,Doublecortin domain-containing protein 2C,13923,96,1.10 [0.83-1.46],0.5115973088065813
Chapter II Neoplasms,Melanoma in situ,DCLRE1C,Protein artemis,13923,96,0.49 [0.25-0.96],0.0370366421125194
Chapter II Neoplasms,Melanoma in situ,DCN,Decorin,16217,107,0.73 [0.34-1.55],0.4096760513450693
Chapter II Neoplasms,Melanoma in situ,DCTD,Deoxycytidylate deaminase,14132,98,1.06 [0.86-1.30],0.6043946801837059
Chapter II Neoplasms,Melanoma in situ,DCTN1,Dynactin subunit 1,16669,112,1.11 [0.86-1.43],0.4318747370345155
Chapter II Neoplasms,Melanoma in situ,DCTN2,Dynactin subunit 2,16439,110,1.04 [0.87-1.25],0.6478668954570121
Chapter II Neoplasms,Melanoma in situ,DCTN6,Dynactin subunit 6,16136,109,0.98 [0.77-1.24],0.8595527952185605
Chapter II Neoplasms,Melanoma in situ,DCTPP1,dCTP pyrophosphatase 1,16502,110,1.36 [0.79-2.35],0.2713251422990382
Chapter II Neoplasms,Melanoma in situ,DCUN1D1,DCN1-like protein 1,13980,98,1.09 [0.86-1.37],0.4787855573870229
Chapter II Neoplasms,Melanoma in situ,DCUN1D2,DCN1-like protein 2,13923,96,1.15 [0.93-1.42],0.201504274333136
Chapter II Neoplasms,Melanoma in situ,DCXR,L-xylulose reductase,16578,111,0.98 [0.71-1.36],0.8965393155413885
Chapter II Neoplasms,Melanoma in situ,DDA1,DET1- and DDB1-associated protein 1,13959,100,0.45 [0.24-0.83],0.0110567812984779
Chapter II Neoplasms,Melanoma in situ,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16439,110,1.19 [0.82-1.74],0.352895731054819
Chapter II Neoplasms,Melanoma in situ,DDC,Aromatic-L-amino-acid decarboxylase,16476,110,1.18 [0.83-1.68],0.3570735217956983
Chapter II Neoplasms,Melanoma in situ,DDHD2,Phospholipase DDHD2,14396,100,0.94 [0.70-1.27],0.7048743789320298
Chapter II Neoplasms,Melanoma in situ,DDI2,Protein DDI1 homolog 2,14132,98,0.97 [0.76-1.24],0.813941601547446
Chapter II Neoplasms,Melanoma in situ,DDR1,Epithelial discoidin domain-containing receptor 1,16642,112,0.70 [0.33-1.50],0.3606225331611703
Chapter II Neoplasms,Melanoma in situ,DDT,D-dopachrome decarboxylase,14428,100,1.03 [0.65-1.62],0.9103837923571496
Chapter II Neoplasms,Melanoma in situ,DDX1,ATP-dependent RNA helicase DDX1,14355,100,0.75 [0.48-1.19],0.2242979938739633
Chapter II Neoplasms,Melanoma in situ,DDX25,ATP-dependent RNA helicase DDX25,14048,97,0.93 [0.54-1.62],0.8043545069707844
Chapter II Neoplasms,Melanoma in situ,DDX39A,ATP-dependent RNA helicase DDX39A,13991,93,1.35 [0.66-2.77],0.4168479412875866
Chapter II Neoplasms,Melanoma in situ,DDX4,Probable ATP-dependent RNA helicase DDX4,13991,93,0.76 [0.49-1.19],0.2259496781707693
Chapter II Neoplasms,Melanoma in situ,DDX53,Probable ATP-dependent RNA helicase DDX53,14048,97,1.05 [0.61-1.79],0.8664370742052838
Chapter II Neoplasms,Melanoma in situ,DDX58,Antiviral innate immune response receptor RIG-I,16170,109,1.06 [0.79-1.42],0.7022631584058594
Chapter II Neoplasms,Melanoma in situ,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16479,111,0.99 [0.83-1.18],0.911333431202077
Chapter II Neoplasms,Melanoma in situ,DEFA1_DEFA1B,Neutrophil defensin 1,16212,107,1.00 [0.72-1.38],0.9930501882783508
Chapter II Neoplasms,Melanoma in situ,DEFB103A_DEFB103B,Beta-defensin 103,13877,93,0.87 [0.51-1.47],0.6042764232398437
Chapter II Neoplasms,Melanoma in situ,DEFB104A_DEFB104B,Beta-defensin 104,13980,98,1.10 [0.79-1.54],0.583480720546926
Chapter II Neoplasms,Melanoma in situ,DEFB116,Beta-defensin 116,13980,98,1.32 [1.09-1.60],0.003916243714047
Chapter II Neoplasms,Melanoma in situ,DEFB118,Beta-defensin 118,13980,98,0.92 [0.63-1.33],0.6485383457973062
Chapter II Neoplasms,Melanoma in situ,DEFB4A_DEFB4B,Beta-defensin 4A,16297,109,1.06 [0.95-1.19],0.3073656330096651
Chapter II Neoplasms,Melanoma in situ,DENND2B,DENN domain-containing protein 2B,13959,100,1.09 [0.78-1.53],0.6193230242804714
Chapter II Neoplasms,Melanoma in situ,DENR,Density-regulated protein,13991,93,0.94 [0.65-1.35],0.7278313477241154
Chapter II Neoplasms,Melanoma in situ,DFFA,DNA fragmentation factor subunit alpha,16683,112,1.18 [0.92-1.50],0.1963456672603405
Chapter II Neoplasms,Melanoma in situ,DGCR6,Protein DGCR6,13980,98,0.93 [0.58-1.49],0.7641479415200452
Chapter II Neoplasms,Melanoma in situ,DGKA,Diacylglycerol kinase alpha,13991,93,0.94 [0.64-1.37],0.7433914329985326
Chapter II Neoplasms,Melanoma in situ,DGKZ,Diacylglycerol kinase zeta,16225,109,1.05 [0.65-1.71],0.831185461280444
Chapter II Neoplasms,Melanoma in situ,DHODH,Dihydroorotate dehydrogenase,13959,100,1.00 [0.67-1.48],0.9820937418985464
Chapter II Neoplasms,Melanoma in situ,DHPS,Deoxyhypusine synthase,14369,100,1.11 [0.71-1.74],0.6357842316218348
Chapter II Neoplasms,Melanoma in situ,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14404,100,1.04 [0.69-1.56],0.8448050000465557
Chapter II Neoplasms,Melanoma in situ,DIABLO,"Diablo homolog, mitochondrial",16465,110,1.05 [0.90-1.22],0.5548502210467015
Chapter II Neoplasms,Melanoma in situ,DIPK1C,Divergent protein kinase domain 1C,14048,97,0.77 [0.46-1.28],0.3118080893883868
Chapter II Neoplasms,Melanoma in situ,DIPK2B,Divergent protein kinase domain 2B,14132,98,1.07 [0.53-2.19],0.8454904162336345
Chapter II Neoplasms,Melanoma in situ,DKK1,Dickkopf-related protein 1,16642,112,1.06 [0.80-1.41],0.6786770565357256
Chapter II Neoplasms,Melanoma in situ,DKK3,Dickkopf-related protein 3,16720,111,0.94 [0.53-1.65],0.8180210013805916
Chapter II Neoplasms,Melanoma in situ,DKK4,Dickkopf-related protein 4,16348,108,1.07 [0.74-1.55],0.7291082384643028
Chapter II Neoplasms,Melanoma in situ,DKKL1,Dickkopf-like protein 1,16439,110,1.03 [0.85-1.26],0.7474194822765917
Chapter II Neoplasms,Melanoma in situ,DLG4,Disks large homolog 4,14404,100,1.05 [0.81-1.37],0.7092280179871459
Chapter II Neoplasms,Melanoma in situ,DLGAP5,Disks large-associated protein 5,14396,100,0.90 [0.60-1.37],0.6327104545408924
Chapter II Neoplasms,Melanoma in situ,DLK1,Protein delta homolog 1,16720,111,0.98 [0.72-1.33],0.8759770340077835
Chapter II Neoplasms,Melanoma in situ,DLL1,Delta-like protein 1,16578,111,1.17 [0.67-2.06],0.5858748548603951
Chapter II Neoplasms,Melanoma in situ,DLL4,Delta-like protein 4,14058,96,0.80 [0.56-1.13],0.2056244541064603
Chapter II Neoplasms,Melanoma in situ,DMD,Dystrophin,14058,96,0.99 [0.65-1.49],0.9451799064478874
Chapter II Neoplasms,Melanoma in situ,DMP1,Dentin matrix acidic phosphoprotein 1,14058,96,1.06 [0.75-1.49],0.739537893610125
Chapter II Neoplasms,Melanoma in situ,DNAJA1,DnaJ homolog subfamily A member 1,13923,96,0.83 [0.51-1.34],0.438780781727445
Chapter II Neoplasms,Melanoma in situ,DNAJA2,DnaJ homolog subfamily A member 2,16645,112,1.04 [0.85-1.27],0.717228487898463
Chapter II Neoplasms,Melanoma in situ,DNAJA4,DnaJ homolog subfamily A member 4,14404,100,0.96 [0.73-1.25],0.7605355912836063
Chapter II Neoplasms,Melanoma in situ,DNAJB1,DnaJ homolog subfamily B member 1,16439,110,1.05 [0.86-1.27],0.6376227949387195
Chapter II Neoplasms,Melanoma in situ,DNAJB14,DnaJ homolog subfamily B member 14,14355,100,0.98 [0.72-1.32],0.8762257646823811
Chapter II Neoplasms,Melanoma in situ,DNAJB2,DnaJ homolog subfamily B member 2,14132,98,1.11 [0.78-1.58],0.5741530705956205
Chapter II Neoplasms,Melanoma in situ,DNAJB6,DnaJ homolog subfamily B member 6,13997,98,1.02 [0.81-1.29],0.8557710395240343
Chapter II Neoplasms,Melanoma in situ,DNAJB8,DnaJ homolog subfamily B member 8,16217,107,0.87 [0.62-1.21],0.3939454497202633
Chapter II Neoplasms,Melanoma in situ,DNAJC21,DnaJ homolog subfamily C member 21,14404,100,0.99 [0.60-1.63],0.9627147077672972
Chapter II Neoplasms,Melanoma in situ,DNAJC6,Putative tyrosine-protein phosphatase auxilin,14058,96,1.08 [0.85-1.37],0.5203983041285505
Chapter II Neoplasms,Melanoma in situ,DNAJC9,DnaJ homolog subfamily C member 9,14355,100,1.02 [0.80-1.31],0.8725043993382988
Chapter II Neoplasms,Melanoma in situ,DNER,Delta and Notch-like epidermal growth factor-related receptor,16479,112,0.69 [0.35-1.36],0.2868808784367802
Chapter II Neoplasms,Melanoma in situ,DNLZ,DNL-type zinc finger protein,13980,98,0.98 [0.78-1.22],0.8532279377776235
Chapter II Neoplasms,Melanoma in situ,DNM1,Dynamin-1,14355,100,1.00 [0.84-1.19],0.9913707589704474
Chapter II Neoplasms,Melanoma in situ,DNM3,Dynamin-3,14396,100,0.96 [0.67-1.37],0.80771590340849
Chapter II Neoplasms,Melanoma in situ,DNMBP,Dynamin-binding protein,16369,109,1.08 [0.82-1.43],0.5681031618815642
Chapter II Neoplasms,Melanoma in situ,DNPEP,Aspartyl aminopeptidase,14404,100,1.27 [0.90-1.79],0.180393645070997
Chapter II Neoplasms,Melanoma in situ,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16566,112,1.01 [0.73-1.39],0.9666296888323952
Chapter II Neoplasms,Melanoma in situ,DOC2B,Double C2-like domain-containing protein beta,14048,97,0.80 [0.43-1.50],0.4932664348441063
Chapter II Neoplasms,Melanoma in situ,DOCK9,Dedicator of cytokinesis protein 9,13980,98,0.99 [0.84-1.17],0.9460427045791694
Chapter II Neoplasms,Melanoma in situ,DOK1,Docking protein 1,14404,100,1.04 [0.90-1.20],0.6031448708926841
Chapter II Neoplasms,Melanoma in situ,DOK2,Docking protein 2,16502,110,1.08 [0.94-1.24],0.3084427672451352
Chapter II Neoplasms,Melanoma in situ,DPEP1,Dipeptidase 1,16340,109,0.82 [0.58-1.14],0.2310427955014305
Chapter II Neoplasms,Melanoma in situ,DPEP2,Dipeptidase 2,16439,110,0.88 [0.49-1.58],0.6671829367327502
Chapter II Neoplasms,Melanoma in situ,DPP10,Inactive dipeptidyl peptidase 10,16479,111,0.91 [0.56-1.49],0.7108219716914195
Chapter II Neoplasms,Melanoma in situ,DPP4,Dipeptidyl peptidase 4,16260,109,0.73 [0.39-1.36],0.3216348835629644
Chapter II Neoplasms,Melanoma in situ,DPP6,Dipeptidyl aminopeptidase-like protein 6,16439,110,0.78 [0.47-1.29],0.3302368903873808
Chapter II Neoplasms,Melanoma in situ,DPP7,Dipeptidyl peptidase 2,16378,108,0.85 [0.63-1.13],0.2497186891611834
Chapter II Neoplasms,Melanoma in situ,DPT,Dermatopontin,16720,111,1.17 [0.60-2.32],0.643166112281913
Chapter II Neoplasms,Melanoma in situ,DPY30,Protein dpy-30 homolog,16610,111,1.10 [0.83-1.45],0.5021642802828163
Chapter II Neoplasms,Melanoma in situ,DRAXIN,Draxin,16369,109,1.01 [0.68-1.51],0.9446466077076576
Chapter II Neoplasms,Melanoma in situ,DRG2,Developmentally-regulated GTP-binding protein 2,16439,110,1.16 [0.86-1.55],0.3325310708290472
Chapter II Neoplasms,Melanoma in situ,DSC2,Desmocollin-2,16354,111,0.88 [0.53-1.46],0.6146150592677168
Chapter II Neoplasms,Melanoma in situ,DSCAM,Down syndrome cell adhesion molecule,14396,100,1.29 [0.75-2.21],0.3556590675132941
Chapter II Neoplasms,Melanoma in situ,DSG2,Desmoglein-2,16531,111,0.84 [0.45-1.58],0.5924489755257201
Chapter II Neoplasms,Melanoma in situ,DSG3,Desmoglein-3,16613,110,1.02 [0.62-1.69],0.9299702886932986
Chapter II Neoplasms,Melanoma in situ,DSG4,Desmoglein-4,16384,110,0.71 [0.50-0.99],0.0430395662906473
Chapter II Neoplasms,Melanoma in situ,DTD1,D-aminoacyl-tRNA deacylase 1,14132,98,0.94 [0.75-1.18],0.6012616273915661
Chapter II Neoplasms,Melanoma in situ,DTNB,Dystrobrevin beta,14338,99,1.52 [0.98-2.35],0.0605606919237288
Chapter II Neoplasms,Melanoma in situ,DTX2,Probable E3 ubiquitin-protein ligase DTX2,14048,97,0.95 [0.69-1.33],0.783230471829623
Chapter II Neoplasms,Melanoma in situ,DTX3,Probable E3 ubiquitin-protein ligase DTX3,16439,110,0.53 [0.25-1.13],0.1016502467178524
Chapter II Neoplasms,Melanoma in situ,DTYMK,Thymidylate kinase,14415,100,1.06 [0.80-1.40],0.7000354103147102
Chapter II Neoplasms,Melanoma in situ,DUOX2,Dual oxidase 2,16217,107,0.78 [0.58-1.04],0.091388649126622
Chapter II Neoplasms,Melanoma in situ,DUSP13,Dual specificity protein phosphatase 13 isoform A,14369,100,0.84 [0.52-1.36],0.4748415052074143
Chapter II Neoplasms,Melanoma in situ,DUSP29,Dual specificity phosphatase 29,14048,97,0.99 [0.73-1.34],0.9502563121519186
Chapter II Neoplasms,Melanoma in situ,DUSP3,Dual specificity protein phosphatase 3,16136,109,1.19 [1.02-1.39],0.0271258899517223
Chapter II Neoplasms,Melanoma in situ,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14355,100,1.02 [0.85-1.23],0.8016588170756354
Chapter II Neoplasms,Melanoma in situ,DXO,Decapping and exoribonuclease protein,14404,100,1.38 [0.92-2.07],0.124277212856679
Chapter II Neoplasms,Melanoma in situ,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14369,100,0.59 [0.35-1.01],0.0541518333141389
Chapter II Neoplasms,Melanoma in situ,DYNLT1,Dynein light chain Tctex-type 1,14048,97,1.07 [0.85-1.36],0.560775507958484
Chapter II Neoplasms,Melanoma in situ,DYNLT3,Dynein light chain Tctex-type 3,14369,100,1.19 [0.77-1.83],0.429616347669004
Chapter II Neoplasms,Melanoma in situ,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16369,109,1.09 [0.91-1.30],0.3482231178450999
Chapter II Neoplasms,Melanoma in situ,EBI3_IL27,Interleukin-27,16639,112,1.05 [0.60-1.83],0.8664121994098493
Chapter II Neoplasms,Melanoma in situ,ECE1,Endothelin-converting enzyme 1,16136,109,0.91 [0.56-1.48],0.7090889867981078
Chapter II Neoplasms,Melanoma in situ,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14415,100,0.93 [0.70-1.22],0.5984374597703201
Chapter II Neoplasms,Melanoma in situ,ECHS1,"Enoyl-CoA hydratase, mitochondrial",14058,96,0.95 [0.77-1.17],0.6136354387171465
Chapter II Neoplasms,Melanoma in situ,ECI2,Enoyl-CoA delta isomerase 2,13959,100,0.94 [0.68-1.30],0.6989018548057059
Chapter II Neoplasms,Melanoma in situ,ECM1,Extracellular matrix protein 1,14056,97,0.75 [0.46-1.22],0.2521023507151673
Chapter II Neoplasms,Melanoma in situ,ECSCR,Endothelial cell-specific chemotaxis regulator,13980,98,0.86 [0.57-1.30],0.4696881699315893
Chapter II Neoplasms,Melanoma in situ,EDA2R,Tumor necrosis factor receptor superfamily member 27,16669,112,0.68 [0.45-1.03],0.0683338842225532
Chapter II Neoplasms,Melanoma in situ,EDAR,Tumor necrosis factor receptor superfamily member EDAR,16479,111,1.08 [0.90-1.30],0.4148263122645657
Chapter II Neoplasms,Melanoma in situ,EDDM3B,Epididymal secretory protein E3-beta,14369,100,1.33 [0.94-1.88],0.1028260026851878
Chapter II Neoplasms,Melanoma in situ,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,13959,100,0.50 [0.26-0.98],0.0450161832328624
Chapter II Neoplasms,Melanoma in situ,EDF1,Endothelial differentiation-related factor 1,14396,100,0.89 [0.66-1.21],0.4687519370476498
Chapter II Neoplasms,Melanoma in situ,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16217,107,0.58 [0.34-1.00],0.0484266201539934
Chapter II Neoplasms,Melanoma in situ,EDN1,Endothelin-1,14058,96,0.70 [0.36-1.39],0.3100353828717946
Chapter II Neoplasms,Melanoma in situ,EDNRB,Endothelin receptor type B,13991,93,0.70 [0.40-1.23],0.2155595917930264
Chapter II Neoplasms,Melanoma in situ,EEF1D,Elongation factor 1-delta,14415,100,1.09 [0.89-1.34],0.3950267820014681
Chapter II Neoplasms,Melanoma in situ,EFCAB14,EF-hand calcium-binding domain-containing protein 14,14355,100,0.94 [0.47-1.90],0.8638095305868014
Chapter II Neoplasms,Melanoma in situ,EFCAB2,Dynein regulatory complex protein 8,14160,99,0.98 [0.56-1.72],0.9456242390456088
Chapter II Neoplasms,Melanoma in situ,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16587,110,0.97 [0.56-1.68],0.9094840129294952
Chapter II Neoplasms,Melanoma in situ,EFHD1,EF-hand domain-containing protein D1,14396,100,0.54 [0.30-1.00],0.0490753102928613
Chapter II Neoplasms,Melanoma in situ,EFNA1,Ephrin-A1,16510,111,1.25 [0.69-2.24],0.4636625324121518
Chapter II Neoplasms,Melanoma in situ,EFNA4,Ephrin-A4,16341,108,0.75 [0.41-1.35],0.3379376390736985
Chapter II Neoplasms,Melanoma in situ,EFNB2,Ephrin-B2,14048,97,1.11 [0.80-1.55],0.5330446319479989
Chapter II Neoplasms,Melanoma in situ,EGF,Pro-epidermal growth factor,16495,111,1.03 [0.87-1.21],0.7290345468497014
Chapter II Neoplasms,Melanoma in situ,EGFL7,Epidermal growth factor-like protein 7,16170,109,1.10 [0.72-1.67],0.671163627132646
Chapter II Neoplasms,Melanoma in situ,EGFLAM,Pikachurin,14355,100,1.12 [0.61-2.06],0.7225936233814683
Chapter II Neoplasms,Melanoma in situ,EGFR,Epidermal growth factor receptor,16720,111,1.15 [0.41-3.27],0.7897913330326803
Chapter II Neoplasms,Melanoma in situ,EGLN1,Egl nine homolog 1,16479,111,1.06 [0.80-1.42],0.6725929374532822
Chapter II Neoplasms,Melanoma in situ,EHBP1,EH domain-binding protein 1,14415,100,0.99 [0.77-1.29],0.9654034183306004
Chapter II Neoplasms,Melanoma in situ,EHD3,EH domain-containing protein 3,14058,96,1.04 [0.88-1.24],0.6216674957670153
Chapter II Neoplasms,Melanoma in situ,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14404,100,0.96 [0.68-1.37],0.8245763830369428
Chapter II Neoplasms,Melanoma in situ,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14293,100,1.07 [0.90-1.28],0.4583422293818865
Chapter II Neoplasms,Melanoma in situ,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,13959,100,1.00 [0.75-1.35],0.9784030103869878
Chapter II Neoplasms,Melanoma in situ,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14058,96,0.70 [0.42-1.19],0.1865918038593633
Chapter II Neoplasms,Melanoma in situ,EIF4B,Eukaryotic translation initiation factor 4B,16369,109,1.12 [0.83-1.51],0.4632657760094367
Chapter II Neoplasms,Melanoma in situ,EIF4E,Eukaryotic translation initiation factor 4E,13991,93,0.98 [0.78-1.23],0.8560437228034719
Chapter II Neoplasms,Melanoma in situ,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16502,110,1.08 [0.84-1.40],0.5519463800794114
Chapter II Neoplasms,Melanoma in situ,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16683,112,1.10 [0.93-1.30],0.2834753010828907
Chapter II Neoplasms,Melanoma in situ,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14396,100,0.97 [0.72-1.30],0.825525804418852
Chapter II Neoplasms,Melanoma in situ,EIF5,Eukaryotic translation initiation factor 5,13959,100,0.79 [0.48-1.28],0.3316186911354482
Chapter II Neoplasms,Melanoma in situ,EIF5A,Eukaryotic translation initiation factor 5A-1,16225,109,0.73 [0.40-1.36],0.3270607073794087
Chapter II Neoplasms,Melanoma in situ,ELAC1,Zinc phosphodiesterase ELAC protein 1,14396,100,1.09 [0.87-1.37],0.4381982415922717
Chapter II Neoplasms,Melanoma in situ,ELAVL4,ELAV-like protein 4,13980,98,0.92 [0.72-1.18],0.5078800991554877
Chapter II Neoplasms,Melanoma in situ,ELN,Elastin,14415,100,1.12 [0.65-1.95],0.6836665012783603
Chapter II Neoplasms,Melanoma in situ,ELOA,Elongin-A,16439,110,0.91 [0.65-1.28],0.589498596712584
Chapter II Neoplasms,Melanoma in situ,ELOB,Elongin-B,13959,100,0.78 [0.45-1.36],0.3776683271744322
Chapter II Neoplasms,Melanoma in situ,ENAH,Protein enabled homolog,16225,109,1.00 [0.69-1.44],0.995481949050554
Chapter II Neoplasms,Melanoma in situ,ENDOU,Poly(U)-specific endoribonuclease,13284,90,1.05 [0.71-1.54],0.8224555322642997
Chapter II Neoplasms,Melanoma in situ,ENG,Endoglin,16720,111,0.97 [0.36-2.57],0.9439632129768242
Chapter II Neoplasms,Melanoma in situ,ENO1,Alpha-enolase,16485,111,1.12 [0.90-1.39],0.3079850466576032
Chapter II Neoplasms,Melanoma in situ,ENO2,Gamma-enolase,16642,112,1.04 [0.80-1.35],0.7629852961831883
Chapter II Neoplasms,Melanoma in situ,ENO3,Beta-enolase,14058,96,0.96 [0.68-1.37],0.8334294262404017
Chapter II Neoplasms,Melanoma in situ,ENOPH1,Enolase-phosphatase E1,14369,100,0.72 [0.49-1.07],0.1040745820490227
Chapter II Neoplasms,Melanoma in situ,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13959,100,0.66 [0.31-1.38],0.2691102621313246
Chapter II Neoplasms,Melanoma in situ,ENPEP,Glutamyl aminopeptidase,13959,100,0.74 [0.43-1.27],0.2781464506173897
Chapter II Neoplasms,Melanoma in situ,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16720,111,0.97 [0.52-1.83],0.9339903420565436
Chapter II Neoplasms,Melanoma in situ,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16583,112,0.80 [0.57-1.13],0.2098931849027587
Chapter II Neoplasms,Melanoma in situ,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14058,96,1.05 [0.61-1.81],0.8703752006861616
Chapter II Neoplasms,Melanoma in situ,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,15956,107,0.90 [0.74-1.11],0.3342234938851177
Chapter II Neoplasms,Melanoma in situ,ENSA,Alpha-endosulfine,14369,100,0.77 [0.52-1.15],0.2026145225996258
Chapter II Neoplasms,Melanoma in situ,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16170,109,0.86 [0.58-1.28],0.4703658218680434
Chapter II Neoplasms,Melanoma in situ,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16217,107,1.13 [0.50-2.54],0.7746300292550935
Chapter II Neoplasms,Melanoma in situ,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16217,107,0.60 [0.35-1.02],0.059107114226598
Chapter II Neoplasms,Melanoma in situ,ENTR1,Endosome-associated-trafficking regulator 1,14058,96,0.83 [0.57-1.21],0.3408524072446645
Chapter II Neoplasms,Melanoma in situ,EP300,Histone acetyltransferase p300,13991,93,1.01 [0.54-1.91],0.9711692832358604
Chapter II Neoplasms,Melanoma in situ,EPB41L5,Band 4.1-like protein 5,14048,97,0.92 [0.66-1.28],0.611628094588742
Chapter II Neoplasms,Melanoma in situ,EPCAM,Epithelial cell adhesion molecule,16499,112,1.11 [0.94-1.32],0.2012177154327786
Chapter II Neoplasms,Melanoma in situ,EPGN,Epigen,14369,100,1.21 [0.87-1.71],0.2603906082894024
Chapter II Neoplasms,Melanoma in situ,EPHA1,Ephrin type-A receptor 1,16566,112,0.63 [0.38-1.04],0.0723087101073837
Chapter II Neoplasms,Melanoma in situ,EPHA10,Ephrin type-A receptor 10,16136,109,1.04 [0.81-1.33],0.7605941554577776
Chapter II Neoplasms,Melanoma in situ,EPHA2,Ephrin type-A receptor 2,15941,107,0.84 [0.47-1.50],0.5573381132820998
Chapter II Neoplasms,Melanoma in situ,EPHA4,Ephrin type-A receptor 4,14132,98,0.79 [0.40-1.56],0.5002804847443791
Chapter II Neoplasms,Melanoma in situ,EPHB4,Ephrin type-B receptor 4,16720,111,0.87 [0.44-1.72],0.6885701287190802
Chapter II Neoplasms,Melanoma in situ,EPHB6,Ephrin type-B receptor 6,16340,109,0.76 [0.44-1.30],0.3168633445867787
Chapter II Neoplasms,Melanoma in situ,EPHX2,Bifunctional epoxide hydrolase 2,16217,107,0.91 [0.67-1.22],0.5261097813299138
Chapter II Neoplasms,Melanoma in situ,EPN1,Epsin-1,14160,99,0.80 [0.49-1.32],0.3851215827216536
Chapter II Neoplasms,Melanoma in situ,EPO,Erythropoietin,16479,111,1.17 [0.94-1.45],0.1557852269181703
Chapter II Neoplasms,Melanoma in situ,EPPK1,Epiplakin,14058,96,1.10 [0.84-1.45],0.4763112263619041
Chapter II Neoplasms,Melanoma in situ,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16640,111,0.95 [0.54-1.68],0.8569284397697137
Chapter II Neoplasms,Melanoma in situ,ERBB2,Receptor tyrosine-protein kinase erbB-2,16578,111,0.56 [0.27-1.14],0.1113119619645395
Chapter II Neoplasms,Melanoma in situ,ERBB3,Receptor tyrosine-protein kinase erbB-3,16477,112,1.91 [0.84-4.38],0.1251298822807389
Chapter II Neoplasms,Melanoma in situ,ERBB4,Receptor tyrosine-protein kinase erbB-4,16578,111,0.77 [0.38-1.58],0.4798533058804861
Chapter II Neoplasms,Melanoma in situ,ERBIN,Erbin,16439,110,1.05 [0.89-1.24],0.5844744088076474
Chapter II Neoplasms,Melanoma in situ,ERC2,ERC protein 2,14048,97,0.97 [0.74-1.27],0.8140050847144138
Chapter II Neoplasms,Melanoma in situ,ERCC1,DNA excision repair protein ERCC-1,13923,96,0.69 [0.36-1.34],0.2714780563626239
Chapter II Neoplasms,Melanoma in situ,EREG,Proepiregulin,16340,109,1.10 [0.90-1.36],0.3480792477246004
Chapter II Neoplasms,Melanoma in situ,ERI1,3'-5' exoribonuclease 1,14160,99,1.08 [0.61-1.92],0.7837315033062462
Chapter II Neoplasms,Melanoma in situ,ERMAP,Erythroid membrane-associated protein,13991,93,1.17 [0.75-1.83],0.4958328449761526
Chapter II Neoplasms,Melanoma in situ,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14369,100,0.82 [0.48-1.39],0.4550552190217101
Chapter II Neoplasms,Melanoma in situ,ERP29,Endoplasmic reticulum resident protein 29,14132,98,1.01 [0.86-1.20],0.8784968841425117
Chapter II Neoplasms,Melanoma in situ,ERP44,Endoplasmic reticulum resident protein 44,16407,110,1.14 [0.59-2.20],0.700982819633133
Chapter II Neoplasms,Melanoma in situ,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,13959,100,0.81 [0.50-1.32],0.4021045994356493
Chapter II Neoplasms,Melanoma in situ,ESAM,Endothelial cell-selective adhesion molecule,16720,111,0.98 [0.58-1.68],0.9502754387818544
Chapter II Neoplasms,Melanoma in situ,ESM1,Endothelial cell-specific molecule 1,16504,112,1.26 [0.77-2.05],0.3616484102013633
Chapter II Neoplasms,Melanoma in situ,ESPL1,Separin,13923,96,0.98 [0.69-1.39],0.8906366493317412
Chapter II Neoplasms,Melanoma in situ,ESR1,Estrogen receptor,13991,93,0.84 [0.56-1.27],0.404054869746774
Chapter II Neoplasms,Melanoma in situ,ESYT2,Extended synaptotagmin-2,14404,100,0.98 [0.77-1.24],0.8490627246409056
Chapter II Neoplasms,Melanoma in situ,EVI2B,Protein EVI2B,13923,96,1.24 [0.83-1.85],0.2885770774317139
Chapter II Neoplasms,Melanoma in situ,EVI5,Ecotropic viral integration site 5 protein homolog,13991,93,1.00 [0.80-1.25],0.9741409554811046
Chapter II Neoplasms,Melanoma in situ,EVPL,Envoplakin,14160,99,0.85 [0.46-1.56],0.5947049403553426
Chapter II Neoplasms,Melanoma in situ,EXOSC10,Exosome component 10,13959,100,1.03 [0.74-1.43],0.8679010867525832
Chapter II Neoplasms,Melanoma in situ,EXTL1,Exostosin-like 1,13959,100,0.71 [0.44-1.15],0.1643918920367314
Chapter II Neoplasms,Melanoma in situ,EZR,Ezrin,16642,112,0.94 [0.46-1.94],0.8729924038823599
Chapter II Neoplasms,Melanoma in situ,F10,Coagulation factor X,14434,100,1.04 [0.53-2.07],0.9008871581498474
Chapter II Neoplasms,Melanoma in situ,F11,Coagulation factor XI,14236,97,0.67 [0.33-1.35],0.2593223862056176
Chapter II Neoplasms,Melanoma in situ,F11R,Junctional adhesion molecule A,16531,111,1.11 [0.82-1.49],0.5052177522279475
Chapter II Neoplasms,Melanoma in situ,F12,Coagulation factor XII,14443,100,0.80 [0.52-1.25],0.3341242766559255
Chapter II Neoplasms,Melanoma in situ,F13B,Coagulation factor XIII B chain,14368,100,0.54 [0.26-1.13],0.1046235542445279
Chapter II Neoplasms,Melanoma in situ,F2,Prothrombin,14443,100,0.51 [0.15-1.79],0.2957841307418143
Chapter II Neoplasms,Melanoma in situ,F2R,Proteinase-activated receptor 1,16558,112,1.14 [0.85-1.54],0.3787175597721577
Chapter II Neoplasms,Melanoma in situ,F3,Tissue factor,16570,112,0.87 [0.46-1.65],0.6761317146832893
Chapter II Neoplasms,Melanoma in situ,F7,Coagulation factor VII,16589,110,1.08 [0.62-1.89],0.7904492201750588
Chapter II Neoplasms,Melanoma in situ,F9,Coagulation factor IX,16577,110,1.58 [0.62-4.04],0.336938596220237
Chapter II Neoplasms,Melanoma in situ,FABP1,"Fatty acid-binding protein, liver",16504,112,1.06 [0.89-1.26],0.5299518050173999
Chapter II Neoplasms,Melanoma in situ,FABP2,"Fatty acid-binding protein, intestinal",16502,110,1.09 [0.88-1.34],0.4404704665134393
Chapter II Neoplasms,Melanoma in situ,FABP3,"Fatty acid-binding protein, heart",14415,100,0.95 [0.64-1.40],0.7885410089575369
Chapter II Neoplasms,Melanoma in situ,FABP4,"Fatty acid-binding protein, adipocyte",16720,111,0.79 [0.55-1.12],0.187975616836759
Chapter II Neoplasms,Melanoma in situ,FABP5,Fatty acid-binding protein 5,16581,111,1.06 [0.83-1.36],0.6544619505739696
Chapter II Neoplasms,Melanoma in situ,FABP6,Gastrotropin,16186,106,1.01 [0.75-1.37],0.940238448435998
Chapter II Neoplasms,Melanoma in situ,FABP9,Fatty acid-binding protein 9,16479,111,0.90 [0.66-1.22],0.496330245079103
Chapter II Neoplasms,Melanoma in situ,FADD,FAS-associated death domain protein,16502,110,1.01 [0.81-1.26],0.9439165341563668
Chapter II Neoplasms,Melanoma in situ,FAM13A,Protein FAM13A,14355,100,1.04 [0.78-1.38],0.7930573983760341
Chapter II Neoplasms,Melanoma in situ,FAM171A2,Protein FAM171A2,14396,100,1.00 [0.88-1.13],0.9746846828707022
Chapter II Neoplasms,Melanoma in situ,FAM171B,Protein FAM171B,14369,100,1.17 [0.62-2.23],0.6265985761778174
Chapter II Neoplasms,Melanoma in situ,FAM172A,Cotranscriptional regulator FAM172A,14058,96,0.97 [0.70-1.34],0.8383603701958778
Chapter II Neoplasms,Melanoma in situ,FAM20A,Pseudokinase FAM20A,14415,100,0.94 [0.47-1.87],0.8522657511802497
Chapter II Neoplasms,Melanoma in situ,FAM3B,Protein FAM3B,16439,110,0.64 [0.40-1.04],0.0727853436719334
Chapter II Neoplasms,Melanoma in situ,FAM3C,Protein FAM3C,16476,110,1.21 [0.69-2.14],0.5020613274658595
Chapter II Neoplasms,Melanoma in situ,FAM3D,Protein FAM3D,14355,100,1.05 [0.84-1.31],0.6897174117809428
Chapter II Neoplasms,Melanoma in situ,FAP,Prolyl endopeptidase FAP,16720,111,0.56 [0.30-1.04],0.0642935281798167
Chapter II Neoplasms,Melanoma in situ,FARSA,Phenylalanine--tRNA ligase alpha subunit,14048,97,0.96 [0.72-1.28],0.778339082402916
Chapter II Neoplasms,Melanoma in situ,FAS,Tumor necrosis factor receptor superfamily member 6,16682,111,0.68 [0.37-1.25],0.2133059172450881
Chapter II Neoplasms,Melanoma in situ,FASLG,Tumor necrosis factor ligand superfamily member 6,16683,112,0.84 [0.53-1.32],0.4383426414062115
Chapter II Neoplasms,Melanoma in situ,FBLN2,Fibulin-2,14428,100,0.82 [0.44-1.55],0.5435860227312446
Chapter II Neoplasms,Melanoma in situ,FBN2,Fibrillin-2,14048,97,0.86 [0.62-1.20],0.3729520401538332
Chapter II Neoplasms,Melanoma in situ,FBP1,"Fructose-1,6-bisphosphatase 1",16502,110,1.09 [0.87-1.37],0.4734461327269119
Chapter II Neoplasms,Melanoma in situ,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14415,100,0.98 [0.75-1.29],0.9109628073456404
Chapter II Neoplasms,Melanoma in situ,FCAR,Immunoglobulin alpha Fc receptor,16479,111,1.11 [0.78-1.57],0.5620891260697036
Chapter II Neoplasms,Melanoma in situ,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14396,100,0.41 [0.22-0.74],0.0031223149432068
Chapter II Neoplasms,Melanoma in situ,FCER2,Low affinity immunoglobulin epsilon Fc receptor,16531,111,0.98 [0.70-1.39],0.9207439244054688
Chapter II Neoplasms,Melanoma in situ,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16479,109,1.02 [0.77-1.36],0.8941241238263257
Chapter II Neoplasms,Melanoma in situ,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16170,109,1.07 [0.80-1.44],0.6356204997804162
Chapter II Neoplasms,Melanoma in situ,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16563,110,0.93 [0.66-1.31],0.6863479034192908
Chapter II Neoplasms,Melanoma in situ,FCN1,Ficolin-1,14406,100,1.07 [0.75-1.51],0.7190321783241009
Chapter II Neoplasms,Melanoma in situ,FCN2,Ficolin-2,16468,110,1.19 [0.77-1.85],0.4316267657910008
Chapter II Neoplasms,Melanoma in situ,FCRL1,Fc receptor-like protein 1,16502,110,0.93 [0.63-1.37],0.7267808352846272
Chapter II Neoplasms,Melanoma in situ,FCRL2,Fc receptor-like protein 2,16598,111,0.95 [0.67-1.35],0.7737326518978926
Chapter II Neoplasms,Melanoma in situ,FCRL3,Fc receptor-like protein 3,16225,109,1.08 [0.79-1.46],0.6410507689781426
Chapter II Neoplasms,Melanoma in situ,FCRL5,Fc receptor-like protein 5,16531,111,0.88 [0.65-1.19],0.4129405080306139
Chapter II Neoplasms,Melanoma in situ,FCRL6,Fc receptor-like protein 6,16479,111,1.12 [0.88-1.43],0.3514195186632698
Chapter II Neoplasms,Melanoma in situ,FCRLB,Fc receptor-like B,16170,109,0.80 [0.58-1.10],0.1641805710983084
Chapter II Neoplasms,Melanoma in situ,FDX1,"Adrenodoxin, mitochondrial",13959,100,0.76 [0.53-1.09],0.1413723045159416
Chapter II Neoplasms,Melanoma in situ,FDX2,"Ferredoxin-2, mitochondrial",13959,100,0.72 [0.49-1.07],0.1019108136895578
Chapter II Neoplasms,Melanoma in situ,FEN1,Flap endonuclease 1,16170,109,1.04 [0.81-1.33],0.7579270337951135
Chapter II Neoplasms,Melanoma in situ,FES,Tyrosine-protein kinase Fes/Fps,16170,109,0.83 [0.56-1.22],0.333732223550528
Chapter II Neoplasms,Melanoma in situ,FETUB,Fetuin-B,16577,110,1.09 [0.64-1.85],0.7564417717753729
Chapter II Neoplasms,Melanoma in situ,FGA,Fibrinogen alpha chain,14103,95,1.27 [0.67-2.42],0.4643289711241983
Chapter II Neoplasms,Melanoma in situ,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14396,100,0.92 [0.72-1.17],0.506110713592819
Chapter II Neoplasms,Melanoma in situ,FGF12,Fibroblast growth factor 12,13991,93,1.10 [0.76-1.60],0.6082353129612031
Chapter II Neoplasms,Melanoma in situ,FGF16,Fibroblast growth factor 16,13991,93,1.21 [0.84-1.75],0.3018026140777595
Chapter II Neoplasms,Melanoma in situ,FGF19,Fibroblast growth factor 19,16583,112,0.97 [0.78-1.21],0.8077714007419826
Chapter II Neoplasms,Melanoma in situ,FGF2,Fibroblast growth factor 2,16479,111,0.98 [0.76-1.25],0.8549153490520973
Chapter II Neoplasms,Melanoma in situ,FGF20,Fibroblast growth factor 20,13991,93,1.05 [0.69-1.60],0.802197209631125
Chapter II Neoplasms,Melanoma in situ,FGF21,Fibroblast growth factor 21,16639,112,0.93 [0.80-1.08],0.366456859301967
Chapter II Neoplasms,Melanoma in situ,FGF23,Fibroblast growth factor 23,16645,112,1.17 [0.87-1.57],0.2967650184903877
Chapter II Neoplasms,Melanoma in situ,FGF3,Fibroblast growth factor 3,13991,93,0.87 [0.43-1.77],0.702631844560904
Chapter II Neoplasms,Melanoma in situ,FGF5,Fibroblast growth factor 5,16225,109,0.68 [0.40-1.16],0.1596338829299595
Chapter II Neoplasms,Melanoma in situ,FGF6,Fibroblast growth factor 6,13991,93,1.00 [0.61-1.66],0.9928635836506696
Chapter II Neoplasms,Melanoma in situ,FGF7,Fibroblast growth factor 7,13923,96,1.00 [0.78-1.29],0.9970836263450435
Chapter II Neoplasms,Melanoma in situ,FGF9,Fibroblast growth factor 9,13900,95,0.77 [0.50-1.20],0.2472168957246632
Chapter II Neoplasms,Melanoma in situ,FGFBP1,Fibroblast growth factor-binding protein 1,16578,111,1.14 [0.67-1.93],0.6259115500088464
Chapter II Neoplasms,Melanoma in situ,FGFBP2,Fibroblast growth factor-binding protein 2,14428,100,0.89 [0.60-1.31],0.5473232685069109
Chapter II Neoplasms,Melanoma in situ,FGFBP3,Fibroblast growth factor-binding protein 3,14404,100,1.18 [0.70-1.98],0.5341109209255388
Chapter II Neoplasms,Melanoma in situ,FGFR2,Fibroblast growth factor receptor 2,16578,111,0.64 [0.29-1.45],0.2863459856920261
Chapter II Neoplasms,Melanoma in situ,FGFR4,Fibroblast growth factor receptor 4,14132,98,1.08 [0.75-1.56],0.6907074369181685
Chapter II Neoplasms,Melanoma in situ,FGL1,Fibrinogen-like protein 1,14434,100,1.26 [0.94-1.69],0.1242367760390166
Chapter II Neoplasms,Melanoma in situ,FGR,Tyrosine-protein kinase Fgr,16136,109,1.12 [0.87-1.45],0.3807058059951702
Chapter II Neoplasms,Melanoma in situ,FH,"Fumarate hydratase, mitochondrial",13980,98,0.88 [0.67-1.14],0.3266093514364184
Chapter II Neoplasms,Melanoma in situ,FHIP2A,FHF complex subunit HOOK interacting protein 2A,13959,100,0.68 [0.43-1.07],0.0942835740862303
Chapter II Neoplasms,Melanoma in situ,FHIT,Bis(5'-adenosyl)-triphosphatase,16136,109,1.06 [0.84-1.34],0.6095413088369374
Chapter II Neoplasms,Melanoma in situ,FIS1,Mitochondrial fission 1 protein,16528,112,1.00 [0.80-1.24],0.9701279239638037
Chapter II Neoplasms,Melanoma in situ,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14396,100,1.06 [0.87-1.28],0.5762070092997792
Chapter II Neoplasms,Melanoma in situ,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16546,109,1.05 [0.90-1.22],0.5154532217516243
Chapter II Neoplasms,Melanoma in situ,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16369,109,1.08 [0.73-1.59],0.7073634662131802
Chapter II Neoplasms,Melanoma in situ,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16369,109,1.13 [0.94-1.35],0.1984272682441167
Chapter II Neoplasms,Melanoma in situ,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16107,109,0.84 [0.56-1.25],0.3935808590187262
Chapter II Neoplasms,Melanoma in situ,FKBPL,FK506-binding protein-like,14355,100,1.05 [0.75-1.45],0.7799473436229198
Chapter II Neoplasms,Melanoma in situ,FLI1,Friend leukemia integration 1 transcription factor,16170,109,1.01 [0.86-1.18],0.9268147314171508
Chapter II Neoplasms,Melanoma in situ,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16369,109,0.67 [0.37-1.24],0.2041623573348854
Chapter II Neoplasms,Melanoma in situ,FLT1,Vascular endothelial growth factor receptor 1,16403,110,0.57 [0.25-1.32],0.1909506399703451
Chapter II Neoplasms,Melanoma in situ,FLT3,Receptor-type tyrosine-protein kinase FLT3,16170,109,1.05 [0.61-1.81],0.8550233777
Chapter II Neoplasms,Melanoma in situ,FLT3LG,Fms-related tyrosine kinase 3 ligand,16683,112,0.56 [0.34-0.92],0.0214995174359131
Chapter II Neoplasms,Melanoma in situ,FLT4,Vascular endothelial growth factor receptor 3,16578,111,1.53 [0.91-2.57],0.1118668523408253
Chapter II Neoplasms,Melanoma in situ,FMNL1,Formin-like protein 1,16136,109,1.02 [0.79-1.32],0.8678754846497435
Chapter II Neoplasms,Melanoma in situ,FMR1,Synaptic functional regulator FMR1,16170,109,1.00 [0.61-1.64],0.98869232469199
Chapter II Neoplasms,Melanoma in situ,FN1,Fibronectin,14443,100,0.50 [0.29-0.87],0.0141876337083231
Chapter II Neoplasms,Melanoma in situ,FNDC1,Fibronectin type III domain-containing protein 1,14404,100,0.76 [0.50-1.15],0.1924168982406078
Chapter II Neoplasms,Melanoma in situ,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14369,100,1.04 [0.60-1.81],0.8931423202549542
Chapter II Neoplasms,Melanoma in situ,FOLH1,Glutamate carboxypeptidase 2,13991,93,1.02 [0.85-1.23],0.8414794765916639
Chapter II Neoplasms,Melanoma in situ,FOLR1,Folate receptor alpha,16508,110,0.79 [0.43-1.44],0.433224513159384
Chapter II Neoplasms,Melanoma in situ,FOLR2,Folate receptor beta,16642,112,0.89 [0.50-1.57],0.678494210967381
Chapter II Neoplasms,Melanoma in situ,FOLR3,Folate receptor gamma,16526,111,0.99 [0.90-1.08],0.7736669526482949
Chapter II Neoplasms,Melanoma in situ,FOS,Proto-oncogene c-Fos,13900,95,0.75 [0.43-1.32],0.3213377146643569
Chapter II Neoplasms,Melanoma in situ,FOSB,Protein fosB,16136,109,0.94 [0.60-1.49],0.8058314636956414
Chapter II Neoplasms,Melanoma in situ,FOXJ3,Forkhead box protein J3,13991,93,0.82 [0.50-1.34],0.4222762622207855
Chapter II Neoplasms,Melanoma in situ,FOXO1,Forkhead box protein O1,16479,111,1.06 [0.87-1.29],0.5797453983113754
Chapter II Neoplasms,Melanoma in situ,FOXO3,Forkhead box protein O3,16170,109,1.02 [0.86-1.23],0.7891678816185166
Chapter II Neoplasms,Melanoma in situ,FRMD4B,FERM domain-containing protein 4B,13959,100,1.05 [0.80-1.39],0.721186976842827
Chapter II Neoplasms,Melanoma in situ,FRMD7,FERM domain-containing protein 7,14048,97,0.95 [0.53-1.71],0.8715902491337616
Chapter II Neoplasms,Melanoma in situ,FRZB,Secreted frizzled-related protein 3,16314,108,1.25 [0.61-2.55],0.5416547911899012
Chapter II Neoplasms,Melanoma in situ,FSHB,Follitropin subunit beta,14058,96,1.08 [0.76-1.55],0.6687819760470872
Chapter II Neoplasms,Melanoma in situ,FST,Follistatin,16558,112,1.14 [0.82-1.60],0.438726844242021
Chapter II Neoplasms,Melanoma in situ,FSTL1,Follistatin-related protein 1,14058,96,0.93 [0.38-2.29],0.8770973806896322
Chapter II Neoplasms,Melanoma in situ,FSTL3,Follistatin-related protein 3,16475,111,1.15 [0.67-1.96],0.6110227945648394
Chapter II Neoplasms,Melanoma in situ,FTCD,Formimidoyltransferase-cyclodeaminase,14373,99,0.83 [0.65-1.07],0.1452752109130392
Chapter II Neoplasms,Melanoma in situ,FUCA1,Tissue alpha-L-fucosidase,16633,110,0.96 [0.79-1.17],0.6701909668214674
Chapter II Neoplasms,Melanoma in situ,FUOM,Fucose mutarotase,14132,98,0.95 [0.69-1.32],0.7766028116256734
Chapter II Neoplasms,Melanoma in situ,FURIN,Furin,16578,111,1.10 [0.65-1.85],0.7329136317595124
Chapter II Neoplasms,Melanoma in situ,FUS,RNA-binding protein FUS,16147,109,0.99 [0.64-1.54],0.9621330481486872
Chapter II Neoplasms,Melanoma in situ,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14126,98,0.61 [0.41-0.90],0.0140213461750448
Chapter II Neoplasms,Melanoma in situ,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16642,112,0.64 [0.45-0.92],0.0153309681172886
Chapter II Neoplasms,Melanoma in situ,FUT8,"Alpha-(1,6)-fucosyltransferase",16369,109,1.12 [0.84-1.49],0.4314754272044616
Chapter II Neoplasms,Melanoma in situ,FXN,"Frataxin, mitochondrial",16669,112,1.00 [0.80-1.26],0.9674506705304332
Chapter II Neoplasms,Melanoma in situ,FXYD5,FXYD domain-containing ion transport regulator 5,16225,109,0.99 [0.75-1.29],0.9161257468186004
Chapter II Neoplasms,Melanoma in situ,FYB1,FYN-binding protein 1,16496,111,1.05 [0.87-1.26],0.6219252007364238
Chapter II Neoplasms,Melanoma in situ,FZD10,Frizzled-10,14048,97,0.85 [0.58-1.25],0.415871294434747
Chapter II Neoplasms,Melanoma in situ,FZD8,Frizzled-8,13980,98,1.09 [0.72-1.65],0.6927659635937121
Chapter II Neoplasms,Melanoma in situ,GABARAP,Gamma-aminobutyric acid receptor-associated protein,14369,100,1.01 [0.68-1.50],0.959252104929724
Chapter II Neoplasms,Melanoma in situ,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14160,99,0.83 [0.59-1.17],0.2809495931347696
Chapter II Neoplasms,Melanoma in situ,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,13980,98,0.94 [0.68-1.31],0.7312554097488773
Chapter II Neoplasms,Melanoma in situ,GAD1,Glutamate decarboxylase 1,13923,96,1.04 [0.49-2.22],0.9118908771175426
Chapter II Neoplasms,Melanoma in situ,GAD2,Glutamate decarboxylase 2,13991,93,0.80 [0.49-1.33],0.3958790522958512
Chapter II Neoplasms,Melanoma in situ,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14160,99,0.97 [0.65-1.45],0.8834949576130748
Chapter II Neoplasms,Melanoma in situ,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14058,96,0.90 [0.61-1.32],0.5829441994194189
Chapter II Neoplasms,Melanoma in situ,GAGE2A,G antigen 2A,13923,96,0.71 [0.48-1.05],0.0837268405074189
Chapter II Neoplasms,Melanoma in situ,GAL,Galanin peptides,16583,112,1.11 [0.86-1.45],0.4252948615058153
Chapter II Neoplasms,Melanoma in situ,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16439,110,0.73 [0.39-1.35],0.311484066657868
Chapter II Neoplasms,Melanoma in situ,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16669,112,0.94 [0.50-1.76],0.8423420216220188
Chapter II Neoplasms,Melanoma in situ,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16225,109,0.82 [0.55-1.23],0.3393727295433925
Chapter II Neoplasms,Melanoma in situ,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14415,100,0.95 [0.48-1.88],0.875511469195062
Chapter II Neoplasms,Melanoma in situ,GALNT7,N-acetylgalactosaminyltransferase 7,16439,110,0.51 [0.23-1.12],0.0921283382466794
Chapter II Neoplasms,Melanoma in situ,GAMT,Guanidinoacetate N-methyltransferase,13959,100,0.78 [0.42-1.44],0.4261278717926253
Chapter II Neoplasms,Melanoma in situ,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13812,97,1.58 [0.82-3.03],0.1680288113045643
Chapter II Neoplasms,Melanoma in situ,GART,Trifunctional purine biosynthetic protein adenosine-3,14396,100,1.13 [0.57-2.21],0.7296319189222777
Chapter II Neoplasms,Melanoma in situ,GAS2,Growth arrest-specific protein 2,14160,99,0.88 [0.58-1.33],0.5496757109125595
Chapter II Neoplasms,Melanoma in situ,GAS6,Growth arrest-specific protein 6,16631,111,0.66 [0.33-1.30],0.2288988024415781
Chapter II Neoplasms,Melanoma in situ,GASK1A,Golgi-associated kinase 1A,13959,100,0.78 [0.49-1.23],0.2786204961006924
Chapter II Neoplasms,Melanoma in situ,GAST,Gastrin,14404,100,0.98 [0.86-1.13],0.8090418336806579
Chapter II Neoplasms,Melanoma in situ,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13923,96,0.87 [0.41-1.83],0.7091766914694807
Chapter II Neoplasms,Melanoma in situ,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14058,96,0.97 [0.75-1.26],0.8339688914291039
Chapter II Neoplasms,Melanoma in situ,GBA,Lysosomal acid glucosylceramidase,14048,97,1.24 [0.88-1.74],0.2160783659291117
Chapter II Neoplasms,Melanoma in situ,GBP1,Guanylate-binding protein 1,14378,100,0.99 [0.74-1.34],0.97091973333522
Chapter II Neoplasms,Melanoma in situ,GBP2,Guanylate-binding protein 2,16225,109,1.00 [0.75-1.33],0.9861388182240772
Chapter II Neoplasms,Melanoma in situ,GBP4,Guanylate-binding protein 4,16136,109,0.99 [0.70-1.41],0.963818896283081
Chapter II Neoplasms,Melanoma in situ,GBP6,Guanylate-binding protein 6,13959,100,0.99 [0.65-1.52],0.963522253281651
Chapter II Neoplasms,Melanoma in situ,GC,Vitamin D-binding protein,14443,100,1.03 [0.49-2.14],0.9372391522353244
Chapter II Neoplasms,Melanoma in situ,GCC1,GRIP and coiled-coil domain-containing protein 1,14404,100,1.04 [0.87-1.25],0.6490865909241115
Chapter II Neoplasms,Melanoma in situ,GCG,Pro-glucagon,16170,109,0.87 [0.76-1.00],0.0473476563295603
Chapter II Neoplasms,Melanoma in situ,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13801,98,0.97 [0.65-1.46],0.8996619643392564
Chapter II Neoplasms,Melanoma in situ,GCLM,Glutamate--cysteine ligase regulatory subunit,13959,100,0.74 [0.46-1.21],0.2294347742534265
Chapter II Neoplasms,Melanoma in situ,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16439,110,1.38 [0.85-2.23],0.1931726849684066
Chapter II Neoplasms,Melanoma in situ,GDF15,Growth/differentiation factor 15,16720,111,1.08 [0.73-1.61],0.6877995086222131
Chapter II Neoplasms,Melanoma in situ,GDF2,Growth/differentiation factor 2,16502,110,0.66 [0.41-1.07],0.093155146717459
Chapter II Neoplasms,Melanoma in situ,GDNF,Glial cell line-derived neurotrophic factor,16136,109,1.29 [0.84-1.98],0.2403417556640564
Chapter II Neoplasms,Melanoma in situ,GET3,ATPase GET3,14415,100,0.77 [0.51-1.15],0.2006977828203544
Chapter II Neoplasms,Melanoma in situ,GFAP,Glial fibrillary acidic protein,16138,109,1.02 [0.72-1.45],0.8925548772899108
Chapter II Neoplasms,Melanoma in situ,GFER,FAD-linked sulfhydryl oxidase ALR,16170,109,1.05 [0.80-1.38],0.7209820285351697
Chapter II Neoplasms,Melanoma in situ,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16170,109,0.88 [0.74-1.04],0.1278574148605768
Chapter II Neoplasms,Melanoma in situ,GFRA1,GDNF family receptor alpha-1,16639,112,0.85 [0.46-1.57],0.614417726477012
Chapter II Neoplasms,Melanoma in situ,GFRA2,GDNF family receptor alpha-2,16439,110,0.77 [0.35-1.70],0.5159485976351381
Chapter II Neoplasms,Melanoma in situ,GFRA3,GDNF family receptor alpha-3,16325,106,0.46 [0.25-0.87],0.0170051508702108
Chapter II Neoplasms,Melanoma in situ,GFRAL,GDNF family receptor alpha-like,13961,100,0.95 [0.69-1.30],0.7389206833405848
Chapter II Neoplasms,Melanoma in situ,GGA1,ADP-ribosylation factor-binding protein GGA1,16136,109,0.61 [0.43-0.87],0.0069213942403253
Chapter II Neoplasms,Melanoma in situ,GGACT,Gamma-glutamylaminecyclotransferase,14415,100,1.11 [0.85-1.45],0.4538476267874165
Chapter II Neoplasms,Melanoma in situ,GGCT,Gamma-glutamylcyclotransferase,14382,100,1.27 [0.86-1.86],0.2248687860496127
Chapter II Neoplasms,Melanoma in situ,GGH,Gamma-glutamyl hydrolase,16280,108,0.70 [0.42-1.17],0.1694319415001579
Chapter II Neoplasms,Melanoma in situ,GGT1,Glutathione hydrolase 1 proenzyme,16510,111,0.92 [0.65-1.32],0.6670203601255775
Chapter II Neoplasms,Melanoma in situ,GGT5,Glutathione hydrolase 5 proenzyme,16369,109,0.91 [0.42-1.94],0.8027773370036464
Chapter II Neoplasms,Melanoma in situ,GH1,Somatotropin,16476,110,0.94 [0.85-1.04],0.2111771234671093
Chapter II Neoplasms,Melanoma in situ,GH2,Growth hormone variant,16170,109,0.99 [0.89-1.10],0.8561554136677985
Chapter II Neoplasms,Melanoma in situ,GHR,Growth hormone receptor,14132,98,0.93 [0.46-1.88],0.8483489198444885
Chapter II Neoplasms,Melanoma in situ,GHRHR,Growth hormone-releasing hormone receptor,16136,109,0.89 [0.63-1.26],0.5254823909893036
Chapter II Neoplasms,Melanoma in situ,GHRL,Appetite-regulating hormone,16502,110,0.89 [0.73-1.08],0.2356786541370656
Chapter II Neoplasms,Melanoma in situ,GID8,Glucose-induced degradation protein 8 homolog,14396,100,0.88 [0.47-1.64],0.685858100269827
Chapter II Neoplasms,Melanoma in situ,GIGYF2,GRB10-interacting GYF protein 2,14396,100,1.03 [0.80-1.33],0.8200301132529138
Chapter II Neoplasms,Melanoma in situ,GIMAP7,GTPase IMAP family member 7,14132,98,0.76 [0.39-1.47],0.4073032995172492
Chapter II Neoplasms,Melanoma in situ,GIMAP8,GTPase IMAP family member 8,13923,96,1.19 [0.85-1.65],0.3072459067523103
Chapter II Neoplasms,Melanoma in situ,GIP,Gastric inhibitory polypeptide,14058,96,0.97 [0.70-1.35],0.8709557300559492
Chapter II Neoplasms,Melanoma in situ,GIPC2,PDZ domain-containing protein GIPC2,14404,100,0.81 [0.42-1.56],0.5289250029991247
Chapter II Neoplasms,Melanoma in situ,GIPC3,PDZ domain-containing protein GIPC3,14355,100,0.97 [0.80-1.19],0.7985309424376836
Chapter II Neoplasms,Melanoma in situ,GIPR,Gastric inhibitory polypeptide receptor,13991,93,0.54 [0.31-0.92],0.0228596519915763
Chapter II Neoplasms,Melanoma in situ,GIT1,ARF GTPase-activating protein GIT1,13991,93,1.11 [0.90-1.36],0.3388795683948949
Chapter II Neoplasms,Melanoma in situ,GJA8,Gap junction alpha-8 protein,13923,96,0.74 [0.51-1.07],0.1100682928868825
Chapter II Neoplasms,Melanoma in situ,GKN1,Gastrokine-1,15833,106,0.69 [0.37-1.29],0.2427862133046835
Chapter II Neoplasms,Melanoma in situ,GLA,Alpha-galactosidase A,14108,98,0.78 [0.45-1.34],0.3622538007769916
Chapter II Neoplasms,Melanoma in situ,GLB1,Beta-galactosidase,16369,109,0.61 [0.39-0.94],0.0250745246061178
Chapter II Neoplasms,Melanoma in situ,GLI2,Zinc finger protein GLI2,13991,93,0.80 [0.41-1.57],0.5238283173040712
Chapter II Neoplasms,Melanoma in situ,GLO1,Lactoylglutathione lyase,16217,107,0.98 [0.73-1.32],0.9142519705158658
Chapter II Neoplasms,Melanoma in situ,GLOD4,Glyoxalase domain-containing protein 4,16503,112,1.23 [0.76-1.98],0.4027482364511048
Chapter II Neoplasms,Melanoma in situ,GLP1R,Glucagon-like peptide 1 receptor,13980,98,0.81 [0.45-1.43],0.4579494312083473
Chapter II Neoplasms,Melanoma in situ,GLRX,Glutaredoxin-1,16384,109,1.15 [0.86-1.54],0.3571771269334312
Chapter II Neoplasms,Melanoma in situ,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14132,98,1.01 [0.81-1.26],0.9227713267538546
Chapter II Neoplasms,Melanoma in situ,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16136,109,1.09 [0.77-1.55],0.6154747654239427
Chapter II Neoplasms,Melanoma in situ,GLYR1,Putative oxidoreductase GLYR1,14369,100,0.85 [0.58-1.24],0.4040605435942301
Chapter II Neoplasms,Melanoma in situ,GM2A,Ganglioside GM2 activator,14070,99,0.93 [0.56-1.55],0.7750052384482955
Chapter II Neoplasms,Melanoma in situ,GMFG,Glia maturation factor gamma,14415,100,1.00 [0.76-1.30],0.9761733504967536
Chapter II Neoplasms,Melanoma in situ,GMPR,GMP reductase 1,16683,112,1.03 [0.73-1.43],0.8832414980000995
Chapter II Neoplasms,Melanoma in situ,GMPR2,GMP reductase 2,14132,98,1.11 [0.83-1.49],0.4672993117939314
Chapter II Neoplasms,Melanoma in situ,GNAS,Neuroendocrine secretory protein 55,14396,100,0.79 [0.61-1.04],0.0931070824440966
Chapter II Neoplasms,Melanoma in situ,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16170,109,1.11 [0.86-1.44],0.4162013257664819
Chapter II Neoplasms,Melanoma in situ,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14048,97,0.99 [0.66-1.47],0.9525800841880258
Chapter II Neoplasms,Melanoma in situ,GNLY,Granulysin,16531,111,0.91 [0.66-1.25],0.5565071786315205
Chapter II Neoplasms,Melanoma in situ,GNPDA1,Glucosamine-6-phosphate isomerase 1,14058,96,0.98 [0.54-1.78],0.9534142771150084
Chapter II Neoplasms,Melanoma in situ,GNPDA2,Glucosamine-6-phosphate isomerase 2,14132,98,0.97 [0.56-1.67],0.9078386794626384
Chapter II Neoplasms,Melanoma in situ,GOLGA3,Golgin subfamily A member 3,14396,100,1.06 [0.83-1.36],0.6174339960232109
Chapter II Neoplasms,Melanoma in situ,GOLM2,Protein GOLM2,16642,112,1.65 [0.81-3.35],0.1643335895578827
Chapter II Neoplasms,Melanoma in situ,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16479,111,1.06 [0.90-1.26],0.4846673409042746
Chapter II Neoplasms,Melanoma in situ,GORASP2,Golgi reassembly-stacking protein 2,14355,100,1.02 [0.68-1.53],0.9369999196937704
Chapter II Neoplasms,Melanoma in situ,GOT1,"Aspartate aminotransferase, cytoplasmic",14428,100,0.92 [0.57-1.50],0.7518968177323337
Chapter II Neoplasms,Melanoma in situ,GP1BA,Platelet glycoprotein Ib alpha chain,16468,110,1.17 [0.70-1.96],0.5498387793155587
Chapter II Neoplasms,Melanoma in situ,GP1BB,Platelet glycoprotein Ib beta chain,13959,100,0.99 [0.74-1.31],0.9307701338240808
Chapter II Neoplasms,Melanoma in situ,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16026,106,1.02 [0.83-1.25],0.8607120549947221
Chapter II Neoplasms,Melanoma in situ,GP5,Platelet glycoprotein V,14132,98,1.09 [0.63-1.90],0.7561706436502892
Chapter II Neoplasms,Melanoma in situ,GP6,Platelet glycoprotein VI,16496,111,1.12 [0.92-1.36],0.2489224842210631
Chapter II Neoplasms,Melanoma in situ,GPA33,Cell surface A33 antigen,16439,110,1.06 [0.94-1.20],0.3087365603144571
Chapter II Neoplasms,Melanoma in situ,GPC1,Glypican-1,16669,112,0.95 [0.54-1.69],0.8732871971909224
Chapter II Neoplasms,Melanoma in situ,GPC5,Glypican-5,16369,109,1.04 [0.77-1.42],0.7831571172443437
Chapter II Neoplasms,Melanoma in situ,GPD1,Glycerol-3-phosphate dehydrogenase,14369,100,1.12 [0.77-1.63],0.5443630114860203
Chapter II Neoplasms,Melanoma in situ,GPHA2,Glycoprotein hormone alpha-2,14355,100,1.27 [0.90-1.80],0.1789650670806112
Chapter II Neoplasms,Melanoma in situ,GPI,Glucose-6-phosphate isomerase,14434,100,1.05 [0.70-1.59],0.7975044280168314
Chapter II Neoplasms,Melanoma in situ,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14355,100,1.04 [0.79-1.38],0.7619397466776971
Chapter II Neoplasms,Melanoma in situ,GPKOW,G-patch domain and KOW motifs-containing protein,16136,109,1.21 [0.72-2.01],0.4696787420443036
Chapter II Neoplasms,Melanoma in situ,GPNMB,Transmembrane glycoprotein NMB,16054,105,0.84 [0.46-1.55],0.5830916625544595
Chapter II Neoplasms,Melanoma in situ,GPR101,Probable G-protein coupled receptor 101,13980,98,0.96 [0.68-1.37],0.8400423022793457
Chapter II Neoplasms,Melanoma in situ,GPR158,Probable G-protein coupled receptor 158,14396,100,1.23 [0.75-2.01],0.4066635322827318
Chapter II Neoplasms,Melanoma in situ,GPR15L,Protein GPR15L,14355,100,1.01 [0.73-1.39],0.9664826533937338
Chapter II Neoplasms,Melanoma in situ,GPR37,Prosaposin receptor GPR37,16217,107,0.80 [0.62-1.05],0.1032197472208435
Chapter II Neoplasms,Melanoma in situ,GPRC5C,G-protein coupled receptor family C group 5 member C,14369,100,0.82 [0.55-1.21],0.3207315523406033
Chapter II Neoplasms,Melanoma in situ,GRAP2,GRB2-related adapter protein 2,16502,110,1.05 [0.92-1.20],0.509070826706643
Chapter II Neoplasms,Melanoma in situ,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14415,100,1.02 [0.76-1.39],0.8742801282075874
Chapter II Neoplasms,Melanoma in situ,GRIK2,"Glutamate receptor ionotropic, kainate 2",14396,100,0.66 [0.40-1.09],0.1039317036410295
Chapter II Neoplasms,Melanoma in situ,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",13980,98,1.20 [0.91-1.58],0.1990974935743785
Chapter II Neoplasms,Melanoma in situ,GRK5,G protein-coupled receptor kinase 5,16217,107,0.93 [0.65-1.34],0.7008148326524406
Chapter II Neoplasms,Melanoma in situ,GRN,Progranulin,16454,111,1.31 [0.64-2.66],0.4593321106710227
Chapter II Neoplasms,Melanoma in situ,GRP,Gastrin-releasing peptide,14058,96,0.92 [0.64-1.32],0.6620154492567419
Chapter II Neoplasms,Melanoma in situ,GRPEL1,"GrpE protein homolog 1, mitochondrial",16439,110,1.00 [0.74-1.35],0.9998226451341564
Chapter II Neoplasms,Melanoma in situ,GRSF1,G-rich sequence factor 1,13846,95,0.97 [0.76-1.24],0.7925475745206421
Chapter II Neoplasms,Melanoma in situ,GSAP,Gamma-secretase-activating protein,16170,109,1.04 [0.87-1.26],0.6551790798296296
Chapter II Neoplasms,Melanoma in situ,GSN,Gelsolin,14383,100,0.67 [0.29-1.54],0.3451136902243351
Chapter II Neoplasms,Melanoma in situ,GSR,"Glutathione reductase, mitochondrial",14352,100,1.59 [0.66-3.84],0.2996829766130524
Chapter II Neoplasms,Melanoma in situ,GSTA1,Glutathione S-transferase A1,16473,110,1.00 [0.81-1.23],0.9956713367164728
Chapter II Neoplasms,Melanoma in situ,GSTA3,Glutathione S-transferase A3,16170,109,0.93 [0.74-1.17],0.5421212806645805
Chapter II Neoplasms,Melanoma in situ,GSTM4,Glutathione S-transferase Mu 4,13959,100,1.01 [0.78-1.31],0.9568453642213312
Chapter II Neoplasms,Melanoma in situ,GSTP1,Glutathione S-transferase P,16040,109,1.17 [0.93-1.47],0.1862121624697628
Chapter II Neoplasms,Melanoma in situ,GSTT2B,Glutathione S-transferase theta-2B,14404,100,1.01 [0.93-1.09],0.826741977966059
Chapter II Neoplasms,Melanoma in situ,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14160,99,0.98 [0.74-1.30],0.8913834253269711
Chapter II Neoplasms,Melanoma in situ,GTPBP2,GTP-binding protein 2,14048,97,1.03 [0.80-1.31],0.8406934911990067
Chapter II Neoplasms,Melanoma in situ,GUCA2A,Guanylin,16440,110,1.04 [0.63-1.71],0.8806478768105445
Chapter II Neoplasms,Melanoma in situ,GUCY2C,Heat-stable enterotoxin receptor,14160,99,0.87 [0.66-1.14],0.3172607066980722
Chapter II Neoplasms,Melanoma in situ,GUK1,Guanylate kinase,13959,100,0.40 [0.21-0.77],0.0056185777102537
Chapter II Neoplasms,Melanoma in situ,GUSB,Beta-glucuronidase,16617,110,0.92 [0.69-1.22],0.5544192188778285
Chapter II Neoplasms,Melanoma in situ,GYS1,"Glycogen [starch] synthase, muscle",16217,107,1.01 [0.84-1.22],0.9323448581342976
Chapter II Neoplasms,Melanoma in situ,GZMA,Granzyme A,16683,112,1.13 [0.71-1.82],0.6036403298798785
Chapter II Neoplasms,Melanoma in situ,GZMB,Granzyme B,16479,111,0.94 [0.72-1.23],0.6647724732742097
Chapter II Neoplasms,Melanoma in situ,GZMH,Granzyme H,16217,107,1.01 [0.81-1.26],0.9321015803338956
Chapter II Neoplasms,Melanoma in situ,H2AP,Huntingtin-interacting protein M,13923,96,1.02 [0.70-1.48],0.9277181009367802
Chapter II Neoplasms,Melanoma in situ,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",13959,100,0.69 [0.46-1.04],0.0793268668611491
Chapter II Neoplasms,Melanoma in situ,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16611,112,0.99 [0.79-1.25],0.929588076242031
Chapter II Neoplasms,Melanoma in situ,HAO1,Hydroxyacid oxidase 1,16669,112,0.91 [0.79-1.05],0.1874029058903559
Chapter II Neoplasms,Melanoma in situ,HARS1,"Histidine--tRNA ligase, cytoplasmic",16531,111,1.09 [0.87-1.35],0.4607624328610121
Chapter II Neoplasms,Melanoma in situ,HAVCR1,Hepatitis A virus cellular receptor 1,16641,112,1.40 [1.08-1.81],0.009825696257991
Chapter II Neoplasms,Melanoma in situ,HAVCR2,Hepatitis A virus cellular receptor 2,16531,111,1.13 [0.70-1.82],0.61265879605901
Chapter II Neoplasms,Melanoma in situ,HBEGF,Proheparin-binding EGF-like growth factor,16611,112,1.14 [0.91-1.44],0.2619827771743194
Chapter II Neoplasms,Melanoma in situ,HBQ1,Hemoglobin subunit theta-1,16669,112,0.99 [0.76-1.30],0.9528253907965026
Chapter II Neoplasms,Melanoma in situ,HBZ,Hemoglobin subunit zeta,14415,100,1.09 [0.91-1.30],0.3390111785843269
Chapter II Neoplasms,Melanoma in situ,HCG22,Protein PBMUCL2,13959,100,0.51 [0.29-0.91],0.023308145429033
Chapter II Neoplasms,Melanoma in situ,HCLS1,Hematopoietic lineage cell-specific protein,16683,112,1.21 [0.89-1.64],0.2303671696443504
Chapter II Neoplasms,Melanoma in situ,HDAC8,Histone deacetylase 8,13991,93,0.91 [0.63-1.31],0.5988614922474587
Chapter II Neoplasms,Melanoma in situ,HDAC9,Histone deacetylase 9,13980,98,0.97 [0.72-1.31],0.8645386906266773
Chapter II Neoplasms,Melanoma in situ,HDDC2,5'-deoxynucleotidase HDDC2,14355,100,1.17 [0.76-1.79],0.4708672346798306
Chapter II Neoplasms,Melanoma in situ,HDGF,Hepatoma-derived growth factor,16635,112,1.19 [1.00-1.42],0.0495282504754868
Chapter II Neoplasms,Melanoma in situ,HDGFL2,Hepatoma-derived growth factor-related protein 2,14404,100,0.99 [0.73-1.34],0.95078311953978
Chapter II Neoplasms,Melanoma in situ,HEBP1,Heme-binding protein 1,16217,107,1.08 [0.80-1.45],0.6027990331730327
Chapter II Neoplasms,Melanoma in situ,HEG1,Protein HEG homolog 1,14132,98,0.57 [0.27-1.20],0.139350710095783
Chapter II Neoplasms,Melanoma in situ,HEPACAM2,HEPACAM family member 2,14404,100,0.82 [0.52-1.29],0.3900448425096448
Chapter II Neoplasms,Melanoma in situ,HEPH,Hephaestin,14415,100,1.50 [0.70-3.19],0.298972357403388
Chapter II Neoplasms,Melanoma in situ,HEXIM1,Protein HEXIM1,16479,111,1.15 [0.93-1.41],0.1947347372655891
Chapter II Neoplasms,Melanoma in situ,HGF,Hepatocyte growth factor,16683,112,1.14 [0.70-1.87],0.6029015140073357
Chapter II Neoplasms,Melanoma in situ,HGFAC,Hepatocyte growth factor activator,14296,97,0.81 [0.44-1.52],0.518025825194846
Chapter II Neoplasms,Melanoma in situ,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16170,109,1.04 [0.83-1.30],0.7284618943431693
Chapter II Neoplasms,Melanoma in situ,HHEX,Hematopoietically-expressed homeobox protein HHEX,14404,100,1.09 [0.84-1.40],0.5160104590731109
Chapter II Neoplasms,Melanoma in situ,HIF1A,Hypoxia-inducible factor 1-alpha,13991,93,0.96 [0.69-1.34],0.8180267872914051
Chapter II Neoplasms,Melanoma in situ,HIP1,Huntingtin-interacting protein 1,13959,100,0.66 [0.34-1.31],0.2400566576273645
Chapter II Neoplasms,Melanoma in situ,HIP1R,Huntingtin-interacting protein 1-related protein,14368,100,0.90 [0.57-1.45],0.6765671908865862
Chapter II Neoplasms,Melanoma in situ,HJV,Hemojuvelin,14396,100,0.91 [0.57-1.43],0.6725312088373256
Chapter II Neoplasms,Melanoma in situ,HK2,Hexokinase-2,16217,107,1.04 [0.56-1.93],0.9007545482210004
Chapter II Neoplasms,Melanoma in situ,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",14396,100,1.03 [0.58-1.86],0.9094246184032254
Chapter II Neoplasms,Melanoma in situ,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16434,111,1.50 [0.97-2.34],0.0695517861483166
Chapter II Neoplasms,Melanoma in situ,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16479,111,1.55 [0.91-2.66],0.1077954785313841
Chapter II Neoplasms,Melanoma in situ,HMBS,Porphobilinogen deaminase,16669,112,0.85 [0.58-1.24],0.3909800849723117
Chapter II Neoplasms,Melanoma in situ,HMCN2,Hemicentin-2,14107,97,0.98 [0.70-1.38],0.9038645464056824
Chapter II Neoplasms,Melanoma in situ,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14058,96,0.94 [0.62-1.42],0.7791277417427751
Chapter II Neoplasms,Melanoma in situ,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",13959,100,0.62 [0.38-1.03],0.0662225552414693
Chapter II Neoplasms,Melanoma in situ,HMMR,Hyaluronan mediated motility receptor,13892,95,1.19 [0.84-1.68],0.3258920145134807
Chapter II Neoplasms,Melanoma in situ,HMOX1,Heme oxygenase 1,16330,108,0.98 [0.69-1.41],0.9310475679360768
Chapter II Neoplasms,Melanoma in situ,HMOX2,Heme oxygenase 2,16136,109,0.93 [0.62-1.38],0.7069313528493151
Chapter II Neoplasms,Melanoma in situ,HNF1A,Hepatocyte nuclear factor 1-alpha,14048,97,0.95 [0.70-1.28],0.7263252870681791
Chapter II Neoplasms,Melanoma in situ,HNMT,Histamine N-methyltransferase,16289,108,0.77 [0.53-1.10],0.1488333950704345
Chapter II Neoplasms,Melanoma in situ,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16173,106,0.97 [0.77-1.21],0.7709117772027263
Chapter II Neoplasms,Melanoma in situ,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14396,100,1.10 [0.76-1.60],0.6074322123231728
Chapter II Neoplasms,Melanoma in situ,HPCAL1,Hippocalcin-like protein 1,16683,112,1.08 [0.86-1.36],0.4986966135416523
Chapter II Neoplasms,Melanoma in situ,HPGDS,Hematopoietic prostaglandin D synthase,16170,109,0.86 [0.54-1.36],0.5095428609755702
Chapter II Neoplasms,Melanoma in situ,HPSE,Heparanase,14237,99,1.06 [0.86-1.31],0.5648911932191512
Chapter II Neoplasms,Melanoma in situ,HRAS,GTPase Hras,14124,99,0.97 [0.79-1.19],0.7826804211166483
Chapter II Neoplasms,Melanoma in situ,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14058,96,0.71 [0.38-1.35],0.3016210136301386
Chapter II Neoplasms,Melanoma in situ,HRG,Histidine-rich glycoprotein,14368,100,0.60 [0.33-1.10],0.0963766895762809
Chapter II Neoplasms,Melanoma in situ,HS1BP3,HCLS1-binding protein 3,14058,96,1.08 [0.86-1.35],0.5038733546698747
Chapter II Neoplasms,Melanoma in situ,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16439,110,0.75 [0.48-1.18],0.2146732170267084
Chapter II Neoplasms,Melanoma in situ,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16669,112,0.88 [0.54-1.43],0.5962206277844675
Chapter II Neoplasms,Melanoma in situ,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,13991,93,0.78 [0.42-1.43],0.4144949782172467
Chapter II Neoplasms,Melanoma in situ,HSBP1,Heat shock factor-binding protein 1,14058,96,1.10 [0.90-1.36],0.3436867968076067
Chapter II Neoplasms,Melanoma in situ,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16479,111,0.88 [0.57-1.35],0.5621542416549864
Chapter II Neoplasms,Melanoma in situ,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14404,100,0.97 [0.71-1.33],0.8719456175543486
Chapter II Neoplasms,Melanoma in situ,HSD17B3,Testosterone 17-beta-dehydrogenase 3,13959,100,0.90 [0.60-1.36],0.6256501131040303
Chapter II Neoplasms,Melanoma in situ,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14058,96,0.82 [0.53-1.25],0.3590174839777622
Chapter II Neoplasms,Melanoma in situ,HSP90B1,Endoplasmin,16055,109,0.98 [0.76-1.28],0.9056853242074248
Chapter II Neoplasms,Melanoma in situ,HSPA1A,Heat shock 70 kDa protein 1A,16566,112,1.05 [0.83-1.33],0.6877497841814245
Chapter II Neoplasms,Melanoma in situ,HSPA2,Heat shock-related 70 kDa protein 2,14369,100,0.93 [0.52-1.69],0.8224413036961769
Chapter II Neoplasms,Melanoma in situ,HSPB1,Heat shock protein beta-1,16264,109,1.20 [0.92-1.57],0.1718054328434826
Chapter II Neoplasms,Melanoma in situ,HSPB6,Heat shock protein beta-6,16669,112,0.79 [0.50-1.24],0.3083074694550523
Chapter II Neoplasms,Melanoma in situ,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16424,109,0.88 [0.45-1.72],0.714444336709424
Chapter II Neoplasms,Melanoma in situ,HTR1A,5-hydroxytryptamine receptor 1A,13980,98,0.83 [0.61-1.13],0.2308810489567413
Chapter II Neoplasms,Melanoma in situ,HTR1B,5-hydroxytryptamine receptor 1B,13980,98,0.93 [0.59-1.46],0.745455316443566
Chapter II Neoplasms,Melanoma in situ,HTRA2,"Serine protease HTRA2, mitochondrial",16578,111,1.06 [0.81-1.40],0.6621460895012892
Chapter II Neoplasms,Melanoma in situ,HYAL1,Hyaluronidase-1,16454,109,0.50 [0.23-1.07],0.0744490463353094
Chapter II Neoplasms,Melanoma in situ,HYOU1,Hypoxia up-regulated protein 1,16720,111,0.88 [0.42-1.85],0.7337140571235421
Chapter II Neoplasms,Melanoma in situ,ICA1,Islet cell autoantigen 1,16225,109,1.09 [0.88-1.35],0.4377356769016491
Chapter II Neoplasms,Melanoma in situ,ICAM1,Intercellular adhesion molecule 1,16474,110,1.31 [0.72-2.38],0.3824357662868722
Chapter II Neoplasms,Melanoma in situ,ICAM2,Intercellular adhesion molecule 2,16720,111,1.39 [0.82-2.35],0.2182525008910046
Chapter II Neoplasms,Melanoma in situ,ICAM3,Intercellular adhesion molecule 3,16720,111,1.09 [0.57-2.10],0.7939850360359262
Chapter II Neoplasms,Melanoma in situ,ICAM4,Intercellular adhesion molecule 4,16479,111,1.02 [0.74-1.40],0.9179151984142566
Chapter II Neoplasms,Melanoma in situ,ICAM5,Intercellular adhesion molecule 5,16502,110,0.63 [0.44-0.91],0.0134890955469401
Chapter II Neoplasms,Melanoma in situ,ICOSLG,ICOS ligand,16439,110,1.20 [0.49-2.91],0.693726819035398
Chapter II Neoplasms,Melanoma in situ,ID4,DNA-binding protein inhibitor ID-4,14160,99,1.04 [0.68-1.59],0.8562360175347
Chapter II Neoplasms,Melanoma in situ,IDI2,Isopentenyl-diphosphate delta-isomerase 2,16136,109,0.86 [0.59-1.25],0.4264263358419525
Chapter II Neoplasms,Melanoma in situ,IDO1,"Indoleamine 2,3-dioxygenase 1",14058,96,1.02 [0.75-1.39],0.890493220454076
Chapter II Neoplasms,Melanoma in situ,IDS,Iduronate 2-sulfatase,16683,112,1.29 [0.18-9.17],0.801691501071542
Chapter II Neoplasms,Melanoma in situ,IDUA,Alpha-L-iduronidase,16669,112,0.74 [0.52-1.05],0.0925996677801288
Chapter II Neoplasms,Melanoma in situ,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,13989,97,0.74 [0.44-1.25],0.256140458950415
Chapter II Neoplasms,Melanoma in situ,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14160,99,0.82 [0.55-1.21],0.312918158283776
Chapter II Neoplasms,Melanoma in situ,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14160,99,1.06 [0.64-1.75],0.8317612249850139
Chapter II Neoplasms,Melanoma in situ,IFNAR1,Interferon alpha/beta receptor 1,14355,100,1.22 [0.61-2.46],0.5724240373097238
Chapter II Neoplasms,Melanoma in situ,IFNG,Interferon gamma,16225,109,1.01 [0.86-1.17],0.9447368117009214
Chapter II Neoplasms,Melanoma in situ,IFNGR1,Interferon gamma receptor 1,16583,112,0.88 [0.39-1.99],0.7660698358378373
Chapter II Neoplasms,Melanoma in situ,IFNGR2,Interferon gamma receptor 2,16369,109,1.00 [0.72-1.39],0.9817575207565516
Chapter II Neoplasms,Melanoma in situ,IFNL1,Interferon lambda-1,16136,109,1.19 [0.82-1.72],0.3544911229039582
Chapter II Neoplasms,Melanoma in situ,IFNL2,Interferon lambda-2,13980,98,0.91 [0.64-1.28],0.5732389782667624
Chapter II Neoplasms,Melanoma in situ,IFNLR1,Interferon lambda receptor 1,16479,111,1.09 [0.69-1.73],0.7117474509264201
Chapter II Neoplasms,Melanoma in situ,IFNW1,Interferon omega-1,13959,100,0.99 [0.58-1.68],0.9560465887794274
Chapter II Neoplasms,Melanoma in situ,IFT20,Intraflagellar transport protein 20 homolog,14048,97,1.03 [0.66-1.61],0.8982753860940221
Chapter II Neoplasms,Melanoma in situ,IGBP1,Immunoglobulin-binding protein 1,14396,100,1.02 [0.74-1.39],0.9244997209278124
Chapter II Neoplasms,Melanoma in situ,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,13980,98,1.06 [0.72-1.57],0.7501906510743149
Chapter II Neoplasms,Melanoma in situ,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14428,100,0.65 [0.32-1.30],0.2217260451732945
Chapter II Neoplasms,Melanoma in situ,IGF1R,Insulin-like growth factor 1 receptor,16439,110,0.58 [0.25-1.32],0.1906347532044859
Chapter II Neoplasms,Melanoma in situ,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,13959,100,0.69 [0.42-1.15],0.1571020595054772
Chapter II Neoplasms,Melanoma in situ,IGF2R,Cation-independent mannose-6-phosphate receptor,16531,111,0.76 [0.37-1.57],0.4543015708482738
Chapter II Neoplasms,Melanoma in situ,IGFBP1,Insulin-like growth factor-binding protein 1,16698,111,1.00 [0.87-1.15],0.960989916581319
Chapter II Neoplasms,Melanoma in situ,IGFBP2,Insulin-like growth factor-binding protein 2,16698,111,1.08 [0.82-1.44],0.5795524704364553
Chapter II Neoplasms,Melanoma in situ,IGFBP3,Insulin-like growth factor-binding protein 3,16607,110,0.76 [0.45-1.29],0.3077311276113432
Chapter II Neoplasms,Melanoma in situ,IGFBP4,Insulin-like growth factor-binding protein 4,16331,109,0.80 [0.53-1.21],0.2911595721695319
Chapter II Neoplasms,Melanoma in situ,IGFBP6,Insulin-like growth factor-binding protein 6,16466,110,0.90 [0.51-1.60],0.7263555273443887
Chapter II Neoplasms,Melanoma in situ,IGFBP7,Insulin-like growth factor-binding protein 7,16720,111,1.50 [0.92-2.44],0.1054746458216539
Chapter II Neoplasms,Melanoma in situ,IGFBPL1,Insulin-like growth factor-binding protein-like 1,16502,110,1.08 [0.65-1.78],0.7789395596175339
Chapter II Neoplasms,Melanoma in situ,IGFL4,Insulin growth factor-like family member 4,13991,93,1.16 [0.93-1.44],0.1832468417641803
Chapter II Neoplasms,Melanoma in situ,IGHMBP2,DNA-binding protein SMUBP-2,13959,100,0.75 [0.51-1.11],0.147619128364171
Chapter II Neoplasms,Melanoma in situ,IGLC2,Immunoglobulin lambda constant 2,14413,100,0.66 [0.26-1.68],0.3824167620774418
Chapter II Neoplasms,Melanoma in situ,IGLON5,IgLON family member 5,13923,96,1.04 [0.86-1.27],0.6832773882150269
Chapter II Neoplasms,Melanoma in situ,IGSF21,Immunoglobulin superfamily member 21,14058,96,0.69 [0.39-1.21],0.1932980261248533
Chapter II Neoplasms,Melanoma in situ,IGSF3,Immunoglobulin superfamily member 3,16439,110,0.92 [0.54-1.57],0.7644172915511287
Chapter II Neoplasms,Melanoma in situ,IGSF8,Immunoglobulin superfamily member 8,16502,110,1.31 [0.76-2.27],0.3266069306923992
Chapter II Neoplasms,Melanoma in situ,IGSF9,Protein turtle homolog A,14415,100,0.88 [0.69-1.12],0.3028407816537971
Chapter II Neoplasms,Melanoma in situ,IKBKG,NF-kappa-B essential modulator,16479,111,1.19 [0.98-1.43],0.0720161634935912
Chapter II Neoplasms,Melanoma in situ,IKZF2,Zinc finger protein Helios,16170,109,0.94 [0.76-1.16],0.5614888613077061
Chapter II Neoplasms,Melanoma in situ,IL10,Interleukin-10,16225,109,1.04 [0.85-1.27],0.6994119875100644
Chapter II Neoplasms,Melanoma in situ,IL10RA,Interleukin-10 receptor subunit alpha,16225,109,0.82 [0.58-1.17],0.2738760895150459
Chapter II Neoplasms,Melanoma in situ,IL10RB,Interleukin-10 receptor subunit beta,16583,112,0.57 [0.31-1.04],0.0658706922427895
Chapter II Neoplasms,Melanoma in situ,IL11,Interleukin-11,16225,109,0.83 [0.61-1.13],0.2409280480230622
Chapter II Neoplasms,Melanoma in situ,IL12A_IL12B,Interleukin-12,16439,110,0.96 [0.78-1.20],0.7467033550234945
Chapter II Neoplasms,Melanoma in situ,IL12B,Interleukin-12 subunit beta,16683,112,0.94 [0.69-1.28],0.6968935888026337
Chapter II Neoplasms,Melanoma in situ,IL12RB1,Interleukin-12 receptor subunit beta-1,16225,109,1.09 [0.69-1.71],0.7113549288465885
Chapter II Neoplasms,Melanoma in situ,IL12RB2,Interleukin-12 receptor subunit beta-2,13991,93,1.08 [0.67-1.75],0.7437493531664567
Chapter II Neoplasms,Melanoma in situ,IL13,Interleukin-13,16225,109,0.92 [0.62-1.36],0.6675873800608488
Chapter II Neoplasms,Melanoma in situ,IL13RA1,Interleukin-13 receptor subunit alpha-1,16329,109,0.49 [0.22-1.09],0.0789394319513419
Chapter II Neoplasms,Melanoma in situ,IL13RA2,Interleukin-13 receptor subunit alpha-2,13980,98,0.53 [0.27-1.03],0.0600598799501656
Chapter II Neoplasms,Melanoma in situ,IL15,Interleukin-15,16479,111,1.04 [0.62-1.74],0.8787909758477033
Chapter II Neoplasms,Melanoma in situ,IL15RA,Interleukin-15 receptor subunit alpha,16225,109,0.90 [0.56-1.47],0.687857843103707
Chapter II Neoplasms,Melanoma in situ,IL16,Pro-interleukin-16,16683,112,1.19 [0.82-1.73],0.3689520601815453
Chapter II Neoplasms,Melanoma in situ,IL17A,Interleukin-17A,16204,109,0.93 [0.62-1.40],0.7200895717695852
Chapter II Neoplasms,Melanoma in situ,IL17C,Interleukin-17C,16225,109,1.16 [0.93-1.43],0.1852406417255139
Chapter II Neoplasms,Melanoma in situ,IL17D,Interleukin-17D,16225,109,0.83 [0.47-1.46],0.5269775501310565
Chapter II Neoplasms,Melanoma in situ,IL17F,Interleukin-17F,16225,109,1.02 [0.81-1.27],0.8850210338278645
Chapter II Neoplasms,Melanoma in situ,IL17RA,Interleukin-17 receptor A,16531,111,0.91 [0.62-1.33],0.6174672991894703
Chapter II Neoplasms,Melanoma in situ,IL17RB,Interleukin-17 receptor B,16279,111,0.95 [0.68-1.31],0.7330253008510115
Chapter II Neoplasms,Melanoma in situ,IL18,Interleukin-18,16457,112,1.14 [0.79-1.63],0.4858416295377868
Chapter II Neoplasms,Melanoma in situ,IL18BP,Interleukin-18-binding protein,16607,110,1.17 [0.68-2.02],0.5691975465231129
Chapter II Neoplasms,Melanoma in situ,IL18R1,Interleukin-18 receptor 1,16683,112,1.70 [1.02-2.81],0.0399433270527792
Chapter II Neoplasms,Melanoma in situ,IL18RAP,Interleukin-18 receptor accessory protein,16265,108,1.00 [0.91-1.10],0.9898790249368776
Chapter II Neoplasms,Melanoma in situ,IL19,Interleukin-19,16081,105,1.29 [1.03-1.61],0.0275198185931601
Chapter II Neoplasms,Melanoma in situ,IL1A,Interleukin-1 alpha,16225,109,0.65 [0.45-0.94],0.0236488942303484
Chapter II Neoplasms,Melanoma in situ,IL1B,Interleukin-1 beta,16155,108,1.02 [0.76-1.38],0.8803492654256065
Chapter II Neoplasms,Melanoma in situ,IL1R1,Interleukin-1 receptor type 1,16510,111,0.72 [0.34-1.52],0.3893496484386667
Chapter II Neoplasms,Melanoma in situ,IL1R2,Interleukin-1 receptor type 2,16486,112,0.43 [0.19-0.99],0.0481725602691339
Chapter II Neoplasms,Melanoma in situ,IL1RAP,Interleukin-1 receptor accessory protein,16531,111,1.16 [0.81-1.67],0.4241175955746462
Chapter II Neoplasms,Melanoma in situ,IL1RL1,Interleukin-1 receptor-like 1,16682,111,0.92 [0.63-1.33],0.6560650167898996
Chapter II Neoplasms,Melanoma in situ,IL1RL2,Interleukin-1 receptor-like 2,16225,109,1.16 [0.73-1.82],0.5345773358705652
Chapter II Neoplasms,Melanoma in situ,IL1RN,Interleukin-1 receptor antagonist protein,16495,112,1.06 [0.78-1.44],0.7237147520063485
Chapter II Neoplasms,Melanoma in situ,IL2,Interleukin-2,16225,109,0.94 [0.55-1.62],0.8234605826907996
Chapter II Neoplasms,Melanoma in situ,IL20,Interleukin-20,16225,109,0.73 [0.49-1.11],0.1411124820336645
Chapter II Neoplasms,Melanoma in situ,IL20RA,Interleukin-20 receptor subunit alpha,16225,109,0.96 [0.65-1.43],0.8431592898444674
Chapter II Neoplasms,Melanoma in situ,IL20RB,Interleukin-20 receptor subunit beta,13991,93,0.88 [0.53-1.44],0.60760810612507
Chapter II Neoplasms,Melanoma in situ,IL21R,Interleukin-21 receptor,13991,93,0.88 [0.59-1.31],0.5273300759408757
Chapter II Neoplasms,Melanoma in situ,IL22,Interleukin-22,14369,100,0.95 [0.71-1.26],0.7190934685925885
Chapter II Neoplasms,Melanoma in situ,IL22RA1,Interleukin-22 receptor subunit alpha-1,16225,109,1.00 [0.68-1.47],0.9915786046668912
Chapter II Neoplasms,Melanoma in situ,IL24,Interleukin-24,16225,109,1.15 [0.85-1.57],0.3544456231581465
Chapter II Neoplasms,Melanoma in situ,IL25,Interleukin-25,13870,95,0.79 [0.45-1.40],0.4183327414838027
Chapter II Neoplasms,Melanoma in situ,IL2RA,Interleukin-2 receptor subunit alpha,16394,109,1.00 [0.66-1.54],0.9823232906537064
Chapter II Neoplasms,Melanoma in situ,IL2RB,Interleukin-2 receptor subunit beta,16225,109,1.20 [0.81-1.77],0.3714481867778196
Chapter II Neoplasms,Melanoma in situ,IL2RG,Cytokine receptor common subunit gamma,14369,100,0.71 [0.39-1.30],0.2665867368980562
Chapter II Neoplasms,Melanoma in situ,IL3,Interleukin-3,13923,96,0.69 [0.55-0.85],0.0005774672535837
Chapter II Neoplasms,Melanoma in situ,IL31,Interleukin-31,13991,93,1.13 [0.82-1.56],0.4565256978718861
Chapter II Neoplasms,Melanoma in situ,IL31RA,Interleukin-31 receptor subunit alpha,13930,93,0.60 [0.35-1.02],0.0584527483927541
Chapter II Neoplasms,Melanoma in situ,IL32,Interleukin-32,16479,111,0.74 [0.49-1.13],0.1649135942319633
Chapter II Neoplasms,Melanoma in situ,IL33,Interleukin-33,16225,109,0.87 [0.56-1.34],0.5280942735070975
Chapter II Neoplasms,Melanoma in situ,IL34,Interleukin-34,16113,109,0.81 [0.52-1.29],0.3804656764194036
Chapter II Neoplasms,Melanoma in situ,IL36A,Interleukin-36 alpha,13991,93,0.96 [0.67-1.38],0.8138238087600669
Chapter II Neoplasms,Melanoma in situ,IL36G,Interleukin-36 gamma,13929,93,1.13 [0.87-1.48],0.3548151620742993
Chapter II Neoplasms,Melanoma in situ,IL3RA,Interleukin-3 receptor subunit alpha,16225,109,0.99 [0.58-1.69],0.964791917533819
Chapter II Neoplasms,Melanoma in situ,IL4,Interleukin-4,16225,109,0.98 [0.82-1.17],0.8352755655682348
Chapter II Neoplasms,Melanoma in situ,IL4R,Interleukin-4 receptor subunit alpha,16479,111,1.07 [0.67-1.72],0.7721051929007158
Chapter II Neoplasms,Melanoma in situ,IL5,Interleukin-5,16225,109,1.06 [0.94-1.18],0.3479481343201368
Chapter II Neoplasms,Melanoma in situ,IL5RA,Interleukin-5 receptor subunit alpha,16479,111,0.92 [0.68-1.26],0.6152802055119013
Chapter II Neoplasms,Melanoma in situ,IL6,Interleukin-6,16439,110,1.05 [0.85-1.31],0.6332532413788607
Chapter II Neoplasms,Melanoma in situ,IL6R,Interleukin-6 receptor subunit alpha,16452,110,1.24 [0.75-2.03],0.3987229646155265
Chapter II Neoplasms,Melanoma in situ,IL6ST,Interleukin-6 receptor subunit beta,16502,110,0.94 [0.35-2.51],0.8949501908916414
Chapter II Neoplasms,Melanoma in situ,IL7,Interleukin-7,16479,111,0.93 [0.71-1.21],0.5692893103910779
Chapter II Neoplasms,Melanoma in situ,IL7R,Interleukin-7 receptor subunit alpha,16531,111,0.94 [0.69-1.30],0.7241917012885846
Chapter II Neoplasms,Melanoma in situ,IL9,Interleukin-9,14160,99,0.94 [0.66-1.36],0.7543427553749571
Chapter II Neoplasms,Melanoma in situ,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16114,108,1.05 [0.78-1.41],0.7663134831731948
Chapter II Neoplasms,Melanoma in situ,IMMT,MICOS complex subunit MIC60,14369,100,1.12 [0.74-1.70],0.5936864432521499
Chapter II Neoplasms,Melanoma in situ,IMPA1,Inositol monophosphatase 1,16369,109,1.14 [0.87-1.51],0.3462552916734964
Chapter II Neoplasms,Melanoma in situ,IMPACT,Protein IMPACT,14404,100,1.08 [0.77-1.52],0.652054479738289
Chapter II Neoplasms,Melanoma in situ,IMPG1,Interphotoreceptor matrix proteoglycan 1,13980,98,0.40 [0.19-0.88],0.0216110527987876
Chapter II Neoplasms,Melanoma in situ,ING1,Inhibitor of growth protein 1,16107,109,1.05 [0.73-1.50],0.78959873806452
Chapter II Neoplasms,Melanoma in situ,INHBB,Inhibin beta B chain,14132,98,0.92 [0.63-1.35],0.6787030516386857
Chapter II Neoplasms,Melanoma in situ,INHBC,Inhibin beta C chain,16531,111,1.25 [0.82-1.90],0.3043716849793287
Chapter II Neoplasms,Melanoma in situ,INPP1,Inositol polyphosphate 1-phosphatase,16439,110,1.25 [0.92-1.69],0.162545874779664
Chapter II Neoplasms,Melanoma in situ,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14058,96,1.23 [0.87-1.74],0.232531264868918
Chapter II Neoplasms,Melanoma in situ,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14396,100,0.91 [0.57-1.45],0.6908772928687608
Chapter II Neoplasms,Melanoma in situ,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16439,110,1.10 [0.93-1.31],0.2692442981270947
Chapter II Neoplasms,Melanoma in situ,INSL3,Insulin-like 3,14404,100,1.01 [0.79-1.29],0.9483667792593424
Chapter II Neoplasms,Melanoma in situ,INSL4,Early placenta insulin-like peptide,14369,100,1.27 [0.94-1.73],0.125306861692962
Chapter II Neoplasms,Melanoma in situ,INSL5,Insulin-like peptide INSL5,14355,100,0.86 [0.70-1.07],0.1680089261142182
Chapter II Neoplasms,Melanoma in situ,INSR,Insulin receptor,13991,93,1.23 [0.38-4.05],0.7298136076098143
Chapter II Neoplasms,Melanoma in situ,IPCEF1,Interactor protein for cytohesin exchange factors 1,16341,108,1.13 [0.93-1.37],0.229108266854274
Chapter II Neoplasms,Melanoma in situ,IQGAP2,Ras GTPase-activating-like protein IQGAP2,16439,110,1.05 [0.77-1.43],0.7644805607807236
Chapter II Neoplasms,Melanoma in situ,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16217,107,1.03 [0.85-1.25],0.7504471749088664
Chapter II Neoplasms,Melanoma in situ,IRAK1,Interleukin-1 receptor-associated kinase 1,16225,109,1.06 [0.83-1.37],0.6229401756689364
Chapter II Neoplasms,Melanoma in situ,IRAK4,Interleukin-1 receptor-associated kinase 4,16479,111,1.10 [0.93-1.30],0.2614103522323584
Chapter II Neoplasms,Melanoma in situ,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15918,107,0.84 [0.53-1.33],0.4480068111565161
Chapter II Neoplasms,Melanoma in situ,ISM1,Isthmin-1,16479,111,0.74 [0.48-1.16],0.1898378565580789
Chapter II Neoplasms,Melanoma in situ,ISM2,Isthmin-2,14428,100,0.65 [0.40-1.04],0.0747836153816768
Chapter II Neoplasms,Melanoma in situ,IST1,IST1 homolog,14239,99,1.01 [0.83-1.23],0.9223923542302273
Chapter II Neoplasms,Melanoma in situ,ITGA11,Integrin alpha-11,16479,111,0.78 [0.47-1.29],0.3299623063296959
Chapter II Neoplasms,Melanoma in situ,ITGA2,Integrin alpha-2,14132,98,0.75 [0.42-1.33],0.3274970454379752
Chapter II Neoplasms,Melanoma in situ,ITGA5,Integrin alpha-5,16531,111,0.76 [0.38-1.54],0.4504136018187826
Chapter II Neoplasms,Melanoma in situ,ITGA6,Integrin alpha-6,16479,111,0.96 [0.69-1.34],0.8139088038590176
Chapter II Neoplasms,Melanoma in situ,ITGAL,Integrin alpha-L,13991,93,0.97 [0.62-1.53],0.905868532167718
Chapter II Neoplasms,Melanoma in situ,ITGAM,Integrin alpha-M,16531,111,0.70 [0.40-1.20],0.1900671786374618
Chapter II Neoplasms,Melanoma in situ,ITGAV,Integrin alpha-V,16669,112,0.56 [0.20-1.56],0.2640549156478003
Chapter II Neoplasms,Melanoma in situ,ITGAX,Integrin alpha-X,14160,99,1.09 [0.77-1.53],0.6399830297741819
Chapter II Neoplasms,Melanoma in situ,ITGB1,Integrin beta-1,16536,110,0.82 [0.36-1.86],0.6297990598040848
Chapter II Neoplasms,Melanoma in situ,ITGB1BP1,Integrin beta-1-binding protein 1,16170,109,0.81 [0.54-1.23],0.3270109374432126
Chapter II Neoplasms,Melanoma in situ,ITGB1BP2,Integrin beta-1-binding protein 2,16217,107,1.01 [0.86-1.18],0.9353450817346728
Chapter II Neoplasms,Melanoma in situ,ITGB2,Integrin beta-2,16434,110,0.58 [0.31-1.08],0.0872575618144676
Chapter II Neoplasms,Melanoma in situ,ITGB5,Integrin beta-5,16578,111,0.93 [0.59-1.49],0.7731410212063186
Chapter II Neoplasms,Melanoma in situ,ITGB6,Integrin beta-6,16225,109,0.77 [0.44-1.35],0.3622543732806889
Chapter II Neoplasms,Melanoma in situ,ITGB7,Integrin beta-7,16669,112,0.96 [0.67-1.39],0.8411037936325813
Chapter II Neoplasms,Melanoma in situ,ITGBL1,Integrin beta-like protein 1,14428,100,1.05 [0.61-1.79],0.8670813586530057
Chapter II Neoplasms,Melanoma in situ,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14443,100,0.50 [0.18-1.39],0.1854446470942139
Chapter II Neoplasms,Melanoma in situ,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16607,110,0.95 [0.60-1.49],0.8242122254856696
Chapter II Neoplasms,Melanoma in situ,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14443,100,0.83 [0.38-1.79],0.6255256182607312
Chapter II Neoplasms,Melanoma in situ,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14369,100,1.15 [0.78-1.71],0.4796985167005159
Chapter II Neoplasms,Melanoma in situ,ITM2A,Integral membrane protein 2A,16479,111,0.96 [0.73-1.26],0.7599719944454575
Chapter II Neoplasms,Melanoma in situ,ITPA,Inosine triphosphate pyrophosphatase,13959,100,1.13 [0.84-1.50],0.4184977965107374
Chapter II Neoplasms,Melanoma in situ,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14058,96,1.33 [1.07-1.66],0.0115483075536733
Chapter II Neoplasms,Melanoma in situ,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",13980,98,0.79 [0.48-1.30],0.3547520293346854
Chapter II Neoplasms,Melanoma in situ,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16136,109,0.94 [0.67-1.33],0.7354820321080435
Chapter II Neoplasms,Melanoma in situ,IZUMO1,Izumo sperm-egg fusion protein 1,13923,96,0.86 [0.53-1.37],0.517383899508846
Chapter II Neoplasms,Melanoma in situ,JAM2,Junctional adhesion molecule B,16642,112,0.73 [0.38-1.42],0.3573942171427038
Chapter II Neoplasms,Melanoma in situ,JAM3,Junctional adhesion molecule C,14132,98,0.84 [0.55-1.27],0.3981245448221151
Chapter II Neoplasms,Melanoma in situ,JCHAIN,Immunoglobulin J chain,16225,109,1.07 [0.81-1.41],0.6345269101839021
Chapter II Neoplasms,Melanoma in situ,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13923,96,1.02 [0.73-1.43],0.9059619838547022
Chapter II Neoplasms,Melanoma in situ,JPT2,Jupiter microtubule associated homolog 2,14355,100,1.09 [0.87-1.36],0.4701158690793008
Chapter II Neoplasms,Melanoma in situ,JUN,Transcription factor AP-1,16225,109,0.81 [0.54-1.22],0.3223295850463621
Chapter II Neoplasms,Melanoma in situ,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16439,110,1.27 [0.86-1.88],0.2350874840945324
Chapter II Neoplasms,Melanoma in situ,KAZN,Kazrin,14355,100,1.12 [0.93-1.35],0.225677205279381
Chapter II Neoplasms,Melanoma in situ,KCNC4,Potassium voltage-gated channel subfamily C member 4,13980,98,1.55 [1.27-1.89],1.743227021625432e-05
Chapter II Neoplasms,Melanoma in situ,KCNH2,Potassium voltage-gated channel subfamily H member 2,14048,97,1.04 [0.82-1.32],0.7260898636666884
Chapter II Neoplasms,Melanoma in situ,KCNIP4,Kv channel-interacting protein 4,16136,109,0.91 [0.62-1.32],0.6041888527596502
Chapter II Neoplasms,Melanoma in situ,KCTD5,BTB/POZ domain-containing protein KCTD5,14142,99,1.03 [0.66-1.59],0.9099900185139048
Chapter II Neoplasms,Melanoma in situ,KDM3A,Lysine-specific demethylase 3A,13991,93,0.93 [0.73-1.19],0.5864031462223966
Chapter II Neoplasms,Melanoma in situ,KDR,Vascular endothelial growth factor receptor 2,16578,111,1.23 [0.62-2.43],0.5489580433297119
Chapter II Neoplasms,Melanoma in situ,KEL,Kell blood group glycoprotein,16136,109,0.68 [0.42-1.09],0.109890932097108
Chapter II Neoplasms,Melanoma in situ,KHDC3L,KH domain-containing protein 3,13923,96,0.66 [0.44-1.00],0.0481348096806858
Chapter II Neoplasms,Melanoma in situ,KHK,Ketohexokinase,14058,96,1.02 [0.74-1.41],0.8849958620334034
Chapter II Neoplasms,Melanoma in situ,KIAA0319,Dyslexia-associated protein KIAA0319,14404,100,0.76 [0.39-1.46],0.4085602939563234
Chapter II Neoplasms,Melanoma in situ,KIAA1549,UPF0606 protein KIAA1549,14160,99,1.08 [0.83-1.41],0.58065601029647
Chapter II Neoplasms,Melanoma in situ,KIAA1549L,UPF0606 protein KIAA1549L,14160,99,0.44 [0.21-0.93],0.0308627139455094
Chapter II Neoplasms,Melanoma in situ,KIAA2013,Uncharacterized protein KIAA2013,14369,100,0.92 [0.64-1.34],0.667319397018425
Chapter II Neoplasms,Melanoma in situ,KIF1C,Kinesin-like protein KIF1C,13959,100,0.58 [0.29-1.16],0.1220013417808485
Chapter II Neoplasms,Melanoma in situ,KIF20B,Kinesin-like protein KIF20B,13980,98,0.85 [0.64-1.12],0.2488345321726512
Chapter II Neoplasms,Melanoma in situ,KIF22,Kinesin-like protein KIF22,13959,100,1.12 [0.95-1.31],0.1835023482887534
Chapter II Neoplasms,Melanoma in situ,KIFBP,KIF-binding protein,16439,110,1.07 [0.87-1.32],0.5056460173739709
Chapter II Neoplasms,Melanoma in situ,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14369,100,1.10 [0.89-1.36],0.3914907628643284
Chapter II Neoplasms,Melanoma in situ,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16170,109,1.00 [0.81-1.24],0.9940251970101868
Chapter II Neoplasms,Melanoma in situ,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14355,100,0.98 [0.88-1.09],0.7044174297791926
Chapter II Neoplasms,Melanoma in situ,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16170,109,0.85 [0.74-0.97],0.0199281760398696
Chapter II Neoplasms,Melanoma in situ,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13923,96,1.05 [0.85-1.30],0.6381667587563236
Chapter II Neoplasms,Melanoma in situ,KIRREL1,Kin of IRRE-like protein 1,13980,98,0.75 [0.49-1.17],0.2078649566929377
Chapter II Neoplasms,Melanoma in situ,KIRREL2,Kin of IRRE-like protein 2,16136,109,0.75 [0.48-1.17],0.201999702809507
Chapter II Neoplasms,Melanoma in situ,KIT,Mast/stem cell growth factor receptor Kit,16577,110,1.26 [0.71-2.23],0.4343613845378752
Chapter II Neoplasms,Melanoma in situ,KITLG,Kit ligand,16502,110,0.79 [0.49-1.25],0.308476210267442
Chapter II Neoplasms,Melanoma in situ,KLB,Beta-klotho,16136,109,0.84 [0.67-1.06],0.1496658117529119
Chapter II Neoplasms,Melanoma in situ,KLF4,Krueppel-like factor 4,13980,98,1.14 [0.72-1.79],0.5730447020671079
Chapter II Neoplasms,Melanoma in situ,KLHL41,Kelch-like protein 41,14396,100,1.04 [0.69-1.55],0.8606573674780358
Chapter II Neoplasms,Melanoma in situ,KLK1,Kallikrein-1,16356,109,0.88 [0.77-1.02],0.0870325949394773
Chapter II Neoplasms,Melanoma in situ,KLK10,Kallikrein-10,16526,111,0.86 [0.56-1.32],0.494121068975953
Chapter II Neoplasms,Melanoma in situ,KLK11,Kallikrein-11,16420,111,0.97 [0.56-1.66],0.8989520554310277
Chapter II Neoplasms,Melanoma in situ,KLK12,Kallikrein-12,16170,109,0.93 [0.83-1.05],0.2733782039416712
Chapter II Neoplasms,Melanoma in situ,KLK13,Kallikrein-13,16157,109,1.15 [0.79-1.68],0.4561748892680687
Chapter II Neoplasms,Melanoma in situ,KLK14,Kallikrein-14,16669,112,0.73 [0.51-1.06],0.0958629110240517
Chapter II Neoplasms,Melanoma in situ,KLK15,Kallikrein-15,14346,100,0.72 [0.50-1.02],0.0677481977230358
Chapter II Neoplasms,Melanoma in situ,KLK3,Prostate-specific antigen,14428,100,1.10 [0.89-1.36],0.361000465420189
Chapter II Neoplasms,Melanoma in situ,KLK4,Kallikrein-4,16669,112,1.20 [0.93-1.55],0.1593430531912788
Chapter II Neoplasms,Melanoma in situ,KLK6,Kallikrein-6,16549,111,1.41 [0.82-2.44],0.2165650126518594
Chapter II Neoplasms,Melanoma in situ,KLK7,Kallikrein-7,13777,98,0.66 [0.38-1.12],0.1254500763759195
Chapter II Neoplasms,Melanoma in situ,KLK8,Kallikrein-8,15983,109,1.18 [0.74-1.88],0.494184057807327
Chapter II Neoplasms,Melanoma in situ,KLKB1,Plasma kallikrein,14132,99,0.87 [0.39-1.92],0.7288751185958735
Chapter II Neoplasms,Melanoma in situ,KLRB1,Killer cell lectin-like receptor subfamily B member 1,16683,112,0.98 [0.63-1.53],0.9393882779908242
Chapter II Neoplasms,Melanoma in situ,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,13980,98,0.93 [0.65-1.33],0.691184954408014
Chapter II Neoplasms,Melanoma in situ,KLRD1,Natural killer cells antigen CD94,16683,112,1.24 [0.87-1.77],0.23050407607947
Chapter II Neoplasms,Melanoma in situ,KLRF1,Killer cell lectin-like receptor subfamily F member 1,13991,93,0.81 [0.48-1.37],0.4427637617720067
Chapter II Neoplasms,Melanoma in situ,KLRK1,NKG2-D type II integral membrane protein,14404,100,0.98 [0.66-1.47],0.9339901627852176
Chapter II Neoplasms,Melanoma in situ,KRT14,"Keratin, type I cytoskeletal 14",15612,103,0.90 [0.47-1.70],0.7448021437310899
Chapter II Neoplasms,Melanoma in situ,KRT17,"Keratin, type I cytoskeletal 17",13959,100,0.73 [0.42-1.25],0.2490930776542359
Chapter II Neoplasms,Melanoma in situ,KRT18,"Keratin, type I cytoskeletal 18",16439,110,0.90 [0.72-1.13],0.3727072976797392
Chapter II Neoplasms,Melanoma in situ,KRT19,"Keratin, type I cytoskeletal 19",16444,111,0.86 [0.66-1.12],0.2605355664973692
Chapter II Neoplasms,Melanoma in situ,KRT5,"Keratin, type II cytoskeletal 5",16136,109,1.07 [0.77-1.50],0.6747038721790066
Chapter II Neoplasms,Melanoma in situ,KRT6C,"Keratin, type II cytoskeletal 6C",13959,100,0.97 [0.57-1.67],0.9148514456939532
Chapter II Neoplasms,Melanoma in situ,KRT8,"Keratin, type II cytoskeletal 8",13980,98,0.66 [0.44-0.98],0.0388580222130379
Chapter II Neoplasms,Melanoma in situ,KYAT1,Kynurenine--oxoglutarate transaminase 1,16482,110,1.11 [0.83-1.50],0.4811371517240479
Chapter II Neoplasms,Melanoma in situ,KYNU,Kynureninase,16683,112,1.20 [0.83-1.75],0.3313383101807288
Chapter II Neoplasms,Melanoma in situ,L1CAM,Neural cell adhesion molecule L1,16578,111,0.70 [0.39-1.27],0.2406976557706226
Chapter II Neoplasms,Melanoma in situ,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14415,100,0.90 [0.73-1.12],0.3645374616211504
Chapter II Neoplasms,Melanoma in situ,LACRT,Extracellular glycoprotein lacritin,14335,100,1.29 [0.95-1.75],0.1032302006134501
Chapter II Neoplasms,Melanoma in situ,LACTB2,Endoribonuclease LACTB2,16502,110,1.12 [0.87-1.45],0.3802805689943099
Chapter II Neoplasms,Melanoma in situ,LAG3,Lymphocyte activation gene 3 protein,16439,110,1.09 [0.71-1.66],0.7060422461373395
Chapter II Neoplasms,Melanoma in situ,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16504,112,1.00 [0.63-1.59],0.9958534019628702
Chapter II Neoplasms,Melanoma in situ,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16369,109,0.99 [0.85-1.16],0.9198322251191174
Chapter II Neoplasms,Melanoma in situ,LAMA1,Laminin subunit alpha-1,13959,100,0.88 [0.59-1.33],0.5487859363435732
Chapter II Neoplasms,Melanoma in situ,LAMA4,Laminin subunit alpha-4,16583,112,1.12 [0.67-1.85],0.6695843144708636
Chapter II Neoplasms,Melanoma in situ,LAMB1,Laminin subunit beta-1,14058,96,0.72 [0.37-1.39],0.3278893904895016
Chapter II Neoplasms,Melanoma in situ,LAMP1,Lysosome-associated membrane glycoprotein 1,14021,98,0.77 [0.34-1.74],0.528957681085417
Chapter II Neoplasms,Melanoma in situ,LAMP2,Lysosome-associated membrane glycoprotein 2,16008,108,1.47 [0.60-3.59],0.3993809154298636
Chapter II Neoplasms,Melanoma in situ,LAMP3,Lysosome-associated membrane glycoprotein 3,16658,112,1.10 [0.80-1.52],0.5551651954066712
Chapter II Neoplasms,Melanoma in situ,LAMTOR5,Ragulator complex protein LAMTOR5,14369,100,1.01 [0.63-1.62],0.9575335329766268
Chapter II Neoplasms,Melanoma in situ,LAP3,Cytosol aminopeptidase,16225,109,0.99 [0.69-1.42],0.9519550987537142
Chapter II Neoplasms,Melanoma in situ,LARP1,La-related protein 1,14369,100,0.93 [0.67-1.28],0.6460192737663345
Chapter II Neoplasms,Melanoma in situ,LAT,Linker for activation of T-cells family member 1,16683,112,1.10 [0.88-1.38],0.4111634076783139
Chapter II Neoplasms,Melanoma in situ,LAT2,Linker for activation of T-cells family member 2,16439,110,1.02 [0.89-1.17],0.7891079076780873
Chapter II Neoplasms,Melanoma in situ,LATS1,Serine/threonine-protein kinase LATS1,13991,93,1.07 [0.84-1.36],0.5869095871300933
Chapter II Neoplasms,Melanoma in situ,LAYN,Layilin,16340,109,0.76 [0.45-1.26],0.2859497332524926
Chapter II Neoplasms,Melanoma in situ,LBP,Lipopolysaccharide-binding protein,16607,110,0.98 [0.73-1.30],0.8743263676743783
Chapter II Neoplasms,Melanoma in situ,LBR,Delta(14)-sterol reductase LBR,16642,112,1.06 [0.84-1.34],0.6344436660139432
Chapter II Neoplasms,Melanoma in situ,LCAT,Phosphatidylcholine-sterol acyltransferase,14434,100,1.75 [0.71-4.31],0.2261205705258577
Chapter II Neoplasms,Melanoma in situ,LCN15,Lipocalin-15,14396,100,0.68 [0.46-0.99],0.0468458278721876
Chapter II Neoplasms,Melanoma in situ,LCN2,Neutrophil gelatinase-associated lipocalin,16063,106,1.06 [0.68-1.65],0.8003815508393071
Chapter II Neoplasms,Melanoma in situ,LCP1,Plastin-2,14428,100,0.83 [0.54-1.27],0.3870302307219511
Chapter II Neoplasms,Melanoma in situ,LDLR,Low-density lipoprotein receptor,16563,109,1.00 [0.72-1.40],0.9886543169141396
Chapter II Neoplasms,Melanoma in situ,LDLRAP1,Low density lipoprotein receptor adapter protein 1,14396,100,1.08 [0.88-1.31],0.4710267622627785
Chapter II Neoplasms,Melanoma in situ,LECT2,Leukocyte cell-derived chemotaxin-2,14415,100,0.98 [0.73-1.31],0.8733644166075616
Chapter II Neoplasms,Melanoma in situ,LEFTY2,Left-right determination factor 2,16639,112,0.59 [0.42-0.83],0.0021882332441229
Chapter II Neoplasms,Melanoma in situ,LEG1,Protein LEG1 homolog,13672,93,1.26 [0.95-1.67],0.111118351667281
Chapter II Neoplasms,Melanoma in situ,LELP1,Late cornified envelope-like proline-rich protein 1,13980,98,0.97 [0.74-1.28],0.8431525331654768
Chapter II Neoplasms,Melanoma in situ,LEO1,RNA polymerase-associated protein LEO1,14396,100,0.67 [0.32-1.40],0.2870881535811797
Chapter II Neoplasms,Melanoma in situ,LEP,Leptin,16502,110,0.95 [0.74-1.23],0.7193827672834254
Chapter II Neoplasms,Melanoma in situ,LEPR,Leptin receptor,16502,110,1.10 [0.64-1.88],0.7400046438261292
Chapter II Neoplasms,Melanoma in situ,LETM1,Mitochondrial proton/calcium exchanger protein,14396,100,0.81 [0.55-1.19],0.2865032074306504
Chapter II Neoplasms,Melanoma in situ,LGALS1,Galectin-1,16502,110,0.89 [0.54-1.48],0.6581660107523957
Chapter II Neoplasms,Melanoma in situ,LGALS3,Galectin-3,16568,111,0.80 [0.46-1.41],0.444955354779158
Chapter II Neoplasms,Melanoma in situ,LGALS3BP,Galectin-3-binding protein,14443,100,0.50 [0.24-1.01],0.0539989305113583
Chapter II Neoplasms,Melanoma in situ,LGALS4,Galectin-4,16504,112,1.08 [0.80-1.45],0.6327313804790444
Chapter II Neoplasms,Melanoma in situ,LGALS7_LGALS7B,Galectin-7,16483,111,1.14 [0.77-1.68],0.5213102377553249
Chapter II Neoplasms,Melanoma in situ,LGALS8,Galectin-8,16642,112,1.05 [0.80-1.39],0.7214258713605386
Chapter II Neoplasms,Melanoma in situ,LGALS9,Galectin-9,16520,112,1.07 [0.62-1.83],0.8147699915134448
Chapter II Neoplasms,Melanoma in situ,LGMN,Legumain,16583,112,1.13 [0.71-1.81],0.6006221503749557
Chapter II Neoplasms,Melanoma in situ,LHB,Lutropin subunit beta,16170,109,0.91 [0.73-1.13],0.3853623222839086
Chapter II Neoplasms,Melanoma in situ,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16533,112,0.95 [0.71-1.26],0.705869599672889
Chapter II Neoplasms,Melanoma in situ,LIF,Leukemia inhibitory factor,16136,109,0.92 [0.65-1.31],0.640273459881477
Chapter II Neoplasms,Melanoma in situ,LIFR,Leukemia inhibitory factor receptor,16479,111,1.53 [0.76-3.07],0.2356421300953532
Chapter II Neoplasms,Melanoma in situ,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16531,111,1.18 [0.72-1.91],0.5133703807481462
Chapter II Neoplasms,Melanoma in situ,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14428,100,1.02 [0.89-1.18],0.7437469610967852
Chapter II Neoplasms,Melanoma in situ,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,13959,100,0.70 [0.45-1.11],0.1310496324877236
Chapter II Neoplasms,Melanoma in situ,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16476,110,0.90 [0.53-1.52],0.6858827526776706
Chapter II Neoplasms,Melanoma in situ,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14415,100,1.01 [0.78-1.31],0.9225399450572276
Chapter II Neoplasms,Melanoma in situ,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16720,111,0.90 [0.48-1.66],0.7264141496300194
Chapter II Neoplasms,Melanoma in situ,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16660,111,1.08 [0.66-1.76],0.7655341651481106
Chapter II Neoplasms,Melanoma in situ,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16225,109,0.89 [0.60-1.31],0.5488374330325168
Chapter II Neoplasms,Melanoma in situ,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16720,111,0.84 [0.67-1.05],0.1245945062149372
Chapter II Neoplasms,Melanoma in situ,LIPF,Gastric triacylglycerol lipase,14058,96,0.83 [0.60-1.14],0.2513189951218791
Chapter II Neoplasms,Melanoma in situ,LMNB1,Lamin-B1,14329,99,0.97 [0.70-1.33],0.8271117515707019
Chapter II Neoplasms,Melanoma in situ,LMNB2,Lamin-B2,14404,100,0.80 [0.39-1.64],0.5436285792473086
Chapter II Neoplasms,Melanoma in situ,LMOD1,Leiomodin-1,14396,100,0.74 [0.41-1.36],0.3367393664761063
Chapter II Neoplasms,Melanoma in situ,LMOD2,Leiomodin-2,13980,98,0.73 [0.50-1.05],0.0866938095930742
Chapter II Neoplasms,Melanoma in situ,LONP1,"Lon protease homolog, mitochondrial",14058,96,0.97 [0.77-1.22],0.7805281696136469
Chapter II Neoplasms,Melanoma in situ,LPA,Apolipoprotein(a),14110,97,0.99 [0.89-1.10],0.8558677304053324
Chapter II Neoplasms,Melanoma in situ,LPCAT2,Lysophosphatidylcholine acyltransferase 2,16439,110,1.16 [0.84-1.61],0.3657762307103126
Chapter II Neoplasms,Melanoma in situ,LPL,Lipoprotein lipase,16502,110,0.94 [0.66-1.35],0.7395922314852864
Chapter II Neoplasms,Melanoma in situ,LPO,Lactoperoxidase,15942,105,1.43 [1.07-1.89],0.0142085910928669
Chapter II Neoplasms,Melanoma in situ,LPP,Lipoma-preferred partner,13959,100,0.90 [0.67-1.22],0.4914646018294442
Chapter II Neoplasms,Melanoma in situ,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13959,100,0.90 [0.67-1.21],0.4902615553140336
Chapter II Neoplasms,Melanoma in situ,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14048,97,0.62 [0.36-1.07],0.0843770084606469
Chapter II Neoplasms,Melanoma in situ,LRG1,Leucine-rich alpha-2-glycoprotein,14443,100,1.24 [0.60-2.55],0.5589983300645014
Chapter II Neoplasms,Melanoma in situ,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16611,112,1.17 [0.72-1.89],0.5249955556221602
Chapter II Neoplasms,Melanoma in situ,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13939,93,0.58 [0.25-1.30],0.184753298119894
Chapter II Neoplasms,Melanoma in situ,LRP1,Prolow-density lipoprotein receptor-related protein 1,16439,110,0.73 [0.38-1.40],0.3405056007664775
Chapter II Neoplasms,Melanoma in situ,LRP11,Low-density lipoprotein receptor-related protein 11,16502,110,1.01 [0.63-1.62],0.95713778058723
Chapter II Neoplasms,Melanoma in situ,LRP2,Low-density lipoprotein receptor-related protein 2,14048,97,0.84 [0.47-1.47],0.5349314019801663
Chapter II Neoplasms,Melanoma in situ,LRP2BP,LRP2-binding protein,14048,97,0.90 [0.69-1.17],0.4169031043879416
Chapter II Neoplasms,Melanoma in situ,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16642,112,0.89 [0.65-1.22],0.4673755763379065
Chapter II Neoplasms,Melanoma in situ,LRRC25,Leucine-rich repeat-containing protein 25,16439,110,1.08 [0.69-1.67],0.7375114380970289
Chapter II Neoplasms,Melanoma in situ,LRRC37A2,Leucine-rich repeat-containing protein 37A2,14355,100,0.99 [0.63-1.54],0.9594621630153554
Chapter II Neoplasms,Melanoma in situ,LRRC38,Leucine-rich repeat-containing protein 38,14048,97,0.92 [0.61-1.39],0.7029444293317924
Chapter II Neoplasms,Melanoma in situ,LRRC59,Leucine-rich repeat-containing protein 59,14415,100,0.99 [0.66-1.49],0.9702912297114912
Chapter II Neoplasms,Melanoma in situ,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14369,100,1.07 [0.72-1.59],0.7424903524858373
Chapter II Neoplasms,Melanoma in situ,LRRN1,Leucine-rich repeat neuronal protein 1,16225,109,0.68 [0.44-1.05],0.0795892894619239
Chapter II Neoplasms,Melanoma in situ,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14048,97,0.94 [0.58-1.54],0.8182607827755397
Chapter II Neoplasms,Melanoma in situ,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14396,100,0.84 [0.40-1.79],0.6569376172984677
Chapter II Neoplasms,Melanoma in situ,LSM1,U6 snRNA-associated Sm-like protein LSm1,16170,109,1.05 [0.78-1.42],0.741968904789805
Chapter II Neoplasms,Melanoma in situ,LSM8,U6 snRNA-associated Sm-like protein LSm8,14160,99,0.95 [0.74-1.20],0.6467624175960985
Chapter II Neoplasms,Melanoma in situ,LSP1,Lymphocyte-specific protein 1,16479,111,1.27 [0.84-1.91],0.2599074302269278
Chapter II Neoplasms,Melanoma in situ,LTA,Lymphotoxin-alpha,16479,111,0.98 [0.64-1.49],0.918376710564977
Chapter II Neoplasms,Melanoma in situ,LTA4H,Leukotriene A-4 hydrolase,16669,112,1.01 [0.76-1.35],0.9362988866141548
Chapter II Neoplasms,Melanoma in situ,LTB,Lymphotoxin-beta,14369,100,1.05 [0.62-1.78],0.8465497927301134
Chapter II Neoplasms,Melanoma in situ,LTBP2,Latent-transforming growth factor beta-binding protein 2,16720,111,1.15 [0.67-1.97],0.6114458482037806
Chapter II Neoplasms,Melanoma in situ,LTBP3,Latent-transforming growth factor beta-binding protein 3,16170,109,0.89 [0.63-1.26],0.5237357183191944
Chapter II Neoplasms,Melanoma in situ,LTBR,Tumor necrosis factor receptor superfamily member 3,16449,112,0.87 [0.48-1.59],0.6532039125424729
Chapter II Neoplasms,Melanoma in situ,LTO1,Protein LTO1 homolog,16225,109,1.07 [0.71-1.61],0.753200172628491
Chapter II Neoplasms,Melanoma in situ,LUZP2,Leucine zipper protein 2,14369,100,1.26 [0.85-1.84],0.2460832744343368
Chapter II Neoplasms,Melanoma in situ,LXN,Latexin,16300,109,1.00 [0.78-1.28],0.9798487964007316
Chapter II Neoplasms,Melanoma in situ,LY6D,Lymphocyte antigen 6D,16457,111,1.12 [0.72-1.73],0.6203130862830675
Chapter II Neoplasms,Melanoma in situ,LY75,Lymphocyte antigen 75,16479,111,1.39 [0.89-2.18],0.1505490013337985
Chapter II Neoplasms,Melanoma in situ,LY9,T-lymphocyte surface antigen Ly-9,16302,109,1.44 [0.80-2.59],0.2211239987412183
Chapter II Neoplasms,Melanoma in situ,LY96,Lymphocyte antigen 96,16369,109,0.67 [0.40-1.10],0.1147673855114347
Chapter II Neoplasms,Melanoma in situ,LYAR,Cell growth-regulating nucleolar protein,16170,109,0.99 [0.72-1.36],0.9316731310337156
Chapter II Neoplasms,Melanoma in situ,LYN,Tyrosine-protein kinase Lyn,16439,110,1.03 [0.84-1.26],0.7621223609625041
Chapter II Neoplasms,Melanoma in situ,LYPD1,Ly6/PLAUR domain-containing protein 1,16136,109,0.83 [0.59-1.16],0.2676179955483526
Chapter II Neoplasms,Melanoma in situ,LYPD3,Ly6/PLAUR domain-containing protein 3,16436,111,0.88 [0.53-1.47],0.6276011121598399
Chapter II Neoplasms,Melanoma in situ,LYPD8,Ly6/PLAUR domain-containing protein 8,16170,109,0.92 [0.64-1.31],0.6349802463253085
Chapter II Neoplasms,Melanoma in situ,LYPLA2,Acyl-protein thioesterase 2,13980,98,0.82 [0.65-1.03],0.087093059010999
Chapter II Neoplasms,Melanoma in situ,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14048,97,1.08 [0.91-1.29],0.3521670018343262
Chapter II Neoplasms,Melanoma in situ,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14443,100,0.67 [0.25-1.78],0.4234947842012349
Chapter II Neoplasms,Melanoma in situ,LYZL2,Lysozyme-like protein 2,13923,96,1.03 [0.60-1.77],0.9224399589725382
Chapter II Neoplasms,Melanoma in situ,LZTFL1,Leucine zipper transcription factor-like protein 1,14132,98,1.07 [0.81-1.41],0.6220900502989363
Chapter II Neoplasms,Melanoma in situ,M6PR,Cation-dependent mannose-6-phosphate receptor,14058,96,1.10 [0.70-1.74],0.6734351997329917
Chapter II Neoplasms,Melanoma in situ,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16306,109,0.94 [0.65-1.35],0.72498045210697
Chapter II Neoplasms,Melanoma in situ,MAEA,E3 ubiquitin-protein transferase MAEA,16170,109,0.83 [0.52-1.32],0.4246088991204222
Chapter II Neoplasms,Melanoma in situ,MAG,Myelin-associated glycoprotein,14048,97,0.92 [0.62-1.38],0.6909427729356707
Chapter II Neoplasms,Melanoma in situ,MAGEA3,Melanoma-associated antigen 3,14160,99,1.09 [0.86-1.37],0.4799265768063393
Chapter II Neoplasms,Melanoma in situ,MAGED1,Melanoma-associated antigen D1,16170,109,1.10 [0.78-1.56],0.5900692413326561
Chapter II Neoplasms,Melanoma in situ,MAMDC2,MAM domain-containing protein 2,14415,100,1.08 [0.63-1.84],0.782014384107804
Chapter II Neoplasms,Melanoma in situ,MAMDC4,Apical endosomal glycoprotein,14369,100,0.75 [0.52-1.09],0.1328626012413684
Chapter II Neoplasms,Melanoma in situ,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14058,96,1.20 [0.54-2.67],0.6543853281612044
Chapter II Neoplasms,Melanoma in situ,MAN2B2,Epididymis-specific alpha-mannosidase,14415,100,0.67 [0.49-0.92],0.0122242957373132
Chapter II Neoplasms,Melanoma in situ,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13923,96,0.86 [0.58-1.29],0.4681992595900802
Chapter II Neoplasms,Melanoma in situ,MANF,Mesencephalic astrocyte-derived neurotrophic factor,16583,112,1.05 [0.91-1.21],0.5266741996665089
Chapter II Neoplasms,Melanoma in situ,MANSC1,MANSC domain-containing protein 1,16578,111,1.12 [0.61-2.07],0.7116859420729862
Chapter II Neoplasms,Melanoma in situ,MANSC4,MANSC domain-containing protein 4,13959,100,0.66 [0.49-0.90],0.0073344589284742
Chapter II Neoplasms,Melanoma in situ,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,13980,98,1.09 [0.59-2.02],0.7815153956046169
Chapter II Neoplasms,Melanoma in situ,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,13959,100,0.75 [0.50-1.12],0.1585768607474599
Chapter II Neoplasms,Melanoma in situ,MAP2,Microtubule-associated protein 2,14404,100,1.24 [0.84-1.83],0.2881932155208393
Chapter II Neoplasms,Melanoma in situ,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14355,100,1.03 [0.76-1.39],0.8583071512430347
Chapter II Neoplasms,Melanoma in situ,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16479,111,1.02 [0.86-1.21],0.8025798593552933
Chapter II Neoplasms,Melanoma in situ,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16170,109,1.07 [0.90-1.27],0.4370243007081145
Chapter II Neoplasms,Melanoma in situ,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16340,109,1.08 [0.93-1.26],0.333078245497851
Chapter II Neoplasms,Melanoma in situ,MAPK13,Mitogen-activated protein kinase 13,13923,96,0.76 [0.46-1.25],0.280880554561683
Chapter II Neoplasms,Melanoma in situ,MAPK9,Mitogen-activated protein kinase 9,16479,111,1.53 [1.04-2.26],0.0311050292416244
Chapter II Neoplasms,Melanoma in situ,MAPKAPK2,MAP kinase-activated protein kinase 2,14160,99,1.00 [0.77-1.31],0.991849756864444
Chapter II Neoplasms,Melanoma in situ,MAPRE3,Microtubule-associated protein RP/EB family member 3,13923,96,0.99 [0.86-1.13],0.8357547998661614
Chapter II Neoplasms,Melanoma in situ,MAPT,Microtubule-associated protein tau,16136,109,0.76 [0.58-1.01],0.0553130460267559
Chapter II Neoplasms,Melanoma in situ,MARCO,Macrophage receptor MARCO,16502,110,0.70 [0.36-1.36],0.2937551303800714
Chapter II Neoplasms,Melanoma in situ,MARS1,"Methionine--tRNA ligase, cytoplasmic",14108,98,1.05 [0.84-1.33],0.6608079195637819
Chapter II Neoplasms,Melanoma in situ,MASP1,Mannan-binding lectin serine protease 1,16340,109,0.80 [0.38-1.68],0.5588576187774064
Chapter II Neoplasms,Melanoma in situ,MATN2,Matrilin-2,16532,112,0.82 [0.46-1.47],0.502209177549082
Chapter II Neoplasms,Melanoma in situ,MATN3,Matrilin-3,16341,108,1.13 [0.67-1.90],0.6479615355995205
Chapter II Neoplasms,Melanoma in situ,MAVS,Mitochondrial antiviral-signaling protein,16170,109,1.06 [0.88-1.27],0.5670948083587319
Chapter II Neoplasms,Melanoma in situ,MAX,Protein max,16136,109,1.07 [0.91-1.26],0.4171964279364824
Chapter II Neoplasms,Melanoma in situ,MB,Myoglobin,16720,111,1.11 [0.81-1.51],0.5213956163784186
Chapter II Neoplasms,Melanoma in situ,MBL2,Mannose-binding protein C,14239,98,0.98 [0.82-1.17],0.8336186976986056
Chapter II Neoplasms,Melanoma in situ,MCAM,Cell surface glycoprotein MUC18,16607,110,0.80 [0.47-1.34],0.3883065578022261
Chapter II Neoplasms,Melanoma in situ,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14396,100,0.95 [0.59-1.54],0.8443871850262534
Chapter II Neoplasms,Melanoma in situ,MCEMP1,Mast cell-expressed membrane protein 1,13991,93,1.01 [0.81-1.26],0.9483555123231048
Chapter II Neoplasms,Melanoma in situ,MCFD2,Multiple coagulation factor deficiency protein 2,16416,108,1.26 [0.86-1.87],0.2404344582827036
Chapter II Neoplasms,Melanoma in situ,MCTS1,Malignant T-cell-amplified sequence 1,14355,100,0.85 [0.40-1.84],0.6847491127586478
Chapter II Neoplasms,Melanoma in situ,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16369,109,1.02 [0.80-1.31],0.849505048921679
Chapter II Neoplasms,Melanoma in situ,MDH1,"Malate dehydrogenase, cytoplasmic",14354,100,1.17 [0.73-1.86],0.5183776397677081
Chapter II Neoplasms,Melanoma in situ,MDK,Midkine,16536,110,1.09 [0.79-1.49],0.603084239423213
Chapter II Neoplasms,Melanoma in situ,MDM1,Nuclear protein MDM1,14048,97,0.52 [0.27-1.01],0.0542242647576955
Chapter II Neoplasms,Melanoma in situ,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14058,96,1.01 [0.81-1.25],0.95850825711797
Chapter II Neoplasms,Melanoma in situ,MED18,Mediator of RNA polymerase II transcription subunit 18,16170,109,1.08 [0.86-1.36],0.4866452218151681
Chapter II Neoplasms,Melanoma in situ,MED21,Mediator of RNA polymerase II transcription subunit 21,13959,100,0.69 [0.42-1.13],0.1393766537374615
Chapter II Neoplasms,Melanoma in situ,MEGF10,Multiple epidermal growth factor-like domains protein 10,16504,112,0.98 [0.63-1.53],0.934000388951302
Chapter II Neoplasms,Melanoma in situ,MEGF11,Multiple epidermal growth factor-like domains protein 11,13959,100,0.43 [0.20-0.90],0.0244286178507294
Chapter II Neoplasms,Melanoma in situ,MEGF9,Multiple epidermal growth factor-like domains protein 9,16682,111,0.70 [0.29-1.71],0.4360419003126958
Chapter II Neoplasms,Melanoma in situ,MELTF,Melanotransferrin,14415,100,1.20 [0.63-2.27],0.5838850135185583
Chapter II Neoplasms,Melanoma in situ,MENT,Protein MENT,14132,98,0.66 [0.28-1.55],0.3414996256082939
Chapter II Neoplasms,Melanoma in situ,MEP1A,Meprin A subunit alpha,14355,100,1.08 [0.83-1.42],0.559037454171891
Chapter II Neoplasms,Melanoma in situ,MEP1B,Meprin A subunit beta,16502,110,1.07 [0.92-1.24],0.3690013665688364
Chapter II Neoplasms,Melanoma in situ,MEPE,Matrix extracellular phosphoglycoprotein,16504,112,1.04 [0.53-2.04],0.8992248138702019
Chapter II Neoplasms,Melanoma in situ,MERTK,Tyrosine-protein kinase Mer,16683,112,0.75 [0.39-1.46],0.3995444432575888
Chapter II Neoplasms,Melanoma in situ,MESD,LRP chaperone MESD,16531,111,1.04 [0.91-1.20],0.5666863004845825
Chapter II Neoplasms,Melanoma in situ,MET,Hepatocyte growth factor receptor,16565,109,0.78 [0.33-1.83],0.5656139422813524
Chapter II Neoplasms,Melanoma in situ,METAP1,Methionine aminopeptidase 1,16136,109,0.83 [0.46-1.52],0.5541625173022299
Chapter II Neoplasms,Melanoma in situ,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16479,111,1.01 [0.82-1.24],0.932298576107765
Chapter II Neoplasms,Melanoma in situ,METAP2,Methionine aminopeptidase 2,16639,112,1.03 [0.77-1.39],0.8316302635955973
Chapter II Neoplasms,Melanoma in situ,MFAP3,Microfibril-associated glycoprotein 3,16217,107,1.05 [0.75-1.48],0.7654368054371619
Chapter II Neoplasms,Melanoma in situ,MFAP3L,Microfibrillar-associated protein 3-like,14048,97,0.95 [0.70-1.30],0.7650167730924607
Chapter II Neoplasms,Melanoma in situ,MFAP4,Microfibril-associated glycoprotein 4,14132,98,0.86 [0.46-1.60],0.6350369405198852
Chapter II Neoplasms,Melanoma in situ,MFAP5,Microfibrillar-associated protein 5,16720,111,0.93 [0.61-1.40],0.7151109358606585
Chapter II Neoplasms,Melanoma in situ,MFGE8,Lactadherin,16531,111,0.66 [0.44-0.99],0.0421507279346849
Chapter II Neoplasms,Melanoma in situ,MGLL,Monoglyceride lipase,16558,112,1.08 [0.88-1.31],0.466059581281713
Chapter II Neoplasms,Melanoma in situ,MGMT,Methylated-DNA--protein-cysteine methyltransferase,16479,111,1.04 [0.90-1.20],0.5870036253088751
Chapter II Neoplasms,Melanoma in situ,MIA,Melanoma-derived growth regulatory protein,16578,111,1.01 [0.64-1.59],0.9761909299461432
Chapter II Neoplasms,Melanoma in situ,MICALL2,MICAL-like protein 2,14048,97,1.11 [0.84-1.45],0.4650242296402459
Chapter II Neoplasms,Melanoma in situ,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16479,111,1.04 [0.92-1.18],0.5038720056082633
Chapter II Neoplasms,Melanoma in situ,MIF,Macrophage migration inhibitory factor,16509,111,1.08 [0.84-1.39],0.5263390000692973
Chapter II Neoplasms,Melanoma in situ,MILR1,Allergin-1,16225,109,0.73 [0.51-1.03],0.0717558700613683
Chapter II Neoplasms,Melanoma in situ,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14369,100,0.99 [0.83-1.19],0.9406983954915094
Chapter II Neoplasms,Melanoma in situ,MINK1,Misshapen-like kinase 1,14404,100,1.06 [0.86-1.30],0.5977703674267071
Chapter II Neoplasms,Melanoma in situ,MITD1,MIT domain-containing protein 1,16369,109,1.07 [0.90-1.28],0.436615497475842
Chapter II Neoplasms,Melanoma in situ,MKI67,Proliferation marker protein Ki-67,13991,93,0.98 [0.59-1.64],0.9528848570610836
Chapter II Neoplasms,Melanoma in situ,MLLT1,Protein ENL,13923,96,1.17 [0.90-1.52],0.2421322434282374
Chapter II Neoplasms,Melanoma in situ,MLN,Promotilin,16479,111,0.80 [0.67-0.97],0.0241730140255375
Chapter II Neoplasms,Melanoma in situ,MME,Neprilysin,16439,110,0.88 [0.71-1.10],0.2535188569283382
Chapter II Neoplasms,Melanoma in situ,MMP1,Interstitial collagenase,15900,105,1.10 [0.90-1.33],0.3445446998321008
Chapter II Neoplasms,Melanoma in situ,MMP10,Stromelysin-2,16473,112,1.00 [0.75-1.34],0.9767802862776754
Chapter II Neoplasms,Melanoma in situ,MMP12,Macrophage metalloelastase,16535,110,0.96 [0.70-1.32],0.8051211609062464
Chapter II Neoplasms,Melanoma in situ,MMP13,Collagenase 3,16136,109,0.72 [0.42-1.21],0.2156335079996366
Chapter II Neoplasms,Melanoma in situ,MMP15,Matrix metalloproteinase-15,14415,100,0.62 [0.34-1.10],0.1036039412539203
Chapter II Neoplasms,Melanoma in situ,MMP3,Stromelysin-1,16531,111,1.09 [0.78-1.53],0.6098657454215262
Chapter II Neoplasms,Melanoma in situ,MMP7,Matrilysin,16191,107,0.96 [0.68-1.36],0.8202318677462354
Chapter II Neoplasms,Melanoma in situ,MMP8,Neutrophil collagenase,16610,112,1.06 [0.84-1.33],0.6140119137073436
Chapter II Neoplasms,Melanoma in situ,MMP9,Matrix metalloproteinase-9,16503,111,0.94 [0.71-1.25],0.687959914881724
Chapter II Neoplasms,Melanoma in situ,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",13959,100,0.68 [0.44-1.04],0.0777566792404818
Chapter II Neoplasms,Melanoma in situ,MN1,Transcriptional activator MN1,14048,97,0.78 [0.53-1.15],0.211055476728029
Chapter II Neoplasms,Melanoma in situ,MNAT1,CDK-activating kinase assembly factor MAT1,14160,99,0.67 [0.40-1.11],0.118888902193681
Chapter II Neoplasms,Melanoma in situ,MNDA,Myeloid cell nuclear differentiation antigen,16473,110,1.01 [0.86-1.19],0.910988325191804
Chapter II Neoplasms,Melanoma in situ,MOCS2,Molybdopterin synthase catalytic subunit,14132,98,1.06 [0.79-1.43],0.7088642945673574
Chapter II Neoplasms,Melanoma in situ,MOG,Myelin-oligodendrocyte glycoprotein,16669,112,0.83 [0.50-1.39],0.4864759364893948
Chapter II Neoplasms,Melanoma in situ,MORC3,MORC family CW-type zinc finger protein 3,14404,100,0.67 [0.31-1.47],0.3156390251350908
Chapter II Neoplasms,Melanoma in situ,MORF4L1,Mortality factor 4-like protein 1,14160,99,0.91 [0.54-1.51],0.7106261558043077
Chapter II Neoplasms,Melanoma in situ,MORF4L2,Mortality factor 4-like protein 2,13923,96,0.90 [0.53-1.54],0.7108204336770205
Chapter II Neoplasms,Melanoma in situ,MORN4,MORN repeat-containing protein 4,13923,96,0.83 [0.61-1.12],0.217476740758961
Chapter II Neoplasms,Melanoma in situ,MPHOSPH8,M-phase phosphoprotein 8,16217,107,0.90 [0.71-1.14],0.3824851553246181
Chapter II Neoplasms,Melanoma in situ,MPI,Mannose-6-phosphate isomerase,16439,110,1.02 [0.83-1.24],0.852174776563225
Chapter II Neoplasms,Melanoma in situ,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16558,112,1.08 [0.86-1.35],0.509425656980045
Chapter II Neoplasms,Melanoma in situ,MPO,Myeloperoxidase,16531,111,1.06 [0.74-1.50],0.7629791978778623
Chapter II Neoplasms,Melanoma in situ,MPRIP,Myosin phosphatase Rho-interacting protein,14335,99,1.18 [0.78-1.79],0.4260418354036124
Chapter II Neoplasms,Melanoma in situ,MRC1,Macrophage mannose receptor 1,14434,100,0.48 [0.26-0.90],0.022127798457148
Chapter II Neoplasms,Melanoma in situ,MRI1,Methylthioribose-1-phosphate isomerase,14048,97,0.94 [0.70-1.25],0.6608466132146855
Chapter II Neoplasms,Melanoma in situ,MRPL24,"39S ribosomal protein L24, mitochondrial",13959,100,0.72 [0.40-1.29],0.272447400575438
Chapter II Neoplasms,Melanoma in situ,MRPL28,"39S ribosomal protein L28, mitochondrial",14396,100,0.92 [0.53-1.61],0.7754016896630137
Chapter II Neoplasms,Melanoma in situ,MRPL46,"39S ribosomal protein L46, mitochondrial",16136,109,0.86 [0.45-1.64],0.6475281342261264
Chapter II Neoplasms,Melanoma in situ,MRPL52,"39S ribosomal protein L52, mitochondrial",13892,95,0.40 [0.18-0.89],0.0255139150442277
Chapter II Neoplasms,Melanoma in situ,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14396,100,0.99 [0.76-1.29],0.9396473743292212
Chapter II Neoplasms,Melanoma in situ,MRPS16,"28S ribosomal protein S16, mitochondrial",13991,93,0.80 [0.37-1.75],0.5828986012259576
Chapter II Neoplasms,Melanoma in situ,MSLN,Mesothelin,16409,110,1.21 [0.91-1.59],0.1852349307267155
Chapter II Neoplasms,Melanoma in situ,MSLNL,Mesothelin-like protein,14048,97,1.35 [0.88-2.08],0.1715178819876768
Chapter II Neoplasms,Melanoma in situ,MSMB,Beta-microseminoprotein,16484,109,0.99 [0.78-1.25],0.9134660272406198
Chapter II Neoplasms,Melanoma in situ,MSR1,Macrophage scavenger receptor types I and II,16642,112,1.01 [0.70-1.47],0.9428353505560692
Chapter II Neoplasms,Melanoma in situ,MSRA,Mitochondrial peptide methionine sulfoxide reductase,16578,111,1.09 [0.86-1.37],0.4924510890703183
Chapter II Neoplasms,Melanoma in situ,MST1,Hepatocyte growth factor-like protein,14199,97,0.92 [0.71-1.19],0.5301257538422315
Chapter II Neoplasms,Melanoma in situ,MSTN,Growth/differentiation factor 8,16217,107,0.82 [0.59-1.14],0.2388013735382077
Chapter II Neoplasms,Melanoma in situ,MTDH,Protein LYRIC,13991,93,1.03 [0.83-1.28],0.7743496209042695
Chapter II Neoplasms,Melanoma in situ,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14404,100,0.33 [0.13-0.80],0.0139379607129032
Chapter II Neoplasms,Melanoma in situ,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14160,99,0.99 [0.83-1.18],0.8939381045368835
Chapter II Neoplasms,Melanoma in situ,MTIF3,"Translation initiation factor IF-3, mitochondrial",14355,100,1.01 [0.81-1.26],0.9153613813382352
Chapter II Neoplasms,Melanoma in situ,MTPN,Myotrophin,16217,107,1.31 [0.86-2.01],0.2102919962856129
Chapter II Neoplasms,Melanoma in situ,MTR,Methionine synthase,13959,100,0.70 [0.48-1.01],0.0594489412696488
Chapter II Neoplasms,Melanoma in situ,MTSS1,Protein MTSS 1,14355,100,1.09 [0.92-1.29],0.3301486881937681
Chapter II Neoplasms,Melanoma in situ,MTSS2,Protein MTSS 2,14369,100,1.06 [0.87-1.29],0.5508985894921123
Chapter II Neoplasms,Melanoma in situ,MTUS1,Microtubule-associated tumor suppressor 1,14160,99,1.16 [0.84-1.61],0.3672841975139975
Chapter II Neoplasms,Melanoma in situ,MUC13,Mucin-13,16136,109,0.89 [0.63-1.26],0.5001593186583818
Chapter II Neoplasms,Melanoma in situ,MUC16,Mucin-16,16439,110,0.99 [0.91-1.08],0.8562708814210251
Chapter II Neoplasms,Melanoma in situ,MUC2,Mucin-2,14428,100,0.79 [0.64-0.98],0.0301086502874414
Chapter II Neoplasms,Melanoma in situ,MUCL3,Mucin-like protein 3,13923,96,0.86 [0.51-1.43],0.5545167170089511
Chapter II Neoplasms,Melanoma in situ,MVK,Mevalonate kinase,16225,109,1.05 [0.84-1.30],0.6639710388293132
Chapter II Neoplasms,Melanoma in situ,MXRA8,Matrix remodeling-associated protein 8,14132,98,0.70 [0.37-1.33],0.2810820730114097
Chapter II Neoplasms,Melanoma in situ,MYBPC1,"Myosin-binding protein C, slow-type",14415,100,1.08 [0.83-1.41],0.5684868830684765
Chapter II Neoplasms,Melanoma in situ,MYBPC2,"Myosin-binding protein C, fast-type",14058,96,0.95 [0.74-1.22],0.6916628398994773
Chapter II Neoplasms,Melanoma in situ,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14396,100,0.81 [0.59-1.11],0.1854700379790992
Chapter II Neoplasms,Melanoma in situ,MYDGF,Myeloid-derived growth factor,14415,100,1.01 [0.83-1.22],0.9586679070790888
Chapter II Neoplasms,Melanoma in situ,MYH4,Myosin-4,13959,100,0.81 [0.50-1.32],0.4040873288769797
Chapter II Neoplasms,Melanoma in situ,MYH7B,Myosin-7B,13923,96,0.97 [0.61-1.52],0.8880166013478703
Chapter II Neoplasms,Melanoma in situ,MYH9,Myosin-9,14428,100,1.10 [0.93-1.30],0.2688771857513359
Chapter II Neoplasms,Melanoma in situ,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",13959,100,1.12 [0.70-1.80],0.6361829299264962
Chapter II Neoplasms,Melanoma in situ,MYL3,Myosin light chain 3,14058,96,0.95 [0.72-1.26],0.7180052158497996
Chapter II Neoplasms,Melanoma in situ,MYL4,Myosin light chain 4,14058,96,0.97 [0.67-1.42],0.8901804840088617
Chapter II Neoplasms,Melanoma in situ,MYL6B,Myosin light chain 6B,14048,97,0.97 [0.78-1.21],0.7775662743805332
Chapter II Neoplasms,Melanoma in situ,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14048,97,1.41 [1.03-1.91],0.0295697447219357
Chapter II Neoplasms,Melanoma in situ,MYO6,Unconventional myosin-VI,14396,100,0.56 [0.30-1.05],0.0686462684978255
Chapter II Neoplasms,Melanoma in situ,MYO9B,Unconventional myosin-IXb,16225,109,1.02 [0.79-1.32],0.8525714760240073
Chapter II Neoplasms,Melanoma in situ,MYOC,Myocilin,16531,111,0.99 [0.68-1.45],0.958060419254142
Chapter II Neoplasms,Melanoma in situ,MYOM1,Myomesin-1,13980,98,1.05 [0.71-1.55],0.8062168993379357
Chapter II Neoplasms,Melanoma in situ,MYOM2,Myomesin-2,13959,100,1.04 [0.70-1.54],0.8487706928303045
Chapter II Neoplasms,Melanoma in situ,MYOM3,Myomesin-3,14132,98,0.92 [0.74-1.14],0.4348152422252833
Chapter II Neoplasms,Melanoma in situ,MZB1,Marginal zone B- and B1-cell-specific protein,16557,112,0.84 [0.61-1.18],0.3213319568512852
Chapter II Neoplasms,Melanoma in situ,MZT1,Mitotic-spindle organizing protein 1,16170,109,0.98 [0.70-1.39],0.925501571533657
Chapter II Neoplasms,Melanoma in situ,NAA10,N-alpha-acetyltransferase 10,13959,100,0.97 [0.66-1.43],0.891089137461324
Chapter II Neoplasms,Melanoma in situ,NAA80,N-alpha-acetyltransferase 80,14048,97,1.03 [0.88-1.21],0.7124929891124219
Chapter II Neoplasms,Melanoma in situ,NAAA,N-acylethanolamine-hydrolyzing acid amidase,16294,109,0.78 [0.57-1.05],0.1040378258908294
Chapter II Neoplasms,Melanoma in situ,NACC1,Nucleus accumbens-associated protein 1,14369,100,0.93 [0.65-1.33],0.6905964932615387
Chapter II Neoplasms,Melanoma in situ,NADK,NAD kinase,16502,110,1.14 [0.86-1.51],0.3503800455500373
Chapter II Neoplasms,Melanoma in situ,NAGA,Alpha-N-acetylgalactosaminidase,13959,93,0.90 [0.61-1.32],0.581761946568095
Chapter II Neoplasms,Melanoma in situ,NAGK,N-acetyl-D-glucosamine kinase,14031,96,1.12 [0.79-1.59],0.5334781599818128
Chapter II Neoplasms,Melanoma in situ,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14132,98,1.00 [0.40-2.52],0.9994859596576466
Chapter II Neoplasms,Melanoma in situ,NAMPT,Nicotinamide phosphoribosyltransferase,16170,109,1.07 [0.79-1.43],0.6686136559016018
Chapter II Neoplasms,Melanoma in situ,NAP1L4,Nucleosome assembly protein 1-like 4,14324,99,0.97 [0.61-1.54],0.8926271779097171
Chapter II Neoplasms,Melanoma in situ,NAPRT,Nicotinate phosphoribosyltransferase,14404,100,0.93 [0.52-1.65],0.8017972600391079
Chapter II Neoplasms,Melanoma in situ,NARS1,"Asparagine--tRNA ligase, cytoplasmic",14396,100,1.13 [0.75-1.71],0.5549062752876204
Chapter II Neoplasms,Melanoma in situ,NBL1,Neuroblastoma suppressor of tumorigenicity 1,16578,111,0.90 [0.47-1.70],0.7392915728338119
Chapter II Neoplasms,Melanoma in situ,NBN,Nibrin,16225,109,0.98 [0.71-1.36],0.9093091450575752
Chapter II Neoplasms,Melanoma in situ,NCAM1,Neural cell adhesion molecule 1,16607,110,0.82 [0.47-1.45],0.4993597746928483
Chapter II Neoplasms,Melanoma in situ,NCAM2,Neural cell adhesion molecule 2,16531,111,1.07 [0.58-1.98],0.8300471469280091
Chapter II Neoplasms,Melanoma in situ,NCAN,Neurocan core protein,16642,112,0.89 [0.57-1.39],0.6038896143866503
Chapter II Neoplasms,Melanoma in situ,NCF2,Neutrophil cytosol factor 2,16453,111,1.05 [0.87-1.27],0.5878887752006743
Chapter II Neoplasms,Melanoma in situ,NCK2,Cytoplasmic protein NCK2,16583,112,1.02 [0.87-1.20],0.76478067525858
Chapter II Neoplasms,Melanoma in situ,NCLN,Nicalin,16225,109,0.94 [0.66-1.35],0.7521601754652938
Chapter II Neoplasms,Melanoma in situ,NCR1,Natural cytotoxicity triggering receptor 1,16454,111,1.08 [0.68-1.70],0.7431301858233756
Chapter II Neoplasms,Melanoma in situ,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14355,100,1.11 [0.63-1.96],0.7141489002137116
Chapter II Neoplasms,Melanoma in situ,NCS1,Neuronal calcium sensor 1,16669,112,0.71 [0.39-1.30],0.2673958730095119
Chapter II Neoplasms,Melanoma in situ,NDRG1,Protein NDRG1,16136,109,0.82 [0.60-1.12],0.2126250826475405
Chapter II Neoplasms,Melanoma in situ,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14369,100,1.03 [0.77-1.38],0.8458130755119792
Chapter II Neoplasms,Melanoma in situ,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,13973,93,0.82 [0.46-1.47],0.5119963322021805
Chapter II Neoplasms,Melanoma in situ,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14355,100,0.98 [0.78-1.22],0.8312984349413186
Chapter II Neoplasms,Melanoma in situ,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16170,109,0.91 [0.71-1.16],0.4501274643546711
Chapter II Neoplasms,Melanoma in situ,NEB,Nebulin,13959,100,1.30 [0.86-1.96],0.2206403904437534
Chapter II Neoplasms,Melanoma in situ,NECAP2,Adaptin ear-binding coat-associated protein 2,13959,100,0.98 [0.73-1.31],0.8818497410824188
Chapter II Neoplasms,Melanoma in situ,NECTIN1,Nectin-1,13991,93,0.88 [0.47-1.65],0.6902454353505864
Chapter II Neoplasms,Melanoma in situ,NECTIN2,Nectin-2,16476,110,1.30 [0.74-2.27],0.3612885816219922
Chapter II Neoplasms,Melanoma in situ,NECTIN4,Nectin-4,16578,111,0.83 [0.48-1.45],0.5207907153988864
Chapter II Neoplasms,Melanoma in situ,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,13991,93,1.08 [0.71-1.64],0.7140064504734662
Chapter II Neoplasms,Melanoma in situ,NEDD9,Enhancer of filamentation 1,13991,93,0.88 [0.47-1.64],0.6921832677072569
Chapter II Neoplasms,Melanoma in situ,NEFL,Neurofilament light polypeptide,16082,108,0.87 [0.58-1.30],0.4936872199091696
Chapter II Neoplasms,Melanoma in situ,NEK7,Serine/threonine-protein kinase Nek7,14160,99,0.94 [0.72-1.23],0.6543531071012025
Chapter II Neoplasms,Melanoma in situ,NELL1,Protein kinase C-binding protein NELL1,16578,111,0.94 [0.63-1.39],0.7469532932184614
Chapter II Neoplasms,Melanoma in situ,NELL2,Protein kinase C-binding protein NELL2,16583,112,0.84 [0.47-1.52],0.564183193072159
Chapter II Neoplasms,Melanoma in situ,NENF,Neudesin,14369,100,1.03 [0.88-1.21],0.6770686384445593
Chapter II Neoplasms,Melanoma in situ,NEO1,Neogenin,14396,100,0.79 [0.32-1.95],0.6165283518643865
Chapter II Neoplasms,Melanoma in situ,NEXN,Nexilin,14434,100,1.11 [0.84-1.46],0.4551885628618892
Chapter II Neoplasms,Melanoma in situ,NFASC,Neurofascin,16683,112,0.52 [0.28-0.96],0.0375061440728163
Chapter II Neoplasms,Melanoma in situ,NFAT5,Nuclear factor of activated T-cells 5,13991,93,1.16 [0.93-1.45],0.184981898109301
Chapter II Neoplasms,Melanoma in situ,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16479,111,1.10 [0.92-1.30],0.3043179865114522
Chapter II Neoplasms,Melanoma in situ,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16225,109,1.04 [0.78-1.39],0.7760569622700995
Chapter II Neoplasms,Melanoma in situ,NFE2,Transcription factor NF-E2 45 kDa subunit,14058,96,1.14 [0.87-1.48],0.3352549333672956
Chapter II Neoplasms,Melanoma in situ,NFIC,Nuclear factor 1 C-type,14396,100,0.93 [0.58-1.48],0.7481863785430042
Chapter II Neoplasms,Melanoma in situ,NFKB1,Nuclear factor NF-kappa-B p105 subunit,13959,100,1.06 [0.81-1.38],0.6699111580294668
Chapter II Neoplasms,Melanoma in situ,NFKB2,Nuclear factor NF-kappa-B p100 subunit,14160,99,0.43 [0.23-0.82],0.0097931534996218
Chapter II Neoplasms,Melanoma in situ,NFKBIE,NF-kappa-B inhibitor epsilon,16170,109,1.09 [0.77-1.54],0.6248493126851413
Chapter II Neoplasms,Melanoma in situ,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14355,100,0.97 [0.80-1.17],0.7633896175836826
Chapter II Neoplasms,Melanoma in situ,NFX1,Transcriptional repressor NF-X1,13959,100,1.01 [0.76-1.35],0.947185034071207
Chapter II Neoplasms,Melanoma in situ,NFYA,Nuclear transcription factor Y subunit alpha,13959,100,0.83 [0.48-1.43],0.4966225536873705
Chapter II Neoplasms,Melanoma in situ,NGF,Beta-nerve growth factor,16369,109,0.36 [0.09-1.48],0.1566064547143501
Chapter II Neoplasms,Melanoma in situ,NGFR,Tumor necrosis factor receptor superfamily member 16,14415,100,0.72 [0.35-1.48],0.3691525042526673
Chapter II Neoplasms,Melanoma in situ,NGRN,Neugrin,14404,100,0.73 [0.29-1.84],0.503916979326875
Chapter II Neoplasms,Melanoma in situ,NHLRC3,NHL repeat-containing protein 3,13770,97,1.16 [0.61-2.22],0.6487536794753214
Chapter II Neoplasms,Melanoma in situ,NID1,Nidogen-1,16547,110,0.79 [0.51-1.24],0.3054865003545894
Chapter II Neoplasms,Melanoma in situ,NID2,Nidogen-2,16531,111,1.07 [0.86-1.33],0.5485245980766291
Chapter II Neoplasms,Melanoma in situ,NINJ1,Ninjurin-1,16170,109,0.95 [0.69-1.33],0.785155528463989
Chapter II Neoplasms,Melanoma in situ,NIT1,Deaminated glutathione amidase,14058,96,1.22 [0.79-1.88],0.3620451865887012
Chapter II Neoplasms,Melanoma in situ,NIT2,Omega-amidase NIT2,14363,100,1.03 [0.79-1.35],0.8141378267931529
Chapter II Neoplasms,Melanoma in situ,NLGN1,Neuroligin-1,14048,97,0.98 [0.73-1.31],0.8962905370684746
Chapter II Neoplasms,Melanoma in situ,NLGN2,Neuroligin-2,13980,98,0.75 [0.46-1.21],0.234362364368599
Chapter II Neoplasms,Melanoma in situ,NME1,Nucleoside diphosphate kinase A,13991,93,0.48 [0.18-1.26],0.1351640634969821
Chapter II Neoplasms,Melanoma in situ,NME3,Nucleoside diphosphate kinase 3,16532,112,0.74 [0.34-1.57],0.4272059160846526
Chapter II Neoplasms,Melanoma in situ,NMI,N-myc-interactor,14318,99,1.00 [0.76-1.31],0.9966802535689224
Chapter II Neoplasms,Melanoma in situ,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16369,109,0.96 [0.75-1.21],0.704094989025574
Chapter II Neoplasms,Melanoma in situ,NMRK2,Nicotinamide riboside kinase 2,13923,96,1.01 [0.62-1.64],0.9829146124418072
Chapter II Neoplasms,Melanoma in situ,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14396,100,0.99 [0.74-1.32],0.9213371369725032
Chapter II Neoplasms,Melanoma in situ,NOMO1,Nodal modulator 1,16531,111,0.94 [0.45-1.95],0.8676203034710197
Chapter II Neoplasms,Melanoma in situ,NOP56,Nucleolar protein 56,13959,100,0.98 [0.82-1.17],0.8153038872542169
Chapter II Neoplasms,Melanoma in situ,NOS1,"Nitric oxide synthase, brain",16136,109,1.18 [0.86-1.62],0.3143165338241228
Chapter II Neoplasms,Melanoma in situ,NOS2,"Nitric oxide synthase, inducible",13959,100,0.52 [0.30-0.90],0.0205381987991433
Chapter II Neoplasms,Melanoma in situ,NOS3,"Nitric oxide synthase, endothelial",16136,109,0.68 [0.47-0.99],0.0420264710844811
Chapter II Neoplasms,Melanoma in situ,NOTCH1,Neurogenic locus notch homolog protein 1,16720,111,0.81 [0.27-2.40],0.6975347318042573
Chapter II Neoplasms,Melanoma in situ,NOTCH2,Neurogenic locus notch homolog protein 2,14428,100,0.43 [0.16-1.19],0.1043106233940824
Chapter II Neoplasms,Melanoma in situ,NOTCH3,Neurogenic locus notch homolog protein 3,16720,111,1.13 [0.68-1.88],0.6355433889396513
Chapter II Neoplasms,Melanoma in situ,NPC2,NPC intracellular cholesterol transporter 2,14183,99,0.88 [0.47-1.63],0.6833582686178455
Chapter II Neoplasms,Melanoma in situ,NPDC1,Neural proliferation differentiation and control protein 1,16502,110,0.99 [0.58-1.71],0.9852977700669662
Chapter II Neoplasms,Melanoma in situ,NPHS1,Nephrin,13991,93,0.57 [0.30-1.07],0.0784455106847211
Chapter II Neoplasms,Melanoma in situ,NPHS2,Podocin,13991,93,0.88 [0.71-1.10],0.2577118293078074
Chapter II Neoplasms,Melanoma in situ,NPL,N-acetylneuraminate lyase,14415,100,0.78 [0.50-1.21],0.2630620015384465
Chapter II Neoplasms,Melanoma in situ,NPPB,Natriuretic peptides B,16217,107,0.98 [0.87-1.11],0.8015017238307363
Chapter II Neoplasms,Melanoma in situ,NPPC,C-type natriuretic peptide,16479,111,0.63 [0.43-0.92],0.0184726722357554
Chapter II Neoplasms,Melanoma in situ,NPR1,Atrial natriuretic peptide receptor 1,13959,100,0.55 [0.30-1.03],0.0605449803379291
Chapter II Neoplasms,Melanoma in situ,NPTN,Neuroplastin,16170,109,1.08 [0.89-1.31],0.4443713576879755
Chapter II Neoplasms,Melanoma in situ,NPTX1,Neuronal pentraxin-1,16531,111,0.86 [0.56-1.32],0.4835172791653805
Chapter II Neoplasms,Melanoma in situ,NPTX2,Neuronal pentraxin-2,14428,100,0.74 [0.41-1.35],0.3309011227489326
Chapter II Neoplasms,Melanoma in situ,NPTXR,Neuronal pentraxin receptor,16502,110,1.10 [0.67-1.80],0.7174234797913451
Chapter II Neoplasms,Melanoma in situ,NPY,Pro-neuropeptide Y,16669,112,0.81 [0.63-1.04],0.1019280510994661
Chapter II Neoplasms,Melanoma in situ,NRCAM,Neuronal cell adhesion molecule,16502,110,0.76 [0.41-1.41],0.3875092632300904
Chapter II Neoplasms,Melanoma in situ,NRGN,Neurogranin,14434,100,1.09 [0.88-1.35],0.4175167885116643
Chapter II Neoplasms,Melanoma in situ,NRN1,Neuritin,14396,100,1.17 [0.74-1.85],0.5118377737558701
Chapter II Neoplasms,Melanoma in situ,NRP1,Neuropilin-1,16630,110,1.20 [0.65-2.22],0.5534511974623197
Chapter II Neoplasms,Melanoma in situ,NRP2,Neuropilin-2,16531,111,0.75 [0.41-1.38],0.3594844320391991
Chapter II Neoplasms,Melanoma in situ,NRTN,Neurturin,16225,109,1.15 [0.85-1.57],0.3672989140260488
Chapter II Neoplasms,Melanoma in situ,NRXN3,Neurexin-3,14048,97,0.99 [0.57-1.71],0.9778150326079392
Chapter II Neoplasms,Melanoma in situ,NSFL1C,NSFL1 cofactor p47,16642,112,1.08 [0.84-1.39],0.552564573248369
Chapter II Neoplasms,Melanoma in situ,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14415,100,0.91 [0.70-1.18],0.4740257932933801
Chapter II Neoplasms,Melanoma in situ,NT5C1A,Cytosolic 5'-nucleotidase 1A,14404,100,1.01 [0.54-1.89],0.9683096727884803
Chapter II Neoplasms,Melanoma in situ,NT5C3A,Cytosolic 5'-nucleotidase 3A,16455,111,1.08 [0.89-1.32],0.4398714532850037
Chapter II Neoplasms,Melanoma in situ,NT5E,5'-nucleotidase,16578,111,0.84 [0.61-1.16],0.297034996322652
Chapter II Neoplasms,Melanoma in situ,NTF3,Neurotrophin-3,16479,111,0.61 [0.38-1.00],0.0508686064647398
Chapter II Neoplasms,Melanoma in situ,NTF4,Neurotrophin-4,16170,109,0.96 [0.60-1.52],0.8500813624321414
Chapter II Neoplasms,Melanoma in situ,NTRK2,BDNF/NT-3 growth factors receptor,16502,110,1.03 [0.53-2.00],0.9333696205242084
Chapter II Neoplasms,Melanoma in situ,NTRK3,NT-3 growth factor receptor,16642,112,0.65 [0.30-1.43],0.2874985297864133
Chapter II Neoplasms,Melanoma in situ,NTproBNP,N-terminal prohormone of brain natriuretic peptide,16502,110,1.08 [0.93-1.25],0.3345983075253576
Chapter II Neoplasms,Melanoma in situ,NUB1,NEDD8 ultimate buster 1,16479,111,1.08 [0.88-1.32],0.4616925704999707
Chapter II Neoplasms,Melanoma in situ,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14369,100,1.01 [0.84-1.22],0.8992111316354894
Chapter II Neoplasms,Melanoma in situ,NUCB2,Nucleobindin-2,16635,112,1.08 [0.68-1.71],0.7423340328548946
Chapter II Neoplasms,Melanoma in situ,NUDC,Nuclear migration protein nudC,16683,112,1.21 [0.92-1.59],0.1674534199276377
Chapter II Neoplasms,Melanoma in situ,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14058,96,0.59 [0.23-1.50],0.2661880078965642
Chapter II Neoplasms,Melanoma in situ,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,13959,100,0.97 [0.66-1.42],0.8747326960804539
Chapter II Neoplasms,Melanoma in situ,NUDT16,U8 snoRNA-decapping enzyme,14326,100,1.09 [0.87-1.36],0.4392577046715241
Chapter II Neoplasms,Melanoma in situ,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16439,110,1.20 [0.91-1.58],0.1985621016634554
Chapter II Neoplasms,Melanoma in situ,NUDT5,ADP-sugar pyrophosphatase,16531,111,1.07 [0.77-1.50],0.6931382234149569
Chapter II Neoplasms,Melanoma in situ,NUMB,Protein numb homolog,13991,93,1.09 [0.86-1.40],0.4684007513975744
Chapter II Neoplasms,Melanoma in situ,NUP50,Nuclear pore complex protein Nup50,13959,100,0.38 [0.17-0.84],0.0170691577677779
Chapter II Neoplasms,Melanoma in situ,NXPE4,NXPE family member 4,13959,100,0.47 [0.23-0.96],0.0394900513682756
Chapter II Neoplasms,Melanoma in situ,NXPH1,Neurexophilin-1,16136,109,1.15 [0.76-1.76],0.5077571046548152
Chapter II Neoplasms,Melanoma in situ,NXPH3,Neurexophilin-3,13991,93,0.68 [0.35-1.31],0.2467488322660594
Chapter II Neoplasms,Melanoma in situ,OBP2B,Odorant-binding protein 2b,16320,107,1.15 [0.86-1.54],0.3443189540553868
Chapter II Neoplasms,Melanoma in situ,OCLN,Occludin,14396,100,0.82 [0.51-1.31],0.4114279232398556
Chapter II Neoplasms,Melanoma in situ,ODAM,Odontogenic ameloblast-associated protein,16113,109,0.68 [0.48-0.96],0.0299824282324433
Chapter II Neoplasms,Melanoma in situ,OFD1,Oral-facial-digital syndrome 1 protein,14160,99,0.73 [0.50-1.07],0.1042266975355591
Chapter II Neoplasms,Melanoma in situ,OGA,Protein O-GlcNAcase,14355,100,1.11 [0.84-1.46],0.456766416195422
Chapter II Neoplasms,Melanoma in situ,OGFR,Opioid growth factor receptor,16439,110,1.43 [0.86-2.39],0.1730088958985824
Chapter II Neoplasms,Melanoma in situ,OGN,Mimecan,16531,111,0.85 [0.56-1.28],0.4398149172367225
Chapter II Neoplasms,Melanoma in situ,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14160,99,1.04 [0.78-1.39],0.800954194641162
Chapter II Neoplasms,Melanoma in situ,OLFM4,Olfactomedin-4,13582,95,1.08 [0.91-1.28],0.3636083017066502
Chapter II Neoplasms,Melanoma in situ,OLR1,Oxidized low-density lipoprotein receptor 1,16349,109,1.05 [0.79-1.39],0.7566144496225684
Chapter II Neoplasms,Melanoma in situ,OMD,Osteomodulin,16583,112,0.99 [0.66-1.48],0.9499488941721193
Chapter II Neoplasms,Melanoma in situ,OMG,Oligodendrocyte-myelin glycoprotein,16439,110,1.04 [0.80-1.34],0.7687280347151679
Chapter II Neoplasms,Melanoma in situ,OMP,Olfactory marker protein,13980,98,0.89 [0.59-1.35],0.5859045848055586
Chapter II Neoplasms,Melanoma in situ,OPHN1,Oligophrenin-1,14404,100,1.08 [0.90-1.29],0.4300877130119791
Chapter II Neoplasms,Melanoma in situ,OPLAH,5-oxoprolinase,14058,96,0.99 [0.74-1.33],0.9457456981697784
Chapter II Neoplasms,Melanoma in situ,OPTC,Opticin,16439,110,1.08 [0.76-1.53],0.6767315422554667
Chapter II Neoplasms,Melanoma in situ,ORM1,Alpha-1-acid glycoprotein 1,14388,100,1.56 [0.61-4.01],0.3578812878571812
Chapter II Neoplasms,Melanoma in situ,OSBPL2,Oxysterol-binding protein-related protein 2,14404,100,1.41 [1.01-1.96],0.0454837885056348
Chapter II Neoplasms,Melanoma in situ,OSCAR,Osteoclast-associated immunoglobulin-like receptor,16532,112,1.34 [0.82-2.20],0.2437829003147367
Chapter II Neoplasms,Melanoma in situ,OSM,Oncostatin-M,16414,111,0.98 [0.77-1.25],0.8810674012485394
Chapter II Neoplasms,Melanoma in situ,OSMR,Oncostatin-M-specific receptor subunit beta,16630,110,0.70 [0.30-1.64],0.4154757615402583
Chapter II Neoplasms,Melanoma in situ,OSTN,Osteocrin,14048,97,0.58 [0.31-1.06],0.074856144014965
Chapter II Neoplasms,Melanoma in situ,OTOA,Otoancorin,13980,98,1.18 [0.86-1.61],0.2985672985185955
Chapter II Neoplasms,Melanoma in situ,OTUD6B,Deubiquitinase OTUD6B,14355,100,1.01 [0.73-1.41],0.9394573018764408
Chapter II Neoplasms,Melanoma in situ,OTUD7B,OTU domain-containing protein 7B,14396,100,1.01 [0.74-1.38],0.950327349862276
Chapter II Neoplasms,Melanoma in situ,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14058,96,1.01 [0.76-1.35],0.9390187228478234
Chapter II Neoplasms,Melanoma in situ,OXT,Oxytocin-neurophysin 1,16642,112,0.96 [0.85-1.08],0.4651364825959285
Chapter II Neoplasms,Melanoma in situ,P4HB,Protein disulfide-isomerase,16444,109,0.92 [0.59-1.45],0.7293956087500131
Chapter II Neoplasms,Melanoma in situ,PACS2,Phosphofurin acidic cluster sorting protein 2,13959,100,0.96 [0.70-1.33],0.8186740011827325
Chapter II Neoplasms,Melanoma in situ,PADI2,Protein-arginine deiminase type-2,16225,109,0.83 [0.59-1.19],0.3192915435981347
Chapter II Neoplasms,Melanoma in situ,PADI4,Protein-arginine deiminase type-4,16113,109,1.00 [0.80-1.25],0.9950891559803444
Chapter II Neoplasms,Melanoma in situ,PAEP,Glycodelin,16369,109,0.91 [0.74-1.11],0.3566150140801086
Chapter II Neoplasms,Melanoma in situ,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14396,100,1.01 [0.86-1.18],0.9501042496380908
Chapter II Neoplasms,Melanoma in situ,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14160,99,0.93 [0.62-1.39],0.7284312527618775
Chapter II Neoplasms,Melanoma in situ,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16217,107,0.99 [0.72-1.35],0.9289936789056592
Chapter II Neoplasms,Melanoma in situ,PAGR1,PAXIP1-associated glutamate-rich protein 1,14058,96,0.86 [0.53-1.39],0.5322003498902677
Chapter II Neoplasms,Melanoma in situ,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13900,95,0.69 [0.46-1.05],0.0858420364287485
Chapter II Neoplasms,Melanoma in situ,PAK4,Serine/threonine-protein kinase PAK 4,16136,109,1.18 [0.91-1.53],0.2120925387924058
Chapter II Neoplasms,Melanoma in situ,PALLD,Palladin,13991,93,0.90 [0.52-1.54],0.6897519614783364
Chapter II Neoplasms,Melanoma in situ,PALM,Paralemmin-1,14268,98,0.62 [0.37-1.05],0.073861569465652
Chapter II Neoplasms,Melanoma in situ,PALM2,Paralemmin-2,14404,100,0.68 [0.39-1.19],0.1753384365281965
Chapter II Neoplasms,Melanoma in situ,PALM3,Paralemmin-3,13959,100,0.97 [0.74-1.27],0.8255011632811418
Chapter II Neoplasms,Melanoma in situ,PAM,Peptidyl-glycine alpha-amidating monooxygenase,16637,111,0.60 [0.35-1.02],0.0612717418826862
Chapter II Neoplasms,Melanoma in situ,PAMR1,Inactive serine protease PAMR1,16531,111,1.34 [0.71-2.52],0.3712182610701006
Chapter II Neoplasms,Melanoma in situ,PAPPA,Pappalysin-1,16225,109,1.04 [0.72-1.50],0.849039457801975
Chapter II Neoplasms,Melanoma in situ,PARD3,Partitioning defective 3 homolog,14160,99,0.80 [0.59-1.07],0.1348479989325981
Chapter II Neoplasms,Melanoma in situ,PARK7,Parkinson disease protein 7,16531,111,1.13 [0.82-1.56],0.4486461049197323
Chapter II Neoplasms,Melanoma in situ,PARP1,Poly [ADP-ribose] polymerase 1,16479,111,0.89 [0.64-1.24],0.496628806767592
Chapter II Neoplasms,Melanoma in situ,PAXX,Protein PAXX,14132,98,1.06 [0.69-1.64],0.7825988168279798
Chapter II Neoplasms,Melanoma in situ,PBK,Lymphokine-activated killer T-cell-originated protein kinase,13923,96,0.92 [0.49-1.75],0.8098179734034434
Chapter II Neoplasms,Melanoma in situ,PBLD,Phenazine biosynthesis-like domain-containing protein,16136,109,1.09 [0.77-1.53],0.6373033027984714
Chapter II Neoplasms,Melanoma in situ,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14355,100,0.68 [0.34-1.38],0.2902355675786927
Chapter II Neoplasms,Melanoma in situ,PCARE,Photoreceptor cilium actin regulator,13980,98,1.00 [0.80-1.26],0.999230743228233
Chapter II Neoplasms,Melanoma in situ,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14108,98,1.03 [0.67-1.59],0.8885476075897156
Chapter II Neoplasms,Melanoma in situ,PCBP2,Poly(rC)-binding protein 2,14396,100,0.96 [0.73-1.26],0.7731098135406893
Chapter II Neoplasms,Melanoma in situ,PCDH1,Protocadherin-1,16631,112,1.41 [0.69-2.88],0.341016231054509
Chapter II Neoplasms,Melanoma in situ,PCDH12,Protocadherin-12,14396,100,0.41 [0.20-0.86],0.0175786219806283
Chapter II Neoplasms,Melanoma in situ,PCDH17,Protocadherin-17,16502,110,0.71 [0.44-1.16],0.170038178681839
Chapter II Neoplasms,Melanoma in situ,PCDH7,Protocadherin-7,14355,100,0.74 [0.40-1.39],0.3512060035518185
Chapter II Neoplasms,Melanoma in situ,PCDH9,Protocadherin-9,14355,100,1.06 [0.60-1.88],0.8422016553689279
Chapter II Neoplasms,Melanoma in situ,PCDHB15,Protocadherin beta-15,14369,100,0.94 [0.58-1.53],0.8103912388763539
Chapter II Neoplasms,Melanoma in situ,PCNA,Proliferating cell nuclear antigen,13923,96,0.88 [0.62-1.26],0.4933918190274216
Chapter II Neoplasms,Melanoma in situ,PCSK7,Proprotein convertase subtilisin/kexin type 7,14369,100,0.75 [0.46-1.20],0.2255545768198152
Chapter II Neoplasms,Melanoma in situ,PCSK9,Proprotein convertase subtilisin/kexin type 9,16720,111,1.04 [0.68-1.59],0.8687026516559624
Chapter II Neoplasms,Melanoma in situ,PCYT2,Ethanolamine-phosphate cytidylyltransferase,14355,100,1.10 [0.85-1.42],0.4753778966150385
Chapter II Neoplasms,Melanoma in situ,PDAP1,28 kDa heat- and acid-stable phosphoprotein,14415,100,1.09 [0.89-1.33],0.4054612251314724
Chapter II Neoplasms,Melanoma in situ,PDCD1,Programmed cell death protein 1,16639,111,0.90 [0.60-1.35],0.625582097377588
Chapter II Neoplasms,Melanoma in situ,PDCD1LG2,Programmed cell death 1 ligand 2,16439,110,1.32 [0.77-2.26],0.3131514810952671
Chapter II Neoplasms,Melanoma in situ,PDCD5,Programmed cell death protein 5,16642,112,1.08 [0.82-1.44],0.5771270509791235
Chapter II Neoplasms,Melanoma in situ,PDCD6,Programmed cell death protein 6,16502,110,1.20 [0.91-1.60],0.2026367988518915
Chapter II Neoplasms,Melanoma in situ,PDCL2,Phosducin-like protein 2,13923,96,0.99 [0.68-1.44],0.9595967473501278
Chapter II Neoplasms,Melanoma in situ,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13923,96,0.74 [0.47-1.17],0.2025169455872839
Chapter II Neoplasms,Melanoma in situ,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",13959,100,1.13 [0.84-1.51],0.4320699929983996
Chapter II Neoplasms,Melanoma in situ,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14132,98,1.07 [0.88-1.29],0.5009334549330677
Chapter II Neoplasms,Melanoma in situ,PDGFA,Platelet-derived growth factor subunit A,16720,111,1.11 [0.88-1.41],0.3628032782363242
Chapter II Neoplasms,Melanoma in situ,PDGFB,Platelet-derived growth factor subunit B,16583,112,1.02 [0.84-1.24],0.838652116239121
Chapter II Neoplasms,Melanoma in situ,PDGFC,Platelet-derived growth factor C,16170,109,1.24 [0.69-2.24],0.4637264663473757
Chapter II Neoplasms,Melanoma in situ,PDGFRA,Platelet-derived growth factor receptor alpha,16502,110,0.86 [0.47-1.57],0.6275783867502981
Chapter II Neoplasms,Melanoma in situ,PDGFRB,Platelet-derived growth factor receptor beta,16720,111,1.05 [0.65-1.71],0.8425069419136074
Chapter II Neoplasms,Melanoma in situ,PDIA2,Protein disulfide-isomerase A2,13923,96,0.57 [0.33-1.01],0.0557593018161643
Chapter II Neoplasms,Melanoma in situ,PDIA3,Protein disulfide-isomerase A3,14132,98,0.71 [0.31-1.63],0.4169677275892897
Chapter II Neoplasms,Melanoma in situ,PDIA4,Protein disulfide-isomerase A4,14428,100,0.93 [0.67-1.28],0.641176894928492
Chapter II Neoplasms,Melanoma in situ,PDIA5,Protein disulfide-isomerase A5,13923,96,0.96 [0.68-1.34],0.8095913788758142
Chapter II Neoplasms,Melanoma in situ,PDLIM5,PDZ and LIM domain protein 5,14396,100,1.00 [0.85-1.18],0.9944069280963088
Chapter II Neoplasms,Melanoma in situ,PDLIM7,PDZ and LIM domain protein 7,16583,112,1.05 [0.92-1.20],0.4509629002898182
Chapter II Neoplasms,Melanoma in situ,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16170,109,0.72 [0.48-1.09],0.1187797610470288
Chapter II Neoplasms,Melanoma in situ,PDRG1,p53 and DNA damage-regulated protein 1,14048,97,0.75 [0.49-1.17],0.2037288104665132
Chapter II Neoplasms,Melanoma in situ,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13923,96,0.64 [0.36-1.12],0.1162429802217842
Chapter II Neoplasms,Melanoma in situ,PDZD2,PDZ domain-containing protein 2,13959,100,0.87 [0.61-1.23],0.4287647877040687
Chapter II Neoplasms,Melanoma in situ,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,13991,93,0.91 [0.56-1.49],0.7063004615326134
Chapter II Neoplasms,Melanoma in situ,PEAR1,Platelet endothelial aggregation receptor 1,16720,111,1.21 [0.58-2.54],0.6110388988350763
Chapter II Neoplasms,Melanoma in situ,PEBP1,Phosphatidylethanolamine-binding protein 1,16531,111,1.10 [0.82-1.47],0.5182134922083477
Chapter II Neoplasms,Melanoma in situ,PECAM1,Platelet endothelial cell adhesion molecule,16531,111,1.06 [0.60-1.85],0.8508874418834156
Chapter II Neoplasms,Melanoma in situ,PECR,Peroxisomal trans-2-enoyl-CoA reductase,14058,96,0.54 [0.24-1.20],0.1314288702074782
Chapter II Neoplasms,Melanoma in situ,PENK,Proenkephalin-A,14132,98,1.03 [0.56-1.92],0.9214278712363616
Chapter II Neoplasms,Melanoma in situ,PEPD,Xaa-Pro dipeptidase,14434,100,0.63 [0.31-1.31],0.2173895789430896
Chapter II Neoplasms,Melanoma in situ,PER3,Period circadian protein homolog 3,13991,93,1.04 [0.89-1.22],0.6262190400741499
Chapter II Neoplasms,Melanoma in situ,PF4,Platelet factor 4,14340,100,1.03 [0.85-1.25],0.7568706471503347
Chapter II Neoplasms,Melanoma in situ,PFDN2,Prefoldin subunit 2,16136,109,0.96 [0.70-1.30],0.7844293420689276
Chapter II Neoplasms,Melanoma in situ,PFDN4,Prefoldin subunit 4,13923,96,0.77 [0.50-1.17],0.2240093460066204
Chapter II Neoplasms,Melanoma in situ,PFDN6,Prefoldin subunit 6,14048,97,0.86 [0.61-1.22],0.3963303425514771
Chapter II Neoplasms,Melanoma in situ,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16407,110,1.06 [0.85-1.32],0.5939178126763505
Chapter II Neoplasms,Melanoma in situ,PGA4,Pepsin A-4,14434,100,0.91 [0.72-1.14],0.3922824999112128
Chapter II Neoplasms,Melanoma in situ,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14415,100,1.36 [0.96-1.91],0.081663852519883
Chapter II Neoplasms,Melanoma in situ,PGF,Placenta growth factor,16683,112,0.93 [0.46-1.85],0.8333166379925452
Chapter II Neoplasms,Melanoma in situ,PGLYRP1,Peptidoglycan recognition protein 1,16660,111,0.95 [0.64-1.43],0.8161886049379848
Chapter II Neoplasms,Melanoma in situ,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14263,98,0.58 [0.31-1.08],0.0832896576552846
Chapter II Neoplasms,Melanoma in situ,PGLYRP4,Peptidoglycan recognition protein 4,13959,100,0.90 [0.63-1.28],0.5460848835487344
Chapter II Neoplasms,Melanoma in situ,PGM2,Phosphoglucomutase-2,14048,97,1.24 [0.96-1.60],0.1001082464592368
Chapter II Neoplasms,Melanoma in situ,PGR,Progesterone receptor,13991,93,1.09 [0.92-1.30],0.3234723492033223
Chapter II Neoplasms,Melanoma in situ,PHACTR2,Phosphatase and actin regulator 2,14396,100,1.04 [0.88-1.23],0.6409849060043062
Chapter II Neoplasms,Melanoma in situ,PHLDB1,Pleckstrin homology-like domain family B member 1,14355,100,1.09 [0.75-1.57],0.6598827061851249
Chapter II Neoplasms,Melanoma in situ,PHLDB2,Pleckstrin homology-like domain family B member 2,13923,96,0.94 [0.75-1.17],0.5720406422568414
Chapter II Neoplasms,Melanoma in situ,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16369,109,0.92 [0.52-1.64],0.7856069427995638
Chapter II Neoplasms,Melanoma in situ,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14132,98,1.00 [0.62-1.63],0.992657211325788
Chapter II Neoplasms,Melanoma in situ,PI16,Peptidase inhibitor 16,14434,100,0.81 [0.37-1.75],0.5916265492805048
Chapter II Neoplasms,Melanoma in situ,PI3,Elafin,16324,108,1.53 [1.17-1.99],0.0017246504910113
Chapter II Neoplasms,Melanoma in situ,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14396,100,1.05 [0.82-1.35],0.6811631639546794
Chapter II Neoplasms,Melanoma in situ,PIGR,Polymeric immunoglobulin receptor,16318,110,1.18 [0.72-1.91],0.5163307916076353
Chapter II Neoplasms,Melanoma in situ,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16479,111,1.29 [0.99-1.68],0.0569428164949082
Chapter II Neoplasms,Melanoma in situ,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16531,111,0.78 [0.42-1.48],0.4515792805084386
Chapter II Neoplasms,Melanoma in situ,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,13991,93,1.07 [0.75-1.53],0.7068486687174258
Chapter II Neoplasms,Melanoma in situ,PILRA,Paired immunoglobulin-like type 2 receptor alpha,16531,111,0.82 [0.55-1.22],0.3218099228576896
Chapter II Neoplasms,Melanoma in situ,PILRB,Paired immunoglobulin-like type 2 receptor beta,16502,110,0.89 [0.67-1.19],0.4233274544019829
Chapter II Neoplasms,Melanoma in situ,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14132,98,0.73 [0.56-0.95],0.0179460250578111
Chapter II Neoplasms,Melanoma in situ,PITHD1,PITH domain-containing protein 1,13900,95,1.24 [1.03-1.50],0.0262548315901527
Chapter II Neoplasms,Melanoma in situ,PKD1,Polycystin-1,14415,100,0.75 [0.36-1.55],0.4366895583331673
Chapter II Neoplasms,Melanoma in situ,PKD2,Polycystin-2,13959,100,1.09 [0.79-1.51],0.6111164481707498
Chapter II Neoplasms,Melanoma in situ,PKLR,Pyruvate kinase PKLR,16541,112,1.00 [0.78-1.29],0.990801654914658
Chapter II Neoplasms,Melanoma in situ,PKN3,Serine/threonine-protein kinase N3,14160,99,0.94 [0.72-1.22],0.630095525798853
Chapter II Neoplasms,Melanoma in situ,PLA2G10,Group 10 secretory phospholipase A2,16369,109,0.91 [0.68-1.21],0.5051719204793028
Chapter II Neoplasms,Melanoma in situ,PLA2G15,Phospholipase A2 group XV,16578,111,0.88 [0.46-1.69],0.705903814734316
Chapter II Neoplasms,Melanoma in situ,PLA2G1B,Phospholipase A2,16699,110,0.80 [0.55-1.17],0.2537259046868464
Chapter II Neoplasms,Melanoma in situ,PLA2G2A,"Phospholipase A2, membrane associated",16488,110,1.16 [0.87-1.54],0.3033983125463069
Chapter II Neoplasms,Melanoma in situ,PLA2G4A,Cytosolic phospholipase A2,16583,112,1.07 [0.88-1.30],0.4757603695257066
Chapter II Neoplasms,Melanoma in situ,PLA2G7,Platelet-activating factor acetylhydrolase,16531,111,1.16 [0.69-1.95],0.5742393738666765
Chapter II Neoplasms,Melanoma in situ,PLAT,Tissue-type plasminogen activator,16682,111,0.87 [0.62-1.22],0.424189538959033
Chapter II Neoplasms,Melanoma in situ,PLAU,Urokinase-type plasminogen activator,16531,111,0.66 [0.35-1.22],0.1804941994472411
Chapter II Neoplasms,Melanoma in situ,PLAUR,Urokinase plasminogen activator surface receptor,16413,112,0.91 [0.48-1.70],0.760024183964383
Chapter II Neoplasms,Melanoma in situ,PLB1,"Phospholipase B1, membrane-associated",14404,100,1.01 [0.73-1.39],0.9698492530697708
Chapter II Neoplasms,Melanoma in situ,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",13991,93,0.88 [0.53-1.47],0.6306694922945331
Chapter II Neoplasms,Melanoma in situ,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14404,100,0.98 [0.80-1.20],0.8433464661748726
Chapter II Neoplasms,Melanoma in situ,PLEKHO1,Pleckstrin homology domain-containing family O member 1,14404,100,1.08 [0.82-1.42],0.5904198497050639
Chapter II Neoplasms,Melanoma in situ,PLG,Plasminogen,14086,96,0.58 [0.23-1.42],0.2292937171323577
Chapter II Neoplasms,Melanoma in situ,PLIN1,Perilipin-1,16136,109,0.91 [0.55-1.52],0.7205993421873607
Chapter II Neoplasms,Melanoma in situ,PLIN3,Perilipin-3,16502,110,1.11 [0.75-1.65],0.5996038018367505
Chapter II Neoplasms,Melanoma in situ,PLPBP,Pyridoxal phosphate homeostasis protein,16502,110,1.07 [0.83-1.38],0.5921034162171388
Chapter II Neoplasms,Melanoma in situ,PLSCR3,Phospholipid scramblase 3,14377,100,0.90 [0.65-1.27],0.561750746142669
Chapter II Neoplasms,Melanoma in situ,PLTP,Phospholipid transfer protein,16669,111,0.75 [0.47-1.20],0.2352877213692304
Chapter II Neoplasms,Melanoma in situ,PLXDC1,Plexin domain-containing protein 1,16170,109,1.09 [0.66-1.82],0.72496274611932
Chapter II Neoplasms,Melanoma in situ,PLXDC2,Plexin domain-containing protein 2,14404,100,0.66 [0.31-1.40],0.2828824018231986
Chapter II Neoplasms,Melanoma in situ,PLXNA4,Plexin-A4,16479,111,1.03 [0.84-1.26],0.7978788747980732
Chapter II Neoplasms,Melanoma in situ,PLXNB2,Plexin-B2,16653,111,0.87 [0.42-1.78],0.6975003655932859
Chapter II Neoplasms,Melanoma in situ,PLXNB3,Plexin-B3,16455,110,1.34 [0.94-1.91],0.1030195664557131
Chapter II Neoplasms,Melanoma in situ,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16415,110,1.03 [0.94-1.14],0.5045440683316994
Chapter II Neoplasms,Melanoma in situ,PMCH,Pro-MCH,13959,100,1.07 [0.87-1.31],0.5367171247944893
Chapter II Neoplasms,Melanoma in situ,PMM2,Phosphomannomutase 2,13959,100,0.88 [0.63-1.23],0.4640778777598722
Chapter II Neoplasms,Melanoma in situ,PMS1,PMS1 protein homolog 1,14048,97,0.73 [0.47-1.12],0.1486975269810296
Chapter II Neoplasms,Melanoma in situ,PMVK,Phosphomevalonate kinase,16107,109,1.05 [0.89-1.24],0.5503054784762987
Chapter II Neoplasms,Melanoma in situ,PNLIP,Pancreatic triacylglycerol lipase,14434,100,0.98 [0.72-1.33],0.905926684579258
Chapter II Neoplasms,Melanoma in situ,PNLIPRP1,Inactive pancreatic lipase-related protein 1,14404,100,1.18 [0.93-1.50],0.1809460829753468
Chapter II Neoplasms,Melanoma in situ,PNLIPRP2,Pancreatic lipase-related protein 2,16504,112,1.01 [0.95-1.07],0.7103839466586559
Chapter II Neoplasms,Melanoma in situ,PNMA1,Paraneoplastic antigen Ma1,14058,96,1.03 [0.72-1.47],0.8730383900195808
Chapter II Neoplasms,Melanoma in situ,PNMA2,Paraneoplastic antigen Ma2,13980,98,0.95 [0.61-1.48],0.8177529111417402
Chapter II Neoplasms,Melanoma in situ,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16225,109,0.77 [0.63-0.94],0.0087783102898882
Chapter II Neoplasms,Melanoma in situ,PODXL,Podocalyxin,16439,110,0.54 [0.18-1.61],0.2663250978218888
Chapter II Neoplasms,Melanoma in situ,PODXL2,Podocalyxin-like protein 2,16578,111,0.77 [0.42-1.42],0.4050436412166158
Chapter II Neoplasms,Melanoma in situ,POF1B,Protein POF1B,13991,93,0.69 [0.42-1.14],0.1455187059966511
Chapter II Neoplasms,Melanoma in situ,POLR2A,DNA-directed RNA polymerase II subunit RPB1,13991,93,0.88 [0.44-1.78],0.7236273155745878
Chapter II Neoplasms,Melanoma in situ,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16439,110,0.97 [0.58-1.61],0.9059185420061782
Chapter II Neoplasms,Melanoma in situ,POMC,Pro-opiomelanocortin,14058,96,0.93 [0.70-1.24],0.6249020633104954
Chapter II Neoplasms,Melanoma in situ,PON1,Serum paraoxonase/arylesterase 1,14434,100,1.26 [0.60-2.63],0.5391817061851316
Chapter II Neoplasms,Melanoma in situ,PON2,Serum paraoxonase/arylesterase 2,16217,107,0.92 [0.56-1.51],0.7491486684764239
Chapter II Neoplasms,Melanoma in situ,PON3,Serum paraoxonase/lactonase 3,16583,112,0.63 [0.36-1.08],0.0931834896929501
Chapter II Neoplasms,Melanoma in situ,POSTN,Periostin,14428,100,0.70 [0.41-1.18],0.1782981384925014
Chapter II Neoplasms,Melanoma in situ,PPBP,Platelet basic protein,14343,100,1.05 [0.83-1.31],0.6960982175950923
Chapter II Neoplasms,Melanoma in situ,PPCDC,Phosphopantothenoylcysteine decarboxylase,16642,112,1.19 [0.84-1.70],0.3275668295214453
Chapter II Neoplasms,Melanoma in situ,PPIB,Peptidyl-prolyl cis-trans isomerase B,16553,110,1.11 [0.93-1.33],0.2533263326311619
Chapter II Neoplasms,Melanoma in situ,PPIE,Peptidyl-prolyl cis-trans isomerase E,14160,99,1.11 [0.84-1.45],0.467555866877591
Chapter II Neoplasms,Melanoma in situ,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14428,100,0.94 [0.69-1.29],0.7069296504593718
Chapter II Neoplasms,Melanoma in situ,PPL,Periplakin,13991,93,0.64 [0.33-1.24],0.1840898917848726
Chapter II Neoplasms,Melanoma in situ,PPM1A,Protein phosphatase 1A,16170,109,0.97 [0.56-1.68],0.9242571211338444
Chapter II Neoplasms,Melanoma in situ,PPM1B,Protein phosphatase 1B,13991,93,1.13 [0.85-1.49],0.4118058379792123
Chapter II Neoplasms,Melanoma in situ,PPM1F,Protein phosphatase 1F,14415,100,1.05 [0.72-1.51],0.8143930156983937
Chapter II Neoplasms,Melanoma in situ,PPME1,Protein phosphatase methylesterase 1,16439,110,1.20 [0.91-1.58],0.205425614266587
Chapter II Neoplasms,Melanoma in situ,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14369,100,1.00 [0.79-1.26],0.9677516588282912
Chapter II Neoplasms,Melanoma in situ,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16578,111,1.06 [0.89-1.26],0.5291204496225146
Chapter II Neoplasms,Melanoma in situ,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14160,99,0.92 [0.69-1.23],0.592823466286605
Chapter II Neoplasms,Melanoma in situ,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14396,100,1.05 [0.83-1.34],0.6660541966112811
Chapter II Neoplasms,Melanoma in situ,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14396,100,0.85 [0.50-1.43],0.5383483131240132
Chapter II Neoplasms,Melanoma in situ,PPP1R2,Protein phosphatase inhibitor 2,16502,110,1.11 [0.90-1.37],0.3376181406981653
Chapter II Neoplasms,Melanoma in situ,PPP1R9B,Neurabin-2,16683,112,1.14 [0.95-1.36],0.1481101609843206
Chapter II Neoplasms,Melanoma in situ,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14355,100,0.98 [0.83-1.15],0.7934172311192207
Chapter II Neoplasms,Melanoma in situ,PPP3R1,Calcineurin subunit B type 1,16369,109,0.90 [0.59-1.38],0.63393941520992
Chapter II Neoplasms,Melanoma in situ,PPT1,Palmitoyl-protein thioesterase 1,14048,97,0.68 [0.47-0.99],0.045105068746115
Chapter II Neoplasms,Melanoma in situ,PPY,Pancreatic prohormone,16513,111,1.06 [0.90-1.24],0.5128647892228577
Chapter II Neoplasms,Melanoma in situ,PQBP1,Polyglutamine-binding protein 1,16170,109,0.96 [0.70-1.31],0.801930252286964
Chapter II Neoplasms,Melanoma in situ,PRAME,Melanoma antigen preferentially expressed in tumors,13923,96,0.46 [0.21-1.00],0.0490083833213829
Chapter II Neoplasms,Melanoma in situ,PRAP1,Proline-rich acidic protein 1,14428,100,1.38 [0.85-2.24],0.1986620044569483
Chapter II Neoplasms,Melanoma in situ,PRC1,Protein regulator of cytokinesis 1,14369,100,0.82 [0.48-1.39],0.4562121508610612
Chapter II Neoplasms,Melanoma in situ,PRCP,Lysosomal Pro-X carboxypeptidase,16634,109,0.54 [0.31-0.94],0.0283662463086397
Chapter II Neoplasms,Melanoma in situ,PRDX1,Peroxiredoxin-1,16033,107,1.11 [0.92-1.34],0.2866198559661396
Chapter II Neoplasms,Melanoma in situ,PRDX2,Peroxiredoxin-2,14176,98,1.00 [0.74-1.35],0.9892482788363068
Chapter II Neoplasms,Melanoma in situ,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16225,109,0.89 [0.69-1.13],0.3274799152643621
Chapter II Neoplasms,Melanoma in situ,PRDX5,"Peroxiredoxin-5, mitochondrial",16683,112,1.09 [0.84-1.41],0.5031238326889795
Chapter II Neoplasms,Melanoma in situ,PRDX6,Peroxiredoxin-6,16669,112,1.11 [0.85-1.46],0.4365383313533223
Chapter II Neoplasms,Melanoma in situ,PREB,Prolactin regulatory element-binding protein,16225,109,0.83 [0.45-1.52],0.5392096640112879
Chapter II Neoplasms,Melanoma in situ,PRELP,Prolargin,16504,112,1.22 [0.59-2.51],0.59304588240021
Chapter II Neoplasms,Melanoma in situ,PRG2,Bone marrow proteoglycan,14428,100,1.59 [1.12-2.26],0.009765100887648
Chapter II Neoplasms,Melanoma in situ,PRG3,Proteoglycan 3,14428,100,1.15 [0.78-1.70],0.4854600427349527
Chapter II Neoplasms,Melanoma in situ,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16225,109,1.21 [0.90-1.64],0.2075956607263947
Chapter II Neoplasms,Melanoma in situ,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14048,97,0.68 [0.35-1.33],0.2632984309420398
Chapter II Neoplasms,Melanoma in situ,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16502,110,0.96 [0.79-1.18],0.7265876669814435
Chapter II Neoplasms,Melanoma in situ,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14374,100,1.05 [0.83-1.34],0.6768429080636837
Chapter II Neoplasms,Melanoma in situ,PRKCQ,Protein kinase C theta type,16225,109,0.64 [0.40-1.01],0.0570869430353217
Chapter II Neoplasms,Melanoma in situ,PRKD2,Serine/threonine-protein kinase D2,13959,100,0.82 [0.50-1.33],0.4181034489212971
Chapter II Neoplasms,Melanoma in situ,PRKG1,cGMP-dependent protein kinase 1,14132,98,1.02 [0.87-1.19],0.83077368311887
Chapter II Neoplasms,Melanoma in situ,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16170,109,1.00 [0.78-1.29],0.9990666067850192
Chapter II Neoplasms,Melanoma in situ,PRL,Prolactin,16642,112,1.08 [0.87-1.35],0.4892487362367677
Chapter II Neoplasms,Melanoma in situ,PRND,Prion-like protein doppel,14404,100,1.03 [0.70-1.51],0.8942800211616201
Chapter II Neoplasms,Melanoma in situ,PROC,Vitamin K-dependent protein C,16577,110,1.32 [0.66-2.63],0.436237696807713
Chapter II Neoplasms,Melanoma in situ,PROCR,Endothelial protein C receptor,13959,100,0.70 [0.36-1.36],0.29515535160299
Chapter II Neoplasms,Melanoma in situ,PROK1,Prokineticin-1,16479,111,1.03 [0.75-1.40],0.8613116058973176
Chapter II Neoplasms,Melanoma in situ,PROS1,Vitamin K-dependent protein S,14443,100,1.08 [0.51-2.30],0.8397008463240551
Chapter II Neoplasms,Melanoma in situ,PRR4,Proline-rich protein 4,14021,97,1.43 [1.11-1.84],0.0062079585586577
Chapter II Neoplasms,Melanoma in situ,PRR5,Proline-rich protein 5,13991,93,1.27 [0.88-1.85],0.2042529540963315
Chapter II Neoplasms,Melanoma in situ,PRRT3,Proline-rich transmembrane protein 3,14058,96,0.97 [0.57-1.64],0.8994637083070103
Chapter II Neoplasms,Melanoma in situ,PRSS2,Trypsin-2,16607,110,0.95 [0.69-1.31],0.7416502405947272
Chapter II Neoplasms,Melanoma in situ,PRSS22,Brain-specific serine protease 4,13991,93,1.00 [0.57-1.78],0.9889824307755836
Chapter II Neoplasms,Melanoma in situ,PRSS27,Serine protease 27,16465,110,1.21 [0.79-1.84],0.3831363263269344
Chapter II Neoplasms,Melanoma in situ,PRSS53,Serine protease 53,14404,100,0.76 [0.45-1.28],0.3060993452341961
Chapter II Neoplasms,Melanoma in situ,PRSS8,Prostasin,16467,112,1.08 [0.72-1.63],0.714026403771342
Chapter II Neoplasms,Melanoma in situ,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16136,109,1.08 [0.92-1.26],0.3439715781860029
Chapter II Neoplasms,Melanoma in situ,PRTG,Protogenin,16669,112,0.61 [0.32-1.13],0.1169909598980596
Chapter II Neoplasms,Melanoma in situ,PRTN3,Myeloblastin,16101,109,1.19 [0.86-1.64],0.2914548243289567
Chapter II Neoplasms,Melanoma in situ,PRUNE2,Protein prune homolog 2,14160,99,0.45 [0.21-0.99],0.0464636225327481
Chapter II Neoplasms,Melanoma in situ,PSAP,Prosaposin,14291,99,0.73 [0.36-1.51],0.4006883556619268
Chapter II Neoplasms,Melanoma in situ,PSAPL1,Proactivator polypeptide-like 1,14355,100,1.11 [0.75-1.63],0.6023608047464456
Chapter II Neoplasms,Melanoma in situ,PSCA,Prostate stem cell antigen,14355,100,1.04 [0.97-1.12],0.2690902234000745
Chapter II Neoplasms,Melanoma in situ,PSG1,Pregnancy-specific beta-1-glycoprotein 1,16369,109,1.06 [0.91-1.22],0.4786045298598828
Chapter II Neoplasms,Melanoma in situ,PSIP1,PC4 and SFRS1-interacting protein,16479,111,1.09 [0.85-1.39],0.5042747085859401
Chapter II Neoplasms,Melanoma in situ,PSMA1,Proteasome subunit alpha type-1,16170,109,0.95 [0.65-1.39],0.7961274706271524
Chapter II Neoplasms,Melanoma in situ,PSMC3,26S proteasome regulatory subunit 6A,13923,96,0.65 [0.34-1.26],0.2040132964933671
Chapter II Neoplasms,Melanoma in situ,PSMD1,26S proteasome non-ATPase regulatory subunit 1,14396,100,0.95 [0.65-1.41],0.8179219704872898
Chapter II Neoplasms,Melanoma in situ,PSMD5,26S proteasome non-ATPase regulatory subunit 5,14048,97,1.14 [0.85-1.55],0.3775706389643857
Chapter II Neoplasms,Melanoma in situ,PSMD9,26S proteasome non-ATPase regulatory subunit 9,16439,110,1.06 [0.78-1.43],0.7137045287888288
Chapter II Neoplasms,Melanoma in situ,PSME1,Proteasome activator complex subunit 1,16335,108,1.12 [0.71-1.76],0.629176460451589
Chapter II Neoplasms,Melanoma in situ,PSME2,Proteasome activator complex subunit 2,16294,109,1.15 [0.73-1.83],0.5393888525745532
Chapter II Neoplasms,Melanoma in situ,PSMG3,Proteasome assembly chaperone 3,16479,111,1.03 [0.75-1.42],0.8505469473113287
Chapter II Neoplasms,Melanoma in situ,PSMG4,Proteasome assembly chaperone 4,13991,93,0.91 [0.64-1.30],0.5978660916274187
Chapter II Neoplasms,Melanoma in situ,PSPN,Persephin,16479,111,1.03 [0.86-1.23],0.7657692238007398
Chapter II Neoplasms,Melanoma in situ,PSRC1,Proline/serine-rich coiled-coil protein 1,16170,109,0.96 [0.71-1.29],0.7817599549238111
Chapter II Neoplasms,Melanoma in situ,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13659,95,1.09 [0.90-1.32],0.3811407488402806
Chapter II Neoplasms,Melanoma in situ,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16136,109,0.88 [0.50-1.55],0.6555718974643235
Chapter II Neoplasms,Melanoma in situ,PTGDS,Prostaglandin-H2 D-isomerase,16420,110,0.94 [0.53-1.67],0.8349044612685602
Chapter II Neoplasms,Melanoma in situ,PTGES2,Prostaglandin E synthase 2,13883,92,1.18 [0.82-1.70],0.3828754854088513
Chapter II Neoplasms,Melanoma in situ,PTGR1,Prostaglandin reductase 1,14415,100,1.09 [0.87-1.38],0.452732258047308
Chapter II Neoplasms,Melanoma in situ,PTH,Parathyroid hormone,14048,97,1.07 [0.84-1.36],0.606549081864276
Chapter II Neoplasms,Melanoma in situ,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16479,111,0.96 [0.61-1.51],0.8691618204277238
Chapter II Neoplasms,Melanoma in situ,PTK7,Inactive tyrosine-protein kinase 7,16136,109,0.89 [0.57-1.41],0.6230165363729971
Chapter II Neoplasms,Melanoma in situ,PTN,Pleiotrophin,16217,107,1.13 [0.80-1.60],0.4777574492908454
Chapter II Neoplasms,Melanoma in situ,PTP4A3,Protein tyrosine phosphatase type IVA 3,13991,93,0.80 [0.53-1.22],0.3088421430038525
Chapter II Neoplasms,Melanoma in situ,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16369,109,1.07 [0.86-1.33],0.5344344577862055
Chapter II Neoplasms,Melanoma in situ,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16558,112,1.03 [0.86-1.25],0.7298061769900248
Chapter II Neoplasms,Melanoma in situ,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,13970,93,0.81 [0.45-1.45],0.4732049734249566
Chapter II Neoplasms,Melanoma in situ,PTPRB,Receptor-type tyrosine-protein phosphatase beta,14415,100,0.56 [0.28-1.09],0.0888079368500995
Chapter II Neoplasms,Melanoma in situ,PTPRC,Receptor-type tyrosine-protein phosphatase C,14428,100,0.55 [0.23-1.31],0.1775978527674207
Chapter II Neoplasms,Melanoma in situ,PTPRF,Receptor-type tyrosine-protein phosphatase F,16720,111,0.73 [0.41-1.30],0.2843584991069524
Chapter II Neoplasms,Melanoma in situ,PTPRH,Receptor-type tyrosine-protein phosphatase H,14355,100,0.99 [0.66-1.48],0.965795396761048
Chapter II Neoplasms,Melanoma in situ,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14355,100,0.64 [0.24-1.70],0.371441743196923
Chapter II Neoplasms,Melanoma in situ,PTPRM,Receptor-type tyrosine-protein phosphatase mu,16456,111,1.38 [0.69-2.77],0.3640622418505378
Chapter II Neoplasms,Melanoma in situ,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16319,108,1.02 [0.60-1.71],0.9541375762986593
Chapter II Neoplasms,Melanoma in situ,PTPRR,Receptor-type tyrosine-protein phosphatase R,14404,100,0.96 [0.57-1.63],0.8844209166207453
Chapter II Neoplasms,Melanoma in situ,PTPRS,Receptor-type tyrosine-protein phosphatase S,16720,111,1.17 [0.59-2.30],0.659639466930922
Chapter II Neoplasms,Melanoma in situ,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14415,100,0.98 [0.54-1.78],0.945147281253408
Chapter II Neoplasms,Melanoma in situ,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14132,98,1.06 [0.77-1.47],0.7168795926675879
Chapter II Neoplasms,Melanoma in situ,PTS,6-pyruvoyl tetrahydrobiopterin synthase,16059,107,0.94 [0.67-1.30],0.6906062257929855
Chapter II Neoplasms,Melanoma in situ,PTTG1,Securin,14160,99,1.07 [0.68-1.68],0.7672621191883687
Chapter II Neoplasms,Melanoma in situ,PTX3,Pentraxin-related protein PTX3,16479,111,1.05 [0.74-1.50],0.7776467142401684
Chapter II Neoplasms,Melanoma in situ,PVALB,Parvalbumin alpha,16576,112,1.13 [0.97-1.32],0.1278376207638651
Chapter II Neoplasms,Melanoma in situ,PVR,Poliovirus receptor,16642,112,0.73 [0.45-1.19],0.2058556592181926
Chapter II Neoplasms,Melanoma in situ,PXDNL,Peroxidasin-like protein,14369,100,0.83 [0.55-1.26],0.3805915189679985
Chapter II Neoplasms,Melanoma in situ,PXN,Paxillin,16136,109,0.94 [0.67-1.32],0.7235678209228567
Chapter II Neoplasms,Melanoma in situ,PYDC1,Pyrin domain-containing protein 1,14058,96,0.95 [0.58-1.56],0.8534468844532347
Chapter II Neoplasms,Melanoma in situ,PYY,Peptide YY,13959,100,0.80 [0.65-0.98],0.0316873075969593
Chapter II Neoplasms,Melanoma in situ,PZP,Pregnancy zone protein,14443,100,0.89 [0.60-1.32],0.562491454072946
Chapter II Neoplasms,Melanoma in situ,QDPR,Dihydropteridine reductase,16429,109,1.13 [0.76-1.67],0.5582540862958258
Chapter II Neoplasms,Melanoma in situ,QPCT,Glutaminyl-peptide cyclotransferase,16574,109,1.55 [0.83-2.90],0.1715239751942195
Chapter II Neoplasms,Melanoma in situ,QSOX1,Sulfhydryl oxidase 1,14159,97,1.06 [0.68-1.66],0.8017537738521465
Chapter II Neoplasms,Melanoma in situ,RAB10,Ras-related protein Rab-10,14415,100,0.95 [0.66-1.36],0.7720529888356725
Chapter II Neoplasms,Melanoma in situ,RAB11FIP3,Rab11 family-interacting protein 3,14415,100,1.05 [0.88-1.26],0.5877992407398966
Chapter II Neoplasms,Melanoma in situ,RAB27B,Ras-related protein Rab-27B,14415,100,1.05 [0.83-1.33],0.7021349732568867
Chapter II Neoplasms,Melanoma in situ,RAB2B,Ras-related protein Rab-2B,14369,100,0.90 [0.65-1.25],0.5399048601298431
Chapter II Neoplasms,Melanoma in situ,RAB33A,Ras-related protein Rab-33A,13959,100,1.00 [0.74-1.34],0.988339414089619
Chapter II Neoplasms,Melanoma in situ,RAB37,Ras-related protein Rab-37,16225,109,0.81 [0.63-1.04],0.1006786713549555
Chapter II Neoplasms,Melanoma in situ,RAB39B,Ras-related protein Rab-39B,13959,100,1.21 [1.04-1.41],0.0116280409523133
Chapter II Neoplasms,Melanoma in situ,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,13980,98,1.08 [0.79-1.48],0.6103875969244952
Chapter II Neoplasms,Melanoma in situ,RAB44,Ras-related protein Rab-44,14369,100,1.05 [0.70-1.59],0.8063194066304455
Chapter II Neoplasms,Melanoma in situ,RAB6A,Ras-related protein Rab-6A,16479,111,0.62 [0.43-0.91],0.0143024925382714
Chapter II Neoplasms,Melanoma in situ,RAB6B,Ras-related protein Rab-6B,16136,109,0.95 [0.66-1.36],0.7835571091513475
Chapter II Neoplasms,Melanoma in situ,RABEP1,Rab GTPase-binding effector protein 1,14132,98,1.13 [0.88-1.45],0.3416368622884642
Chapter II Neoplasms,Melanoma in situ,RABEPK,Rab9 effector protein with kelch motifs,16170,109,0.65 [0.45-0.94],0.0214686425076628
Chapter II Neoplasms,Melanoma in situ,RABGAP1L,Rab GTPase-activating protein 1-like,16225,109,1.09 [0.82-1.44],0.5570005929739128
Chapter II Neoplasms,Melanoma in situ,RAC3,Ras-related C3 botulinum toxin substrate 3,14048,97,1.11 [0.87-1.42],0.3897175361902617
Chapter II Neoplasms,Melanoma in situ,RAD23B,UV excision repair protein RAD23 homolog B,16170,109,0.98 [0.68-1.41],0.8983153342014283
Chapter II Neoplasms,Melanoma in situ,RAD51,DNA repair protein RAD51 homolog 1,14160,99,1.11 [0.82-1.50],0.5104760669796871
Chapter II Neoplasms,Melanoma in situ,RALB,Ras-related protein Ral-B,13991,93,1.36 [0.74-2.52],0.3253278529472679
Chapter II Neoplasms,Melanoma in situ,RALY,RNA-binding protein Raly,14369,100,1.31 [0.96-1.79],0.0853539707716928
Chapter II Neoplasms,Melanoma in situ,RANBP1,Ran-specific GTPase-activating protein,14058,96,0.98 [0.68-1.42],0.919675068414088
Chapter II Neoplasms,Melanoma in situ,RANBP2,E3 SUMO-protein ligase RanBP2,13980,98,0.95 [0.52-1.72],0.8624577359562702
Chapter II Neoplasms,Melanoma in situ,RANGAP1,Ran GTPase-activating protein 1,16170,109,1.01 [0.70-1.45],0.9641940897612596
Chapter II Neoplasms,Melanoma in situ,RAP1A,Ras-related protein Rap-1A,13991,93,0.86 [0.61-1.20],0.3706413279699319
Chapter II Neoplasms,Melanoma in situ,RAPGEF2,Rap guanine nucleotide exchange factor 2,14160,99,1.34 [0.96-1.88],0.0879288912310515
Chapter II Neoplasms,Melanoma in situ,RARRES1,Retinoic acid receptor responder protein 1,16170,109,1.47 [1.04-2.08],0.0276378694528093
Chapter II Neoplasms,Melanoma in situ,RARRES2,Retinoic acid receptor responder protein 2,16630,110,0.94 [0.65-1.35],0.7415350847879577
Chapter II Neoplasms,Melanoma in situ,RASA1,Ras GTPase-activating protein 1,16136,109,1.08 [0.65-1.78],0.7757913293592528
Chapter II Neoplasms,Melanoma in situ,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13923,96,1.02 [0.65-1.60],0.9257108695099964
Chapter II Neoplasms,Melanoma in situ,RASSF2,Ras association domain-containing protein 2,16170,109,0.88 [0.63-1.22],0.4423971110538254
Chapter II Neoplasms,Melanoma in situ,RBFOX3,RNA binding protein fox-1 homolog 3,14396,100,0.86 [0.50-1.47],0.5773723206408353
Chapter II Neoplasms,Melanoma in situ,RBKS,Ribokinase,16107,107,1.15 [0.82-1.62],0.4086095137563792
Chapter II Neoplasms,Melanoma in situ,RBM17,Splicing factor 45,14396,100,1.08 [0.84-1.39],0.540527266466514
Chapter II Neoplasms,Melanoma in situ,RBM19,Probable RNA-binding protein 19,13959,100,0.48 [0.28-0.85],0.0109642504967562
Chapter II Neoplasms,Melanoma in situ,RBM25,RNA-binding protein 25,13923,96,1.04 [0.69-1.58],0.840160819579345
Chapter II Neoplasms,Melanoma in situ,RBP1,Retinol-binding protein 1,14048,97,0.96 [0.72-1.29],0.8070853858886828
Chapter II Neoplasms,Melanoma in situ,RBP2,Retinol-binding protein 2,16439,110,1.18 [0.95-1.46],0.1374146489599836
Chapter II Neoplasms,Melanoma in situ,RBP5,Retinol-binding protein 5,16439,110,0.97 [0.70-1.32],0.8256226724729968
Chapter II Neoplasms,Melanoma in situ,RBP7,Retinoid-binding protein 7,14355,100,1.10 [0.81-1.48],0.5414971954862258
Chapter II Neoplasms,Melanoma in situ,RBPMS,RNA-binding protein with multiple splicing,13991,93,0.97 [0.72-1.33],0.8642280916556886
Chapter II Neoplasms,Melanoma in situ,RBPMS2,RNA-binding protein with multiple splicing 2,14058,96,1.10 [0.91-1.33],0.3333956072858216
Chapter II Neoplasms,Melanoma in situ,RCC1,Regulator of chromosome condensation,14369,100,1.12 [0.79-1.57],0.5214045010539349
Chapter II Neoplasms,Melanoma in situ,RCOR1,REST corepressor 1,16217,107,0.80 [0.49-1.30],0.3656821773088496
Chapter II Neoplasms,Melanoma in situ,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14058,96,0.49 [0.25-0.97],0.0405643503150704
Chapter II Neoplasms,Melanoma in situ,REEP4,Receptor expression-enhancing protein 4,14396,100,1.08 [0.80-1.46],0.6073628435291905
Chapter II Neoplasms,Melanoma in situ,REG1A,Lithostathine-1-alpha,16429,110,1.10 [0.79-1.53],0.5742780492052313
Chapter II Neoplasms,Melanoma in situ,REG1B,Lithostathine-1-beta,16720,111,1.14 [0.86-1.52],0.3515372009086853
Chapter II Neoplasms,Melanoma in situ,REG3A,Regenerating islet-derived protein 3-alpha,16720,111,0.95 [0.72-1.24],0.6877861836571952
Chapter II Neoplasms,Melanoma in situ,REG3G,Regenerating islet-derived protein 3-gamma,14369,100,0.92 [0.56-1.51],0.7500586091267517
Chapter II Neoplasms,Melanoma in situ,REG4,Regenerating islet-derived protein 4,16532,112,0.84 [0.59-1.18],0.3022857472627294
Chapter II Neoplasms,Melanoma in situ,RELB,Transcription factor RelB,13991,93,1.11 [0.76-1.62],0.5843997267811465
Chapter II Neoplasms,Melanoma in situ,RELT,Tumor necrosis factor receptor superfamily member 19L,16531,111,1.12 [0.62-2.00],0.7078445032896947
Chapter II Neoplasms,Melanoma in situ,REN,Renin,16502,110,0.92 [0.74-1.14],0.4556999944314072
Chapter II Neoplasms,Melanoma in situ,REPS1,RalBP1-associated Eps domain-containing protein 1,13991,93,1.05 [0.63-1.73],0.8639480063792901
Chapter II Neoplasms,Melanoma in situ,REST,RE1-silencing transcription factor,13923,96,0.63 [0.34-1.18],0.1473131353235777
Chapter II Neoplasms,Melanoma in situ,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16439,110,0.61 [0.40-0.94],0.0256499890341871
Chapter II Neoplasms,Melanoma in situ,RETN,Resistin,16492,109,1.10 [0.74-1.64],0.6472498683013564
Chapter II Neoplasms,Melanoma in situ,REXO2,"Oligoribonuclease, mitochondrial",13959,100,0.52 [0.29-0.91],0.0211757091309877
Chapter II Neoplasms,Melanoma in situ,RFC4,Replication factor C subunit 4,14369,100,1.12 [0.45-2.79],0.8072512206192517
Chapter II Neoplasms,Melanoma in situ,RGCC,Regulator of cell cycle RGCC,14396,100,0.95 [0.74-1.23],0.7107653661379502
Chapter II Neoplasms,Melanoma in situ,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14160,99,0.79 [0.54-1.13],0.1974954535010059
Chapter II Neoplasms,Melanoma in situ,RGMA,Repulsive guidance molecule A,16642,112,0.84 [0.49-1.44],0.5261821890561402
Chapter II Neoplasms,Melanoma in situ,RGMB,RGM domain family member B,16642,112,0.71 [0.38-1.33],0.2834692035458024
Chapter II Neoplasms,Melanoma in situ,RGS10,Regulator of G-protein signaling 10,14396,100,0.92 [0.66-1.28],0.6113521914117488
Chapter II Neoplasms,Melanoma in situ,RGS8,Regulator of G-protein signaling 8,16225,109,1.14 [0.91-1.43],0.2480512148684673
Chapter II Neoplasms,Melanoma in situ,RHOC,Rho-related GTP-binding protein RhoC,16269,109,1.08 [0.93-1.25],0.3279854825769654
Chapter II Neoplasms,Melanoma in situ,RICTOR,Rapamycin-insensitive companion of mTOR,13991,93,1.14 [0.80-1.62],0.4621327775690115
Chapter II Neoplasms,Melanoma in situ,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14132,98,1.00 [0.67-1.49],0.9857682539087984
Chapter II Neoplasms,Melanoma in situ,RILP,Rab-interacting lysosomal protein,16611,112,1.09 [0.82-1.44],0.5499826879667375
Chapter II Neoplasms,Melanoma in situ,RILPL2,RILP-like protein 2,14415,100,1.07 [0.88-1.31],0.5035385185401391
Chapter II Neoplasms,Melanoma in situ,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,13959,100,0.64 [0.43-0.95],0.0251505061713604
Chapter II Neoplasms,Melanoma in situ,RLN1,Prorelaxin H1,14396,100,1.14 [0.83-1.58],0.4183597008408889
Chapter II Neoplasms,Melanoma in situ,RLN2,Prorelaxin H2,14104,98,0.89 [0.59-1.34],0.5849848750101276
Chapter II Neoplasms,Melanoma in situ,RNASE1,Ribonuclease pancreatic,14434,100,0.99 [0.47-2.11],0.9884247910440622
Chapter II Neoplasms,Melanoma in situ,RNASE10,Inactive ribonuclease-like protein 10,14058,96,1.21 [0.82-1.78],0.3268276034799125
Chapter II Neoplasms,Melanoma in situ,RNASE3,Eosinophil cationic protein,16436,110,1.02 [0.88-1.19],0.7452609986681878
Chapter II Neoplasms,Melanoma in situ,RNASE4,Ribonuclease 4,13944,94,0.63 [0.36-1.11],0.1089274955052296
Chapter II Neoplasms,Melanoma in situ,RNASE6,Ribonuclease K6,14326,100,0.82 [0.42-1.60],0.568324364536438
Chapter II Neoplasms,Melanoma in situ,RNASEH2A,Ribonuclease H2 subunit A,14396,100,1.00 [0.69-1.47],0.9844139751973852
Chapter II Neoplasms,Melanoma in situ,RNASET2,Ribonuclease T2,16654,109,1.04 [0.55-1.95],0.9110187256778308
Chapter II Neoplasms,Melanoma in situ,RNF149,E3 ubiquitin-protein ligase RNF149,14058,96,1.10 [0.59-2.08],0.7605650184635373
Chapter II Neoplasms,Melanoma in situ,RNF168,E3 ubiquitin-protein ligase RNF168,13991,93,0.91 [0.54-1.53],0.7235043566668073
Chapter II Neoplasms,Melanoma in situ,RNF31,E3 ubiquitin-protein ligase RNF31,13991,93,1.18 [0.74-1.91],0.4857131437865938
Chapter II Neoplasms,Melanoma in situ,RNF4,E3 ubiquitin-protein ligase RNF4,14160,99,1.18 [0.92-1.50],0.1885627848282944
Chapter II Neoplasms,Melanoma in situ,RNF41,E3 ubiquitin-protein ligase NRDP1,16170,109,1.05 [0.81-1.35],0.7296838957235993
Chapter II Neoplasms,Melanoma in situ,RNF43,E3 ubiquitin-protein ligase RNF43,14160,99,0.65 [0.41-1.05],0.0782614366372093
Chapter II Neoplasms,Melanoma in situ,RNF5,E3 ubiquitin-protein ligase RNF5,14058,96,1.07 [0.81-1.41],0.6433105428650767
Chapter II Neoplasms,Melanoma in situ,ROBO1,Roundabout homolog 1,16532,112,0.81 [0.40-1.64],0.5555830622394519
Chapter II Neoplasms,Melanoma in situ,ROBO2,Roundabout homolog 2,16642,112,0.95 [0.46-1.98],0.8908686393773492
Chapter II Neoplasms,Melanoma in situ,ROBO4,Roundabout homolog 4,14058,96,0.44 [0.15-1.33],0.1471640021694154
Chapter II Neoplasms,Melanoma in situ,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16502,110,0.98 [0.57-1.66],0.9277537916082454
Chapter II Neoplasms,Melanoma in situ,RP2,Protein XRP2,16439,110,0.87 [0.57-1.31],0.4963295571096414
Chapter II Neoplasms,Melanoma in situ,RPA2,Replication protein A 32 kDa subunit,13991,93,0.71 [0.35-1.46],0.3557996697954579
Chapter II Neoplasms,Melanoma in situ,RPE,Ribulose-phosphate 3-epimerase,14160,99,1.05 [0.81-1.37],0.7055487889116825
Chapter II Neoplasms,Melanoma in situ,RPGR,X-linked retinitis pigmentosa GTPase regulator,14048,97,0.81 [0.48-1.36],0.4285170120158351
Chapter II Neoplasms,Melanoma in situ,RPL14,60S ribosomal protein L14,14058,96,0.91 [0.54-1.54],0.7196347273486567
Chapter II Neoplasms,Melanoma in situ,RPS10,40S ribosomal protein S10,13959,100,0.59 [0.33-1.05],0.075240122464841
Chapter II Neoplasms,Melanoma in situ,RRAS,Ras-related protein R-Ras,14048,97,0.99 [0.85-1.16],0.9440317572360216
Chapter II Neoplasms,Melanoma in situ,RRM2,Ribonucleoside-diphosphate reductase subunit M2,16170,109,1.10 [0.80-1.50],0.5662299240773073
Chapter II Neoplasms,Melanoma in situ,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16170,109,0.95 [0.74-1.23],0.7191749981403585
Chapter II Neoplasms,Melanoma in situ,RRP15,RRP15-like protein,13980,98,1.17 [0.96-1.43],0.1152641386863418
Chapter II Neoplasms,Melanoma in situ,RSPO1,R-spondin-1,16369,109,1.30 [0.78-2.17],0.3075226029610726
Chapter II Neoplasms,Melanoma in situ,RSPO3,R-spondin-3,16669,112,0.62 [0.33-1.15],0.1292065014218152
Chapter II Neoplasms,Melanoma in situ,RTBDN,Retbindin,16439,110,0.93 [0.51-1.69],0.8127273836616439
Chapter II Neoplasms,Melanoma in situ,RTKN2,Rhotekin-2,13959,100,0.87 [0.57-1.33],0.5139327351421419
Chapter II Neoplasms,Melanoma in situ,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14396,100,0.97 [0.79-1.20],0.8039992144105228
Chapter II Neoplasms,Melanoma in situ,RTN4R,Reticulon-4 receptor,16669,112,0.83 [0.50-1.38],0.4789374257040619
Chapter II Neoplasms,Melanoma in situ,RUVBL1,RuvB-like 1,16170,109,1.02 [0.87-1.19],0.8379861224425089
Chapter II Neoplasms,Melanoma in situ,RWDD1,RWD domain-containing protein 1,16642,112,1.16 [0.89-1.51],0.2680308278679523
Chapter II Neoplasms,Melanoma in situ,RYR1,Ryanodine receptor 1,13959,100,0.47 [0.23-0.95],0.0364455655541745
Chapter II Neoplasms,Melanoma in situ,S100A11,Protein S100-A11,16386,109,1.09 [0.78-1.53],0.6154030033794078
Chapter II Neoplasms,Melanoma in situ,S100A12,Protein S100-A12,16291,109,1.17 [0.94-1.46],0.1616149034526311
Chapter II Neoplasms,Melanoma in situ,S100A13,Protein S100-A13,13991,93,0.71 [0.39-1.30],0.2703197099373003
Chapter II Neoplasms,Melanoma in situ,S100A14,Protein S100-A14,14396,100,1.00 [0.70-1.44],0.9887789249718848
Chapter II Neoplasms,Melanoma in situ,S100A16,Protein S100-A16,16113,109,1.14 [0.87-1.48],0.3382346114279509
Chapter II Neoplasms,Melanoma in situ,S100A3,Protein S100-A3,14369,100,0.96 [0.61-1.50],0.8543675561688642
Chapter II Neoplasms,Melanoma in situ,S100A4,Protein S100-A4,16578,111,1.01 [0.75-1.36],0.9337057745403357
Chapter II Neoplasms,Melanoma in situ,S100G,Protein S100-G,14396,100,0.84 [0.55-1.28],0.4162547152908519
Chapter II Neoplasms,Melanoma in situ,S100P,Protein S100-P,16217,107,1.25 [0.95-1.64],0.105852336908772
Chapter II Neoplasms,Melanoma in situ,SAA4,Serum amyloid A-4 protein,14443,100,1.04 [0.56-1.92],0.909911379252841
Chapter II Neoplasms,Melanoma in situ,SAFB2,Scaffold attachment factor B2,14396,100,0.96 [0.49-1.89],0.8990230414354725
Chapter II Neoplasms,Melanoma in situ,SAG,S-arrestin,13980,98,0.70 [0.47-1.06],0.0919079825469375
Chapter II Neoplasms,Melanoma in situ,SAMD9L,Sterile alpha motif domain-containing protein 9-like,16479,111,1.07 [0.85-1.35],0.584448055119813
Chapter II Neoplasms,Melanoma in situ,SAP18,Histone deacetylase complex subunit SAP18,14160,99,1.01 [0.78-1.31],0.9211933504476306
Chapter II Neoplasms,Melanoma in situ,SARG,Specifically androgen-regulated gene protein,14358,99,1.09 [0.91-1.30],0.3452855285741516
Chapter II Neoplasms,Melanoma in situ,SART1,U4/U6.U5 tri-snRNP-associated protein 1,13959,100,0.79 [0.42-1.46],0.4454913126624722
Chapter II Neoplasms,Melanoma in situ,SAT1,Diamine acetyltransferase 1,13959,100,0.96 [0.64-1.42],0.8191633265618266
Chapter II Neoplasms,Melanoma in situ,SAT2,Thialysine N-epsilon-acetyltransferase,14160,99,0.92 [0.67-1.26],0.5960540146531871
Chapter II Neoplasms,Melanoma in situ,SATB1,DNA-binding protein SATB1,14396,100,0.81 [0.40-1.63],0.5513171166059743
Chapter II Neoplasms,Melanoma in situ,SBSN,Suprabasin,14398,100,0.60 [0.34-1.06],0.0787449395531186
Chapter II Neoplasms,Melanoma in situ,SCAMP3,Secretory carrier-associated membrane protein 3,16439,110,1.09 [0.90-1.33],0.3776696257999755
Chapter II Neoplasms,Melanoma in situ,SCARA5,Scavenger receptor class A member 5,16642,112,0.46 [0.26-0.81],0.0068808970595984
Chapter II Neoplasms,Melanoma in situ,SCARB1,Scavenger receptor class B member 1,16136,109,1.05 [0.80-1.40],0.7129398018943107
Chapter II Neoplasms,Melanoma in situ,SCARB2,Lysosome membrane protein 2,16063,108,0.97 [0.56-1.70],0.9233418839658996
Chapter II Neoplasms,Melanoma in situ,SCARF1,Scavenger receptor class F member 1,16720,111,1.12 [0.75-1.67],0.5840513314004426
Chapter II Neoplasms,Melanoma in situ,SCARF2,Scavenger receptor class F member 2,16642,112,0.79 [0.45-1.41],0.425594018262231
Chapter II Neoplasms,Melanoma in situ,SCG2,Secretogranin-2,16577,112,0.88 [0.52-1.48],0.6334913100451508
Chapter II Neoplasms,Melanoma in situ,SCG3,Secretogranin-3,16532,112,0.94 [0.57-1.54],0.7955240008788806
Chapter II Neoplasms,Melanoma in situ,SCGB1A1,Uteroglobin,16524,112,0.85 [0.63-1.16],0.3063716544703966
Chapter II Neoplasms,Melanoma in situ,SCGB2A2,Mammaglobin-A,13959,100,0.78 [0.39-1.56],0.48891385616345
Chapter II Neoplasms,Melanoma in situ,SCGB3A1,Secretoglobin family 3A member 1,14132,98,2.09 [1.00-4.35],0.0498515066427702
Chapter II Neoplasms,Melanoma in situ,SCGB3A2,Secretoglobin family 3A member 2,16558,112,0.88 [0.71-1.10],0.25916274115244
Chapter II Neoplasms,Melanoma in situ,SCGN,Secretagogin,16225,109,0.82 [0.55-1.21],0.3175213690423797
Chapter II Neoplasms,Melanoma in situ,SCIN,Adseverin,13980,98,0.87 [0.65-1.16],0.3437217373533875
Chapter II Neoplasms,Melanoma in situ,SCLY,Selenocysteine lyase,16611,112,1.04 [0.72-1.50],0.8304641144035945
Chapter II Neoplasms,Melanoma in situ,SCN2A,Sodium channel protein type 2 subunit alpha,13980,98,0.86 [0.55-1.34],0.5101431629813891
Chapter II Neoplasms,Melanoma in situ,SCN2B,Sodium channel subunit beta-2,14048,97,1.13 [0.58-2.20],0.7118195531866027
Chapter II Neoplasms,Melanoma in situ,SCN3A,Sodium channel protein type 3 subunit alpha,14048,97,1.18 [0.72-1.92],0.5204844651163117
Chapter II Neoplasms,Melanoma in situ,SCN3B,Sodium channel subunit beta-3,13980,98,0.94 [0.62-1.43],0.785386332984307
Chapter II Neoplasms,Melanoma in situ,SCN4B,Sodium channel subunit beta-4,14058,96,1.09 [0.69-1.75],0.7042542332292441
Chapter II Neoplasms,Melanoma in situ,SCP2,Non-specific lipid-transfer protein,16170,109,0.72 [0.53-0.97],0.0314854634933115
Chapter II Neoplasms,Melanoma in situ,SCPEP1,Retinoid-inducible serine carboxypeptidase,14004,96,1.13 [0.76-1.69],0.5526602047625155
Chapter II Neoplasms,Melanoma in situ,SCRG1,Scrapie-responsive protein 1,14415,100,0.75 [0.36-1.55],0.4413736939842051
Chapter II Neoplasms,Melanoma in situ,SCRIB,Protein scribble homolog,14058,96,1.03 [0.84-1.27],0.7807027006885561
Chapter II Neoplasms,Melanoma in situ,SCRN1,Secernin-1,16479,111,1.23 [0.92-1.64],0.1682917587145904
Chapter II Neoplasms,Melanoma in situ,SCT,Secretin,14048,97,1.00 [0.67-1.50],0.9973103259478564
Chapter II Neoplasms,Melanoma in situ,SDC1,Syndecan-1,16502,110,1.27 [0.83-1.95],0.2622484452339181
Chapter II Neoplasms,Melanoma in situ,SDC4,Syndecan-4,16502,110,1.10 [0.76-1.59],0.6166315075650779
Chapter II Neoplasms,Melanoma in situ,SDCCAG8,Serologically defined colon cancer antigen 8,14369,100,1.09 [0.92-1.30],0.3000856470752012
Chapter II Neoplasms,Melanoma in situ,SDHB,Succinate dehydrogenase,14355,100,0.82 [0.59-1.14],0.2392285733256983
Chapter II Neoplasms,Melanoma in situ,SDK2,Protein sidekick-2,14132,98,0.75 [0.44-1.29],0.3000189624574202
Chapter II Neoplasms,Melanoma in situ,SEC31A,Protein transport protein Sec31A,14058,96,1.03 [0.79-1.33],0.8236818843940225
Chapter II Neoplasms,Melanoma in situ,SEL1L,Protein sel-1 homolog 1,14058,96,1.29 [0.78-2.12],0.3226288104295443
Chapter II Neoplasms,Melanoma in situ,SELE,E-selectin,16720,111,1.00 [0.72-1.40],0.9926522764835892
Chapter II Neoplasms,Melanoma in situ,SELENOP,Selenoprotein P,14443,100,0.55 [0.23-1.29],0.1705092368417832
Chapter II Neoplasms,Melanoma in situ,SELL,L-selectin,14443,100,0.70 [0.30-1.63],0.4129650276683474
Chapter II Neoplasms,Melanoma in situ,SELP,P-selectin,16607,110,1.08 [0.80-1.45],0.6280550592055272
Chapter II Neoplasms,Melanoma in situ,SELPLG,P-selectin glycoprotein ligand 1,16479,111,0.78 [0.42-1.45],0.4322078995566202
Chapter II Neoplasms,Melanoma in situ,SEMA3F,Semaphorin-3F,16502,110,1.29 [0.68-2.46],0.4376959783483001
Chapter II Neoplasms,Melanoma in situ,SEMA3G,Semaphorin-3G,14132,98,1.08 [0.70-1.67],0.7307562746399019
Chapter II Neoplasms,Melanoma in situ,SEMA4C,Semaphorin-4C,16439,110,1.58 [0.99-2.52],0.0528506062400062
Chapter II Neoplasms,Melanoma in situ,SEMA4D,Semaphorin-4D,16642,112,1.38 [0.79-2.42],0.2639640560589267
Chapter II Neoplasms,Melanoma in situ,SEMA6C,Semaphorin-6C,13991,93,0.51 [0.21-1.22],0.1303912006095164
Chapter II Neoplasms,Melanoma in situ,SEMA7A,Semaphorin-7A,16682,111,0.85 [0.45-1.61],0.6161958437395537
Chapter II Neoplasms,Melanoma in situ,SEPTIN3,Neuronal-specific septin-3,14396,100,0.84 [0.64-1.10],0.2086211740810875
Chapter II Neoplasms,Melanoma in situ,SEPTIN7,Septin-7,14160,99,1.12 [0.81-1.53],0.4933241692952859
Chapter II Neoplasms,Melanoma in situ,SEPTIN8,Septin-8,14379,100,0.95 [0.51-1.77],0.8815495985556866
Chapter II Neoplasms,Melanoma in situ,SEPTIN9,Septin-9,16439,110,0.92 [0.50-1.68],0.785961013576852
Chapter II Neoplasms,Melanoma in situ,SERPINA1,Alpha-1-antitrypsin,14148,99,1.65 [0.17-16.14],0.6654248372772251
Chapter II Neoplasms,Melanoma in situ,SERPINA11,Serpin A11,16720,111,1.05 [0.69-1.59],0.8174524186482933
Chapter II Neoplasms,Melanoma in situ,SERPINA12,Serpin A12,16012,104,0.86 [0.70-1.05],0.143738447074297
Chapter II Neoplasms,Melanoma in situ,SERPINA3,Alpha-1-antichymotrypsin,14385,100,1.63 [0.51-5.22],0.4121892688586404
Chapter II Neoplasms,Melanoma in situ,SERPINA4,Kallistatin,14164,99,0.76 [0.34-1.69],0.494790163938534
Chapter II Neoplasms,Melanoma in situ,SERPINA5,Plasma serine protease inhibitor,14215,100,0.32 [0.16-0.66],0.0021538689196025
Chapter II Neoplasms,Melanoma in situ,SERPINA6,Corticosteroid-binding globulin,14443,100,0.50 [0.22-1.15],0.1044509990336024
Chapter II Neoplasms,Melanoma in situ,SERPINA7,Thyroxine-binding globulin,14443,100,0.75 [0.26-2.13],0.5909194294505458
Chapter II Neoplasms,Melanoma in situ,SERPINA9,Serpin A9,16352,109,0.80 [0.62-1.03],0.0865078938865737
Chapter II Neoplasms,Melanoma in situ,SERPINB1,Leukocyte elastase inhibitor,16481,111,1.08 [0.90-1.30],0.4065788281431814
Chapter II Neoplasms,Melanoma in situ,SERPINB5,Serpin B5,16217,107,0.79 [0.56-1.10],0.1642129749889381
Chapter II Neoplasms,Melanoma in situ,SERPINB6,Serpin B6,16586,112,1.02 [0.77-1.37],0.8675802356470955
Chapter II Neoplasms,Melanoma in situ,SERPINB8,Serpin B8,16683,112,1.01 [0.77-1.34],0.9180466114105132
Chapter II Neoplasms,Melanoma in situ,SERPINB9,Serpin B9,16369,109,1.28 [0.77-2.14],0.3367704714482999
Chapter II Neoplasms,Melanoma in situ,SERPINC1,Antithrombin-III,14416,100,1.84 [0.50-6.75],0.3597181780034116
Chapter II Neoplasms,Melanoma in situ,SERPIND1,Heparin cofactor 2,14416,100,0.95 [0.47-1.91],0.8872596000290431
Chapter II Neoplasms,Melanoma in situ,SERPINE1,Plasminogen activator inhibitor 1,16720,111,1.07 [0.83-1.37],0.622681799521305
Chapter II Neoplasms,Melanoma in situ,SERPINE2,Glia-derived nexin,14415,100,0.97 [0.72-1.31],0.8600116726391951
Chapter II Neoplasms,Melanoma in situ,SERPINF1,Pigment epithelium-derived factor,14212,99,0.60 [0.28-1.27],0.1808429040157652
Chapter II Neoplasms,Melanoma in situ,SERPINF2,Alpha-2-antiplasmin,14154,99,2.11 [0.51-8.72],0.3030964363136283
Chapter II Neoplasms,Melanoma in situ,SERPING1,Plasma protease C1 inhibitor,14416,100,0.55 [0.19-1.58],0.2640041900424626
Chapter II Neoplasms,Melanoma in situ,SERPINH1,Serpin H1,14160,99,1.02 [0.88-1.19],0.756556489099642
Chapter II Neoplasms,Melanoma in situ,SERPINI1,Neuroserpin,14108,98,0.56 [0.28-1.12],0.0996582743485858
Chapter II Neoplasms,Melanoma in situ,SERPINI2,Serpin I2,14355,100,1.05 [0.74-1.49],0.7848358827958795
Chapter II Neoplasms,Melanoma in situ,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16136,109,1.01 [0.77-1.31],0.9612667506737624
Chapter II Neoplasms,Melanoma in situ,SETMAR,Histone-lysine N-methyltransferase SETMAR,16316,107,0.96 [0.53-1.75],0.9013215862653544
Chapter II Neoplasms,Melanoma in situ,SEZ6,Seizure protein 6 homolog,14048,97,1.10 [0.58-2.07],0.7712760483122199
Chapter II Neoplasms,Melanoma in situ,SEZ6L,Seizure 6-like protein,16578,111,0.62 [0.33-1.15],0.1301464213190122
Chapter II Neoplasms,Melanoma in situ,SEZ6L2,Seizure 6-like protein 2,16439,110,0.69 [0.33-1.46],0.3301601882823582
Chapter II Neoplasms,Melanoma in situ,SF3B4,Splicing factor 3B subunit 4,16439,110,1.03 [0.82-1.29],0.8110236696680992
Chapter II Neoplasms,Melanoma in situ,SFRP1,Secreted frizzled-related protein 1,16320,107,1.40 [0.97-2.01],0.069179373855431
Chapter II Neoplasms,Melanoma in situ,SFRP4,Secreted frizzled-related protein 4,14132,98,1.10 [0.66-1.81],0.7170553866429397
Chapter II Neoplasms,Melanoma in situ,SFTPA1,Pulmonary surfactant-associated protein A1,16170,109,0.89 [0.64-1.25],0.5029625451238426
Chapter II Neoplasms,Melanoma in situ,SFTPA2,Pulmonary surfactant-associated protein A2,16170,109,1.10 [0.79-1.52],0.5772517037669728
Chapter II Neoplasms,Melanoma in situ,SFTPD,Pulmonary surfactant-associated protein D,16502,110,0.96 [0.74-1.23],0.7322948544976317
Chapter II Neoplasms,Melanoma in situ,SGSH,N-sulphoglucosamine sulphohydrolase,14151,99,0.65 [0.45-0.95],0.0271057394666204
Chapter II Neoplasms,Melanoma in situ,SH2B3,SH2B adapter protein 3,16170,109,1.11 [0.93-1.32],0.2514895243052476
Chapter II Neoplasms,Melanoma in situ,SH2D1A,SH2 domain-containing protein 1A,16479,111,0.90 [0.66-1.23],0.5073557711553434
Chapter II Neoplasms,Melanoma in situ,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,13980,98,0.66 [0.43-1.01],0.0544290676150313
Chapter II Neoplasms,Melanoma in situ,SH3BP1,SH3 domain-binding protein 1,14355,100,1.05 [0.72-1.52],0.7986071461843033
Chapter II Neoplasms,Melanoma in situ,SH3GL3,Endophilin-A3,14087,98,1.10 [0.87-1.38],0.4251306978007952
Chapter II Neoplasms,Melanoma in situ,SH3GLB2,Endophilin-B2,14404,100,1.02 [0.77-1.35],0.8888054564547068
Chapter II Neoplasms,Melanoma in situ,SHBG,Sex hormone-binding globulin,14434,100,0.73 [0.50-1.06],0.0983448291446889
Chapter II Neoplasms,Melanoma in situ,SHC1,SHC-transforming protein 1,13923,96,0.97 [0.81-1.15],0.7023973140763843
Chapter II Neoplasms,Melanoma in situ,SHD,SH2 domain-containing adapter protein D,13927,100,0.90 [0.70-1.16],0.4349039224299557
Chapter II Neoplasms,Melanoma in situ,SHH,Sonic hedgehog protein,13991,93,1.11 [0.71-1.72],0.6487335166684343
Chapter II Neoplasms,Melanoma in situ,SHISA5,Protein shisa-5,14428,100,1.04 [0.49-2.18],0.9202656249518416
Chapter II Neoplasms,Melanoma in situ,SHMT1,"Serine hydroxymethyltransferase, cytosolic",16558,112,1.07 [0.87-1.30],0.5309885409961324
Chapter II Neoplasms,Melanoma in situ,SHPK,Sedoheptulokinase,14160,99,0.66 [0.38-1.17],0.156053799402821
Chapter II Neoplasms,Melanoma in situ,SIAE,Sialate O-acetylesterase,16556,111,1.02 [0.71-1.48],0.91011058522578
Chapter II Neoplasms,Melanoma in situ,SIGLEC1,Sialoadhesin,16583,112,0.85 [0.57-1.25],0.4033404975498748
Chapter II Neoplasms,Melanoma in situ,SIGLEC10,Sialic acid-binding Ig-like lectin 10,16479,111,1.33 [0.80-2.22],0.2702261069523041
Chapter II Neoplasms,Melanoma in situ,SIGLEC15,Sialic acid-binding Ig-like lectin 15,16136,109,0.91 [0.71-1.17],0.4554760815583442
Chapter II Neoplasms,Melanoma in situ,SIGLEC5,Sialic acid-binding Ig-like lectin 5,16531,111,0.98 [0.85-1.13],0.8276264240797214
Chapter II Neoplasms,Melanoma in situ,SIGLEC6,Sialic acid-binding Ig-like lectin 6,16669,112,1.08 [0.65-1.79],0.7771763582586132
Chapter II Neoplasms,Melanoma in situ,SIGLEC7,Sialic acid-binding Ig-like lectin 7,16502,110,1.26 [0.69-2.31],0.4538621506211102
Chapter II Neoplasms,Melanoma in situ,SIGLEC8,Sialic acid-binding Ig-like lectin 8,14058,96,1.39 [0.90-2.16],0.1378818944410521
Chapter II Neoplasms,Melanoma in situ,SIGLEC9,Sialic acid-binding Ig-like lectin 9,16641,112,1.07 [0.60-1.90],0.8153334755286499
Chapter II Neoplasms,Melanoma in situ,SIL1,Nucleotide exchange factor SIL1,14058,96,0.69 [0.31-1.52],0.3557194397300002
Chapter II Neoplasms,Melanoma in situ,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16573,111,0.95 [0.71-1.27],0.7137283793995699
Chapter II Neoplasms,Melanoma in situ,SIRPB1,Signal-regulatory protein beta-1,16487,112,1.07 [0.75-1.53],0.6976989193744905
Chapter II Neoplasms,Melanoma in situ,SIRT1,NAD-dependent protein deacetylase sirtuin-1,13991,93,0.99 [0.78-1.26],0.960086096217428
Chapter II Neoplasms,Melanoma in situ,SIRT2,NAD-dependent protein deacetylase sirtuin-2,16439,110,1.08 [0.89-1.30],0.4559536483069246
Chapter II Neoplasms,Melanoma in situ,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16136,109,1.21 [0.92-1.58],0.1659654358423574
Chapter II Neoplasms,Melanoma in situ,SIT1,Signaling threshold-regulating transmembrane adapter 1,16225,109,1.03 [0.76-1.41],0.8389408288409189
Chapter II Neoplasms,Melanoma in situ,SKAP1,Src kinase-associated phosphoprotein 1,16340,109,1.07 [0.85-1.34],0.5921052239012901
Chapter II Neoplasms,Melanoma in situ,SKAP2,Src kinase-associated phosphoprotein 2,16583,112,1.02 [0.87-1.20],0.8075645218095184
Chapter II Neoplasms,Melanoma in situ,SKIV2L,Helicase SKI2W,13959,100,0.88 [0.52-1.47],0.6219733496395934
Chapter II Neoplasms,Melanoma in situ,SLA2,Src-like-adapter 2,14396,100,0.99 [0.82-1.19],0.909140210183867
Chapter II Neoplasms,Melanoma in situ,SLAMF1,Signaling lymphocytic activation molecule,16225,109,0.92 [0.69-1.22],0.558185961927151
Chapter II Neoplasms,Melanoma in situ,SLAMF6,SLAM family member 6,16170,109,0.80 [0.50-1.29],0.3627932273977406
Chapter II Neoplasms,Melanoma in situ,SLAMF7,SLAM family member 7,16479,111,0.96 [0.71-1.28],0.7638246055864252
Chapter II Neoplasms,Melanoma in situ,SLAMF8,SLAM family member 8,16170,109,0.99 [0.72-1.36],0.9634131036743552
Chapter II Neoplasms,Melanoma in situ,SLC12A2,Solute carrier family 12 member 2,13959,100,0.49 [0.27-0.88],0.0163735074960314
Chapter II Neoplasms,Melanoma in situ,SLC13A1,Solute carrier family 13 member 1,14369,100,1.12 [0.85-1.48],0.4258393559882715
Chapter II Neoplasms,Melanoma in situ,SLC16A1,Monocarboxylate transporter 1,16136,109,0.62 [0.42-0.90],0.0131086345791602
Chapter II Neoplasms,Melanoma in situ,SLC1A4,Neutral amino acid transporter A,14048,97,0.62 [0.38-1.02],0.0587583002750695
Chapter II Neoplasms,Melanoma in situ,SLC27A4,Long-chain fatty acid transport protein 4,16136,109,0.97 [0.74-1.27],0.818902098799315
Chapter II Neoplasms,Melanoma in situ,SLC28A1,Sodium/nucleoside cotransporter 1,13923,96,0.69 [0.45-1.05],0.0803069701452132
Chapter II Neoplasms,Melanoma in situ,SLC34A3,Sodium-dependent phosphate transport protein 2C,13923,96,1.15 [0.80-1.66],0.4422387328600354
Chapter II Neoplasms,Melanoma in situ,SLC39A14,Zinc transporter ZIP14,16136,109,0.62 [0.36-1.06],0.0819107588278943
Chapter II Neoplasms,Melanoma in situ,SLC39A5,Zinc transporter ZIP5,16479,111,0.88 [0.63-1.22],0.4311353213468785
Chapter II Neoplasms,Melanoma in situ,SLC44A4,Choline transporter-like protein 4,14048,97,0.95 [0.71-1.28],0.7561409132742325
Chapter II Neoplasms,Melanoma in situ,SLC4A1,Band 3 anion transport protein,14428,100,0.79 [0.52-1.19],0.2576223742267171
Chapter II Neoplasms,Melanoma in situ,SLC51B,Organic solute transporter subunit beta,13959,100,1.19 [0.95-1.49],0.1336227057899407
Chapter II Neoplasms,Melanoma in situ,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14132,98,1.03 [0.81-1.29],0.8332539810028115
Chapter II Neoplasms,Melanoma in situ,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14355,100,0.61 [0.37-1.03],0.0641305409034204
Chapter II Neoplasms,Melanoma in situ,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13923,96,0.91 [0.63-1.32],0.6323612702428324
Chapter II Neoplasms,Melanoma in situ,SLIT2,Slit homolog 2 protein,16136,109,1.02 [0.74-1.41],0.8940943907179615
Chapter II Neoplasms,Melanoma in situ,SLITRK1,SLIT and NTRK-like protein 1,13991,93,1.07 [0.57-2.00],0.8392037498362195
Chapter II Neoplasms,Melanoma in situ,SLITRK2,SLIT and NTRK-like protein 2,16669,112,1.28 [0.84-1.97],0.2545929241301115
Chapter II Neoplasms,Melanoma in situ,SLITRK6,SLIT and NTRK-like protein 6,16217,107,1.08 [0.65-1.77],0.7733773150913363
Chapter II Neoplasms,Melanoma in situ,SLK,STE20-like serine/threonine-protein kinase,14160,99,0.92 [0.71-1.21],0.5597822724176729
Chapter II Neoplasms,Melanoma in situ,SLMAP,Sarcolemmal membrane-associated protein,14355,100,1.06 [0.84-1.34],0.6166719404409098
Chapter II Neoplasms,Melanoma in situ,SLURP1,Secreted Ly-6/uPAR-related protein 1,14311,100,0.70 [0.39-1.26],0.2346862487249611
Chapter II Neoplasms,Melanoma in situ,SMAD1,Mothers against decapentaplegic homolog 1,16170,109,1.04 [0.84-1.28],0.7324728656684327
Chapter II Neoplasms,Melanoma in situ,SMAD2,Mothers against decapentaplegic homolog 2,14369,100,0.96 [0.72-1.27],0.7757095035958658
Chapter II Neoplasms,Melanoma in situ,SMAD3,Mothers against decapentaplegic homolog 3,14369,100,0.97 [0.67-1.42],0.8870041783331651
Chapter II Neoplasms,Melanoma in situ,SMAD5,Mothers against decapentaplegic homolog 5,16439,110,1.51 [0.63-3.62],0.3559591314836129
Chapter II Neoplasms,Melanoma in situ,SMARCA2,Probable global transcription activator SNF2L2,16136,109,0.99 [0.78-1.26],0.9596826546843208
Chapter II Neoplasms,Melanoma in situ,SMC3,Structural maintenance of chromosomes protein 3,13923,96,0.72 [0.47-1.10],0.1244581878230087
Chapter II Neoplasms,Melanoma in situ,SMNDC1,Survival of motor neuron-related-splicing factor 30,14355,100,1.13 [0.85-1.50],0.3947260083441907
Chapter II Neoplasms,Melanoma in situ,SMOC1,SPARC-related modular calcium-binding protein 1,16669,112,0.98 [0.58-1.64],0.9357166038323204
Chapter II Neoplasms,Melanoma in situ,SMOC2,SPARC-related modular calcium-binding protein 2,16583,112,0.60 [0.38-0.94],0.0256268223728182
Chapter II Neoplasms,Melanoma in situ,SMPD1,Sphingomyelin phosphodiesterase,16555,112,0.74 [0.52-1.06],0.098997483105295
Chapter II Neoplasms,Melanoma in situ,SMPD3,Sphingomyelin phosphodiesterase 3,13991,93,1.08 [0.78-1.49],0.6547210748427155
Chapter II Neoplasms,Melanoma in situ,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16566,112,0.75 [0.59-0.95],0.0193087410307231
Chapter II Neoplasms,Melanoma in situ,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14369,100,0.98 [0.76-1.26],0.8675775008480396
Chapter II Neoplasms,Melanoma in situ,SMS,Spermine synthase,13980,98,0.97 [0.71-1.33],0.8597299086161191
Chapter II Neoplasms,Melanoma in situ,SMTN,Smoothelin,14387,100,1.16 [0.95-1.41],0.1464215724379081
Chapter II Neoplasms,Melanoma in situ,SNAP23,Synaptosomal-associated protein 23,16502,110,1.09 [0.89-1.33],0.3867613846562139
Chapter II Neoplasms,Melanoma in situ,SNAP25,Synaptosomal-associated protein 25,13980,98,1.12 [0.75-1.69],0.5815382833529854
Chapter II Neoplasms,Melanoma in situ,SNAP29,Synaptosomal-associated protein 29,16578,111,1.11 [0.92-1.34],0.2603813423571401
Chapter II Neoplasms,Melanoma in situ,SNAPIN,SNARE-associated protein Snapin,14396,100,0.99 [0.71-1.39],0.9751770244932716
Chapter II Neoplasms,Melanoma in situ,SNCA,Alpha-synuclein,14132,98,1.07 [0.90-1.27],0.451169303953036
Chapter II Neoplasms,Melanoma in situ,SNCG,Gamma-synuclein,16369,109,0.85 [0.66-1.09],0.1916568310274111
Chapter II Neoplasms,Melanoma in situ,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14058,96,0.66 [0.35-1.28],0.2204830043946711
Chapter II Neoplasms,Melanoma in situ,SNRPB2,U2 small nuclear ribonucleoprotein B'',14404,100,0.98 [0.64-1.51],0.928751648660059
Chapter II Neoplasms,Melanoma in situ,SNU13,NHP2-like protein 1,13959,100,0.80 [0.55-1.17],0.2502594480600753
Chapter II Neoplasms,Melanoma in situ,SNX15,Sorting nexin-15,14132,98,1.17 [0.82-1.67],0.3814500487597643
Chapter II Neoplasms,Melanoma in situ,SNX18,Sorting nexin-18,14355,100,0.88 [0.55-1.42],0.6086682689301646
Chapter II Neoplasms,Melanoma in situ,SNX2,Sorting nexin-2,14369,100,1.00 [0.79-1.25],0.9844360963899886
Chapter II Neoplasms,Melanoma in situ,SNX5,Sorting nexin-5,14058,96,0.84 [0.42-1.69],0.6277947646888851
Chapter II Neoplasms,Melanoma in situ,SNX9,Sorting nexin-9,16502,110,1.08 [0.84-1.38],0.5580827455615174
Chapter II Neoplasms,Melanoma in situ,SOD1,Superoxide dismutase [Cu-Zn],16227,106,0.96 [0.67-1.37],0.8062606667718406
Chapter II Neoplasms,Melanoma in situ,SOD2,"Superoxide dismutase [Mn], mitochondrial",16531,111,0.87 [0.55-1.40],0.5750786117912374
Chapter II Neoplasms,Melanoma in situ,SOD3,Extracellular superoxide dismutase,14434,100,0.80 [0.53-1.22],0.3028972069796568
Chapter II Neoplasms,Melanoma in situ,SORBS1,Sorbin and SH3 domain-containing protein 1,14396,100,1.04 [0.66-1.66],0.8584051718146012
Chapter II Neoplasms,Melanoma in situ,SORCS2,VPS10 domain-containing receptor SorCS2,16170,109,0.83 [0.51-1.35],0.4535321576131886
Chapter II Neoplasms,Melanoma in situ,SORD,Sorbitol dehydrogenase,16587,112,0.96 [0.74-1.24],0.7537987188109836
Chapter II Neoplasms,Melanoma in situ,SORT1,Sortilin,16476,110,1.28 [0.82-2.02],0.2793850014966577
Chapter II Neoplasms,Melanoma in situ,SOST,Sclerostin,16476,110,0.74 [0.48-1.15],0.1802866991172673
Chapter II Neoplasms,Melanoma in situ,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14048,97,1.14 [0.82-1.58],0.4235390149765058
Chapter II Neoplasms,Melanoma in situ,SOX2,Transcription factor SOX-2,14366,99,1.23 [0.56-2.69],0.6055002396984838
Chapter II Neoplasms,Melanoma in situ,SOX9,Transcription factor SOX-9,14048,97,0.46 [0.23-0.95],0.0352143442272952
Chapter II Neoplasms,Melanoma in situ,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14396,100,0.53 [0.25-1.11],0.0935881649513266
Chapter II Neoplasms,Melanoma in situ,SPAG1,Sperm-associated antigen 1,14396,100,0.85 [0.59-1.22],0.367279428672198
Chapter II Neoplasms,Melanoma in situ,SPARC,SPARC,16578,111,1.09 [0.85-1.38],0.5020537462886459
Chapter II Neoplasms,Melanoma in situ,SPARCL1,SPARC-like protein 1,16551,110,1.29 [0.74-2.26],0.3740386858701185
Chapter II Neoplasms,Melanoma in situ,SPART,Spartin,14132,98,1.09 [0.85-1.41],0.495809425204774
Chapter II Neoplasms,Melanoma in situ,SPESP1,Sperm equatorial segment protein 1,14415,100,0.80 [0.43-1.48],0.4774141037896715
Chapter II Neoplasms,Melanoma in situ,SPINK1,Serine protease inhibitor Kazal-type 1,16531,111,0.89 [0.59-1.34],0.5647876194082424
Chapter II Neoplasms,Melanoma in situ,SPINK2,Serine protease inhibitor Kazal-type 2,14132,98,1.02 [0.60-1.75],0.9330966898378912
Chapter II Neoplasms,Melanoma in situ,SPINK4,Serine protease inhibitor Kazal-type 4,16479,111,1.04 [0.81-1.34],0.7452709679739619
Chapter II Neoplasms,Melanoma in situ,SPINK5,Serine protease inhibitor Kazal-type 5,16531,111,0.62 [0.37-1.04],0.068634403938803
Chapter II Neoplasms,Melanoma in situ,SPINK6,Serine protease inhibitor Kazal-type 6,16669,112,0.87 [0.63-1.19],0.3874287924533206
Chapter II Neoplasms,Melanoma in situ,SPINK8,Serine protease inhibitor Kazal-type 8,13959,100,0.50 [0.25-0.96],0.0384674583543612
Chapter II Neoplasms,Melanoma in situ,SPINT1,Kunitz-type protease inhibitor 1,16488,111,0.98 [0.49-1.98],0.9596727084212788
Chapter II Neoplasms,Melanoma in situ,SPINT2,Kunitz-type protease inhibitor 2,16583,112,1.23 [0.81-1.88],0.3323015244174324
Chapter II Neoplasms,Melanoma in situ,SPINT3,Kunitz-type protease inhibitor 3,14355,100,1.04 [0.91-1.19],0.5526048768838129
Chapter II Neoplasms,Melanoma in situ,SPOCK1,Testican-1,16369,109,0.90 [0.46-1.75],0.7492701496232912
Chapter II Neoplasms,Melanoma in situ,SPON1,Spondin-1,16532,112,0.91 [0.54-1.54],0.7263717492894732
Chapter II Neoplasms,Melanoma in situ,SPON2,Spondin-2,16435,110,0.71 [0.43-1.19],0.1924317352013773
Chapter II Neoplasms,Melanoma in situ,SPP1,Osteopontin,16698,111,0.91 [0.63-1.32],0.6236611501214857
Chapter II Neoplasms,Melanoma in situ,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",13991,93,0.98 [0.61-1.58],0.9280798626564822
Chapter II Neoplasms,Melanoma in situ,SPRING1,SREBP regulating gene protein,13923,96,1.00 [0.72-1.37],0.9790398648124676
Chapter II Neoplasms,Melanoma in situ,SPRR1B,Cornifin-B,14160,99,0.88 [0.67-1.15],0.3453809862036663
Chapter II Neoplasms,Melanoma in situ,SPRR3,Small proline-rich protein 3,14404,100,0.90 [0.68-1.19],0.4552753318897767
Chapter II Neoplasms,Melanoma in situ,SPRY2,Protein sprouty homolog 2,16225,109,0.99 [0.82-1.19],0.900610960324288
Chapter II Neoplasms,Melanoma in situ,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13980,98,0.83 [0.44-1.55],0.553974894736121
Chapter II Neoplasms,Melanoma in situ,SPTLC1,Serine palmitoyltransferase 1,14404,100,0.57 [0.29-1.09],0.0875872791962178
Chapter II Neoplasms,Melanoma in situ,SRC,Proto-oncogene tyrosine-protein kinase Src,16549,111,1.07 [0.93-1.23],0.3749329089577395
Chapter II Neoplasms,Melanoma in situ,SRP14,Signal recognition particle 14 kDa protein,16439,110,1.06 [0.80-1.40],0.6797428635257061
Chapter II Neoplasms,Melanoma in situ,SRPK2,SRSF protein kinase 2,16479,111,1.08 [0.89-1.32],0.4251227350284499
Chapter II Neoplasms,Melanoma in situ,SRPX,Sushi repeat-containing protein SRPX,14415,100,0.80 [0.48-1.35],0.408383688345147
Chapter II Neoplasms,Melanoma in situ,SSB,Lupus La protein,16136,109,1.12 [0.86-1.45],0.3976749834136057
Chapter II Neoplasms,Melanoma in situ,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",13991,93,0.85 [0.46-1.56],0.5912390951278428
Chapter II Neoplasms,Melanoma in situ,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16476,110,0.97 [0.83-1.13],0.6985029994864256
Chapter II Neoplasms,Melanoma in situ,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16607,110,1.05 [0.70-1.58],0.795800612681835
Chapter II Neoplasms,Melanoma in situ,SSH3,Protein phosphatase Slingshot homolog 3,13923,96,0.92 [0.46-1.84],0.8094129273391777
Chapter II Neoplasms,Melanoma in situ,SSNA1,Sjoegren syndrome nuclear autoantigen 1,14355,100,1.07 [0.74-1.54],0.7347007455998428
Chapter II Neoplasms,Melanoma in situ,ST13,Hsc70-interacting protein,14132,98,1.10 [0.78-1.56],0.5749657963106167
Chapter II Neoplasms,Melanoma in situ,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16439,110,1.09 [0.73-1.62],0.6885673846926994
Chapter II Neoplasms,Melanoma in situ,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16720,111,1.27 [0.74-2.17],0.3789988469301802
Chapter II Neoplasms,Melanoma in situ,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",13991,93,0.90 [0.57-1.40],0.6314561247925712
Chapter II Neoplasms,Melanoma in situ,STAB2,Stabilin-2,14428,100,1.09 [0.55-2.17],0.8008413730253383
Chapter II Neoplasms,Melanoma in situ,STAM,Signal transducing adapter molecule 1,14369,100,0.82 [0.47-1.42],0.4810037231484917
Chapter II Neoplasms,Melanoma in situ,STAMBP,STAM-binding protein,16340,109,1.13 [0.86-1.47],0.3722231711875181
Chapter II Neoplasms,Melanoma in situ,STAT2,Signal transducer and activator of transcription 2,13991,93,1.12 [0.86-1.46],0.3883359728057047
Chapter II Neoplasms,Melanoma in situ,STAT5B,Signal transducer and activator of transcription 5B,16439,110,1.04 [0.92-1.18],0.4954686072032822
Chapter II Neoplasms,Melanoma in situ,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13923,96,1.10 [0.84-1.45],0.4767156561893259
Chapter II Neoplasms,Melanoma in situ,STC1,Stanniocalcin-1,16642,112,0.79 [0.52-1.19],0.2544965752080155
Chapter II Neoplasms,Melanoma in situ,STC2,Stanniocalcin-2,16514,111,2.34 [1.14-4.77],0.0200113240763204
Chapter II Neoplasms,Melanoma in situ,STEAP4,Metalloreductase STEAP4,13980,98,1.11 [0.88-1.41],0.3676721669247268
Chapter II Neoplasms,Melanoma in situ,STIP1,Stress-induced-phosphoprotein 1,16509,111,1.12 [0.87-1.44],0.3817609704602083
Chapter II Neoplasms,Melanoma in situ,STK11,Serine/threonine-protein kinase STK11,16217,107,0.95 [0.75-1.21],0.6896632455157248
Chapter II Neoplasms,Melanoma in situ,STK24,Serine/threonine-protein kinase 24,16136,109,1.00 [0.76-1.32],0.9861519642906508
Chapter II Neoplasms,Melanoma in situ,STK4,Serine/threonine-protein kinase 4,16502,110,1.06 [0.87-1.29],0.5483043275508469
Chapter II Neoplasms,Melanoma in situ,STOML2,"Stomatin-like protein 2, mitochondrial",13923,96,1.00 [0.81-1.24],0.9829241401323316
Chapter II Neoplasms,Melanoma in situ,STX16,Syntaxin-16,16170,109,1.15 [0.87-1.50],0.3227163454901864
Chapter II Neoplasms,Melanoma in situ,STX1B,Syntaxin-1B,14048,97,0.77 [0.44-1.35],0.3624193130175802
Chapter II Neoplasms,Melanoma in situ,STX3,Syntaxin-3,14404,100,1.05 [0.66-1.67],0.8499918151768123
Chapter II Neoplasms,Melanoma in situ,STX4,Syntaxin-4,16439,110,0.99 [0.74-1.32],0.957358579877974
Chapter II Neoplasms,Melanoma in situ,STX5,Syntaxin-5,13991,93,1.28 [0.86-1.90],0.2286424607691925
Chapter II Neoplasms,Melanoma in situ,STX6,Syntaxin-6,16170,109,1.13 [0.88-1.43],0.3367937794752365
Chapter II Neoplasms,Melanoma in situ,STX7,Syntaxin-7,13991,93,1.08 [0.72-1.63],0.6929189585679436
Chapter II Neoplasms,Melanoma in situ,STX8,Syntaxin-8,16479,111,1.05 [0.74-1.49],0.7813704686119873
Chapter II Neoplasms,Melanoma in situ,STXBP1,Syntaxin-binding protein 1,14396,100,0.97 [0.76-1.25],0.8377266853441316
Chapter II Neoplasms,Melanoma in situ,STXBP3,Syntaxin-binding protein 3,16170,109,1.02 [0.69-1.51],0.9256932698475452
Chapter II Neoplasms,Melanoma in situ,SUGP1,SURP and G-patch domain-containing protein 1,14355,100,0.88 [0.53-1.45],0.6137006605475102
Chapter II Neoplasms,Melanoma in situ,SUGT1,Protein SGT1 homolog,16170,109,1.06 [0.86-1.32],0.5808818131962115
Chapter II Neoplasms,Melanoma in situ,SULT1A1,Sulfotransferase 1A1,16642,112,1.03 [0.90-1.17],0.668520814311361
Chapter II Neoplasms,Melanoma in situ,SULT2A1,Bile salt sulfotransferase,16479,111,0.92 [0.66-1.27],0.6158649070551295
Chapter II Neoplasms,Melanoma in situ,SUMF1,Formylglycine-generating enzyme,13991,93,1.18 [0.94-1.49],0.1636483543114448
Chapter II Neoplasms,Melanoma in situ,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16642,112,1.06 [0.77-1.47],0.7234603233805896
Chapter II Neoplasms,Melanoma in situ,SUOX,"Sulfite oxidase, mitochondrial",14396,100,0.76 [0.54-1.07],0.1172202691003118
Chapter II Neoplasms,Melanoma in situ,SUSD1,Sushi domain-containing protein 1,16217,107,1.08 [0.75-1.54],0.6814910681858921
Chapter II Neoplasms,Melanoma in situ,SUSD2,Sushi domain-containing protein 2,16531,111,1.11 [0.62-1.99],0.725710583621306
Chapter II Neoplasms,Melanoma in situ,SUSD4,Sushi domain-containing protein 4,14369,100,1.10 [0.70-1.72],0.6783050607170991
Chapter II Neoplasms,Melanoma in situ,SUSD5,Sushi domain-containing protein 5,14054,97,0.94 [0.52-1.68],0.8273067743526001
Chapter II Neoplasms,Melanoma in situ,SV2A,Synaptic vesicle glycoprotein 2A,14048,97,0.93 [0.67-1.30],0.6754076514291523
Chapter II Neoplasms,Melanoma in situ,SWAP70,Switch-associated protein 70,14355,100,0.89 [0.50-1.57],0.6808424278492722
Chapter II Neoplasms,Melanoma in situ,SYAP1,Synapse-associated protein 1,14132,98,1.10 [0.78-1.54],0.5888870283424736
Chapter II Neoplasms,Melanoma in situ,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,13980,98,0.76 [0.51-1.13],0.1746509240020801
Chapter II Neoplasms,Melanoma in situ,SYT1,Synaptotagmin-1,14404,100,1.15 [0.76-1.72],0.5133770510051674
Chapter II Neoplasms,Melanoma in situ,SYTL4,Synaptotagmin-like protein 4,14415,100,1.04 [0.80-1.35],0.7610812429720512
Chapter II Neoplasms,Melanoma in situ,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14160,99,1.06 [0.88-1.28],0.5315419159219577
Chapter II Neoplasms,Melanoma in situ,TACC3,Transforming acidic coiled-coil-containing protein 3,16439,110,1.07 [0.92-1.23],0.390527578289248
Chapter II Neoplasms,Melanoma in situ,TACSTD2,Tumor-associated calcium signal transducer 2,14654,93,0.93 [0.48-1.78],0.8192033655738669
Chapter II Neoplasms,Melanoma in situ,TADA3,Transcriptional adapter 3,14369,100,0.96 [0.59-1.57],0.865401536838476
Chapter II Neoplasms,Melanoma in situ,TAFA5,Chemokine-like protein TAFA-5,16439,110,0.76 [0.47-1.23],0.2687679305913967
Chapter II Neoplasms,Melanoma in situ,TAGLN3,Transgelin-3,13923,96,0.95 [0.68-1.32],0.7545421939803388
Chapter II Neoplasms,Melanoma in situ,TALDO1,Transaldolase,14367,100,1.23 [0.81-1.87],0.3350325348826309
Chapter II Neoplasms,Melanoma in situ,TANK,TRAF family member-associated NF-kappa-B activator,16225,109,1.12 [0.88-1.43],0.371788670246893
Chapter II Neoplasms,Melanoma in situ,TAP1,Antigen peptide transporter 1,14160,99,0.88 [0.61-1.27],0.4917995940561721
Chapter II Neoplasms,Melanoma in situ,TARBP2,RISC-loading complex subunit TARBP2,16136,109,1.11 [0.89-1.37],0.3624432627586033
Chapter II Neoplasms,Melanoma in situ,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14048,97,1.16 [0.93-1.44],0.2014938726221679
Chapter II Neoplasms,Melanoma in situ,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14369,100,0.59 [0.34-1.00],0.0507041708594121
Chapter II Neoplasms,Melanoma in situ,TAX1BP1,Tax1-binding protein 1,14404,100,1.28 [0.96-1.70],0.0936827786987224
Chapter II Neoplasms,Melanoma in situ,TBC1D17,TBC1 domain family member 17,16136,109,1.10 [0.77-1.57],0.6057166015955409
Chapter II Neoplasms,Melanoma in situ,TBC1D23,TBC1 domain family member 23,16439,110,1.07 [0.89-1.29],0.4717581790611284
Chapter II Neoplasms,Melanoma in situ,TBC1D5,TBC1 domain family member 5,16479,111,1.09 [0.89-1.34],0.41921892032338
Chapter II Neoplasms,Melanoma in situ,TBCA,Tubulin-specific chaperone A,14132,98,1.07 [0.85-1.34],0.5798668961963247
Chapter II Neoplasms,Melanoma in situ,TBCB,Tubulin-folding cofactor B,16369,109,1.09 [0.92-1.30],0.3189829860945203
Chapter II Neoplasms,Melanoma in situ,TBCC,Tubulin-specific chaperone C,16369,109,1.19 [0.96-1.47],0.10465762154335
Chapter II Neoplasms,Melanoma in situ,TBL1X,F-box-like/WD repeat-containing protein TBL1X,16170,109,0.97 [0.79-1.18],0.7326126321647144
Chapter II Neoplasms,Melanoma in situ,TBR1,T-box brain protein 1,14048,97,0.41 [0.21-0.78],0.006354329275117
Chapter II Neoplasms,Melanoma in situ,TCL1A,T-cell leukemia/lymphoma protein 1A,16350,107,0.88 [0.74-1.06],0.1731214695822989
Chapter II Neoplasms,Melanoma in situ,TCL1B,T-cell leukemia/lymphoma protein 1B,16217,107,1.05 [0.86-1.28],0.6327840239944149
Chapter II Neoplasms,Melanoma in situ,TCN1,Transcobalamin-1,14129,98,1.59 [1.01-2.52],0.0464609558841841
Chapter II Neoplasms,Melanoma in situ,TCN2,Transcobalamin-2,16698,111,0.93 [0.54-1.61],0.7971993845766546
Chapter II Neoplasms,Melanoma in situ,TCOF1,Treacle protein,14415,100,0.60 [0.30-1.17],0.1344361875191424
Chapter II Neoplasms,Melanoma in situ,TCP11,T-complex protein 11 homolog,14160,99,0.98 [0.69-1.40],0.930925122616166
Chapter II Neoplasms,Melanoma in situ,TCTN3,Tectonic-3,14415,100,0.91 [0.47-1.74],0.7684594122483291
Chapter II Neoplasms,Melanoma in situ,TDGF1,Teratocarcinoma-derived growth factor 1,16136,109,0.88 [0.78-0.99],0.0377524606866148
Chapter II Neoplasms,Melanoma in situ,TDO2,"Tryptophan 2,3-dioxygenase",14048,97,0.51 [0.27-0.98],0.0434045829094737
Chapter II Neoplasms,Melanoma in situ,TDP1,Tyrosyl-DNA phosphodiesterase 1,14369,100,0.96 [0.73-1.27],0.7648913583048458
Chapter II Neoplasms,Melanoma in situ,TDRKH,Tudor and KH domain-containing protein,16136,109,1.06 [0.87-1.30],0.560785269945843
Chapter II Neoplasms,Melanoma in situ,TEF,Thyrotroph embryonic factor,13959,100,1.01 [0.65-1.57],0.96906432767825
Chapter II Neoplasms,Melanoma in situ,TEK,Angiopoietin-1 receptor,16578,111,1.02 [0.47-2.22],0.9522248126930072
Chapter II Neoplasms,Melanoma in situ,TERF1,Telomeric repeat-binding factor 1,13991,93,0.83 [0.41-1.68],0.6027175607658883
Chapter II Neoplasms,Melanoma in situ,TET2,Methylcytosine dioxygenase TET2,14124,99,0.96 [0.78-1.17],0.6693280694162469
Chapter II Neoplasms,Melanoma in situ,TEX101,Testis-expressed protein 101,14048,97,1.32 [0.92-1.89],0.1358273551342542
Chapter II Neoplasms,Melanoma in situ,TEX33,Testis-expressed protein 33,14160,99,0.70 [0.38-1.28],0.2472099307882891
Chapter II Neoplasms,Melanoma in situ,TF,Serotransferrin,14443,100,1.60 [0.66-3.87],0.3019335799952113
Chapter II Neoplasms,Melanoma in situ,TFAP2A,Transcription factor AP-2-alpha,13980,98,0.87 [0.61-1.23],0.4236548326489636
Chapter II Neoplasms,Melanoma in situ,TFF1,Trefoil factor 1,16456,111,1.02 [0.83-1.25],0.858079692037677
Chapter II Neoplasms,Melanoma in situ,TFF2,Trefoil factor 2,16558,112,0.87 [0.64-1.18],0.3766311540873398
Chapter II Neoplasms,Melanoma in situ,TFF3,Trefoil factor 3,16519,109,0.78 [0.48-1.27],0.3198473113466631
Chapter II Neoplasms,Melanoma in situ,TFPI,Tissue factor pathway inhibitor,16509,110,0.78 [0.43-1.39],0.3913895232530535
Chapter II Neoplasms,Melanoma in situ,TFPI2,Tissue factor pathway inhibitor 2,16535,111,0.90 [0.56-1.46],0.6808762546468407
Chapter II Neoplasms,Melanoma in situ,TFRC,Transferrin receptor protein 1,16600,109,1.26 [0.81-1.97],0.2975853094395099
Chapter II Neoplasms,Melanoma in situ,TG,Thyroglobulin,14369,100,0.96 [0.81-1.14],0.6417683130711828
Chapter II Neoplasms,Melanoma in situ,TGFA,Protransforming growth factor alpha,16479,111,1.26 [0.89-1.79],0.1849559379218863
Chapter II Neoplasms,Melanoma in situ,TGFB1,Transforming growth factor beta-1 proprotein,16658,112,1.13 [0.73-1.75],0.5827498113601376
Chapter II Neoplasms,Melanoma in situ,TGFB2,Transforming growth factor beta-2 proprotein,14369,100,1.13 [0.80-1.60],0.4714014304639617
Chapter II Neoplasms,Melanoma in situ,TGFBI,Transforming growth factor-beta-induced protein ig-h3,16452,110,1.02 [0.54-1.93],0.9471804682538564
Chapter II Neoplasms,Melanoma in situ,TGFBR1,TGF-beta receptor type-1,13991,93,0.52 [0.20-1.38],0.1897379521337175
Chapter II Neoplasms,Melanoma in situ,TGFBR2,TGF-beta receptor type-2,16578,111,0.86 [0.51-1.46],0.5776863194642042
Chapter II Neoplasms,Melanoma in situ,TGFBR3,Transforming growth factor beta receptor type 3,16720,111,0.84 [0.50-1.41],0.5017224041684032
Chapter II Neoplasms,Melanoma in situ,TGM2,Protein-glutamine gamma-glutamyltransferase 2,16483,110,0.96 [0.77-1.19],0.6852227297725125
Chapter II Neoplasms,Melanoma in situ,TGOLN2,Trans-Golgi network integral membrane protein 2,14434,100,0.63 [0.31-1.30],0.2109927943316209
Chapter II Neoplasms,Melanoma in situ,THAP12,52 kDa repressor of the inhibitor of the protein kinase,13900,95,1.05 [0.85-1.30],0.6324317184586502
Chapter II Neoplasms,Melanoma in situ,THBD,Thrombomodulin,16502,110,0.88 [0.48-1.60],0.6761903191652443
Chapter II Neoplasms,Melanoma in situ,THBS2,Thrombospondin-2,16531,111,0.74 [0.45-1.20],0.2184571228752517
Chapter II Neoplasms,Melanoma in situ,THBS4,Thrombospondin-4,16547,110,0.83 [0.57-1.22],0.3443631431495803
Chapter II Neoplasms,Melanoma in situ,THOP1,Thimet oligopeptidase,16415,110,1.13 [0.65-1.96],0.661589636864135
Chapter II Neoplasms,Melanoma in situ,THPO,Thrombopoietin,16217,107,1.03 [0.67-1.60],0.8825012148696404
Chapter II Neoplasms,Melanoma in situ,THRAP3,Thyroid hormone receptor-associated protein 3,13959,100,1.04 [0.88-1.23],0.6768468367969349
Chapter II Neoplasms,Melanoma in situ,THSD1,Thrombospondin type-1 domain-containing protein 1,13878,92,1.26 [0.72-2.21],0.4150999683607378
Chapter II Neoplasms,Melanoma in situ,THTPA,Thiamine-triphosphatase,14344,100,1.03 [0.83-1.29],0.7657977444725111
Chapter II Neoplasms,Melanoma in situ,THY1,Thy-1 membrane glycoprotein,16642,112,0.97 [0.54-1.75],0.931250113584026
Chapter II Neoplasms,Melanoma in situ,TIA1,Nucleolysin TIA-1 isoform p40,16036,105,0.97 [0.84-1.12],0.6650470434285922
Chapter II Neoplasms,Melanoma in situ,TIE1,Tyrosine-protein kinase receptor Tie-1,16720,111,0.91 [0.62-1.33],0.6167424107183002
Chapter II Neoplasms,Melanoma in situ,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16107,109,0.71 [0.48-1.05],0.0880835100612117
Chapter II Neoplasms,Melanoma in situ,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14160,99,1.04 [0.63-1.73],0.8838023201987775
Chapter II Neoplasms,Melanoma in situ,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16607,110,1.26 [0.85-1.86],0.2445025368767657
Chapter II Neoplasms,Melanoma in situ,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14415,100,0.83 [0.51-1.37],0.4693918250075704
Chapter II Neoplasms,Melanoma in situ,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14404,100,1.02 [0.82-1.28],0.839072897660619
Chapter II Neoplasms,Melanoma in situ,TIMP1,Metalloproteinase inhibitor 1,16375,108,1.09 [0.59-2.01],0.7742258201516138
Chapter II Neoplasms,Melanoma in situ,TIMP2,Metalloproteinase inhibitor 2,14415,100,0.46 [0.18-1.14],0.0938689915628194
Chapter II Neoplasms,Melanoma in situ,TIMP3,Metalloproteinase inhibitor 3,16583,112,0.96 [0.84-1.09],0.4994622839046539
Chapter II Neoplasms,Melanoma in situ,TIMP4,Metalloproteinase inhibitor 4,16531,111,0.72 [0.47-1.12],0.1457076341873451
Chapter II Neoplasms,Melanoma in situ,TINAGL1,Tubulointerstitial nephritis antigen-like,16452,110,1.56 [0.72-3.37],0.2612474705704413
Chapter II Neoplasms,Melanoma in situ,TJAP1,Tight junction-associated protein 1,16578,111,1.20 [0.98-1.47],0.0754372986058787
Chapter II Neoplasms,Melanoma in situ,TJP3,Tight junction protein ZO-3,13980,98,0.63 [0.36-1.08],0.0920625959386399
Chapter II Neoplasms,Melanoma in situ,TK1,"Thymidine kinase, cytosolic",14160,99,0.65 [0.39-1.08],0.0946887317511605
Chapter II Neoplasms,Melanoma in situ,TLR1,Toll-like receptor 1,13991,93,0.69 [0.32-1.51],0.3522217093868528
Chapter II Neoplasms,Melanoma in situ,TLR2,Toll-like receptor 2,14160,99,0.39 [0.17-0.89],0.0249542807287669
Chapter II Neoplasms,Melanoma in situ,TLR3,Toll-like receptor 3,16683,112,0.89 [0.68-1.16],0.3807659738745307
Chapter II Neoplasms,Melanoma in situ,TLR4,Toll-like receptor 4,13991,93,0.90 [0.44-1.83],0.7679140350551578
Chapter II Neoplasms,Melanoma in situ,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14048,97,0.74 [0.49-1.11],0.1408860253688176
Chapter II Neoplasms,Melanoma in situ,TMED1,Transmembrane emp24 domain-containing protein 1,14160,99,0.75 [0.51-1.12],0.1591839245016565
Chapter II Neoplasms,Melanoma in situ,TMED10,Transmembrane emp24 domain-containing protein 10,13959,100,1.09 [0.77-1.53],0.62584787979834
Chapter II Neoplasms,Melanoma in situ,TMED4,Transmembrane emp24 domain-containing protein 4,13959,100,0.60 [0.37-0.95],0.0307627288420705
Chapter II Neoplasms,Melanoma in situ,TMED8,Protein TMED8,14355,100,1.07 [0.88-1.29],0.4987724375389991
Chapter II Neoplasms,Melanoma in situ,TMEM106A,Transmembrane protein 106A,14369,100,1.06 [0.81-1.39],0.6567315713297435
Chapter II Neoplasms,Melanoma in situ,TMEM132A,Transmembrane protein 132A,14058,96,0.99 [0.72-1.35],0.9361597639856062
Chapter II Neoplasms,Melanoma in situ,TMEM25,Transmembrane protein 25,14396,100,0.74 [0.46-1.19],0.2119934928689348
Chapter II Neoplasms,Melanoma in situ,TMOD4,Tropomodulin-4,13923,96,0.89 [0.54-1.47],0.6604894973128935
Chapter II Neoplasms,Melanoma in situ,TMPRSS11B,Transmembrane protease serine 11B,13980,98,1.14 [0.92-1.41],0.2349530321284526
Chapter II Neoplasms,Melanoma in situ,TMPRSS11D,Transmembrane protease serine 11D,14379,100,1.01 [0.62-1.65],0.9575633944075334
Chapter II Neoplasms,Melanoma in situ,TMPRSS15,Enteropeptidase,16439,110,1.01 [0.84-1.22],0.8901469797908093
Chapter II Neoplasms,Melanoma in situ,TMPRSS5,Transmembrane protease serine 5,16295,105,0.87 [0.56-1.37],0.5568253988405807
Chapter II Neoplasms,Melanoma in situ,TMSB10,Thymosin beta-10,16531,111,1.05 [0.83-1.32],0.6961318576852267
Chapter II Neoplasms,Melanoma in situ,TNC,Tenascin,16607,110,1.10 [0.78-1.57],0.5763264053269397
Chapter II Neoplasms,Melanoma in situ,TNF,Tumor necrosis factor,16192,107,0.89 [0.54-1.46],0.6422601217673386
Chapter II Neoplasms,Melanoma in situ,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14355,100,0.91 [0.60-1.39],0.6625682646504882
Chapter II Neoplasms,Melanoma in situ,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16225,109,1.01 [0.63-1.60],0.9824111089866946
Chapter II Neoplasms,Melanoma in situ,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14132,98,0.98 [0.71-1.34],0.8990109172236702
Chapter II Neoplasms,Melanoma in situ,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16369,109,1.09 [0.65-1.83],0.7453731083947133
Chapter II Neoplasms,Melanoma in situ,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16369,109,0.85 [0.50-1.44],0.5434167455528449
Chapter II Neoplasms,Melanoma in situ,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16563,111,1.12 [0.80-1.58],0.5090852605520534
Chapter II Neoplasms,Melanoma in situ,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16683,112,1.00 [0.65-1.54],0.9855831757457648
Chapter II Neoplasms,Melanoma in situ,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16504,112,0.71 [0.39-1.30],0.2637473544596411
Chapter II Neoplasms,Melanoma in situ,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16578,111,1.02 [0.63-1.67],0.9258379903026008
Chapter II Neoplasms,Melanoma in situ,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16532,112,0.93 [0.54-1.58],0.7775199421612944
Chapter II Neoplasms,Melanoma in situ,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16225,109,0.92 [0.60-1.41],0.6948984573231591
Chapter II Neoplasms,Melanoma in situ,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16532,112,1.02 [0.58-1.79],0.9398759423407907
Chapter II Neoplasms,Melanoma in situ,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14132,98,0.75 [0.47-1.21],0.2384268788503601
Chapter II Neoplasms,Melanoma in situ,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16669,112,0.87 [0.51-1.49],0.6056570919053188
Chapter II Neoplasms,Melanoma in situ,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16531,111,1.03 [0.58-1.82],0.917226894003829
Chapter II Neoplasms,Melanoma in situ,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16531,111,0.98 [0.61-1.58],0.937401485808374
Chapter II Neoplasms,Melanoma in situ,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16642,112,1.07 [0.58-1.98],0.8272910156122674
Chapter II Neoplasms,Melanoma in situ,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16658,112,0.82 [0.52-1.30],0.396061079825399
Chapter II Neoplasms,Melanoma in situ,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16369,109,0.99 [0.72-1.34],0.9236326775747988
Chapter II Neoplasms,Melanoma in situ,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16642,112,0.92 [0.63-1.34],0.6481482041635327
Chapter II Neoplasms,Melanoma in situ,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16369,109,1.06 [0.69-1.63],0.7776685287018866
Chapter II Neoplasms,Melanoma in situ,TNFSF10,Tumor necrosis factor ligand superfamily member 10,16683,112,1.55 [0.80-3.01],0.1947535296264888
Chapter II Neoplasms,Melanoma in situ,TNFSF11,Tumor necrosis factor ligand superfamily member 11,16479,111,0.92 [0.69-1.21],0.5458380569609433
Chapter II Neoplasms,Melanoma in situ,TNFSF12,Tumor necrosis factor ligand superfamily member 12,16683,112,1.29 [0.72-2.33],0.395486107601819
Chapter II Neoplasms,Melanoma in situ,TNFSF13,Tumor necrosis factor ligand superfamily member 13,16583,112,1.59 [0.85-2.97],0.1481230852227868
Chapter II Neoplasms,Melanoma in situ,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16700,111,1.13 [0.62-2.08],0.6878572282837685
Chapter II Neoplasms,Melanoma in situ,TNFSF14,Tumor necrosis factor ligand superfamily member 14,16369,109,1.10 [0.82-1.48],0.5103631863038806
Chapter II Neoplasms,Melanoma in situ,TNFSF8,Tumor necrosis factor ligand superfamily member 8,14428,100,0.91 [0.53-1.57],0.7363704268589167
Chapter II Neoplasms,Melanoma in situ,TNIP1,TNFAIP3-interacting protein 1,14404,100,1.06 [0.86-1.32],0.5703780385707053
Chapter II Neoplasms,Melanoma in situ,TNN,Tenascin-N,14428,100,1.14 [0.74-1.76],0.5594293496665734
Chapter II Neoplasms,Melanoma in situ,TNNI3,"Troponin I, cardiac muscle",16217,107,1.10 [0.89-1.37],0.3708650094172292
Chapter II Neoplasms,Melanoma in situ,TNPO1,Transportin-1,14160,99,0.75 [0.42-1.32],0.3168839713262829
Chapter II Neoplasms,Melanoma in situ,TNR,Tenascin-R,16369,109,1.18 [0.79-1.77],0.4058461357741237
Chapter II Neoplasms,Melanoma in situ,TNXB,Tenascin-X,16531,111,0.84 [0.43-1.63],0.6030964924966795
Chapter II Neoplasms,Melanoma in situ,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14415,100,0.98 [0.76-1.26],0.883530635260243
Chapter II Neoplasms,Melanoma in situ,TOP1,DNA topoisomerase 1,14355,100,0.93 [0.79-1.11],0.4483408485068347
Chapter II Neoplasms,Melanoma in situ,TOP1MT,"DNA topoisomerase I, mitochondrial",13923,96,1.01 [0.69-1.50],0.943483438731062
Chapter II Neoplasms,Melanoma in situ,TOP2B,DNA topoisomerase 2-beta,13991,93,1.11 [0.86-1.42],0.4163453983600467
Chapter II Neoplasms,Melanoma in situ,TOR1AIP1,Torsin-1A-interacting protein 1,14058,96,1.08 [0.75-1.53],0.6870687161425537
Chapter II Neoplasms,Melanoma in situ,TP53,Cellular tumor antigen p53,16170,109,0.79 [0.53-1.19],0.2635349377685302
Chapter II Neoplasms,Melanoma in situ,TP53BP1,TP53-binding protein 1,13991,93,1.05 [0.83-1.31],0.702147770260807
Chapter II Neoplasms,Melanoma in situ,TP53I3,Quinone oxidoreductase PIG3,13822,96,1.15 [0.79-1.67],0.4699859848777322
Chapter II Neoplasms,Melanoma in situ,TP53INP1,Tumor protein p53-inducible nuclear protein 1,16217,107,0.90 [0.50-1.62],0.7300790190922091
Chapter II Neoplasms,Melanoma in situ,TP73,Tumor protein p73,14048,97,0.71 [0.40-1.27],0.2534094340616226
Chapter II Neoplasms,Melanoma in situ,TPBGL,Trophoblast glycoprotein-like,14048,97,0.73 [0.43-1.25],0.250369882046552
Chapter II Neoplasms,Melanoma in situ,TPD52L2,Tumor protein D54,14132,98,1.06 [0.88-1.27],0.556181667963906
Chapter II Neoplasms,Melanoma in situ,TPK1,Thiamin pyrophosphokinase 1,14415,100,0.87 [0.43-1.76],0.6910218429673484
Chapter II Neoplasms,Melanoma in situ,TPM3,Tropomyosin alpha-3 chain,13959,100,0.90 [0.57-1.42],0.6501149609302275
Chapter II Neoplasms,Melanoma in situ,TPMT,Thiopurine S-methyltransferase,16170,109,1.13 [0.90-1.41],0.2834377155430699
Chapter II Neoplasms,Melanoma in situ,TPP1,Tripeptidyl-peptidase 1,16396,111,0.95 [0.64-1.40],0.791458837494464
Chapter II Neoplasms,Melanoma in situ,TPPP2,Tubulin polymerization-promoting protein family member 2,14160,99,0.99 [0.77-1.26],0.9242210407319346
Chapter II Neoplasms,Melanoma in situ,TPPP3,Tubulin polymerization-promoting protein family member 3,16136,109,1.00 [0.65-1.53],0.9826499561844456
Chapter II Neoplasms,Melanoma in situ,TPR,Nucleoprotein TPR,13959,100,1.08 [0.76-1.54],0.6500048044453206
Chapter II Neoplasms,Melanoma in situ,TPRKB,EKC/KEOPS complex subunit TPRKB,13923,96,0.66 [0.44-0.98],0.0377660573961914
Chapter II Neoplasms,Melanoma in situ,TPSAB1,Tryptase alpha/beta-1,16660,112,1.02 [0.74-1.41],0.8952185815807887
Chapter II Neoplasms,Melanoma in situ,TPSD1,Tryptase delta,14396,100,0.95 [0.57-1.59],0.8486031127770098
Chapter II Neoplasms,Melanoma in situ,TPSG1,Tryptase gamma,13991,93,1.02 [0.48-2.18],0.956951098154364
Chapter II Neoplasms,Melanoma in situ,TPT1,Translationally-controlled tumor protein,16225,109,0.97 [0.74-1.27],0.8418160667765442
Chapter II Neoplasms,Melanoma in situ,TRAF2,TNF receptor-associated factor 2,16479,111,1.22 [0.96-1.54],0.0998004154464801
Chapter II Neoplasms,Melanoma in situ,TRAF3,"TNF receptor-associated factor 3, Isoform 2",13991,93,1.15 [0.69-1.92],0.5800859494011064
Chapter II Neoplasms,Melanoma in situ,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,13959,100,0.98 [0.65-1.47],0.907995231403529
Chapter II Neoplasms,Melanoma in situ,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14160,99,1.06 [0.86-1.30],0.5874104591335291
Chapter II Neoplasms,Melanoma in situ,TREH,Trehalase,14428,100,0.94 [0.73-1.22],0.6328816004801817
Chapter II Neoplasms,Melanoma in situ,TREM2,Triggering receptor expressed on myeloid cells 2,16504,112,0.75 [0.54-1.05],0.0916465255981552
Chapter II Neoplasms,Melanoma in situ,TREML1,Trem-like transcript 1 protein,14434,100,0.87 [0.60-1.27],0.4801194600031775
Chapter II Neoplasms,Melanoma in situ,TREML2,Trem-like transcript 2 protein,16531,111,1.07 [0.65-1.77],0.7900912528266036
Chapter II Neoplasms,Melanoma in situ,TRIAP1,TP53-regulated inhibitor of apoptosis 1,16669,112,1.00 [0.76-1.32],0.987172701762574
Chapter II Neoplasms,Melanoma in situ,TRIM21,E3 ubiquitin-protein ligase TRIM21,16479,111,1.19 [0.95-1.49],0.132555678491018
Chapter II Neoplasms,Melanoma in situ,TRIM24,Transcription intermediary factor 1-alpha,14135,98,1.05 [0.78-1.42],0.7363536877631776
Chapter II Neoplasms,Melanoma in situ,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14355,100,1.03 [0.86-1.23],0.7757395297782845
Chapter II Neoplasms,Melanoma in situ,TRIM26,Tripartite motif-containing protein 26,13923,96,1.06 [0.76-1.47],0.7321761464212416
Chapter II Neoplasms,Melanoma in situ,TRIM40,E3 ubiquitin ligase TRIM40,14048,97,1.17 [0.90-1.52],0.2309684845935063
Chapter II Neoplasms,Melanoma in situ,TRIM5,Tripartite motif-containing protein 5,16479,111,1.12 [0.92-1.36],0.2632322457487313
Chapter II Neoplasms,Melanoma in situ,TRIM58,E3 ubiquitin-protein ligase TRIM58,14369,100,1.09 [0.87-1.35],0.4604776519355923
Chapter II Neoplasms,Melanoma in situ,TRPV3,Transient receptor potential cation channel subfamily V member 3,13959,100,0.98 [0.66-1.46],0.9381770679425808
Chapter II Neoplasms,Melanoma in situ,TSC1,Hamartin,13991,93,0.97 [0.74-1.29],0.8578392429524118
Chapter II Neoplasms,Melanoma in situ,TSC22D1,TSC22 domain family protein 1,14396,100,1.06 [0.80-1.42],0.6796192372688437
Chapter II Neoplasms,Melanoma in situ,TSHB,Thyrotropin subunit beta,16502,110,1.06 [0.86-1.31],0.5678704734168032
Chapter II Neoplasms,Melanoma in situ,TSLP,Thymic stromal lymphopoietin,16217,107,0.76 [0.53-1.07],0.1110794858283352
Chapter II Neoplasms,Melanoma in situ,TSNAX,Translin-associated protein X,13959,100,0.82 [0.49-1.35],0.425517386186558
Chapter II Neoplasms,Melanoma in situ,TSPAN1,Tetraspanin-1,16217,107,0.81 [0.60-1.08],0.1521211246362664
Chapter II Neoplasms,Melanoma in situ,TSPAN15,Tetraspanin-15,13959,100,1.02 [0.70-1.48],0.9227037396764248
Chapter II Neoplasms,Melanoma in situ,TSPAN7,Tetraspanin-7,13980,98,0.85 [0.67-1.08],0.1849811450702866
Chapter II Neoplasms,Melanoma in situ,TSPAN8,Tetraspanin-8,14355,100,1.08 [0.89-1.30],0.4466864796830901
Chapter II Neoplasms,Melanoma in situ,TSPYL1,Testis-specific Y-encoded-like protein 1,13991,93,1.12 [0.68-1.82],0.6612014392998493
Chapter II Neoplasms,Melanoma in situ,TST,Thiosulfate sulfurtransferase,16099,108,0.93 [0.74-1.17],0.5265911455001342
Chapter II Neoplasms,Melanoma in situ,TTF2,Transcription termination factor 2,14048,97,0.88 [0.58-1.33],0.5440533860918656
Chapter II Neoplasms,Melanoma in situ,TTN,Titin,13959,100,1.01 [0.76-1.35],0.9348945304977512
Chapter II Neoplasms,Melanoma in situ,TTR,Transthyretin,14285,98,0.91 [0.41-1.98],0.8070878216296546
Chapter II Neoplasms,Melanoma in situ,TUBB3,Tubulin beta-3 chain,13980,98,0.51 [0.25-1.03],0.0595682927226023
Chapter II Neoplasms,Melanoma in situ,TWF2,Twinfilin-2,14428,100,0.96 [0.76-1.21],0.708448012619495
Chapter II Neoplasms,Melanoma in situ,TXK,Tyrosine-protein kinase TXK,14160,99,1.02 [0.80-1.30],0.8820482596523205
Chapter II Neoplasms,Melanoma in situ,TXLNA,Alpha-taxilin,16369,109,1.12 [0.92-1.36],0.2676821245423451
Chapter II Neoplasms,Melanoma in situ,TXN,Thioredoxin,14192,99,0.94 [0.60-1.48],0.8005314741909769
Chapter II Neoplasms,Melanoma in situ,TXNDC15,Thioredoxin domain-containing protein 15,16578,111,0.95 [0.51-1.76],0.8740048994653972
Chapter II Neoplasms,Melanoma in situ,TXNDC5,Thioredoxin domain-containing protein 5,16642,112,1.05 [0.82-1.35],0.7090391292253966
Chapter II Neoplasms,Melanoma in situ,TXNDC9,Thioredoxin domain-containing protein 9,14404,100,0.88 [0.60-1.28],0.4979521470581227
Chapter II Neoplasms,Melanoma in situ,TXNL1,Thioredoxin-like protein 1,13954,98,1.04 [0.87-1.25],0.6597399313773209
Chapter II Neoplasms,Melanoma in situ,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16531,111,1.12 [0.78-1.62],0.5312900922338539
Chapter II Neoplasms,Melanoma in situ,TYMP,Thymidine phosphorylase,16391,108,1.11 [0.85-1.44],0.4359095449932205
Chapter II Neoplasms,Melanoma in situ,TYRO3,Tyrosine-protein kinase receptor TYRO3,16502,110,1.13 [0.62-2.05],0.6900779258967251
Chapter II Neoplasms,Melanoma in situ,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",13991,93,1.25 [0.90-1.73],0.1768431703024996
Chapter II Neoplasms,Melanoma in situ,UBAC1,Ubiquitin-associated domain-containing protein 1,16439,110,1.05 [0.65-1.71],0.8437605468691103
Chapter II Neoplasms,Melanoma in situ,UBE2B,Ubiquitin-conjugating enzyme E2 B,14369,100,0.73 [0.37-1.44],0.3603866424541182
Chapter II Neoplasms,Melanoma in situ,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14415,100,1.20 [0.88-1.63],0.2512241156277041
Chapter II Neoplasms,Melanoma in situ,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,13991,93,1.06 [0.76-1.48],0.7360912801873243
Chapter II Neoplasms,Melanoma in situ,UBQLN3,Ubiquilin-3,13959,100,0.92 [0.62-1.36],0.6819923109195972
Chapter II Neoplasms,Melanoma in situ,UBXN1,UBX domain-containing protein 1,14132,98,1.05 [0.79-1.39],0.7550279835727689
Chapter II Neoplasms,Melanoma in situ,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14355,100,1.04 [0.91-1.20],0.5490436938572206
Chapter II Neoplasms,Melanoma in situ,UGDH,UDP-glucose 6-dehydrogenase,13959,100,0.89 [0.70-1.12],0.3132208050122688
Chapter II Neoplasms,Melanoma in situ,UHRF2,E3 ubiquitin-protein ligase UHRF2,13959,100,0.32 [0.16-0.63],0.0008626894881293
Chapter II Neoplasms,Melanoma in situ,ULBP2,UL16-binding protein 2,16369,109,0.67 [0.41-1.07],0.0940417912119187
Chapter II Neoplasms,Melanoma in situ,UMOD,Uromodulin,16678,111,1.03 [0.75-1.41],0.8533930714273364
Chapter II Neoplasms,Melanoma in situ,UNC5D,Netrin receptor UNC5D,13991,93,0.63 [0.28-1.40],0.2536507619845804
Chapter II Neoplasms,Melanoma in situ,UNC79,Protein unc-79 homolog,13923,96,0.98 [0.69-1.40],0.9080007721848452
Chapter II Neoplasms,Melanoma in situ,UNG,Uracil-DNA glycosylase,14369,100,0.67 [0.37-1.21],0.1849734708738884
Chapter II Neoplasms,Melanoma in situ,UPB1,Beta-ureidopropionase,14415,100,1.00 [0.80-1.24],0.9845437220880964
Chapter II Neoplasms,Melanoma in situ,UPK3A,Uroplakin-3a,13980,98,1.36 [0.98-1.90],0.0660091972405671
Chapter II Neoplasms,Melanoma in situ,UPK3BL1,Uroplakin-3b-like protein 1,14129,98,0.70 [0.43-1.15],0.1581876160265062
Chapter II Neoplasms,Melanoma in situ,UROD,Uroporphyrinogen decarboxylase,14132,98,1.06 [0.80-1.41],0.6866682875935322
Chapter II Neoplasms,Melanoma in situ,UROS,Uroporphyrinogen-III synthase,14048,97,1.03 [0.78-1.36],0.8354661125269938
Chapter II Neoplasms,Melanoma in situ,USO1,General vesicular transport factor p115,16439,110,1.11 [0.92-1.34],0.2966985008729937
Chapter II Neoplasms,Melanoma in situ,USP25,Ubiquitin carboxyl-terminal hydrolase 25,14369,100,1.17 [0.90-1.53],0.2481726195349849
Chapter II Neoplasms,Melanoma in situ,USP28,Ubiquitin carboxyl-terminal hydrolase 28,14404,100,1.15 [0.71-1.85],0.578940783048526
Chapter II Neoplasms,Melanoma in situ,USP47,Ubiquitin carboxyl-terminal hydrolase 47,13959,100,1.05 [0.85-1.31],0.6506442769723912
Chapter II Neoplasms,Melanoma in situ,USP8,Ubiquitin carboxyl-terminal hydrolase 8,16217,107,1.02 [0.85-1.23],0.8330345689022383
Chapter II Neoplasms,Melanoma in situ,UXS1,UDP-glucuronic acid decarboxylase 1,16170,109,0.99 [0.71-1.37],0.9452116504678116
Chapter II Neoplasms,Melanoma in situ,VAMP5,Vesicle-associated membrane protein 5,16217,107,1.06 [0.78-1.43],0.7168338916809155
Chapter II Neoplasms,Melanoma in situ,VAMP8,Vesicle-associated membrane protein 8,13991,93,1.05 [0.84-1.32],0.6649131844501567
Chapter II Neoplasms,Melanoma in situ,VASH1,Tubulinyl-Tyr carboxypeptidase 1,16479,111,0.99 [0.81-1.22],0.937501574367725
Chapter II Neoplasms,Melanoma in situ,VASN,Vasorin,16269,108,0.98 [0.52-1.87],0.9551141939248368
Chapter II Neoplasms,Melanoma in situ,VASP,Vasodilator-stimulated phosphoprotein,14434,100,1.04 [0.79-1.35],0.7888622699554022
Chapter II Neoplasms,Melanoma in situ,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16439,110,1.40 [0.59-3.29],0.4442502023580383
Chapter II Neoplasms,Melanoma in situ,VAV3,Guanine nucleotide exchange factor VAV3,13980,98,1.00 [0.82-1.22],0.991229248151284
Chapter II Neoplasms,Melanoma in situ,VCAM1,Vascular cell adhesion protein 1,16577,110,1.18 [0.63-2.22],0.605360984214524
Chapter II Neoplasms,Melanoma in situ,VCAN,Versican core protein,16642,112,0.98 [0.56-1.72],0.9531322308571044
Chapter II Neoplasms,Melanoma in situ,VCPKMT,Protein-lysine methyltransferase METTL21D,13923,96,1.16 [0.96-1.40],0.1272525648003869
Chapter II Neoplasms,Melanoma in situ,VEGFA,Vascular endothelial growth factor A,16637,111,1.08 [0.81-1.44],0.594488856226047
Chapter II Neoplasms,Melanoma in situ,VEGFB,Vascular endothelial growth factor B,13991,93,0.87 [0.43-1.76],0.696160804070554
Chapter II Neoplasms,Melanoma in situ,VEGFC,Vascular endothelial growth factor C,16578,111,1.06 [0.79-1.44],0.6870893903964796
Chapter II Neoplasms,Melanoma in situ,VEGFD,Vascular endothelial growth factor D,16655,111,1.09 [0.68-1.73],0.73111859578197
Chapter II Neoplasms,Melanoma in situ,VGF,Neurosecretory protein VGF,14396,100,0.91 [0.48-1.70],0.7604433480047581
Chapter II Neoplasms,Melanoma in situ,VIM,Vimentin,16217,107,0.93 [0.81-1.07],0.2978162835275589
Chapter II Neoplasms,Melanoma in situ,VIPR1,Vasoactive intestinal polypeptide receptor 1,14058,96,0.94 [0.41-2.18],0.8871649830529121
Chapter II Neoplasms,Melanoma in situ,VIT,Vitrin,14415,100,0.86 [0.52-1.44],0.5739441002907573
Chapter II Neoplasms,Melanoma in situ,VMO1,Vitelline membrane outer layer protein 1 homolog,16439,110,1.27 [0.97-1.66],0.0792862165016342
Chapter II Neoplasms,Melanoma in situ,VNN1,Pantetheinase,14434,100,0.90 [0.70-1.17],0.4386923962493928
Chapter II Neoplasms,Melanoma in situ,VNN2,Vascular non-inflammatory molecule 2,16439,110,0.86 [0.60-1.24],0.4130699614978739
Chapter II Neoplasms,Melanoma in situ,VPS28,Vacuolar protein sorting-associated protein 28 homolog,14160,99,1.10 [0.83-1.47],0.5088803465821099
Chapter II Neoplasms,Melanoma in situ,VPS37A,Vacuolar protein sorting-associated protein 37A,16439,110,1.13 [0.92-1.39],0.254700679814998
Chapter II Neoplasms,Melanoma in situ,VPS4B,Vacuolar protein sorting-associated protein 4B,14369,100,0.97 [0.79-1.19],0.7878663992899506
Chapter II Neoplasms,Melanoma in situ,VPS53,Vacuolar protein sorting-associated protein 53 homolog,16439,110,1.12 [0.91-1.39],0.29273339606408
Chapter II Neoplasms,Melanoma in situ,VSIG10,V-set and immunoglobulin domain-containing protein 10,14369,100,0.76 [0.41-1.43],0.4005239220402036
Chapter II Neoplasms,Melanoma in situ,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,13959,100,0.71 [0.38-1.34],0.2967315154479634
Chapter II Neoplasms,Melanoma in situ,VSIG2,V-set and immunoglobulin domain-containing protein 2,14369,100,0.95 [0.70-1.28],0.724609394315708
Chapter II Neoplasms,Melanoma in situ,VSIG4,V-set and immunoglobulin domain-containing protein 4,16514,111,1.03 [0.68-1.56],0.8863362197976727
Chapter II Neoplasms,Melanoma in situ,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16473,110,1.09 [0.83-1.43],0.5325797067279474
Chapter II Neoplasms,Melanoma in situ,VSNL1,Visinin-like protein 1,14404,100,0.89 [0.52-1.51],0.6617296811909283
Chapter II Neoplasms,Melanoma in situ,VSTM1,V-set and transmembrane domain-containing protein 1,16136,109,0.80 [0.56-1.13],0.2082399403567258
Chapter II Neoplasms,Melanoma in situ,VSTM2B,V-set and transmembrane domain-containing protein 2B,14160,99,0.82 [0.50-1.37],0.4585713131690672
Chapter II Neoplasms,Melanoma in situ,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16217,107,1.13 [0.87-1.48],0.3596884129360381
Chapter II Neoplasms,Melanoma in situ,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16642,112,1.07 [0.84-1.35],0.5894956670699332
Chapter II Neoplasms,Melanoma in situ,VTCN1,V-set domain-containing T-cell activation inhibitor 1,16170,109,0.84 [0.47-1.49],0.5510354674584295
Chapter II Neoplasms,Melanoma in situ,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14132,98,1.12 [0.80-1.55],0.5154586226989877
Chapter II Neoplasms,Melanoma in situ,VWA1,von Willebrand factor A domain-containing protein 1,16639,112,0.73 [0.49-1.10],0.1347652955198512
Chapter II Neoplasms,Melanoma in situ,VWA5A,von Willebrand factor A domain-containing protein 5A,13923,96,1.00 [0.78-1.29],0.9956908354540216
Chapter II Neoplasms,Melanoma in situ,VWC2,Brorin,16312,108,0.93 [0.60-1.44],0.7588017023588189
Chapter II Neoplasms,Melanoma in situ,VWC2L,von Willebrand factor C domain-containing protein 2-like,14396,100,1.23 [0.87-1.72],0.2395646714879679
Chapter II Neoplasms,Melanoma in situ,VWF,von Willebrand factor,16720,111,0.84 [0.67-1.06],0.1393818625909519
Chapter II Neoplasms,Melanoma in situ,WARS,"Tryptophan--tRNA ligase, cytoplasmic",16531,111,1.21 [0.78-1.89],0.3942729708685012
Chapter II Neoplasms,Melanoma in situ,WAS,Wiskott-Aldrich syndrome protein,16225,109,0.80 [0.61-1.06],0.1167588730931098
Chapter II Neoplasms,Melanoma in situ,WASF1,Wiskott-Aldrich syndrome protein family member 1,16217,107,1.03 [0.86-1.24],0.7351062734434821
Chapter II Neoplasms,Melanoma in situ,WASF3,Wiskott-Aldrich syndrome protein family member 3,16136,109,0.91 [0.74-1.11],0.3552894512734637
Chapter II Neoplasms,Melanoma in situ,WASHC3,WASH complex subunit 3,14404,100,1.01 [0.78-1.30],0.9430516118930056
Chapter II Neoplasms,Melanoma in situ,WASL,Neural Wiskott-Aldrich syndrome protein,13991,93,0.88 [0.62-1.26],0.4820628675280395
Chapter II Neoplasms,Melanoma in situ,WDR46,WD repeat-containing protein 46,14369,100,0.95 [0.54-1.67],0.8649250135414541
Chapter II Neoplasms,Melanoma in situ,WFDC1,WAP four-disulfide core domain protein 1,14062,97,0.54 [0.32-0.90],0.0182049348039576
Chapter II Neoplasms,Melanoma in situ,WFDC12,WAP four-disulfide core domain protein 12,16648,112,1.18 [0.91-1.53],0.2040548128668009
Chapter II Neoplasms,Melanoma in situ,WFDC2,WAP four-disulfide core domain protein 2,15706,106,1.29 [0.84-1.97],0.2398168749242258
Chapter II Neoplasms,Melanoma in situ,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16316,107,1.12 [0.74-1.71],0.5857316343063506
Chapter II Neoplasms,Melanoma in situ,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16532,112,0.65 [0.40-1.06],0.0854790023693828
Chapter II Neoplasms,Melanoma in situ,WIF1,Wnt inhibitory factor 1,16669,112,1.06 [0.65-1.72],0.829423186979253
Chapter II Neoplasms,Melanoma in situ,WNT9A,Protein Wnt-9a,16225,109,0.95 [0.52-1.74],0.8670811654329469
Chapter II Neoplasms,Melanoma in situ,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16369,109,1.23 [0.90-1.68],0.1900867290844896
Chapter II Neoplasms,Melanoma in situ,XCL1,Lymphotactin,16669,112,1.06 [0.79-1.42],0.6923018189952089
Chapter II Neoplasms,Melanoma in situ,XG,Glycoprotein Xg,16645,110,0.97 [0.58-1.63],0.9164714639502756
Chapter II Neoplasms,Melanoma in situ,XIAP,E3 ubiquitin-protein ligase XIAP,13991,93,1.05 [0.74-1.50],0.7830086403542337
Chapter II Neoplasms,Melanoma in situ,XPNPEP2,Xaa-Pro aminopeptidase 2,16578,111,0.89 [0.76-1.06],0.1986354776005482
Chapter II Neoplasms,Melanoma in situ,XRCC4,DNA repair protein XRCC4,16136,109,0.88 [0.55-1.42],0.6067013637850067
Chapter II Neoplasms,Melanoma in situ,YAP1,Transcriptional coactivator YAP1,14404,100,0.64 [0.31-1.34],0.2381346895335531
Chapter II Neoplasms,Melanoma in situ,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14355,100,1.01 [0.89-1.16],0.8578956614284514
Chapter II Neoplasms,Melanoma in situ,YES1,Tyrosine-protein kinase Yes,16439,110,1.07 [0.93-1.25],0.3410339302116322
Chapter II Neoplasms,Melanoma in situ,YJU2,Splicing factor YJU2,14369,100,0.51 [0.26-0.97],0.0414308161720427
Chapter II Neoplasms,Melanoma in situ,YOD1,Ubiquitin thioesterase OTU1,13959,100,0.89 [0.66-1.21],0.4644163459107224
Chapter II Neoplasms,Melanoma in situ,YTHDF3,YTH domain-containing family protein 3,16225,109,1.04 [0.85-1.27],0.7113428757347007
Chapter II Neoplasms,Melanoma in situ,YWHAQ,14-3-3 protein theta,14132,98,1.04 [0.80-1.36],0.7602064259179698
Chapter II Neoplasms,Melanoma in situ,YY1,Transcriptional repressor protein YY1,13991,93,0.54 [0.25-1.14],0.1050502358196945
Chapter II Neoplasms,Melanoma in situ,ZBP1,Z-DNA-binding protein 1,13991,93,1.11 [0.69-1.80],0.6665213344548062
Chapter II Neoplasms,Melanoma in situ,ZBTB16,Zinc finger and BTB domain-containing protein 16,16170,109,1.20 [0.95-1.50],0.1263650101509067
Chapter II Neoplasms,Melanoma in situ,ZBTB17,Zinc finger and BTB domain-containing protein 17,16217,107,0.76 [0.47-1.22],0.248731136463304
Chapter II Neoplasms,Melanoma in situ,ZCCHC8,Zinc finger CCHC domain-containing protein 8,13959,100,0.73 [0.49-1.07],0.1071311221428578
Chapter II Neoplasms,Melanoma in situ,ZFYVE19,Abscission/NoCut checkpoint regulator,14355,100,0.98 [0.79-1.21],0.8233395720013249
Chapter II Neoplasms,Melanoma in situ,ZHX2,Zinc fingers and homeoboxes protein 2,14404,100,1.16 [0.70-1.94],0.5571843812410329
Chapter II Neoplasms,Melanoma in situ,ZNF174,Zinc finger protein 174,13991,93,0.85 [0.48-1.53],0.5938904599466978
Chapter II Neoplasms,Melanoma in situ,ZNF75D,Zinc finger protein 75D,14160,99,0.90 [0.64-1.26],0.5433372207888394
Chapter II Neoplasms,Melanoma in situ,ZNF830,Zinc finger protein 830,14369,100,0.80 [0.59-1.08],0.1480095102846924
Chapter II Neoplasms,Melanoma in situ,ZNRD2,Protein ZNRD2,14355,100,0.93 [0.70-1.24],0.6433427226700897
Chapter II Neoplasms,Melanoma in situ,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14369,100,0.83 [0.57-1.20],0.3254972433618073
Chapter II Neoplasms,Melanoma in situ,ZP3,Zona pellucida sperm-binding protein 3,14058,96,1.04 [0.96-1.12],0.3693722072503469
Chapter II Neoplasms,Melanoma in situ,ZP4,Zona pellucida sperm-binding protein 4,13923,96,0.99 [0.54-1.80],0.9658952923551964
Chapter II Neoplasms,Melanoma in situ,ZPR1,Zinc finger protein ZPR1,13980,98,1.10 [0.92-1.31],0.2843058435031868
